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Abstract 
This project focused on evaluating, constructing and integrating standardised clinical data-
collection tools for obesity management in personalised nutrition practice. A mixed methods 
research design including surveys and interviews was used. A collaborative Delphi survey 
method was undertaken with purposefully selected stakeholder participants, who then 
contributed to the construction of four new tools. 
The project comprised of two research questions: 
1. Is it possible and ethical to standardise a personalised approach to nutrition practice? 
2. If so, what tools can be constructed and validated to help individual health history 
data collection, clinical decision making and clinical outcome analysis to enable the 
development of a case-by-case evidence base for personalised nutrition practice in 
the management of obesity? 
Theoretical frameworks that influenced the project include: the functional medicine 
approach, clinical psychoneuroimmunology (cPNI), the interdisciplinary approach of systems 
science, pathophysiological mechanistic reasoning and translational bioinformatics. The 
project focused on personalised nutrition practice, which is primarily centred on nutritional 
therapy but also draws on the practice of dietitians, nutritionists, functional medicine and 
cPNI practitioners. 
The research project had five stages included in the overall design. The first was a literature 
review undertaken to inform the project approach and tool development. The second stage 
involved gathering, categorising and evaluating existing tools. Surveys and interviews 
assessed practitioner experiences of using tools, while interviews with statisticians and 
academics evaluated their experiences and views on tool development to inform the 
development of new tools. The third stage was the Delphi method: a multi-staged, 
collaborative survey resulting in the development of four new clinical tools. The fourth stage 
was a pilot trial which aimed to achieve face validity and measure feasibility and utility for 
each of the four tools. The final stage included a survey and interviews which aimed to 
evaluate ways standardised tools could be successfully embedded into personalised 
nutrition practice. 
The findings showed that there were few ethical concerns with utilising standardised data-
collection tools in nutrition practice, but there were numerous ethical considerations in 
relation to the development of a case-by-case evidence base for personalised nutrition 
practice. It was possible to construct new tools aimed at standardising individual health 
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history data collection and clinical outcome analysis in order to support clinical decision 
making, but it was not possible to validate these tools. 
This project has been the first of its kind: a synthesis of different nutritional practice 
approaches to support the development of robust translational bioinformatics tools using 
pathophysiological reasoning. The results have created new knowledge in terms of 
understanding, defining and developing an evidence-based personalised nutrition practice 
approach. This could lead to major change initiatives and enhance and strengthen the 
nutrition profession.  
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Chapter 1: Introduction 
This DProf research has been a five-year project to evaluate, construct and integrate 
standardised clinical data-collection tools for obesity management in personalised nutrition 
practice. Four new clinical tools have been constructed for individual health data collection 
and clinical outcome analysis, which aim to support clinical decision making. Numerous 
complex considerations which have impacted on the development and use of standardised 
data-collection tools in personalised nutrition practice were analysed. The practical, 
professional, institutional and ethical implications of what it would take to develop a viable 
and successful personalised nutrition practice model were explored. 
This chapter outlines the objectives of this project, its theoretical underpinnings and terms of 
reference. It explores the context of this project within my doctoral studies, my background, 
and how my own ethical and personal philosophies impact upon this project. It also sets out 
the contents of each chapter. 
1.1 Background 
This project stems from the observation that nutrition and health care practitioners do not 
routinely assess data on the outcomes of their patients and even less frequently compare 
the outcomes of similar patients (Kurtin and Stucky, 2009) in any meaningful, robust or 
standardised way. 
As a nutritional therapist, I am keen to understand the efficacy of interventions that my 
clients experience in order to inform my own clinical decision making. Tools that pool health 
data from an obese population and statistically analyse the effect of changing variables (diet, 
supplements, sleep, stress, etc.) on signs, symptoms and biomarkers of health could provide 
a robust assessment of patient outcomes. This may also enable the development of a new, 
case-by-case evidence base, which could provide evidence on the efficacy of interventions 
and further support clinical decision making, thereby increasing positive health outcomes for 
patients. Such an evidence base could then utilise statistical machine learning to make 
probabilistic predictions for the management of obesity. 
There are numerous limitations to using clinical trials to develop an evidence base for 
personalised nutrition practice (Gibson et al., 2010a), not least because research for nutrition 
and health cannot be modelled on a linear cause-and-effect relationship between one 
nutrient and one physiological effect (Fardet & Rock, 2014). Foods and the human body are 
both multivariable complex systems and our response to nutrients appears to be an 
individual and personal attribute (Whelan et al., 2010). Both deductive and inductive 
reasoning are required to make clinical decisions (Kyriacou, 2004). The development of a 
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case-by-case evidence base may better enable us to understand the impact of diet and 
nutrition on complex health issues such as obesity, diabetes mellitus, cancer, hypertension 
and other chronic diseases. 
Dietetics is currently the only nutrition practice available via the NHS. Making nutritional 
therapy accessible through mainstream health care provision (i.e. to offer equality of access) 
is important to me. Nutritional therapy claims to be a client-focused, evidence-based, 
bioscience complementary therapy (Benbow et al., 2017), however nutrition therapy is not 
one of the ‘big five’ complementary therapies provided in mainstream health care. Assessing 
the effectiveness of nutrition interventions and enabling the development of its evidence 
base appears essential if nutritional therapy practice is going to be accepted (or integrated) 
into mainstream health care provisions. 
Standardised data-collection tools would provide opportunities to: 
• make audit tools available to help practitioners understand the efficacy of their own 
practice outcomes (Johnston et al., 2000); 
• support therapists’ clinical decision making and improve their practice outcomes 
(Paul, 1993); 
• create a new, case-by-case, evidence base for nutritional practitioners, using 
Bayesian Networks, Bayesian Statistics and Statistical Machine Learning to make 
probabilistic predictions from empirical data; 
• create roles for practitioner researchers within the profession; and 
• move towards integration or acceptance of nutritional therapy in mainstream clinical 
medicine. 
1.2 Aims and objectives of the project 
This research project aimed to: 
• evaluate the ethics, limitations and opportunities of standardising data-collection 
methods in personalised nutrition practice; 
• construct new clinical tools for health data collection, clinical decision making and 
clinical outcome analysis that standardise case data-collection methods and enable 
assessment of the efficacy of interventions; and 
• enable the development of a new, case-by-case, evidence base for personalised 
nutrition practice in obesity management. 
The overarching objectives were to: 
• use a mixed methods collaborative research approach to achieve these aims; 
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• gather and evaluate existing clinical tools and review implications for standardising 
data-collection methods; 
• collaboratively construct and trial new tools; and 
• evaluate how these tools can be successfully integrated into practice. 
1.3 Research questions 
The main questions that the project is designed to answer are: 
1. Is it possible and ethical to standardise a personalised approach to nutrition practice? 
2. If so, what tools can be constructed and validated to help individual health history 
data collection, clinical decision making and clinical outcome analysis to enable the 
development of a case-by-case evidence base for personalised nutrition practice in 
the management of obesity? 
1.4 Terminology used 
Some of the terminology used in this project is explained in this section to provide further 
clarity. These terms may be specific to my professional background or have various 
meanings. 
Abductive, inductive and deductive reasoning – reasoning uses existing knowledge to 
draw conclusions, make prediction or provide explanations. Abductive reasoning begins with 
an incomplete set of observations and proceeds to the most likely explanation. Inductive 
reasoning makes broad generalisations from specific observations. Deductive reasoning 
starts with a broad generalisation and moves towards specific conclusions.  
Adiposity - a condition of being severely overweight, or obese. 
Biomedical - relating to both biology and medicine. 
Body mass index (BMI) - a person's weight in kilograms (kg) divided by his or her height in 
meters squared. A measure used to work out if an individual’s weight is healthy. 
Client – an individual who has sought nutrition intervention through a professional nutrition 
practitioner. Some nutrition practitioners, such as dietitians, use the word ‘patient’, so this 
appears in some of the surveys and interview discussions. The terms ‘client’ and ‘patient’ 
can be used interchangeably. 
Clinical psychoneuroimmunology (cPNI) – is a systems biology-based clinical reasoning 
method which incorporates nutritional interventions. “Psychoneuroimmunology is the study 
of the interactions among behavioural, neural, endocrine, and immune processes” (Daruna 
and Daruna, 2012, p. 9). 
Dietetics – the science or art of applying the principles of nutrition to the diet. 
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Functional medicine – “is a systems biology-based clinical approach that focuses on 
identifying and addressing the root cause of disease” (IFM, 2018). Functional medicine 
incorporates nutritional interventions. 
Informatics - the science of processing data for storage and mining; information science. 
Mechanism – refers to a physiological or pathophysiological process. A pathophysiological 
mechanism seeks to explain pathology as a deviation from the normal physiological function 
of a process or mechanism of disease. Mechanistic reasoning aims to provide a 
pathophysiological rationale. 
Nutrition practice – clinical practice by nutrition practitioners. Chapter 2 explores various 
approaches to clinical nutrition practice. 
Nutrition practitioner – this means dietitians, nutritionists, nutritional therapists (NTs). The 
use of ‘nutrition practitioner’ aims to be more inclusive and overcome any issues related to 
collaboration. 
Obesity – a complex health disorder in which excess body fat accumulated, where an 
individual has a BMI (Body Mass Index) of 30 and above. 
Ontological - the branch of metaphysics dealing with the nature of being. 
Pathophysiological reasoning – Pathophysiological reasoning is an approach to clinical 
decision making through the understanding of pathophysiological mechanisms of disease.  
Pathophysiology – the application of a convergence of pathology with physiology as a 
means to understand disease processes. 
Personalised – Nardini et al. (2012) recognise various meanings of ‘personalised’: one 
referring to tailoring to an individual’s needs and another referring to interventions based on 
the genetic profile of the individual. The terms ‘personalised’, ‘tailored’ and ‘individualised’ 
can be used interchangeably. Currently, personalised nutrition includes tailored or 
individualised dietary counselling, which may include nutritional interventions based on the 
client’s genetic profile. This report further explores the meaning of ‘personalised’ and 
‘personalised nutrition practice’. 
Precision medicine – “an innovative approach to tailoring disease prevention and treatment 
that takes into account differences in people’s genes, environments, and lifestyles” (US FDA, 
2017). 
Reductionism - the practice of analysing and describing a complex phenomenon in terms of 
its simple or fundamental constituents, especially when this is said to provide a sufficient 
explanation. 
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Stratification – the arrangement or classification of something into different groups. 
Stratified medicine – “is based on identifying subgroups of patients with distinct 
mechanisms of disease, or particular responses to treatments” (Medical Research Council, 
2017). 
Systems biology – is the study of complex biological networks. It frequently utilises 
mathematical and computational modelling to study the complex interactions within 
biological systems (Yan, 2012). 
Tool(s) – this refers to clinical instruments used by nutrition practitioners to record client 
data. It includes both paper tools, like questionnaires, and online applications such as diet 
and exercise trackers. 
Translational – “the process of applying ideas, insights, and discoveries generated through 
basic scientific inquiry to the treatment or prevention of human disease. The philosophy of 
‘bench to bedside’ underpins the concept of translational medicine, i.e. basic research 
(bench) to patient care (bedside).” (Office for Translational Research, 2017). 
1.5 Scope of the project 
The scope of the project is important to define in order to ensure both depth and breadth of 
analysis could be achieved and to clearly delineate boundaries (Baxter, 2008). This project 
focuses on personalised nutrition practice – which mainly centres on nutritional therapy 
practice – but also draws on the knowledge of other nutritional practitioners such as 
dietitians, nutritionists, functional medicine and cPNI practitioners. The purpose of this was 
the development of collaborative relationships and the insight of various approaches to 
nutrition practice. 
The decision to limit the project by focusing on one health condition, obesity, had strengths 
in that it provided a more targeted research scope and a definable target population. Obesity 
has a complex aetiology, it is linked to many other health conditions and comorbidities, so 
this choice allowed for the consideration of numerous complex health issues that individual 
clients present with. However, focusing on obesity did limit the number of practitioners and 
clients that could participate in pilot trialling the tools. Obesity is also a disease focused 
approach, which is problematic in a personalised approach. These limitations are explored 
further throughout the project. Obesity was chosen because it is a key research topic at the 
Centre for Nutrition Education and Lifestyle Management (CNELM), where I work. 
1.6 The researcher and role within project 
I am the Head of Education at CNELM, leading and directing educational courses in 
nutritional science and personalised nutrition. Although this project was funded by my 
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workplace, this research is not about my workplace. The majority of our students become 
student members of the professional body, the British Association for Nutrition and Lifestyle 
Medicine (BANT). Successful completion of our Nutrition Therapy Education Council (NTEC) 
accredited courses enables our graduates to apply to register with the Complementary and 
Natural Healthcare Council (CNHC) which is the UK voluntary regulator for complementary 
health care practitioners, including NTs. Graduates may then also choose to become full 
BANT members. My roles at CNELM include, but are not limited to: 
• leading, directing and developing programmes; 
• senior management and senior academic team member; 
• module leading and teaching; 
• undertaking staff development; 
• clinical supervision; and 
• research supervision. 
I was a student at CNELM and graduated with a BSc (Hons) Nutritional Therapy in 2006; 
then graduated in 2007 with an MSc in Evidence-Based Nutrition in collaboration with 
CNELM and Middlesex University Work-Based Learning. I am a Fellow member of BANT 
and I am registered with the CNHC. I am also a member of: the Nutrition Society, the Royal 
Society of Biology, the Institute of Learning, and the Royal Society of Medicine. As well as 
working part-time at CNELM, I run a private nutritional therapy practice called Health 
Generation. 
I started studying nutrition while I was ill, at the age of 24, with rheumatoid arthritis. After 
trying several approaches to improve my health following my own research, it was changing 
my diet that had the most profound effect. This has driven me to explore and educate others 
about the importance of individual human physiology, pathology and the role of diet on 
health outcomes. 
I value fairness, equality, justice, empowerment and freedom; widening access to 
personalised nutrition support is important to me. I believe nutrition education is key to 
empowering individuals to support their own health needs. Patient empowerment and the 
rejection of medical paternalism are moral themes which drive my support for the 
development of personalised nutrition (Juengst et al., 2012). My own values align well with 
my organisation’s values and vision. CNELM’s strategic vision includes 
steering the integration of personalised nutrition and nutritional therapy to 
becoming a widely accessible and accepted healthcare option within mainstream and 
complementary healthcare. 
(CNELM, 2017) 
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My role within the project has been one of research facilitator, data gatherer and data 
interpreter. As a practitioner-researcher I have brought my knowledge and skills to this 
project, which have influenced it in numerous ways. I have aimed to give the different views 
and approaches of the participants equal weighting, to limit the inevitable subjectivity my 
position in the project brings (Costley, Elliott and Gibbs, 2010 p. 33) and to overcome the 
drawbacks of collaborative research. The extent to which I have succeeded in these 
endeavours is discussed throughout this thesis. 
Throughout the project, I was both an insider- and outsider-researcher. I may be an NT, but I 
am an outsider in dietetics and other nutrition practices. As anticipated, my dual role as 
practitioner-researcher allowed me to collectively bring together insiders and outsiders, 
resulting in a broad range of diverse views. This helped to limit bias, epistemological 
problems and ethical issues (Elliott, 1984 pp. 19–25) but also led to complexity and conflicts 
in findings, which are explored in chapters 4, 5 and 6. 
It has been my responsibility to undertake and complete the research project within the 
timeframe and to the best of my capabilities, to ensure integrity, rigour and ethical 
competence. It has been the role of my academic advisers to oversee the entire project and 
guide its approach to a successful conclusion. They provided substantial support over the 
term of the doctorate which developed my knowledge and thinking in relation to the project 
and more broadly in terms of leadership and academia. 
I am ideally placed, as Head of Education at CNELM and as an NT with professional and 
regulatory body connections, to disseminate the learnings and insights achieved in this 
project and influence change. As well as implementing the recommendations given in 
Chapter 8, I now wish to be instrumental in facilitating the provision of doctoral research 
supervision at CNELM, in collaboration with an awarding institution. This would be a 
significant advancement for both CNELM and the nutritional therapy profession. 
The IPL4013 Review of Learning module at the outset of the DProf allowed for a reflective 
exploration of how my learning to date prepared me to undertake doctoral research. I 
concluded that due to my access to resources, personal traits, work experience, professional 
contacts and knowledge, I was in a unique position to undertake this research. 
1.7 Theoretical underpinnings 
Research is conducted within the context of existing ideas, literature and evidence. There 
are a number of key theoretical underpinnings within the project which shaped the research 
questions and approaches (Petre and Rugg, 2010, p. 7). 
The overarching aim of personalised medicine is to optimise health care and health 
outcomes for individual patients (Ginsburg and Willard, 2009). Zenker et al. (2007) argue 
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that the current evidence-based medicine paradigm limits the potential to provide truly 
individualised validated care because it focuses on validating interventions for statistically 
identifiable subgroups (Zenker et al., 2007). I agree with Miles, Loughlin and Polychronis 
(2008) that personalised medicine that uses a plurality of evidence should form the basis of 
modern health care practice. 
Theoretical frameworks that influence the way the tools are constructed include: the 
functional medicine approach (Nicolle and Woodriff Bierne, 2010, p. 33), clinical 
psychoneuroimmunology (cPNI), the interdisciplinary approach of systems science, 
pathophysiological mechanistic reasoning and translational bioinformatics. 
The extent to which the tools developed as part of this research have embedded the 
concepts of functional medicine, cPNI, medical data and pathophysiological reasoning was 
guided by the expert professionals who participated in the collaborative approach. 
Standardised data-collection tools must be meaningful from different nutritional perspectives 
and practice approaches, but they must also be tools that would be deemed suitable and 
interpretable by any mainstream health care practitioner. This may enable nutritional therapy 
to be accepted as a mainstream primary care option. 
The use of standardised data-collection methods in personalised nutrition practice may allow 
for the development of a new evidence base which can further bridge theory and practice. 
By creating a feedback loop where clinical evidence is used to refine clinical practice we are 
aspiring to be translational – this has shaped the way the tools were constructed. 
Collaboration, data integration and practical applications are important in translational 
research, and this is also reflected in the collaborative mixed methods approach undertaken 
in this research project. 
Zenker et al. (2007) recognise that using computer-based algorithmic support is important 
for clinical decision making, especially when the data is complex. Mapping clinical 
observations to quantitative hypotheses about the outcomes of health conditions as a result 
of interventions can lead to improved insight and the ability to predict responses to 
interventions (Zenker et al., 2007). Zeevi et al. (2015) demonstrated that machine learning 
algorithms can integrate and compare individual, multi-dimensional data and enable 
evidence-based validation of decision-making algorithms. However, it is beyond the scope of 
this project to develop mathematical or computerised data models. This project is focused on 
designing the questionnaires and tools that can enable the development of a case-by-case 
evidence base for personalised nutrition practice in obesity management. These tools could, 
in time, provide the validated and standardised data which would facilitate the compilation of 
the case-by-case evidence base into a data set on which machine learning algorithms could 
be applied. 
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A collaborative Delphi approach was considered to be the optimal method to develop the 
tools, and a pilot trial was utilised to evaluate the successful integration of standardised tools 
into clinical nutrition practice. It is also recognised that the translation of research discoveries 
into clinical practice is slow and difficult, but the proper management of translational 
research could enable the delivery of reliable and clinically relevant outcomes (Kumar, 2007) 
that would transform personalised nutrition practice. 
1.8 Timeframe 
The structure of the project was formed around the following five stages, which all built 
towards meeting the overall aims and objectives: literature reviews, data gathering, 
collaborative tool development, tool pilot trials and evaluation. 
The estimated schedule, including the project write-up, was 45 months – from October 2013 
to June 2017 – part-time, during term time only. The project exceeded the schedule by 15 
months. It took longer than anticipated to analyse the results of the surveys, interviews and 
Delphi rounds. The pilot trial duration was also extended by six months to promote 
engagement, and a portion of this extra time was focused on producing papers for 
publication. This has so far been successful for two papers (Barrow et al., 2017; Miles and 
Barrow, 2018). 
1.9 Aim and structure of report 
This report sets out the aims and objectives of the project as well as a critical and reflective 
evaluation of its methodology and findings. It aims to critically discuss the project activity, 
research findings, conclusion and recommendations. It aims to demonstrate evidence of 
achievement and lays out the original contributions made to the development of 
organisational and professional knowledge. The design of this report follows the Middlesex 
University Project module handbooks, which were provided throughout this project (between 
2013 and 2018). 
This chapter aims to put my project into context and explains why the project area is 
important. 
Chapter 2, the literature review, explains how the literature shaped and influenced the study 
from the outset. It has eight sections (and a chapter summary): the first explores approaches 
to undertaking the literature reviews; the second explores the meaning of personalised 
nutrition; the third considers evidence-based personalised nutrition practice approaches; the 
fourth explores pathophysiological mechanisms in obesity and pathophysiological reasoning; 
the fifth reviews a range of existing tools for nutrition practice in the management of obesity; 
the sixth discusses a range of considerations for developing a standardised personalised 
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approach; the seventh evaluates ethical considerations for standardising a personalised 
approach; and the eighth explores a vision for transforming personalised nutrition practice. 
Chapter 3 critically describes and justifies the choice of the research approach and data-
collection methods for the research project. The overall reliability of the methodological 
approach is evaluated, and ethical issues are explored. My role as a work-based researcher 
is also evaluated. 
Chapter 4 describes and analyses the project activity and discusses the activity undertaken 
to develop and complete the research methods, surveys and interviews used throughout the 
research. 
Chapter 5 presents the analysis of research findings for each of the research methods 
undertaken to construct new clinical tools. 
Chapter 6 presents the analysis of research findings for each of the research methods 
undertaken to explore how standardised data-collection methods could be integrated into 
nutrition practice. 
Chapter 7 is a reflective account which also explores my own developmental transformation 
throughout the project. 
Chapter 8 summarises the project, draws conclusions and recommendations from the 
findings and evaluates project outputs and their impact on the profession. The dissemination 
of research findings is discussed, and recommendations for further research are made. 
Each chapter starts with an introduction to describe the scope of the chapter and ends with a 
chapter summary to emphasise the key material and provide a conclusion. 
1.10 Chapter summary 
Personalised nutrition practice and the importance of gathering robust clinical data to 
support intervention decision making and the development of a case-by-case evidence base 
are the main themes of the project. My own background, position and personal philosophy 
(and how these have impacted the project) have been explored at a preliminary level and will 
be discussed further in my role as an insider-researcher (section 3.6). 
The expectations of the content for each chapter have been laid out. This project has given 
me a number of opportunities to exemplify “leading transformation in personalised nutrition 
practice” which is the proposed title for the DProf award. It is anticipated that the project 
meets the overall aims and objectives of the doctoral programme.  
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Chapter 2: Literature Review 
This chapter describes the literature reviews undertaken and explores how the literature 
shaped and influenced study from the outset of this project. 
2.1 Approach to literature review 
An extensive search of Summon, Google Scholar, PubMed, Cochrane Library, Science 
Direct, Allied and Complementary Medicine, DH-DATA, Embase and Medline using the 
following keyword searches of the title (or title and abstract) was conducted at the start of the 
project, during October and November 2013. Throughout the project more research and 
literature was utilised to inform the project. This chapter draws on the literature review 
results and wider literature identified throughout the project. 
Search description forms tracked the primary review results, as well as: review title, search 
dates, search terms, inclusion and exclusion criteria and the numbers of papers identified 
and included for each search (see appendices 1 and 2). Across each search, foreign 
language papers, papers published prior to 2003 and unrelated topic papers were excluded. 
Each paper included for full review was then listed in the literature and tool search results 
tracker spreadsheet (see appendix 3). Papers unavailable online were located via the British 
Library and the Royal Society of Medicine. Included papers were analysed in detail to 
assess: type of study, methodology, why the study was done and their relevance to the 
search topic. 
The overarching aim was to critically review a range of relevant ideas and theories and 
explore how personalised nutrition practice could be transformed with the development of a 
new case-by-case evidence base. The objectives for the literature review include: 
• defining ‘personalised nutrition’; 
• comparing personalised nutrition practice, evidence-based practice and various 
approaches to nutritional practice; 
• identifying a range of pathophysiological mechanisms associated with obesity and 
exploring the value of mechanistic reasoning; 
• exploring a range of existing tools relevant for obesity management and nutrition 
practice and considered their utility in supporting a personalised nutrition practice 
approach; 
• exploring a range of considerations for robust standardised data collection tool 
development and their integration with nutrition practice; 
• evaluating ethical considerations of standardising a personalised approach to 
nutrition practice; and 
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• exploring a vision for transforming personalised nutrition practice. 
The review allowed for a thorough search of the literature in a manner that aimed to limit 
researcher bias; the approach was informed by Aveyard’s (2010) book, Doing a Literature 
Review in Health and Social Care. Literature reviews are always limited by the search terms 
used and rely on previously published research. 
The results from various searches are presented under the following headings: personalised 
nutrition, evidence-based personalised nutrition practice, pathophysiological mechanisms in 
obesity and mechanistic reasoning, existing tools for nutrition practice in the management of 
obesity, developing a standardised personalised approach and ethical consideration for 
standardising a personalised approach. The results from all searches are then considered to 
explore a vision for transforming personalised nutrition practice. 
2.2 Personalised nutrition 
 
Figure 1 Numbers of papers reviewed for personalised nutrition keyword searches at the outset of the 
project 
This review aims to define ‘personalised nutrition’. The majority of the 245 papers located by 
searching for the term ‘personalised nutrition’ were review papers of how advances in 
nutrigenomics and nutrigenetics could contribute to the development of personalised 
nutrition. Primary research assessing the effects of nutrigenomics and nutrigenetics in 
obesity and other health conditions is developing rapidly and gaining importance in nutrition 
practice (Joffe and Houghton, 2016). However, the majority of these papers were excluded 
because they were not relevant to obesity or the research aims. 
Of the 15 papers that were included, all except 2 were reviews papers on what personalised 
nutrition means, how it can be developed or delivered, or were analysing related ethical or 
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legal issues. The two primary studies included a focus group analysis on the factors that 
influence consumer uptake of personalised nutrition (Stewart-Knox et al., 2013) and a 
qualitative study which interviewed General Practitioners (GPs) to gather their views on 
barriers and opportunities in relation to gene-based nutrition advice (Bouwman, Molder and 
Hiddink, 2008). 
The term ‘personalised nutrition’ is derived from ‘personalised medicine’ (PM). Historically, 
the main driver for PM has been pharmacogenetics, and the term ‘personalised medicine’ 
does not appear in the heading of articles until after the use of the term ‘pharmacogenomics’ 
(Fierz, 2004). Genomic medicine is defined as: 
The use of information from genomes and their derivatives to guide medical decision 
making. 
(Ginsburg and Willard, 2009) 
Explanations for understanding the numerous meanings of PM have been presented in 
review papers by various authors (Ken Redekop and Mladsi, 2013; Pokorska-Bocci et al., 
2014; Siest, 2014; Patel et al., 2015), but there is no single definition. PM may or may not 
include genetics and/or genomics and is also known as ‘precision medicine’. It may be 
tailored to the individual (also known as person-centred care) and it may also be termed 
stratified medicine, which targets particular groups of patients. Nardini et al. (2012) 
recognise the various meanings of ‘personalised’ with one being personalised to the 
individual’s preferences and needs and another which refers to interventions based on the 
genetic profile of the individual. Day et al. (2017) consider ‘personalised’ to mean biological 
stratification and person-centred care. Day et al. (2017) claim that this dual approach, 
incorporating biological and social aspects of health care, is supported by the UK 
government through funding, as well as within the National Health Service (NHS). 
The term ‘personalised nutrition’ also has various meanings, with one being the use of 
dietary counselling to tailor interventions to the individual’s preferences and needs, and 
another which refers to the adjustment of diet based on results of genetic tests. Görman 
(2006) argues personalised nutrition should also include the notion that people should take 
greater responsibility for their own health. Personalised nutrition practice has not yet been 
defined in the literature. 
Of the review studies included, the most notable (Joost et al., 2007; Görman et al., 2013) 
occurred as a result of the Food4Me project (Gibney and Walsh, 2015), an EU-funded 
programme which undertook a number of multi-centre studies to explore personalised diet, 
genotype and phenotype analysis and how this data could be used to deliver personalised 
online dietary advice. It highlighted that diet-gene-health relationships are poorly understood, 
and that tools for genetic assessment and evidence to support therapeutic interventions are 
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still some time off being meaningfully integrated into nutrition practice (Görman et al., 2013). 
This approach is an emerging, novel concept with numerous challenges (Gibney & Walsh, 
2015). 
More recently, and also of significant interest, has been a flagship study undertaken by Zeevi 
et al. (2015) to predict outcomes of personalised dietary interventions aimed at managing 
post-prandial glycaemic response (PPGR). Management of blood glucose plays a key role in 
obesity and diabetes management, yet predicting PPGR has been difficult, with the 
numerous confounding factors involved. Some 800 individuals (aged 18–70) underwent 
comprehensive profiling, including food frequency assessment, lifestyle and medical 
background questionnaires, anthropometric measures and biomarkers including microbiota 
profiling and metagenomic sequencing. They also had their PPGR monitored for seven 
days, along with their daily activities, including real-time physical activity, sleep and food 
intake measures (using smartphone applications). Zeevi et al. (2015) used machine learning 
algorithms to integrate and compare the individual, multi-dimensional data. Their results 
demonstrated interpersonal variability in PPGR to the same foods, and researchers were 
able to accurately predict individual PPGRs to standardised meals – a finding that was then 
validated in a separate, independent, 100-person cohort study. They then used a blinded 
randomised controlled dietary intervention study to determine if personally tailored dietary 
interventions, based on the same comprehensive profiling of participants, could improve 
PPGRs, which, it was found, they could. Further work needs to be done to understand how 
individuals will respond to standardised meals over longer periods of time, but this was the 
first example of how a systems biology approach can be used to predict the efficacy of 
personalised nutrition interventions. 
As described in Chapter 1, systems biology is the study of complex biological networks. It is 
an interdisciplinary field including genomics, genetics, physiology, pathology, toxicology and 
clinical medicine that uses computational modelling to study the interactions among 
biological elements for a thorough understanding of disease (Yan, 2012). The broader 
considerations of health and disease should also include social, cultural, lifestyle, 
environmental and economic factors. Nutritional science is a systems science (BANT, 
2017a). Systems biology is based on the understanding that the whole is greater than the 
sum of its parts (Noble, 2012). Personalised nutrition needs to extend beyond the idea of 
dietary interventions based on genetic tests, because this view is limited. 
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2.3 Evidence-based personalised nutrition practice 
 
Figure 2 Numbers of papers reviewed for evidence-based personalised nutrition practice keyword 
searches at the outset of the project 
This review aims to explore and compare ‘personalised nutrition practice’, ‘evidence-based 
practice’ and other approaches to nutritional practice. The search for ‘evidence based 
medicine’ and ‘personalised’ initially yielded 364 papers. The majority were excluded 
because they discussed specific health conditions or interventions which were unrelated to 
this project. The papers included were mostly review papers which reflected upon, or directly 
relate to, current thinking on evidence-based medicine (EBM) and PM. Other searches were 
undertaken to consider various approaches to personalised nutrition practice, including 
“functional medicine” and “psychoneuroimmunology”. 
Of the 19 included studies from the search ‘evidence based medicine’ and ‘personalised’, at 
least 5 (Fierz, 2004; Kumar, 2007; Miles, Loughlin and Polychronis, 2008; Bereczki, 2012; 
Greenfield and Kaplan, 2012; Nardini, Annoni and Schiavone, 2012) explore various 
critiques of EBM from its epistemological positioning to its empirical issues. The complex 
range of debates is beyond the scope of this review and have already been comprehensively 
described by Howick’s (2011) The Philosophy of Evidence Based Medicine. Succinctly, one 
of the main issues is that it is limited to narrow and frequently unrepresentative groups of 
patients and the extrapolation of this data to individual patients with individual health 
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considerations is fraught with limitations (Greenfield & Kaplan, 2012; Fierz, 2004). Sackett 
describes EBM as: 
a process of lifelong, self-directed learning aimed at providing the best possible 
patient case using the clinically important available information about diagnosis, 
prognosis, therapy and other clinical and health care issues. 
(Sackett, 1997, p. 2) 
The overarching aim of PM is to optimise health care and health outcomes for individual 
patients (Ginsburg and Willard, 2009) but it could be argued that this is also an aim of EBM. 
The evolution of EBM and PM are described in review papers by de Leon (2012) and 
Bereczki (2012). 
EBM and PM are two different approaches to making and reasoning evidence, with EBM 
grounded on statistical notions and epidemiological data gathered through systematic meta-
analysis and randomised controlled trials (RCTs), whereas PM considers mechanistic 
explanations of molecular interactions, pathways and biomarkers (Nardini et al., 2012). RCT 
do enable causal inference, but they limit the potential to provide truly individualised 
validated care because their focus is on validating interventions for statistically identifiable 
subgroups (Zenker, Rubin and Clermont, 2007). Mechanistic explanations are considered to 
be a low form of evidence in EBM because mechanistic explanations and predictions come 
apart in various ways (Andersen, 2012). Mechanisms can explain what is happening in a 
system while failing to provide the basis for prediction when interventions are applied 
(Andersen, 2012). Bereczki (2012) argues that PM is an upgrade of EBM, because PM 
allows for the use of a range of sources of evidence, including patient preferences and 
individual expertise. However, it is not one approach or the other; it is plurality of evidence 
that should form the basis of modern day health care practice (Miles et al., 2008). 
Of the 7 included studies from the search ‘functional medicine’ and ‘personalised’, 3 
reviewed the application of functional medicine in clinical practice (Macdonald Baker et al., 
2005; Galland, 2006; DeBusk, Sierpina and Kreitzer, 2011). 2 papers reviewed the role of 
functional medicine in relation to dietetics practice (Ford et al., 2011; Swift, 2012) while 
Jones et al. (2009) reviewed functional medicine educational programmes and Ehrlich, 
Callender and Gaster (2013) undertook a survey (n=136) to characterise clinicians utilising 
integrative medicine in practice. 
The functional medicine model was first proposed by Jeff Bland in the 1980s and is being led 
by the Institute of Functional Medicine. According to Ford et al. (2011), integrative and 
functional medicine represents a broader paradigm of medicine that is person-centred, 
appreciates that individuals have unique metabolic patterns, and encompasses actions such 
as decision making. Functional medicine focuses on the mechanisms of biochemical 
pathways that are the basis for metabolic networks and how these are affected by a person’s 
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unique diet, genetic and environmental interactions throughout their lifespan (Ford et al., 
2011). Functional medicine is a clinical approach to personalised health care which has 
been evolving over the past four decades. 
According to Jones et al., functional medicine is a: 
Systems-orientated personalized medicine that recognises common underlying 
mechanisms of complex and chronic diseases and cuts across multiple organ 
systems to shape a patient’s trajectory toward health and disease 
(Jones et al. 2009) 
Of the 452 papers that resulted from searching “clinical psychoneuroimmunology”, the 
majority were excluded for either focusing on specific health conditions or not related to the 
project. The two results that were included came from two chapters of the same book (Yan, 
2008) which explored the complex interactions between psychological and behavioural 
factors and functions of the nervous, immune and endocrine systems that help to explain the 
mechanisms underlying health and disease. 
As defined in Chapter 1, cPNI studies the interactions among behavioural, neural and 
endocrine, and immune processes. Physical and psychological conditions have a close 
impact on each other, with attitudes and social support impacting on disease and life 
expectancy, while physical illness is known to alter mood, behaviour and memory and 
behavioural and lifestyle interventions can improve clinical outcomes (Yan, 2012). Yan 
(2012) considers that PNI research will also help to identify the correlations between 
genotype and phenotype, which is a key issue in PM. A systems biology approach, based on 
the understanding that the whole is greater than the sum of its parts, has been used to 
develop understanding of this complex biopsychosocial paradigm. 
Historically, reductionism (which takes the view that the whole can be explained by its 
component parts), has been the dominant scientific paradigm (Porta, 2008, p. 154) and the 
dominant epistemological approach in nutrition research (Hoffmann, 2003). Epidemiological 
research and associative studies are used to inform public health policy development and 
clinical guidelines. Clinical guidelines support an evidence-based differential diagnosis 
practice approach. 
Differential diagnosis is a hypothetico-deductive clinical reasoning method where the 
patient’s signs and symptoms are used to identify the possible causes and diagnoses of 
illness and disease and derive a testable hypothesis. In the model and process for dietetics 
practice, once a diagnosis has been established clinical guidelines are utilised to form a 
person-centred intervention approach (BDA, 2015). Such health care models have been 
criticised for being disease-based, i.e. that they treat diseases rather than patients (Wade 
and Halligan, 2004). However, great strides have been made to develop and support 
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person-centred care in mainstream health care systems. According to Health Education 
England (HEE): 
Person centred care is about focusing care on the needs of individual. Ensuring that 
people’s preferences, needs and values guide clinical decisions, and providing care 
that is respectful of and responsive to them. 
(HEE, 2018) 
BANT (2017) state: 
Practitioners consider each individual to be unique and recommend personalised 
nutrition and lifestyle programmes rather than a ‘one size fits all’ approach. 
(BANT, 2017a) 
However, BANT (2017) do not define what ‘personalised nutrition’ means. In this context, it 
appears this term may mean ‘person-centred care’. 
Nutrition practitioners use clinical guidelines, such as the National Institute for Health and 
Care Excellence (NICE) guidelines on obesity prevention and management, to make 
evidence-based recommendations (AfN, 2012; BANT, 2018; BDA, 2015). These guidelines 
use an EBM hierarchical approach to determine the value of research, where systematic 
reviews of clinical trials used to determine the efficacy of particular interventions in a given 
population are the gold standard (NICE, 2014b). However, clinical decision making based on 
this approach has inadvertently excluded pathophysiological reasoning because EBM is 
lacking mechanistic explanations (Sharma and Minhas, 2012). 
Extrapolation of clinical guidelines to evidence-based personalised nutrition practice is 
problematic for numerous reasons (Maher et al., 2016); the complexity of individuals, foods 
and individual intake, as well as confounding factors and the limitations of measuring these 
variables robustly (Willett, 1987; Michels, 2003; Gibson et al., 2010b; Jacobs, 2012). 
Disease expression is an individual and complex mix of genetics, environmental, lifestyle 
and dietary interactions. Individual responses to food intake are also a complex mix of 
genetics, environment, lifestyle and dietary interactions (Zeevi et al., 2015). The current 
evidence base provides answers on the average efficacy of an intervention, yet the clinical 
question is whether an intervention works for a specific individual (Lutz et al., 2006). 
Comparative effectiveness research (CER) is becoming a more prominent approach to 
health care data analysis and identifying what works (Khoury et al., 2013). Rather than the 
traditional efficacy and effectiveness research, CER aims to answer three questions: what 
works, for whom, and in whose hands? Answering these will require fundamental changes to 
clinical research, including the direct comparison of interventions (Greenfield and Kaplan, 
2012). The World Health Organization (WHO) explores the meaning of ‘health’ and the 
various approaches to comparing individual health measures (Chatterji et al., 2002). A 
number of patient-centred outcomes will need to be compared to assess the impact of 
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interventions on symptoms, quality of life and biomarker changes (Greenfield & Kaplan, 
2012). Although CER has its critics, it does provide an approach to determine the best 
interventions for individuals (Garber and Tunis, 2009; Kaats, Preuss and Leckie, 2009). 
Some nutrition practitioners may also use research that extends beyond the guidelines to 
inform their clinical decision making and develop a personalised practice approach (NTEC, 
2015). This method has also received numerous criticisms. Distilling a vast amount of 
published disease-oriented and population-based evidence in order to make appropriate 
evidence-based recommendations for individuals is problematic, time-consuming (Spicker, 
2013), and gives sufficient room to make inaccurate inference from the data (Pizzorno, 
2012). 
Some nutrition practitioners use a functional medicine clinical approach (Benbow et al., 
2017). As described in Chapter 1, functional medicine is a systems-based clinical reasoning 
method. It takes the patient’s signs and symptoms, as well as health history, family history, 
environment and lifestyle factors across a lifespan, and categorises them under 
physiological mechanism and functional headings on a matrix map (see Figure 3). Individual 
signs, symptoms, health, diet, lifestyle factors and family history are also viewed as 
antecedents, triggers and mediators of disease and illness. 
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Figure 3 Functional Medicine Matrix to enable practitioners to organise and prioritise individual health 
issues under functional headings (IFM, 2018) 
By organising the patient’s signs, symptoms, health history etc. into this map, the practitioner 
may be able to identify potential physiological and functional imbalances. When there are 
numerous signs, symptoms and health issues clustered under the headings, this indicates 
pathophysiology. Practitioners can then prioritise interventions whose mechanisms of action 
ameliorate mechanisms of pathophysiology function. Although this approach is open to 
interpretation and inaccurate inference by practitioners, it provides a more personalised 
practice approach than the use of clinical guidelines alone because it supports 
pathophysiological reasoning and targets interventions at an individual’s physiological 
function. 
A literature search did not identify research to validate the matrix tools or the headings 
incorporated within the matrix.   It is unlikely that these headings cover the breadth of 
pathophysiological mechanism in disease. It appears from Figure 4 that although the 
functional medicine matrix headings span a range of factors at various systems levels, it 
does not differentiate them. In my opinion, the functional medicine model does not yet 
provide a solution that fully incorporates the social, psychological and behavioural 
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dimensions of disease. The call for a biopsychosocial model in health care goes back as far 
as the late 1970s (Engel, 1977). 
 
Figure 4 Biopsychosocial factors at various systems levels and potential personalised interventions in 
multiple dimensions (Yan, 2012) 
Functional medicine has received numerous critiques (Gorski, 2014; Sampson, 2014) which 
are primarily about validity and semantics. These criticisms appear to misunderstand the 
limitations of EBM and of applying pharmacological research methods, which frequently 
considers one input (drug intervention) and one output (biomarker) in complex multivariate 
systems such as food, nutrients and the human body, which work through multiple complex 
mechanisms (Wade and Halligan, 2004; Ahn et al., 2006; Fardet and Rock, 2015). Although 
the functional medicine model does have limitations and does encompass a number of 
unproven methods, including the use of matrix tools, it does also appear to be trying to 
overcome the limitations of the disease-led and reductionist biomedical model. The 
functional medicine clinical process does extend beyond the matrix: by taking the client 
history and retelling the client story re-conceptualised within the functional matrix framework, 
it aims to promote client understanding, autonomy and reciprocity. However, without robust 
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validation of its tools and clinical approach, the functional medicine model will continue to be 
criticised. 
Nutrition practitioners may utilise laboratory assessments to determine biochemical and 
physiological function as well as markers of disease (BDA, 2015; NTEC, 2015). More 
recently, this has included nutrigenetic assessment (NTEC, 2015). Through the use of test 
results practitioners are able to consider pathophysiological mechanisms contributing to 
disease. This approach also enables practitioners to target interventions more directly to 
individual biochemical and physiological needs, rather than interventions based on 
assumptions or guidelines. However, many laboratory assessments are diagnostic rather 
than functionally oriented, and laboratory assessments are not available to assess the wide 
range of pathophysiological mechanistic functions. Testing, when available, does allow 
practitioners to measure the outcomes of interventions by retesting, which enables 
practitioners to corroborate the efficacy of nutrition intervention against the outcomes of test 
results. 
Traditionally, prospective cohort studies are used to determine the efficacy of nutrition 
interventions (Maher et al., 2016), but this is also considered problematic because the 
research relies on participants retrospectively remembering their dietary intake at the time of 
diagnosis (Michels, 2003). Real-time assessment of diet intake – through the use of 
repetitious and ongoing analysis undertaken over long time periods – is helping to overcome 
this issue (Michels, 2003; Gibson et al., 2010b). 
The competence and ability of the practitioner has a significant influence over the 
effectiveness of interventions (Greenfield & Kaplan, 2012). One of the limitations is the 
variation in practitioners’ ability to think abductively. Kumar (2007) recognises that one of the 
major difficulties for practitioners is selecting the best available evidence. The data used to 
inform clinical decision making is often conflicting and too large to manage or organise by 
using tools such as the functional matrix. This creates variability in patient outcomes 
between the best abductive reasoner and the worst abductive reasoner. When clinical 
decisions are widely divergent, clinical outcomes suffer and patient safety may be 
compromised (Rozich et al., 2004). Historically, clinical guidelines are used to overcome this 
issue. 
There are other influences over the effectiveness of interventions which result from the 
therapeutic relationship. A recent phenomenological analysis (Miles and Barrow, 2018), 
undertaken at CNELM and supervised by myself, demonstrated that the relationship with the 
nutrition practitioner influences client engagement, confidence and compliance with a 
personalised weight loss programme. There are measures for the therapeutic alliance in 
psychology practice (Ardito and Rabellino, 2011) but there appear to be none for nutrition 
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practice. Studies investigating this in nutrition practice have utilised interviews and focus 
groups (Endevelt and Gesser-Edelsburg, 2014). Several studies highlight the value of 
incorporating coaching strategies alongside nutrition interventions to support behavioural 
change (Cecil, 2016; Martin et al., 2018; Miles and Barrow, 2018). Lifestyle coaching, 
teaching cooking skills, developing self-awareness, practising mindfulness and stress 
management skills, should all form part of personalised nutrition practice. Behaviour 
modification is a cornerstone of effective health care (DeBusk et al., 2011) and is already 
embedded in models of nutrition practice (AfN, 2018; BDA, 2015; NTEC, 2015). 
To summarise; some nutrition practitioners utilise health assessment and laboratory tests to 
determine a nutritional diagnosis and use disease-oriented clinical guidelines to make 
person-centred intervention recommendations (BDA, 2015). However, this does not 
constitute a personalised practice approach. Practitioners may also use health assessment 
and laboratory tests to assess physiological function (AfN, 2012; BDA, 2015; NTEC, 2015), 
which allows for interventions to be directly targeted to individual biochemical and 
physiological needs. DeBusk et al. (2011) state that molecular nutrition will become the 
foundation for modern nutrition and that interventions should target underlying 
pathophysiological mechanisms. The current EBM paradigm makes pathophysiological 
reasoning without appropriate test results problematic because of the need to extrapolate 
disease-oriented evidence or utilise low-forms of evidence (mechanistic, observational, case 
studies etc.) to support intervention decisions for individuals. Further mechanistic evidence is 
required to support an evidence-based personalised nutrition practice approach. The 
definition, model and process for personalised nutrition practice has not yet been defined, 
even though ‘personalised nutrition’ is a term used in nutrition practice (BANT, 2017a) and 
more widely in the industry. 
Functional medicine offers a non-validated clinical model to undertaking a mechanistic 
pathophysiological reasoning approach to support clinical decision making. EBM and PM are 
also methods for supporting clinical decision making (Bereczki, 2012) and they provide types 
of evidence, with EBM including epidemiological data and PM including a range of evidence 
(mechanistic, observational etc.). Psychoneuroimmunology (PNI) contributes 
biopsychosocial insight, while systems biology offers an approach to analysing and 
comparing complex health data, including the outcomes of interventions which can translate 
findings to inform clinical practice, hence making it translational (Feldman, 2015). Systems 
biology is also better able to consider the complexity than the use of a reductionist approach 
(Ahn et al., 2006; Mazzocchi, 2008a; Fardet and Rock, 2015). 
If the strengths of each nutrition practice approach were combined into an evidence-based 
personalised practice approach, it would include the use of robust, standardised and 
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validated tools that gather patients’ signs and symptoms, health history, family history, 
environment, lifestyle, social, diet, behavioural and other factors which have an impact on 
physiological processes across a lifespan. The personalised nutrition practice approach 
would then analyse them along with anthropometric measures, laboratory assessments and 
biomarkers for pathophysiological mechanisms. Such tools would pool data into a case-by-
case evidence base which utilises computational network modelling to predict the efficacy of 
personalised nutrition interventions. Prediction on the efficacy of interventions should be 
validated using blinded randomised controlled stratified intervention studies as demonstrated 
by Zeevi et al (2015). This model would provide practitioners with data that supports 
evidence-based pathophysiological reasoning. It would enable clinicians to prioritise 
interventions based on mechanisms of their actions which ameliorate whichever 
mechanisms of pathophysiology are a priority for that individual. Interventions may then be 
applied in a person-centred practice approach. This would transform evidence-based 
personalised nutrition practice into P4 medicine: a personalised, preventative, predictive and 
participatory approach (Hood and Flores, 2012). 
2.4 Pathophysiological mechanisms in obesity and mechanistic 
reasoning 
 
Figure 5 Numbers of papers reviewed for pathophysiological mechanisms in obesity keyword 
searches at the outset of the project 
This review aims to identify a range of pathophysiological mechanisms associated with 
obesity, as well as explore the value of a mechanistic reasoning approach. The 49 results 
from the initial searches gave insight into the clinical assessment of obesity which informed 
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the tool development, however many studies were excluded because their main focus was 
not obesity. Numerous additional resources were also utilised to develop a comprehensive 
list of pathophysiological mechanisms, other diseases, health conditions and red flags for 
tool development (Bowling, 1995a, 2005; Kypreos, 2009; Stern and Kazaks, 2009; Nahikian-
Nelms, 2011; NTEC, 2015). 
From the 51 results, the following 16 pathophysiological mechanisms in obesity were 
identified: 
• infection origin (Pasarica and Dhurandhar, 2007; Bassols et al., 2010); 
• inflammation (Eder et al., 2009; Clària et al., 2010; Fain, 2010; Fuentes, Roszer and 
Ricote, 2010; Tai and Ding, 2010; Yang et al., 2010; Kim et al., 2011; Benozzi, 
Perruzza and Pennacchiotti, 2012; Choi et al., 2013; Deepali, Thomas and Gupte, 
2013); 
• leptin resistance and satiety issues (Erez et al., 2011; Orbetzova et al., 2012); 
• insulin resistance (Lu et al., 2008; Fuentes, Roszer and Ricote, 2010; Yang et al., 
2010; Kurpad and Aeberli, 2012); 
• dyslipidaemia (Eder et al., 2009; Piva et al., 2011); 
• oxidative stress (Piva et al., 2011; Choi et al., 2013); 
• epigenetics (Campión, Milagro and Martínez, 2009, 2010; Tammen, Friso and Choi, 
2013); 
• addiction (Kenny and Shaw, 2011); 
• genetics (Guo et al., 2006; Bouchard and Drake, 2010; Herrera, Keildson and 
Lindgren, 2011); 
• hormonal imbalance (Kushner, 2012); 
• pregnancy (Kushner, 2012); 
• medication related mechanisms (Aronne, 2002; Benozzi, Perruzza and 
Pennacchiotti, 2012); 
• psychological factors (Grossniklaus et al., 2012; Karasu, 2012; Kushner, 2012); and 
• diet intake and energy expenditure. 
Some of these results have been corroborated by a recent review study (Longo, Heymsfield 
and Wadden, 2017) which highlighted lifestyle and environment, genetics and energy 
balance dysregulation as the main pathophysiological mechanisms of obesity. However, this 
study failed to consider a range of other mechanisms, which led to criticism (Calkins, 2017). 
Mechanisms of pathophysiology for adiposity increase risk of comorbidities, such as 
diabetes and sleep apnoea, were presented in a mechanistic map in this review (see Figure 
6), but the pathophysiological mechanisms contributing to obesity were not mapped out. 
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Figure 6 Some pathways through which excess adiposity leads to major risk factors and common 
chronic diseases (Longo et al., 2017) 
Of the 15 included studies which resulted from searching “obesity related diseases”, 44 other 
diseases and health conditions were identified (Browning, 2003a; Martin, Qasim and Reilly, 
2008; Michael I. Goran, 2008; O’Rourke, 2009; Horng and Hotamisligil, 2011; Mathew, 
Okada and Sharma, 2011; Na et al., 2011; Yamauchi and Kadowaki, 2013a; Doron et al., 
2013; Ohashi et al., 2014; Reilly T Enos, Velázquez and Murphy, 2014; Nigro et al., 2014; 
Choi and Snider, 2015; Sarah C Ferrante et al., 2015; Zhang et al., 2015; Lee et al., 2015) 
see Table 7 for the full list of conditions. Health conditions included were associated with 
obesity and/or correlated to the mechanisms of pathophysiology. 
As demonstrated in Figure 6, mechanisms correlate certain inputs with certain outputs. 
Mechanistic reasoning is the ability to make inferences from the knowledge to inform clinical 
decision making (Nardini et al., 2012). One critique of using this type of reasoning approach 
are that the system may be too complex to allow inference about causal interactions (Nardini 
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et al., 2012). This issue may be overcome with stratification, where patients are grouped 
according to genetic variants, characteristics or biomarkers to determine the optimal 
interventions for each subgroup (Smith, 2012; Siest, 2014; Day et al., 2017). 
Overall, the results highlight the complexity of pathophysiological mechanisms in obesity. All 
pathophysiological mechanisms interrelate, and some pathophysiological mechanisms – 
such as inflammation – are at the root of numerous diseases (Hunter, 2012; Ruiz-Núñez et 
al., 2013). Understanding of pathophysiological mechanisms is often incomplete, which may 
be a result of the EBM model prioritising other forms of research. Mechanisms behave 
paradoxically, with more than one mechanism likely to be involved in producing a patient-
relevant effect (Howick, Glasziou and Aronson, 2013). Mechanisms are primarily theoretical, 
and this is supported by examples of treatments based on mechanism of action which have 
subsequently been found to be ineffective (Nardini et al., 2012). Mechanisms like 
dyslipidaemia and oxidative stress do not have defined signs and symptoms; they require 
laboratory assessment to determine their influence in individual disease progression, and not 
all pathophysiological mechanisms have laboratory assessments. 
Broader social, environmental, cultural and ethical influences also contribute to obesity. 
Stress, trauma and adverse events have been shown to be positively associated with adult 
obesity (Palmisano, Innamorati and Vanderlinden, 2016). Social roles and relationships in 
relation to obesity have primarily focused on marital status, but ethnicity, cultural factors and 
social relationships also play a role (Crawford et al., 2010 p106). However, the mechanisms 
by which sociocultural factors are associated with obesity are not well understood (Crawford 
et al., 2010 p107). 
It is beyond the scope of this review to define the complexity of how pathophysiological 
mechanisms contribute to obesity. However, this research is ongoing at CNELM, where 
research students are asked to undertake a systematic literature review of how 
pathophysiological mechanisms contribute to obesity. The students then synthesise 
research from a range of studies, describe and draw pathophysiological mechanistic maps 
from findings, and consider how this mechanistic insight can be used to inform evidence-
based clinical practice. 
In terms of nutrition practice, the British Dietetics Association (BDA 2015) process gathers 
information utilising an ‘ABCDEF’ structure: Anthropometry, Biochemistry, Clinical/physical, 
Dietary, Environmental/behavioural/social, patient Focused. A literature search did not 
identify research to validate this approach and it does not appear to enable 
pathophysiological reasoning, unless functional (rather than diagnostic) laboratory test 
results are available. The functional medicine approach to organising health data under 
functional headings was explained in section 2.3. The BANT (2017b) consultation process 
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uses: environmental inputs, gut function, defence and repair, mind and spirit, hormone and 
neurotransmitter regulation, detoxification, energy production/oxidative stress and structural 
integrity as a model for supporting mechanistic reasoning. These headings are likely derived 
from the IFM matrix and warrant similar criticism in relation to semantics, lack of validity, 
limitations in relation to the breadth of pathophysiological mechanisms, and potential for 
inaccurate inference.   These approaches do demonstrate that some nutrition practitioners 
already collate and interpret information that supports mechanistic pathophysiological 
reasoning.  However, these approaches are not yet fully developed and are limited in terms 
of providing an evidence based personalised nutrition practice approach because 
pathophysiological mechanisms are complex and mechanistic evidence has numerous 
limitations. 
As discussed, systems biology and advances in computational technology provide a 
framework and method for generating comprehensive and complex network maps of the 
physiological and functional interactions which provide mechanistic insight (Mast, Ratushny 
and Aitchison, 2014). Zenker et al. (2007) recognise that using mathematical models of 
physiological mechanisms to map clinical observations to quantitative hypotheses about 
physiological conditions would lead to improved insight and the ability to predict responses 
to interventions. In essence, this is what Zeevi et al. (2015) achieved – the ability to predict 
outcomes of personalised dietary interventions aimed at managing PPGR as a result of 
monitoring multiple physiological mechanisms which affect PPGR. 
Further developing an evidential framework for mechanistic knowledge, as well as processes 
and tools which support mechanistic reasoning, are required to support and develop an 
evidence-based personalised nutrition practice approach. Developing pathophysiological 
mechanistic understanding may also provide opportunities for developing new biomarkers 
and laboratory assessments. Goodman and Gerson (2013) state that, for it to be maximally 
useful, an evidential framework must be applicable to all forms of disease intervention. This 
requires a high degree of generality for the overall structure, but with elements that are 
customisable for particular intervention contexts. 
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2.5 Existing tools for nutrition practice in the management of 
obesity 
 
Figure 7 Online searches to identify existing tools for nutrition practice in the management of obesity 
resulting from keyword searches at the outset of the project 
A total of 3,334 papers were considered for inclusion and a total of 46 papers met the final 
inclusion criteria; those excluded were papers on tools deemed not suitable for clinical 
nutrition practice. The results were used to inform tool development as part of this project, 
which is described in Chapter 3 and Chapter 5. This review explores a range of existing tools 
relevant for obesity management and nutrition practice and considers their utility in 
supporting a personalised nutrition practice approach. 
The final 46 papers selected included a broad range of primary and secondary research 
papers including: review papers which highlighting the strengths and limitations of tools and 
questionnaires used in obesity assessment and management (Han, Sattar and Lean, 2006; 
Koopman and Mainous, 2008; Sharma and Padwal, 2010; Beechy et al., 2012; Levy and 
Heyes, 2012; Lindsay et al., 2013), validity research papers which highlighted numerous 
validity approaches undertaken in tool development (Ziegler et al., 2005; Müller, Bosy-
Westphal and Krawczak, 2010; Therrien et al., 2011; Garaulet et al., 2012), comparative 
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studies (Heinz, Ko and Peterson, 2005; Al-Sultan, 2008; Wee, Davis and Hamel, 2008; 
Jenkins et al., 2013), cross-sectional studies (Ledikwe et al., 2003; Finelli et al., 2006; 
Otsuka et al., 2006; Ozier et al., 2008; Chambers and Swanson, 2010; Martínez-González et 
al., 2012; Hajian-Tilaki and Heidari, 2013) and pilot and trial studies of new tools (Chambers 
and Swanson, 2006; Greenwood et al., 2008). 
Assessments identified included: 
• body mass index (BMI), body composition and anthropometric measures (Heinz, Ko 
and Peterson, 2005; Han, Sattar and Lean, 2006; Al-Sultan, 2008; Müller, Bosy-
Westphal and Krawczak, 2010; Beechy et al., 2012; Martínez-González et al., 2012; 
Hajian-Tilaki and Heidari, 2013); 
• obesity risk factors such as diet and exercise or activity behaviour (Chambers and 
Swanson, 2006; Finelli et al., 2006; Koopman and Mainous, 2008; Beechy et al., 
2012; Lindsay et al., 2013); 
• quality of life assessments (Ziegler et al., 2005; Wee, Davis and Hamel, 2008; 
Therrien et al., 2011; Beechy et al., 2012); 
• weight history assessment (Jenkins et al., 2013); 
• hunger assessments (Beechy et al., 2012); 
• sleep assessments (Beechy et al., 2012); 
• nutritional risks (Ledikwe et al., 2003); 
• psychological influences, eating behaviours and perceived body image assessment 
(Greenwood et al., 2008; Ozier et al., 2008; Beechy et al., 2012; Garaulet et al., 
2012; Ogawa et al., 2012); 
• measure yourself medical outcomes profile (MYMOP) (Paterson, 1996); and 
• patient and clinical decision aids (Levy and Heyes, 2012; Campos, 2013; Reilly-
Harrington et al., 2013). 
Other tools were identified throughout the project, including: 
• the Stanford health assessment (Pecoraro et al., 1979; Bruce and Fries, 2003); 
• quality of life assessments (WHO, 1998; Mannucci et al., 1999; Chambers and 
Swanson, 2010; Forhan, Vrkljan and MacDermid, 2010); 
• medical outcomes surveys (SF12 and SF36) (Wee, Davis and Hamel, 2008); 
• the Rotterdam checklist (Hardy et al., 1999); 
• the Edmonton symptom assessment system (Richardson and Jones, 2009); 
• stress assessment (Cohen et al., 1983; Cohen, Janicki-Deverts and Miller, 2007; 
Torres and Nowson, 2007; Ozier et al., 2008; Greenfield and Marks, 2009; Stewart-
Knox et al., 2012); 
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• food addiction scale (Gearhardt, Corbin and Brownell, 2009; Pursey et al., 2014); 
• motivation assessment tools (Ceccarini et al., 2015); and 
• signs and symptoms analysis (Weatherby, 2004). 
Sharma and Padwal (2010) provide an aetiological framework for the assessment and 
management of obesity. They provide a wide range of considerations regarding the 
underlying pathology and complexity of obesity development including: genetics, gender, 
age, medication, sociocultural factors, physiological and psychological factors. They do not 
provide a health data-collection or assessment tool. The framework is theoretical and lacks a 
practical application. This paper was key for identifying categories/headings of 
pathophysiological mechanisms in the development of the project’s tools. Sharma and 
Padwal (2010) state that although their framework is time-consuming in terms of 
systematically assessing the range of individual factors contributing to obesity, it would save 
costs by allowing practitioners to target interventions to an individual’s underlying pathology 
rather than a one-size-fits-all approach. 
Beechy et al. (2012) undertook a review to provide researchers and clinicians with a guide to 
the current and emerging measurement tools for assessing body composition. They review a 
number of tools used to measure: psychological health, diet intake, physical exercise and 
hunger assessment in obese populations. This helped to identify a range of existing tools 
within these categories to support new tool development. Some of the tools reviewed in this 
study are utilised in clinical trials of anti-obesity drugs or after bariatric surgery. Use of these 
same tools in nutrition practice may allow for a comparison of nutrition intervention to drugs 
and surgery. 
Chambers & Swanson (2006) undertook a pilot trial of a 100 item self-reported health 
assessment questionnaire for multiple risk factors for obesity and related health behaviour 
findings, as well as measures such as BMI. The risk factor categories include food, physical 
activity and inactivity as well as other considerations such as sleep, smoking and current 
weight control behaviours. The tool mainly assesses individual eating and exercise 
behaviour, which allows interventions to be targeted to support individual behaviour change. 
Sleep, childhood, maturity and family background were included as risk factors. A risk factor 
is an attribute which increases the chance of disease, whereas pathophysiology seeks to 
explain the mechanisms by which a disease develops and progresses. Gathering data on 
risk factors may not support clinical decision making, for example: knowing there is a family 
background of obesity suggests a genetic and/or environmental influence (van der Sande et 
al., 2001) but does not provide further insight. A clearer understanding of individual 
pathophysiological mechanisms involved in genetic and environmental influences would 
better support a personalised nutrition practice approach. 
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NICE (2014a) guidelines on obesity assessment, identification and management state that 
the following should be assessed in a nutrition consultation: presenting symptoms, 
underlying causes, comorbidities, risk factors, lifestyle, psychosocial distress, psychological 
problems, medication, family history, the individual’s view of their weight and possible 
reasons for weight gain, eating and physical activity patterns, unhelpful beliefs about eating, 
physical activity or weight gain, ethnic and socioeconomic background information and 
environmental factors, what has been successful for the individual before, their readiness to 
change and confidence in making change. This highlights the need to consider a wide range 
of influences on obesity development beyond pathophysiological mechanisms and beyond 
the range of biopsychosocial factors at various systems levels as presented in Figure 4 
(Yan, 2012a). The NICE guidelines (NICE, 2014a) do not recommend which tools should be 
used for assessing presenting symptoms, underlying causes, comorbidities, risk factors etc. 
It is assumed that the choice of assessment method is left to the practitioner or health 
practice for which the practitioner works. Interestingly, the NICE guidelines (NICE, 2014a) do 
make recommendations for laboratory tests which determine pathophysiological function in 
obesity, such as fasting insulin, lipid profile, endocrine function and liver function 
assessments. 
Ginsburg and Willard (2009) reviewed important steps in the advancement of personalised 
health care. They consider that health risk assessment (HRA) and risk stratification should 
form the basis for prediction and personalisation. They consider HRA in combination with 
family health history (FHH) assessment is critical because it enables the complex 
combination of genetics, environment and lifestyle factors to be assessed. Historically FHH 
has not been well utilised because it lacks validity, standard collection methods, usable 
access and clinical guidance for interpretation and decision making (Ginsburg & Willard, 
2009). 
Tickle-Degnen and Bedell (2003) argue that all relevant, valid and available research 
evidence should be used when making clinical decisions. They critically appraise the 
standard levels of the evidence model and justify a flexible multifaceted approach to 
assessing, selecting and using research evidence for clinical decision making. Making all 
data available for consideration in clinical decision making is arguably appropriate, but it 
would not necessarily support timely decision making without a value-based hierarchy. 
Ginsburg and Willard (2009) also reviewed clinical decision support and the issue of the 
average 17-year duration for clinical research to feed into clinical practice. They state the 
most effective method for providing clinical decision support is to deliver the right, person-
specific data at the most appropriate time (Ginsburg & Willard, 2009). To achieve this would 
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require an online data system, whereas the data-collection tools identified in numerous 
searches undertaken by this project are mainly paper-based. 
In terms of assessing clinical outcomes, Donabedian (2005) undertook a review to evaluate 
current methods for assessing the outcomes and quality of medical care, included clinical 
records and direct observation. Donabedian (2005) acknowledges outcomes are difficult to 
measure. According to MacDermid, Grewal and MacIntyre (2009), the first step in choosing 
an outcome measure is deciding which attributes are of clinical interest. Tools currently in 
use in nutrition practice include the MYMOP, which is a patient generated and individualised 
outcomes assessment. In a comparative study between the MYMOP, the medical outcomes 
short form-36 (SF36) health survey, and a 5-point health change score, the MYMOP showed 
itself to be more sensitive to change than the SF36 (Paterson, 1996). 
Greenhalgh et al. (2005) state that patient-reported outcome and health-related quality of life 
measures have little influence on clinical decision making and that studies which measure 
these outcomes are concerned only with whether the intervention works, rather than how the 
intervention works. Greenhalgh et al. (2005) agrees that insight into pathophysiological 
mechanisms would support clinical decision making as long as the tools used are patient-
centred and the data is fed back to clinicians in a way that it can be integrated with clinical 
information throughout the clinical decision-making process. However, measuring outcomes 
of interventions is still required to determine the efficacy of interventions. 
A task force report on ‘Developing Obesity Outcomes and Learning Standards’ (Wolf, 2002) 
discuss measures such as sleep, quality of life, physical exercise etc. in terms of assessing 
health outcomes in obesity management. They concur that long-term assessment of these 
outcomes may allow for more robust data analysis. 
Vo et al. (2016) undertook a systematic review of tools used to assess the outcomes of 
pharmacist interventions. They managed to identify 82 distinct tools with various structures 
from implicit mono-dimensional to explicit multi-dimensional tools. They concluded that most 
tools focused on clinical assessment, not a range of potential impacts to outcomes as a 
result of intervention. Vo et al. (2016) state that a comprehensive tool for assessing clinical 
outcomes is not yet available. They suggest that this was most likely to be due to the fact 
that tools are constructed on theoretical models and therefore may not be suitable for clinical 
practice. 
The BDA (2015) model and process for nutrition practice provides a list of indicators that can 
measure outcomes when compared against reference standards or baseline measures. 
These include anthropometry, biochemical laboratory markers, clinical and physical 
measures such as nutritional status, complications and symptoms, dietary assessment as 
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well as environmental, behavioural, social and psychological assessment. However, other 
than anthropometry and laboratory assessment, no specific tools are recommended or 
named by the BDA to undertake these assessments. 
The Institute of Functional Medicine (2018) do provide a range of tools including medical 
symptoms questionnaire, female and male health assessment questionnaires, sleep 
questionnaire, activity questionnaire and numerous other non-validated clinical data 
assessment tools. None of the tools seem to enable robust evaluation of the outcomes of 
interventions. Interestingly, the health assessment tools gather individual medical history and 
symptoms data under headings of pathophysiological function including gastrointestinal, 
respiratory, urinary/genital, musculoskeletal, skin, cardiovascular, neurological/emotional 
and inflammatory/immune categories. Further research is required to establish whether 
these tools or this form of data collection is valid and supports clinical decision making. 
Overall, this review has highlighted that although numerous validated tools for obesity 
assessment exist, the majority assess only some risks, measures or mechanisms, such as 
hunger assessment, sleep assessment, quality of life, wellbeing assessment, behaviour and 
addiction (Beechy et al., 2012). Most of these tools were also developed from a research 
perspective rather than a clinical perspective and may therefore not support clinical decision 
making in personalised nutrition practice. There appears to be no comprehensive validated 
tool to assess the range of complex mechanisms involved in obesity. Sources which did 
explore the complexity of obesity (Beechy et al., 2012; NICE, 2014a) did not provide tools for 
use in clinical assessment. Other than anthropometric measurements and laboratory 
assessments, there currently appear to be no standardised data-collection methods to 
gather individual health data or assess the outcomes of interventions utilised in nutrition 
practice (AfN, 2018; BDA, 2015; NTEC, 2015). 
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2.6 Developing a standardised personalised approach 
 
Figure 8 Numbers of papers reviewed for standardising, developing and validating personalised 
nutrition practice tools resulting from keyword searches at the outset of the project 
This review explores a range of considerations for robust standardised data collection tool 
development and their integration with nutrition practice. Of the 2,249 papers initially yielded 
by this search, the majority were excluded because they discussed specific health 
conditions, or standardising clinical practice recommendations, which are unrelated to this 
project. This project does not seek to standardise personalised nutrition practice through the 
development of clinical guidelines. It seeks to standardise health data-collection methods 
from individual clients, so the data can be statistically analysed and compared. 
Of the 9 included studies which utilised “standardised” or “standardi*” in the search term, 
there were 5 reviews which looked at: the experiences of implementing standardised 
electronic health records for Canadian Nurses (Hannah et al., 2009), the clinical utility of 
adopting PM (van Rooij, Wilson and Marsh, 2012), the value of consensus-driven evidence-
based clinical pathways (Kurtin and Stucky, 2009), key factors for the development of new 
tools for personalised health data collection (Harvey et al., 2012) and the data management 
and informatics challenges of integrating and managing individual’s health data (Sheldon 
and Ou, 2013). 
Of the primary studies included, Wood and Nelson (2013) analysed nursing records to 
identify how nurses had historically pursued best practice, and their study identified that their 
36 
approach to improvement was the standardisation of procedures. Bruner et al. (2012) 
analysed nursing literature to explore the concept of clinical significance in relation to 
evidence-based practice and whether clinical significance can exist when it depends on 
individual patient values. Collins et al. (2013) undertook a survey (n=6) to evaluate a 
collaborative project which developed standardised electronic health records. Thiru et al. 
(2003) also utilised a collaborative technique to develop a framework, which aimed to 
facilitate standardised data collection in primary care.  
The major reasons to standardise aspects of the personalised approach are to ensure parity 
of care among practitioners, that the data collected has the most value from a research point 
of view, and that data outcomes are able to inform intervention decisions (van Rooij et al., 
2012). Computerised data interpretation and decision support tools could make better data 
available to practitioners and enable evidence-based validation of decision-making 
algorithms (Zenker, Rubin and Clermont, 2007). The benefits of standardised clinical 
outcomes data are also described by Hannah et al. (2009) as allowing practitioners to see 
the impact of their efforts on patient health outcomes, the benefit to patients as their health 
outcomes improve, improved continuity and quality of patient care and giving decision and 
policy makers more detailed analysis data on effective or ineffective practice. 
Sheldon and Ou (2013) discuss the importance of high quality standardised clinical data 
which also assesses intervention outcomes and analyses information from multiple, 
disparate and heterogeneous sources such as lifestyle, laboratory data, family history, 
clinical trials and clinical practice for the purposes of clinical research. However, clinical data 
is often inconsistent and incomplete, so any data integration approach must have a method 
for separating non-validated or poor-quality data from accurate, complete and standardised 
data (Sheldon & Ou, 2013). This highlights the need for continued quality control and re-
analysis of the validity of data gathered by new tools (Sheldon & Ou, 2013). 
Of the 8 studies included from searching “tool validity”, “validating questionnaires” and 
“developing clinical tools”; 4 undertook validation of health tools: Brisbois-Clarkson et al. 
(2009) validated a micronutrient preference checklist for a specific population. Sharma et al. 
(2004) assessed the feasibility of a global mental health assessment computerised tool 
which standardises the assessment of mental health problems; Cohn et al. (2010) developed 
and evaluated the usability and analytic validity of an online FHH assessment tool and 
Spook et al. (2013) examined the feasibility, utility and economic validity of a smartphone 
application (app) which monitors dietary intake and physical activity levels. What is 
interesting about this last paper is that it discusses the advantages and disadvantages of 
collecting real-time data using smartphone and online apps. They reported that it is possible 
to gather complex health behaviours and related influences through smartphone 
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applications, but that varying compliance comes from the monitoring burden of having to 
constantly input diet and physical activity, which affects the validity of the data. 
Two included studies reviewed commonly used statistical methods to evaluate reliability and 
validity (Jones, 2004; White and van den Broek, 2004). Although types of validity are 
frequently described in the literature, there is no gold standard method for achieving validity. 
Elia and Stratton (2011) critically examined the relevance of validity – specifically concurrent 
and predictive validity for nutrition screening tools. They provide a framework for screening 
clinical tools by assessing the tool’s aims, its application in various care settings and its 
processes for user implementation, as well as the evidence-based principles supporting the 
tool, such as reliability, validity and ease of use. Elia and Stratton (2011) acknowledge that 
there are many dimensions to validity, including content, construct, concurrent, criterion and 
predictive. Jones (2004) makes it clear that a number of studies are required to assess 
validity (as it is an ongoing process) and that numerous validation assessments will have to 
be undertaken on an ongoing basis. 
Thiru et al. (2003) recognise that ruthless standardisation may undermine itself and alienate 
practitioners. In order to successfully engage practitioners in the use of standardised 
information and to achieve successful transformation of clinical practice processes, then 
managing cultural change and highlighting the benefits to practitioners and patients is key 
(Hannah et al., 2009). A collaborative approach may facilitate these changes culturally. 
Bruner et al. (2012) also recognises that standardising definitions, measures and 
methodology is essential to being able to disseminate best practices. 
Bouwman et al. (2008) interviewed 15 GPs, as “gatekeepers of health” who are instrumental 
to influencing the views and perspectives of patients on personalised nutrition. These 
interviews were qualitatively analysed to assess their perceived barriers and opportunities 
towards involvement in gene-based nutrition advice. Only one participant had heard of 
nutrigenomics and nutrigenetics and he perceived it relevant to nutritionists and not general 
practice (Bouwman et al., 2008). Education and involvement of individual consumers and a 
range of health care practitioners, including GPs, is therefore essential to the success of 
future personalised nutrition approaches. 
Harvey et al. (2012) states that the development of new tools for personalised health data 
collection need to not only be standardised but also integrated and harmonised in order to 
collate and analyse data in an integrated and dynamic rather than linear way. 
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Figure 9 Standardisation, integration and harmonisation in personalised medicine taken from Harvey 
et al. (2012) 
Hannah et al. (2009) recognise that in order to successfully engage practitioners in the use 
of standardised health records and to achieve successful transformation of clinical practice 
processes, managing cultural change and highlighting the benefits to the patient and their 
own practice are key. Bruner et al. (2012) states that standardising definitions, measures 
and methodology is essential to being able to disseminate examples of best practice. 
Clinicians should use standardised, validated and reliable measures to evaluate their 
intervention decisions and clinical outcomes (MacDermid, Grewal and MacIntyre, 2009) but 
the ethical considerations of standardising data-collection methods in personalised nutrition 
practice should be fully considered first. 
In 2009 the National Council for Osteopathic Research (NCOR) introduced standardised 
data-collection tools for osteopaths in private practice. Standard data collection is also 
undertaken by members of the Chartered Society of Physiotherapy (2018). Aside from 
anonymised data-collection methods, there were no other ethical issues raised in their 
documentation. Interestingly, the primary motivations for NCOR (2009) standardising data-
collection methods were to enable profiling of professional activities including clinical 
practice, protecting the scope of practice in the face of increasing regulation, increasing 
professional visibility and raising standards of care by focusing on management practices 
and outcomes. 
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2.7 Ethical considerations for standardising a personalised 
approach 
 
Figure 10 Numbers of papers reviewed on ethical considerations for standardising a personalised 
approach resulting from keyword searches at the outset of the project 
This review aims to evaluate ethical considerations for standardising a personalised 
approach to nutrition practice. The search for “ethics” and “personalised” initially yielded 170 
papers. The majority were excluded because they were unrelated to this project. Of the 12 
included studies, 11 were review studies and 1 was a Nuffield Health consultation paper 
(Finnegan, 2009) which provided a comprehensive exploration of bioethical concerns 
relating to PM. Of the included review studies, two resulted from the Food4me study 
(Görman, 2007; Görman et al., 2013) and explored the meanings of ethics, health and 
welfare as well as the role food plays in social, cultural and personal identity. 
Three of the included studies, (Burke and Psaty, 2007; Lévesque et al., 2008; Chalmers et 
al., 2013) review ethics in particular relation to genetic and genomic data. Chalmers et al. 
(2013) points out the blurred lines between research and providing clinical care as well as 
issues including privacy and sharing/pooling of data, consent, management of ‘incidental’ 
findings, comprehensiveness of reporting and the question of return of results to participants, 
in relation to genetic and genomic test results and clinical practice. Also included was a 
study by Shoenbill et al., (2013) which addresses the ethical, logistical and technological 
issues involved in incorporating genetic data into electronic health records. 
Pooling electronic health data into a case-by-case evidence base does present numerous 
issues with informed consent, privacy, transparency, confidentiality and data protection. 
Kaplan (2016) explores the issues around electronic health data, data sharing, big data and 
data mining, including the balance between individual privacy versus the aggregate public 
interest. Solutions for overcoming key issues for data mining electronic health records are 
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discussed in the literature (Blumenthal and Tavenner, 2010; Jensen, Jensen and Brunak, 
2012; Ross, Wei and Ohno-Machado, 2014). Some of these issues of privacy, confidentiality 
and data protection can be overcome by collating anonymised data (Graham, 2012). Clarity 
and transparency related to ownership, trustworthy intermediaries and legal protection are 
also essential (Harvey et al., 2012). 
Gefenas et al. (2011) explored ethics issues of personalised, predictive and preventative 
health care as well as the human rights influences which shifted modern medical ethics from 
paternalism to autonomy-based therapeutic relationships. One potential concern is whether 
the increase in data to support clinical decision making through the increased power of 
prediction will lead to an increase in the authority of the practitioner, lead to a more directive 
type of relationship and the promotion of paternalism (Gefenas et al., 2011). There is a shift 
in the doctor-patient relationship from paternalism to the ethical principle of patient’s 
autonomy, where patients are customers and want to take an active role in decisions that 
affect them (Sacristán, 2013). Sacristán (2013) claims that person-centred health medicine 
is broader than PM as it includes the psychological, social and cultural considerations of the 
patient. I disagree; comprehensive personalised approaches should also include 
psychological, social and cultural considerations. Miles (2013) also discusses ethical issues 
related to person-centred health care and the need to consider individual psychological, 
emotional and social necessities. Individual values and views regarding their health 
outcomes are also important. 
A personalised approach could strengthen patient autonomy and enhance individual health 
control (Nordström et al., 2013). However, owing to the complexity of nutritional information, 
one has to consider autonomy in relation to responsibility and trust. Nordström et al. (2013) 
reviewed autonomy and responsibility and the dilemma of individualisation, such as: the 
conflicts between individual and societal expectations, the rights and capabilities of 
individuals, the complexity of individual health behaviour and trust in companies or 
institutions offering personalised nutrition services. Acceptance of personalised nutrition 
therefore depends on consumers’ understanding of its benefits and implications (de Roos, 
2013). 
As a result of the development of PM, Meslin and Cho (2010) consider the need for updating 
the social contract between science and society, while Corrigan (2014) explores the concept 
and potential inequality, of the consumer of personalised health care. Enabling the 
development of a new case-by-case evidence base for personalised nutrition practice may 
be ethically essential to support therapists’ ability to think abductively and improve their 
practice outcomes (Paul, 1993; Koehn, 1994). 
41 
The stigma of obesity is another ethical issue (Puhl and Brownell, 2001; Puhl and Heuer, 
2009, 2010; Karasu, 2012), including stigma from nutrition practitioners (Berryman et al., 
2006). Discrimination is another issue raised by Chalmers et al. (2013). If this new 
personalised nutrition practice service is paid for by the consumer and is effective at 
supporting clinical decision making and therefore improving health outcomes, are those who 
cannot afford to pay for this approach being discriminated against? Currently nutritional 
therapy is privately funded by individual clients. Dietetics is offered through the NHS, but 
only if a patient has been ‘diagnosed’ with ill-health. If nutritional therapy is going to be 
accepted into mainstream health care, then who pays for it? Finnegan (2009) points out that 
the NHS is founded on the principle that everyone has the right to treatment, but nutrition 
intervention is not currently considered a primary treatment approach – rather a preventative 
one. If the development of a case-by-case evidence base allows for further identification of 
the validity and efficacy of personalised intervention approaches for obesity or other disease, 
and even allows for cost comparisons against conventional treatment approaches, then it 
may become appropriate to integrate nutritional therapy into mainstream health care 
provision. 
Ethical issues raised by Penders et al. (2007) consider whether nutritional categorisation 
/stratification will be a stigma and if certain categories receive more interest from food 
manufacturing companies or for health insurance purposes. Fierz (2004) agrees there is an 
ethical risk that there will be subgroups of minority patients who will be negatively impacted 
by such an approach. Görman (2007) has explored the meanings of ethics, health and 
welfare as well as the role food plays in social, cultural and personal identity. He raises 
interesting ethical questions when using food as an instrument for health and asks: 
Will personalised nutrition contribute to a good life? Or will personalised nutrition 
instead limit the role of some or all food to medicine and transform eating into lifelong 
medication? 
(Görman, 2007) 
This is also explored by Lévesque et al. (2008) who states that “healthism” may raise 
excessively narrowly-focused expectations about one’s health, as well as alter social norms 
about food choices and lead to the medicalisation of food. 
According to the Nuffield Council on Bioethics consultation paper (Finnegan, 2009) there is 
strong commercial pressure to move to a more consumer-driven approach to health care 
because, rather than offering preventative health care, this is expected to expand health 
care markets. Finnegan (2009) quotes the former chair of GlaxoSmithKline who proposed 
that by 2020 there will be more emphasis on “pre-symptomatic” treatment because including 
healthy people would provide a bigger ‘treatment’ market; gaining commercial control of 
diagnostic and prognostic tests are key to achieving this as they would allow for target 
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marketing of health care products and services. Pre-symptomatic treatment is different to a 
preventative approach to health care. Finnegan (2009) goes on to say that a health care 
approach based on marketing products can lead to the neglect of public health. This does 
not explore where the line is between marketing health care products and making patients 
aware of a range of health care choices. The government has policies for reducing obesity 
and improving health by “helping people make healthier choices” (Department of Health 
2015) which are clearly aimed at prevention rather than cure. 
Chalmers et al. (2013) raise valid considerations for obtaining broad consent, stating that as 
much information as possible should be provided and that a strong framework of governance 
needs to be put in place to help safeguard participants’/clients’ rights as well as facilitate 
responsible research. They state that gauging public opinion is essential to the process of 
determining best-practice regulation and governance. 
2.8 Transforming personalised nutrition practice 
By pulling together the results from all the searches so far, and from wider sources, it is 
possible to consider the development of personalised nutrition practice and what it would 
take to achieve the vision of developing a case-by-case evidence base to support it. It is not 
the aim of this project to develop a new case-by-case evidence base. Indeed, it does not 
even seek to build new electronic health record tools for personalised nutrition practice, 
rather, this project has constructed new clinical tools which aim to standardise clinical data-
collection methods and support pathophysiological mechanistic reasoning. Standardised 
tools provide the opportunity to develop a case-by-case database that can both improve the 
quality of care and provide opportunities to undertake translational nutrition research (Khoury 
et al., 2009). Ginsburg and Willard (2009) agree that a personalised approach requires the 
development of robust, standardised and validated tools, including health risk assessment, 
family health history and clinical decision support tools. It also requires integration of these 
tools into health systems and workflows. The development of any health information system 
relies on the quality of the data gathered. The completeness, reliability and validity of each 
tool are key. 
As discussed, it is the plurality of evidence and statistical machine learning that could enable 
us to produce complex statistical models from computer readable clinical descriptions and 
provide weighted predictions, therefore supporting clinical decision making (Carmeli et al., 
2012). Systems biology offers an approach to analysing and comparing complex health data, 
including the outcomes of interventions, which would make this data and research 
translational. cPNI may help to rebuild the philosophical connection between holism and 
reductionism in biomedical health care by establishing integrative models of systemic 
interactions (Yan, 2012a). 
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Person-centred nutrition is currently being provided by nutrition practitioners by tailoring 
nutrition and lifestyle interventions to individual consumers under the name ‘personalised’. 
Bio-molecular laboratory data is required to inform personalised nutrition intervention 
decisions, but that data itself does not constitute ‘personalised nutrition practice’. Although 
genetic testing supports personalised nutrition practice, this data is currently not available for 
most individuals and the evidence to support clinical decision making based on research is 
not yet sufficient (Görman et al., 2013). However, new personalised nutrition tools should be 
able to integrate laboratory data, genetic and genomic data. Molecular nutrition will become 
the foundation for future nutrition practice (DeBusk et al., 2011). 
Biological data is interrelated, and therefore the data gathered is not independent, but an 
interrelated and connected source (Sheldon & Ou, 2013). The issues with using a 
mechanistic approach are that mechanisms are primarily theoretical, and systems may be 
too complex to allow inference about causal interactions (Nardini et al., 2012). Data can 
therefore be gathered using a mechanistic approach to support pathophysiological 
reasoning, but intervention decisions should be based on robust evidence, including clinical 
trials and CER. 
CER should give a rigorous evaluation of the impact of different therapeutic options and the 
extent to which, under normal conditions, they perform as intended (Khoury et al., 2009). 
Randomised control trials (RCTs) are more focused on efficacy – the extent to which an 
intervention produces a beneficial result under ideal conditions, whereas CER use a diverse 
population (typically recruited from a variety of settings) and measures a broad range of 
clinical and health outcomes (Khoury et al., 2009). However, both RCTs and CER give no 
indication of how an intervention caused the outcome, which mechanistic reasoning does 
consider. Howick (2011, p. 154) explores the need for combining mechanistic reasoning with 
CER to bolster the strength of evidence and support clinical decision making. Rather than 
choosing the treatment with the best scientific evidence, we should use the scientific 
evidence to create the best treatment interventions for the individual. This constitutes an 
evidence-based personalised practice approach. 
The use of individual biochemistry, physiology, pathology, psychological, social and cultural 
data to create a unique intervention also constitutes personalised nutrition practice. Tracking 
individual responses to changes in diet, nutrient intake and lifestyle (also known as the N = 1 
approach) can utilise statistical machine learning to produce a comprehensive analysis of 
the impact of dietary interventions. Collating this data for numerous individuals amounts to 
developing a case-by-case evidence base which may be utilised to make probable 
predictions on the outcomes of dietary interventions. This could better support evidence-
based clinical decision making than the current paradigm. 
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However, the number of combinations and permutations of genetic, lifestyle, diet and 
environmental factors is so large it may never be possible to evaluate all such interactions 
(Penders et al., 2007). A solution to this is stratification. An analogy is drawn by Penders et 
al. (2007) who compare stratification with clothing sizes; although a size 10, 12 or 14 is not 
tailored, they are more suitable for individuals. When health and intervention data from 
numerous individuals is stratified into subgroups, where it can be analysed and compared, it 
may then it may be possible to validate interventions for various subgroups, make 
probabilistic predictions on the outcome of interventions and deliver a P4 approach. 
Fierz (2004) reviewed the challenges for delivering personalised health care and agrees that 
the ultimate goal of personal information is robust, comparable, lifelong, comprehensive 
electronic health records. The development of tools that connect personal information, 
including health data and test results, to the existing evidence base would better inform 
clinical decision making. With the advent of the ‘internet of things’, personal health and 
activity data can now be collated from a range of sources, including wearable devices 
(Chiauzzi, Rodarte and DasMahapatra, 2015) which are considered to be a cornerstone in 
the field of health informatics (Zheng et al., 2014). The use of information technology to 
improve dietary assessment and tackle obesity has been assessed by Carter et al. (2012). 
Online applications would allow real-time, long-term data collection by enabling individuals to 
track their own diet intake and other measures such as weight, food intake, exercise, health 
outcomes etc. 
Shklovsky-Kordi et al. (2005) developed a computerised case history data-collection system 
for monitoring patient information and clinical outcomes. They aimed for their system to be 
patient-centred and permit easy communication between different specialities of health 
practitioners, which meant it had to accommodate different documents including test results, 
text files and images. Villa et al. (2012) have also designed a tool that translates ontological 
patient data into visual concept and mind maps to help users understand the clinical case 
and visualise the interrelated medical concepts. This gives an insight into how clinical data 
from new tools may be analysed and interpreted to support clinical decision making. As well 
as visual representations, compressing clinical data to highlight the most important or urgent 
information could add value. Villa et al. (2012) matched the data entered with stored 
protocols for diagnostic procedures and treatment. Although, as previously discussed, in 
personalised nutrition practice, it is not appropriate to use established intervention protocols, 
but rather present a range of evidence-based practice options. This can then can be 
discussed with patients and considered in terms of their individual needs, as well as social, 
cultural and financial implications. 
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Kawamoto et al. (2005) undertook a systematic review of RCT to identify which functions in 
clinical decision support systems helped to improve clinical outcomes. Kawamoto et al. 
(2005) identified that the provision of actionable recommendations, delivered automatically 
and at the time of decision making, have significantly improved patient care. There should 
also be a system which alerts practitioners to relevant updates as a result of new knowledge 
(Sheldon & Ou, 2013). Clinical decision support tools will therefore need to be able to deliver 
data via various systems of working, including updating health records and interactive 
technology (Sheldon & Ou, 2013). 
Bouwman et al. (2005) discusses personalised nutrition communication through interactive 
computer technology and highlights that online approaches can provide individualised 
nutrition advice to a larger reach of people, but that web-based interventions do not 
necessarily tackle behaviour change. Bouwman et al. (2005) presents a framework for 
research on social acceptance of personalised nutrition communication through interactive 
computer technology, which can be used to assess the advantages of any new tools 
developed as online applications. Technology should allow individuals to gain access to 
personally relevant information but also to interact with support groups and health 
professionals (Bouwman et al., 2005). 
The provision of ‘broad consent’ has been implemented in the UK for population-based 
genome projects and ‘tiered consent’ could also be considered. Although Chalmers et al. 
(2013) discussed genetic research, they raise valid considerations for the development of a 
case-by-case evidence base, and suggest that as much information as possible should be 
provided to participants. A strong governance framework needs to be put in place to help 
safeguard participants’ rights, as well as facilitate responsible research. Ginsburg and 
Willard (2009) predict that regulatory and legislative policy will also change to support the 
emerging practice of personalised health care. 
Ethical behaviour and good practice in undertaking and reporting on data is a key 
consideration. Petersen (2009) states that clinical expectations not supported by ‘strong’ 
evidence are unrealistic, misleading and may potentially affect the health and wellbeing of 
individuals and communities. Petersen (2009) goes on to state that modest, qualified claims 
are essential, which seems obvious, but examples of the Bovine Spongiform 
Encephalopathy (BSE) fiasco, the genetic modification controversy and other medical 
scandals given by Peterson (2009) make it clear that this approach has not always been 
taken. It could increase risk of rejection of innovative approaches such as personalised 
nutrition practice and its tools. Meslin and Cho (2010) also highlight the need for reciprocity: 
articulation of what constitutes benefit without overstatement, commitment to greater 
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transparency, involvement of the public in the scientific process and a commitment to 
achieving these goals over the pursuit of personal interest. 
The development of personalised nutrition practice has yet another significant barrier: 
adherence (de Abreu et al., 2013; Grass et al., 2015). Personalised nutrition practice will 
only achieve improved quality of life if the end-users are motivated to change their behaviour 
and act on personalised dietary intervention recommendations (Ronteltap and van Trijp, 
2007). Behaviour, engagement and adherence play a huge role in the success of client 
outcomes in nutrition practice. The benefit of personalised nutrition depends on the 
motivation of the individuals to change their dietary behaviours (Fallaize et al., 2013). A 
client’s beliefs about their health and illnesses are also critically important, as these may be 
influencing the behavioural and physiological response to illness (Galland, 2006). 
If individuals are not willing to change their eating routines, how can personalised nutrition 
practice help to prevent nutrition-associated diseases like obesity? Görman et al. (2013) 
demonstrate that the results of genetic tests may help to improve individual compliance to 
dietary changes, but this could be true of any test results which demonstrate the potential 
efficacy of the intervention. It may be education around the benefits of the intervention that 
positively influences compliance rather than the test result itself. Therefore, if practitioners 
are able to make probabilistic predictions on the efficacy of interventions, will that yield the 
same motivation? Implementing appropriate and sustained dietary change requires person-
centred behavioural counselling (DeBusk et al., 2011). Developing effective evidence-based 
personalised nutrition practice tools may also enable practitioners to have more time to 
spend with clients to work on behaviour modification and education by spending less time on 
research and data gathering. 
Problems with the feasibility of the mission of the project 
Problems with the feasibility of fulfilling the long term aims (the mission) of the project firstly 
lie in the limitations of the numerous gaps in the data collected, ranging from reporting bias 
to tacit and unique variables of the therapeutic relationship. Secondly, the impact of 
standardising data collection methods may not be desirable if it limits practice flexibility. The 
art of the therapeutic consultation should aim to improve the client experience and enhance 
the therapeutic relationship.  Any developments in the standardisation of data collection 
should support and not impinge negatively on this.   
2.9 Chapter summary 
This chapter has reviewed a wide range of literature pertinent to the work undertaken in this 
project and related directly to the project aims and research questions. The background of 
evidence-based and personalised nutrition practice has been explored along with a vision 
and potential scope for the development of a case-by-case evidence base for obesity 
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management which could transform personalised nutrition practice. Such a vision cannot be 
realised without underpinning tools which are robust and valid. The next chapter will further 
explore the methods undertaken for the construction of new clinical tools which aim to 
standardise case data-collection methods and enable assessment on the efficacy of nutrition 
interventions in obesity management.  
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Chapter 3 Project Design and Methodology 
This chapter critically describes and justifies the choice of the research approach and data-
collection methods. The overall reliability of the methodological approach is evaluated and 
ethical issues are explored. The author’s role as an insider-researcher is also evaluated. 
3.3 Project aims and objectives 
As described in Chapter 1, the overarching project aims were to: 
• evaluate the ethics, limitations and opportunities of standardising data-collection 
methods in personalised nutrition practice; 
• construct new clinical tools for health data collection, clinical decision making and 
clinical outcome analysis that standardise case data-collection methods and enable 
assessment of the efficacy of interventions; and 
• enable the development of a new, case-by-case, evidence base for personalised 
nutrition practice in obesity management. 
The objectives were to: 
• use a mixed methods collaborative research approach to achieve these aims; 
• gather and evaluate existing clinical tools and review implications for standardising 
data-collection methods; 
• collaboratively construct and trial new tools; and 
• evaluate how these tools can be successfully integrated into practice. 
3.4 Research questions 
The main questions that the project is designed to answer are: 
1. Is it possible and ethical to standardise a personalised approach to nutrition practice? 
2. If so, what tools can be constructed and validated to help individual health history 
data collection, clinical decision making and clinical outcome analysis to enable the 
development of a case-by-case evidence base for personalised nutrition practice in 
the management of obesity? 
Further questions raised by the main questions include: 
• What are the implications and ethical considerations of standardising a personalised 
approach to nutrition practice? 
• Is it possible to have a standardised tool that does not detract from personalised 
nutrition practice? 
• What are the practitioner’s views on the ethics and implications of standardising 
approaches to personalised nutrition practice? 
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• What tools currently support individual health history data collection, clinical decision 
making and clinical outcome analysis in nutrition practice for the management of 
obesity? 
• What are the practitioner’s experiences and views on using these tools? 
• Do these tools measure a comprehensive range of pathophysiological mechanisms 
affecting individual aetiology of obesity? 
• What are the strengths and weaknesses of these tools? 
• What new tools could be constructed to enable individual health history data 
collection, clinical decision making and clinical outcome analysis in nutrition practice 
to support the management of obesity? 
• Do these new tools measure a comprehensive range of pathophysiological 
mechanisms affecting individual aetiology of obesity? 
• What are the clients’ and practitioners’ views and experiences of using these new 
tools? 
• What is the impact of these tools on practice processes? 
• What reliable and valid data do these new tools provide? 
• How can standardised tools be integrated into personalised nutrition practice? 
• How can standardised tools be used to build a case-by-case evidence base for 
personalised nutrition practice? 
3.5 Ontological and epistemological considerations 
The ontological and epistemological positioning of this project is complex for a number of 
reasons: the transdisciplinary positioning of the project (personalised health care, nutrition, 
obesity, health and wellbeing, translational bioinformatics, complexity, systems science etc.), 
the use of qualitative research methods to develop tools that require statistically measurable 
and comparable outcomes, and the subjective nature of self-reported health issues. 
Clinical biomedical research has been shifting towards integrative and translational 
methodologies and frameworks (Zerhouni, 2006; Payne, Embi and Sen, 2009). Personalised 
nutrition practice aspires to be a predictive, translational systems science by creating a 
feedback loop where clinical evidence is used to refine clinical practice. It has been 
proposed that approaches such as emergence in complex systems and systems biology are 
better able to consider complexity than the reductionist approach (Ahn et al., 2006; 
Mazzocchi, 2008b; Fardet and Rock, 2014), on the basis that the ‘rules’ that exist in 
biochemistry and pathology are subject to modification by environmental and evolutionary 
forces. 
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Mixed method research does not necessarily mean “better” research (Brannen, 2005), 
however, in the context of this study it allowed for abductive, inductive and deductive 
reasoning and incorporated the ‘intersubjectivity’ of the researcher to conceive and produce 
robust measures for new tools by using multiple paths to explain meaning (Jupp, 2006, p. 
116). Research methods reflect the complexities of the outcomes sought and were chosen 
to help achieve sustainable change. The Delphi survey method allowed for collaboration with 
representatives from diverse backgrounds and aimed to enhance the quality of the research, 
shape its products and help to limit researcher bias (Costley et al., 2010, p. 108). 
Collaboration sits within an interactionist research paradigm (Costley et al., 2010, p. 107). 
The Delphi survey method is considered to favour a positivist paradigm with a realist 
ontology and representational epistemology (Hanafin, 2004). However, the approach taken 
for this project is qualitative and subjective; it gathered the participant’s opinions of the tools 
throughout iterative tool development using a series of Delphi survey rounds. Although it 
aimed to gain group consensus, this was rarely achieved. The results of the survey rounds 
were used to refine tool development, and therefore this element of the project sits within the 
constructivist paradigm. 
The structured and standardised tools that resulted from the Delphi survey method sit within 
a positivist paradigm. These tools gather a mix of both objective and subjective health data 
and are designed to be statistically analysed and robust. 
Concepts of health, wellbeing and quality of life are social and individual constructs. The 
WHO (Chatterji et al., 2002) has explored some of the issues relating the measuring 
concepts of health and disease. Chatterji et al. (2002) describe the necessity for a set of 
core health-measuring domains to facilitate valid, reliable and comparable tool development. 
The health-measuring domains for this project have emerged from key physiological 
mechanisms, which appear to contribute to obesity development, as identified during the 
research process. 
3.6 Overall design 
The research was designed to meet the research aims and objectives as well as the 
professional doctorate learning outcomes, which included making “a significant contribution 
to practice” (Coghlan, 2007). The project employed a mixed methods research design, 
including the Delphi survey method, to structure the group communication process so that 
the collaborative process was as effective as possible (Linstone and Turoff, 2002, p. 3). 
The strengths of the approach include the collaborative, mixed methods design to consider 
this broad and complex problem with representatives from diverse backgrounds. Schon 
(1983) argues that professional knowledge has a wide scope of dynamic and complex 
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knowledge which was essential to explore. Collaborative research can benefit and enhance 
the quality of research (Costley, Elliott and Gibbs, 2010, p. 108). 
There were five stages included in the overall design (see figure 11): 
1. Literature review – to inform the project approach, tool development and answer 
research questions. The literature review was presented in Chapter 2. 
2. Data gathering – to gather, categorise and evaluate existing tools and assess 
experiences of using tools, or tool development, to inform new tool construction. 
3. Collaborative tool development – a multi-staged, Delphi survey method which aimed 
to achieve consensus for new tool development (Keeney, Hasson & McKenna, 
2011). 
4. Pilot trial – to trial new tools in practitioner’s clinical setting. 
5. Evaluation – to evaluate ways in which standardised tools can be embedded into 
personalised nutrition practice and enable the development of a new evidence base 
for personalised nutrition practice. 
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Figure 11 Flow chart of the five stages of the research project 
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Reflective practice took place throughout and between each of the stages to assess 
reflexivity and project progression through the use of a reflective journal. Reflective 
discussions with research supervisors, peers and participants were also recorded in the 
journal. The value of reflection for enhancing learning at doctoral level has been explored by 
Klenowski and Lunt (2008). Reflecting on my reflective journal entries was undertaken 
regularly to explore my personal development, subjectivity and reflexivity. Reflexivity is an 
essential component of research (Finlay, 1998) and is explored at length in Chapter 7. 
Positionality and my roles within the research project, as research facilitator, data gatherer 
and data interpreter, were briefly discussed in section 1.5. This is discussed again in the 
next section, as I aim to explore the impact of my role as an insider researcher on the project 
design, methodology and the potential bias that my position brings. 
3.7 My role as an insider-researcher 
Coghlan (2007) has explored some of the opportunities and challenges of insider research. 
Being within the nutritional therapy profession places me outside traditional dietetics or 
medical models, which influences my perception of the limitations of the current health care 
research model, but may also limit my understanding of what it would take to make the new 
proposed model work in mainstream health care. Drawing in a range of participants was 
therefore intended to support professional development and limit bias (Mitchell, Reilly and 
Logue, 2009). The benefits and tensions of collaborative research have been well explored 
in the literature (Hague and Snyder, 1991; Godin and Gingras, 2000; Macduff and Netting, 
2000; Cummings and Kiesler, 2005; Li and Qiu, 2006; Cook, Learning and Hempstead, 
2010; Hettiger, 2010; Paulson, Wajdi and Manz, 2012; Collins et al., 2013; Cheruvelil et al., 
2014). 
The complexities of the politics within the various nutrition professions have also impacted 
on the project outcomes. Dietitians and nutritionists appeared more reluctant to participate in 
the project than NTs. This observation may stem from my own perception and concerns as 
an outsider to these professions and stronger professional connections with NTs. This may 
also be due to the fact that my relationships with NTs are stronger, and, because of my 
insider position, which is why NTs were more willing participate in the project. 
It is my belief that nutritional therapy is perceived to be less ‘legitimate’ than other nutritional 
professions because it is positioned as a complementary therapy. This drives my desire to 
be able to demonstrate the efficacy of nutritional therapy interventions and help to place it 
squarely within mainstream health care. Achieving this goal may lead to unintended 
consequences. For example, could the integration of NTs into mainstream health care 
actually spell the end of nutritional therapy due to the constraints of government guidelines 
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and nutrition policy? Some consequences are likely, but as well as the drawbacks there may 
also be unintended benefits. 
Mercer (2009) states that as an insider-researcher I would enjoy freer access, stronger 
rapport and a deeper, more readily available frame of shared references with which to 
interpret the data I collected. However, I also had to limit the bias of my own preconceptions 
throughout the project – particularly during data analysis. Reflection allowed me to regularly 
question my approach, assumptions and role dynamics, as well as appraise ethical 
dilemmas as they arose. Collaborative enquiry has allowed me to more deeply explore and 
theorise my own areas of practice. 
The following table represents how I envisage my position within the context of the 
participants and approaches to nutrition practice. The middle column represents where I am 
both an insider and outsider: for example, I teach and understand elements of functional 
medicine and clinical psychoneuroimmunology, but I am not registered as a practitioner at 
the IFM and I have not undertaken certified cPNI training. Although I am not a medical 
practitioner, I perceive myself to be part of teaching and developing a PM approach to health 
care. I have been a client of nutritional therapy and dietetics practitioners in the past but 
because of my training I am now an outsider as a client. 
Table 1 My insider/outsider positioning within the context of the participants and approaches to 
nutrition practice 
Insider Insider & outsider Outsider 
Nutritional therapist Functional medicine Dietetics 
Researcher Clinical 
psychoneuroimmunology 
Nutritionist 
Academic Personalised medicine Obese 
Personalised nutrition Nutrition practitioner client Statistician 
3.7.1 Roles and responsibilities 
Throughout the project, I have had a number of roles including: research co-ordinator, 
researcher, Head of Education at CNELM, nutritional therapist (in my own private practice), 
clinic supervisor and research supervisor. 
Being an insider-researcher has had an impact on the research process and activities. The 
project has included a range and number of research participants, without whom this project 
would not have been possible. During the research process, there was a need to adapt the 
research activities based on participant feedback in order to gain participation. This is 
discussed further in Chapter 4. 
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It has been the responsibility of the nutrition practitioner participants to manage their clients 
as per the client information sheet (appendix 4). They tested the developed tools in their 
consultation process and were asked to ensure the client is provided with nutrition 
interventions that met their needs. It was also their responsibility to ensure they follow the 
guidelines and procedures set out for the research and undertaking the pilot trial 
(appendices 5 and 6). This approach ensured client confidentiality, but it also placed me 
outside of managing the client participants in the pilot trial phase, which made that process 
difficult to manage. 
Overall, the positionality of insider research did impact on the research outcomes in that it 
was those participants who saw me as an insider that were easier to engage. It may have 
been better to focus solely on building tools for nutritional therapy practitioners, but the 
concern was that this could move nutritional therapy practice further away from mainstream 
acceptance rather than towards it. 
3.8 Research methods 
The mixed methods approach included: 
1. Online searches for existing tools in obesity management and personalised nutrition 
practice, as well as the categorisation and evaluation of these tools. 
2. A survey of nutrition practitioners to identify which tools they use in clinical practice 
and why. 
3. Interviews with some of the survey participants to gather their views on clinical 
assessment and clinical decision making, as well as their views on ethics and 
standardising approaches to personalised nutrition practice. 
4. Interviews with academics and statisticians to evaluate their views on and experience 
in how to undertake robust tool development for this project. 
5. A Delphi survey to construct new robust clinical tools which assess the efficacy of 
personalised nutrition practice in obesity management. 
6. A pilot trial of new tools with practitioners in clinical practice to achieve face validity 
and measure feasibility and utility for each of the four tools. 
7. A survey of NTs to explore their engagement with an obese (BMI>30) population. 
8. Interviews with nutrition practitioners to identify ways to embed standardised tools in 
personalised nutrition practice and explore potential approaches to overcome 
barriers. 
3.9 Ethics and ethics approval 
Ethics approval was obtained from the Middlesex University Ethics Committee in December 
2013 (appendix 7), including approval for the data-collection procedures utilised in this study, 
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participant information sheets and consent forms. The research undertaken has complied 
with the Health and Social Care Research Ethics Sub-Committee guides. Two amendments 
were made to the ethics application. In May 2015, approval was obtained to include 
individuals from an obese population in Delphi group surveys (appendix 8). Sensitivity 
around seeking obese individuals was considered when recruiting participants. Then, in 
January 2017 approval was obtained to remove the word ‘obesity’ from the client 
participation sheet (appendix 10), as practitioner feedback during the pilot trial raised that 
practitioners may not be able to ascertain if their client met the obese (BMI >30) inclusion 
criteria before the consultation, and the client may not yet be aware that they are obese prior 
to the nutrition consultation. 
The word ‘obese’ has numerous social stigmas (Puhl & Heuer, 2010). It was felt that this 
could be a barrier in engaging practitioners and their clients with the pilot trial process. Bias, 
stigma and discrimination towards obese individuals is unfortunately still pervasive (Puhl & 
Brownell, 2001). I therefore aimed to be as sensitive and supportive as possible, changing 
the wording as the project developed to exclude the use of the term ‘obese’ and instead 
referring to “clients seeking to lose weight”. 
Overall, the guiding principles of the Code of Human Research Ethics from the British 
Psychological Society (BPS, 2010) were followed: to obtain informed consent from potential 
research participants, to minimise the risk of harm to participants and protect their anonymity 
and confidentiality, to avoid using deceptive practices and to give participants the right to 
withdraw from the research. 
It has been my role to ensure the relationship with these participants is based on principles 
of honesty and empowerment. The roles of the participants were made explicit in the 
participant information sheets (see appendices 4 and 5). Signed consent forms were sought 
from interview participants (see Appendix 10). To make the process easier and to encourage 
engagement, the data from the consent forms was transferred to the surveys, making it clear 
that their participation was entirely voluntary, that they could withdraw at any time and were 
free to omit any answers. They were also made aware that the data provided may be used 
for analysis and subsequent publication. 
Procedures were implemented to maintain the confidentiality of the participant data. 
Personal information was stored in locked cabinets and computer files were secured by 
means of passwords. Only the researcher and authorised supervisors were able to access 
the information. 
Silverman’s (2006, p. 323) ethical safeguards model informed the relationship with 
participants. Participants were volunteers whose involvement was kept confidential. All those 
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involved were protected from harm and I aimed to build a mutual trust between the research 
and participants. Honesty was central to the relationship between the researcher, 
participants and institutional representatives (Walliman, 2005). Appropriate interpretation 
and translation of findings was conducted and I ensured that research results were fed back 
to participants where possible (Lienert, 2002). 
Ethical considerations were reviewed at every stage. During the Delphi stage it became 
apparent from practitioner feedback that one of the questions relating to trauma on the newly 
developed tools could be a trigger for some clients. Stress and trauma is positively 
associated with adult obesity. A systematic review by Palmisano et al. (2016) which 
reviewed 70 studies (N=306,583 participants) concluded that 87% of those studies reported 
adverse events as a risk factor for developing obesity. Regardless of the association, in the 
final review of the tools, post-pilot trial, this one question relating to trauma was removed as 
in order to minimise risk of harm this question should not be asked via an online tool. 
The ethical dimensions of complex research are themselves complex. One key area that I 
explored throughout the project was that of professionalism and ethics in complementary 
medicine, as nutritional therapy describes itself as a client-focused, evidence-based, 
complementary therapy (Benbow et al., 2017). Koehn’s (1994) book on professional ethics 
was particularly thought-provoking in terms of professional expertise and authority. This 
seemed to reinforce the idea that enabling the development of new case-by-case evidence 
base for personalised nutrition practice was ethically essential to support therapists’ ability to 
think abductively and improve their practice outcomes (Paul, 1993). 
Another key area that I explored throughout the project were the differences in health care 
paradigms and practice approaches between complementary therapists and mainstream 
health care. I believe that nutritional therapy should be accessible through mainstream 
health care provision to offer equality of access. The Professional Standards Agency (PSA) 
are encouraging mainstream health care practices to create broader disciplinarily teams 
which include NTs (Professional Standards Authority, 2015). However, the stigma and 
perception that all complementary therapies are ‘anti-science’ is still pervasive (Crellin & 
Ania, 2002). 
3.10 Data collection, analysis and evaluation 
3.10.1 Identification, categorisation and evaluation of existing tools 
An extensive search of Summon, Google Scholar, PubMed, Cochrane Library, Science 
Direct, Allied and Complementary Medicine, DH-DATA, Embase and Medline using the 
following keywords (see Table 2) in the title or title and abstract was conducted to identify 
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existing tools which support individual health history data collection, clinical decision making 
and clinical outcome analysis suitable for nutrition practice in the management of obesity. 
Online searches were broken down into the following stages: 
1. Broad search to identify tools 
2. Categorisation of tools identified 
3. Searches for tools related to each category 
4. Evaluation of final results 
Eight broad searches for existing tools were undertaken and tracked. 
Table 2 Search terms used for broad online searches to identify existing tools 
1 ‘obesity tool’ 
2 ‘assessment’ AND ‘obesity’ 
3 ‘obesity’ AND ‘questionnaire’ 
4 ‘individual health history data’ AND 
‘tool’ 
5 ‘clinical decision making’ AND ‘tool’ 
6 ‘clinical outcome analysis’ AND ‘tool’ 
7 ‘measure clinical outcomes’ 
8 ‘obesity’ AND ‘nutrition screening’ 
The terms ‘obesity’ and ‘tool’ helped to focus the search results, as terms like ‘individual 
health history data’ and ‘nutrition screening’ were too broad. A search description form was 
completed for each of the search terms used (see example in appendix 1). Results were 
recorded with a brief critical summary in a “literature and tool search results tracker 
spreadsheet” (see appendix 3). The purpose of the results tracker spreadsheet was to make 
the search methodology both transparent and replicable. Any tools not deemed relevant for 
clinical nutrition practice to gather individual health history data, support clinical decision 
making or analyse clinical outcomes for adults in personalised nutrition practice obesity 
management were excluded. 
Papers were reviewed and coded into themes via Nvivo. Specific tools or measures 
identified were then listed in the tool categorisation spreadsheet (see appendix 11). These 
results allowed for the identification of broad categories and some specific measures. When 
reviewing the results, the categories in the spreadsheet were emergently developed and 
notes about measures and tools were made within each of the eleven subject categories. 
The following categories were identified: 
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1. General 
2. Diet and nutrition 
3. Psychology 
4. Physical activity 
5. Genetics and family history 
6. Physiological 
7. Sociocultural 
8. Body composition 
9. Test results 
10. Goals and outcomes 
11. Intervention tracking 
Once all papers identified from the first round of searches had been reviewed and the 
categorisation spreadsheet developed, it became clear that this initial broad search had not 
identified all relevant tools. Further searches were therefore conducted to identify tools 
relevant to each category before final evaluation of the results. 
The benefits of this broad approach resulted in the identification of research papers 
highlighting the strengths and limitations of specific tools and research papers reviewing how 
to develop clinical tools. 
A second search was therefore undertaken, utilising the same methodology as before, to 
identify tools related to each category. 
 
Table 3 Search terms used for online searches to identify existing tools for categories 
General 
category: 
‘assessment’ AND ‘obesity’ 
‘obesity’ AND ‘questionnaire’  
Diet and 
nutrition 
category: 
‘obesity’ AND ‘nutrition screening’  
‘nutrition’ AND ‘obesity’ AND ‘assessment’ OR ‘questionnaire’ OR 
‘measure’ 
‘Diet’ AND ‘obesity’ AND ‘assessment’ OR ‘questionnaire’ OR ‘measure’ 
Psychology: ‘psychology’ AND ‘obesity’ AND ‘assessment’ OR ‘questionnaire’ OR 
‘measure’ 
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Physical 
activity1 
‘physical activity’ AND ‘obesity’ AND ‘assessment’ OR ‘questionnaire’ OR 
‘measure’ 
Genetic 
predisposition 
 
‘genetics tool’ AND ‘obesity’ AND ‘assessment’ OR ‘questionnaire’ OR 
‘measure’ 
‘family history’ AND ‘obesity’ AND ‘assessment’ OR ‘questionnaire’ OR 
‘measure’ 
Physiological ‘physiol*’ AND ‘obesity’ AND ‘assessment’ OR ‘questionnaire’ OR 
‘measure’ 
Sociocultural Socio AND ‘obesity’ AND ‘assessment’ OR ‘questionnaire’ OR ‘measure’ 
Body 
composition 
‘composition’ AND ‘obesity’ AND ‘assessment’ OR ‘questionnaire’ OR 
‘measure’ 
Test results ‘blood’ AND ‘obesity’ AND ‘assessment’ OR ‘questionnaire’ OR ‘measure’ 
No specific tools for this, just specific markers such as blood tests.  
Goals and 
outcomes 
 
‘goals’ AND ‘obesity’ AND ‘assessment’ OR ‘questionnaire’ OR ‘measure’ 
‘outcome’ AND ‘obesity’ AND ‘assessment’ OR ‘questionnaire’ OR 
‘measure’ (measuring outcomes of obesity interventions only) 
Intervention 
tracking 
‘intervention’ AND ‘obesity’ AND ‘assessment’ OR ‘questionnaire’ OR 
‘measure’ 
Again, a search description form was completed for each of the search terms used (see 
appendix 1); see appendix 2 for inclusion and exclusion criteria and numbers of results. 
Results were also recorded in the literature and tool search results tracker spreadsheet 
(appendix 3). The tool categorisation spreadsheet (appendix 11) was updated to include 
further categories and measures. Quality assessment of the tools was undertaken. Tools 
and measures that were shown to be unreliable or invalid were excluded. Tools not suitable 
for an obese population or for nutrition practice were excluded. Tools where modification and 
distribution were prohibited were also excluded. Permission was sought to utilise tools 
identified as a part of this research project, where required. If permission was unobtainable 
then tools were excluded. Reasons for other exclusions were captured in the tool 
categorisation spreadsheet (appendix 11) under the following headings: 
• aim of the tool’s measurements; 
                                               
1 Physical activity was compared to exercise as a search term and physical activity provided more 
salient results. 
61 
• target population; 
• permission to use tool; 
• content; 
• application e.g. self-reported or expert required; 
• outcome measures; 
• feasibility (cost, time burden); 
• reliability, validity, interpretability, readability; 
• comparative studies; and 
• inclusion and exclusion criteria. 
Resources were utilised to develop the above headings and formulate a robust quality 
assessment method (Bowling, 2005; Nahm et al., 2007; Beechy et al., 2012). 
See Table 4 for a list of online literature searches conducted to inform new tool development 
and enable categorisation of questions according to pathophysiological mechanisms for 
obesity. 
Table 4 Search terms used for online searches to identify a range of pathophysiological mechanisms, 
‘other diseases’, health conditions and red flags associated with obesity and tools and tests/measures 
assessing those mechanisms 
5.1 ‘signs and symptoms of obesity’ 
5.2 ‘biomarker’ AND ‘obesity’ 
5.3 ‘genetic marker’ AND ‘obesity’ 
5.4 ‘epigenetic marker’ AND ‘obesity’ 
5.5 ‘types of obesity’ 
5.6 ‘mediator’ AND ‘obesity’ 
5.1 ‘obesity related disease’  
Again, a search description form was completed for each of the search terms used (see 
appendix 1). See appendix 2 for inclusion and exclusion criteria and numbers of results, and 
results were also recorded in the literature and tool search results tracker spreadsheet 
(appendix 3). Numerous other resources were also utilised to develop a comprehensive list 
of pathophysiological mechanisms, other diseases, health conditions and red flags (Bowling, 
1995a, 2005; Kypreos, 2009; Stern and Kazaks, 2009; Nahikian-Nelms, 2011; NTEC, 2015). 
3.10.2 Survey of nutrition practitioners 
Results from the identification, categorisation and evaluation of existing tools were used to 
create a survey for nutrition practitioners which aimed to determine which of the tools 
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identified were being utilised in clinical nutrition practice, as well as gather practitioners’ 
views on the strengths and weaknesses of these tools and identify other tools and data-
collection methods practitioners utilise to gather client data. 
The survey was conducted via the online tool SurveyMonkey (Finley, 1999). Thematising 
and designing of the survey was supported by review of the tailored design method 
guidelines in the 2009 book on surveys by Dillman et al. The survey was pilot tested twice 
with two nutrition practitioners before the link to the online survey was distributed via email to 
nutrition practitioners between October and December 2014. Recipients included: contacts 
generated from the online searches for tools, BANT members, my own contact list and the 
CNELM contact list. 
A survey search and send tracker spreadsheet tracked the dates of the emails sent and 
holds the contact data for practitioners who had been emailed the survey (appendix 12). A 
total of 98 practitioners were emailed to complete the survey. When the survey closed on 1 
January 2015 a total of 32 questionnaires had been completed. The response rate was 32%, 
which is considered to be average (Sheehan, 2006). Reminder emails were sent to increase 
response rates. 
A mix of multiple-choice and open-ended questions in the surveys gathered quantitative and 
qualitative data. SurveyMonkey has a number of data analysis features. All response data 
was downloaded so the results could be analysed and evaluated. Quantitative data analysis 
was measured to identify the numbers of respondents using the tools or assessment 
methods and the most perceived strengths and weaknesses of the assessment methods. 
Qualitative data analysis is not traditionally measured, but analysis allowed the identification 
of themes and informed new tool development. All participants who stated they were willing 
to allow the researcher to view the clinical tools forms and/or questionnaires they used or 
created were asked to provide them with written consent for use within the research project. 
These tools were reviewed to inform new tool development. The analysis of results also 
supported the formulation of interview questions for the interviews of participants, which 
allowed for triangulation of the data. 
3.10.3 Interviews of survey participants 
Results of the practitioner survey informed interview questions. All participants who stated in 
the survey that they were willing to participate in interviews were invited for interview. 
Interviews aimed to gather views on clinical tools, assessment and decision making, as well 
as evaluate views on the ethics and implications of standardising approaches to 
personalised nutrition. The objectives were to: 
• evaluate practitioner views on standardising approaches to personalised practice; 
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• identify ways in which practitioners use clinical assessment to make clinical 
decisions; 
• identify ways in which practitioners engage with the evidence base; 
• evaluate implications for building new tools; and 
• discuss potential ethical issues of building a case-by-case evidence base. 
Interview techniques, ethics and strategies for improving quality were gleaned from Kval’s 
(1996, p. 87) book titled Interviews, and its seven-step interview approach was utilised: 
Step 1 – Thematising: Pulled together a list of potential participants and thoughts about the 
aims and questions. 
Step 2 – Designing: interview aims and objectives and the interview guide were developed. 
A mix of open-ended, semi-structured questions were included to facilitate conversational 
dialogue. 
Step 3 – Pilot testing questions: - feedback from my research supervisors was gathered 
on the interview guide, which led to a reordering of questions and eliminating any repetition 
for similar questions. Once completed, the interview guide (appendix 13) was sent to 
interviewees at least 5 days in advance to ensure that they had time to prepare. 
Step 4 – Undertaking the interviews: Between 18 March and 9 April 2015, six interviews 
with nutrition practitioners were conducted. The interviewees included: 
• two specialist obesity dietitians; 
• two NTs who run group weight loss programmes; 
• one NT and lecturer; and 
• one naturopath and weight loss coach. 
The interviews were held via an online conference facility (gotomeeting.com) at times 
convenient for the interviewees. The interviews were recorded for transcription purposes. 
Step 5 – Transcribing: the audio recording was transcribed verbatim, uploaded to Nvivo 
and then coded under the following themes: 
• standardised approaches; 
• ethical issues; 
• practitioner views on using tools; 
• patient/client-centredness; 
• health history assessment; 
• clinical decision making; 
• engagement with the evidence base; 
• linking new tools to the evidence base; 
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• case studies; 
• clinical outcome analysis. 
Step 6 - Analysing: Kvale (1996, p. 192) describes a five-step interview analysis method 
that was utilised, including: 
1. meaning condensation – summarising large interviewee statements into briefer ones 
2. meaning categorisation – coding into categories 
3. narrative structuring - structuring narratives in categories 
4. meaning interpretation – interpreting the meaning of the texts 
5. generating meaning through ad hoc methods – adding more context. 
Step 7 – Verification: results were triangulated with literature during the writing up of 
results. 
3.10.4 Interviews of academics and statisticians 
The aim of the interviews with academics and statisticians was to evaluate their experience 
and views on tool development and validation and/or data set management to inform new 
tool development. 
Objectives were to: 
• evaluate ways in which new tools can provide reliable and statistically validated data; 
• identify ways in which new tools can relate to the existing evidence base; 
• evaluate ways in which tools can best be pilot tested or trialled; and 
• identify implications and ethical issues of building a case-by-case evidence base. 
Kvale’s (1996, p. 87) seven-step interview approach was utilised, as with previous 
interviews. Participants were selectively sampled based on their experience of tools 
development, research skills or potential knowledge contribution. They were identified via 
LinkedIn and personal contacts. A mix of open-ended and semi-structured questions were 
included to facilitate conversational dialogue. The interview guides (see appendix 14) 
included the aims and objectives as well as the main questions. This was sent to 
interviewees at least five days in advance to ensure that they had time to prepare. The 
interviews were held via online gotomeeting.com at times convenient to the interviewees. 
Between 17 February 2015 and 9 April 2015 six interviews were conducted with the 
following participants: 
• senior principal statistician for a clinical research institute with a PhD in Organic 
Chemistry and an MSc in Medical Statistics; 
• director of research at CNELM with a PhD in computer science; 
• senior lecturer in nutrition and public health with a PhD in Nutritional Epidemiology; 
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• senior lecturer and module leader for methods of nutritional assessment and dietitian; 
• chartered psychologist and director of a research organisation with a PhD in Health 
and medical psychology; and 
• senior lecturer, health psychologist and programme director for NHS education who 
developed a self-reported tool for multiple risk factors in obesity. 
The contents of the interviews were transcribed verbatim, uploaded to Nvivo and then coded 
under the following themes: 
• developing new tools; 
• desired from new tools; 
• tool validation; 
• data sets; 
• database research; 
• online applications; 
• Delphi groups; and 
• tools identified from interviews. 
Kvale’s (1996, p. 187) five-step analysis method, within the seven-step interview approach, 
was then utilised as per the previous interviews and the results were verified by triangulation 
with literature. 
3.10.5 Delphi project 
The aim of the Delphi survey was to construct new clinical tools for health data collection 
and clinical outcome analysis that standardise case data-collection methods and enable 
assessment of the efficacy of interventions. Objectives were to: 
• gain opinion on which tools should be developed; 
• gain opinion and consensus on content for tools; 
• construct tools so that they can provide reliable and statistically validated data; 
• evaluate ways in which these new tools can relate to existing evidence base; and 
• measure feasibility, utility and achieve face validity for each new tool. 
Participants were purposefully identified and selected to include a range of stakeholders, 
including: nutrition practitioners working with obese individuals, representatives from 
educational establishments, representatives from professional bodies, information systems 
experts and statisticians, experienced tool developers, academics and obesity researchers, 
as well as nutrition patients seeking to manage obesity and/or weight loss. 
Procedure undertaken for selecting participants: 
1. Identify relevant disciplines and organisations. 
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2. Identify individuals in relevant disciplines and organisations. 
3. Contact experts. 
4. Categorise experts within each panel and rank according to their qualifications, 
knowledge and potential contribution. 
5. Invite experts for each panel. Target size 15–20. 
The participant panels were divided into three perspectives: clinical utility, research utility 
and client/patient acceptance. 
The final panel of participants was 17 including: 
• five nutrition patients who were seeking to manage obesity/weight loss; 
• seven nutrition practitioners (one dietitian, two weight management consultants, one 
nutritionist, one NT, one deputy head of care, one GP reviewing from a clinical 
perspective); 
• two academics and/or obesity researchers; 
• two statisticians and/or information systems management experts; and 
• one other reviewing from a research perspective. 
Participants were asked to complete three rounds of structured questionnaires anonymously. 
At the start of each round, there was a brief introduction video explaining the developments 
in tool construction to date, a summary of participant responses from the previous round 
(except for Round 1), as well as the aims and objectives of the round and requirements for 
feedback via the questionnaire. 
The Delphi method is a flexible but structured way to gain opinion and consensus from a 
group of experts and stakeholders. No definitive guidelines exist for undertaking this 
research methodology, but the following resources were reviewed as a guide: Keeney et al. 
(2011), Linstone and Turoff (2002), Albert (1999), Hasson et al. (2000), Trevelyan and 
Robinson (2015). 
Aims of Round 1 
The aims of the first survey were to review a range of tools and assessment approaches and 
rank them according to which were perceived to be most important for new tool 
development. The objectives were to gather consensus from: nutrition practitioners on which 
assessments provided the most clinical utility, from academics and researchers on which 
assessments were most useful for research purposes and from nutrition clients on which 
assessments they would be willing to provide personal data. 
Round 1 survey questions were developed based on the categorisation of tools, as well as 
responses to a survey of practitioners, and interviews of practitioners and experts, which 
were previously undertaken as part of this research project. For example, all assessments 
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used by the majority of practitioners who responded to the survey were included in the first 
Delphi survey. 
Practitioner and research questionnaires collated in previous stages of the research, as well 
as Jeor, (1997), Allison (1995), Bowling (1995) and Bowling (2005), were also reviewed for 
additional assessment methods. SurveyMonkey software was used to develop and 
undertake the online surveys. Each Delphi survey was pilot trialled and reviewed by the 
research supervisors, then updated as a result of feedback. Each survey round was online 
for two weeks and reminder emails were sent to participants after one week and again 
before the deadline. Round 1 was completed in October 2015. 
After analysis of Round 1 and a review of existing tools, obesity literature was reviewed to 
identify: a range of pathophysiological mechanisms, other diseases, health conditions and 
red flags associated with obesity and tools and tests/measures assessing those 
mechanisms. These mechanisms provided headings so that tools could be restructured in 
Round 2. The aim of structuring questions under mechanisms of pathophysiology (such as 
hormone imbalance, inflammation and dyslipidaemia) was to enable nutrition practitioners to 
more easily identify which mechanisms of pathophysiology may be a priority for the 
management of their client. This therefore supports pathophysiological reasoning as well as 
clinical decision making. 
Aims of Round 2 
The aims of Round 2 were to review the content of tools and approaches which were 
structured under headings of mechanisms of pathophysiology relating to obesity, rank 
satisfaction with the questions/approaches or their wording and identify areas for further 
development. 
Objectives were: 
• To gather consensus from nutrition practitioners on their satisfaction, specifically: that 
the questions/approaches correlate with mechanism and question aim and that the 
questions/approaches may help practitioners identify contributing obesity 
mechanisms for individuals’ clients/patients – and therefore support clinical decision 
making. 
• To gather consensus from academics and researchers on whether the questions 
were appropriately phrased to limit bias and support statistical analysis, the 
questions/approaches correlated with question aims, and assessment and 
reassessment at six months, one year, two years etc. would allow for meaningful 
statistical analysis. 
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• To gather consensus from nutrition clients on whether they were satisfied the 
wording of the questions/approaches was clear and enabled them to give a suitable 
answer, they were satisfied the wording of the questions/approaches was appropriate 
and free of emotional charge, and that they would be willing to answer the questions. 
SurveyMonkey software was used to develop and undertake the online survey. Each Delphi 
survey was pilot trialled and reviewed by the research supervisors, then updated as a result 
of feedback. Each survey round was online for two weeks, and reminder emails were sent to 
participants after one week and before the deadline. Round 2 was completed in March 2016. 
Following Round 2 analysis, four new tools were constructed: 
1. Personalised health history questionnaire – this aims to collect health history and 
family history data around mechanisms of obesity, as well as collect a range of 
baseline health measurements. This questionnaire is for the client to complete before 
the first consultation. 
2. Intervention record – this aims to capture which interventions were recommended 
by the nutrition practitioner at the end of each consultation. This tool is designed to 
be completed by the nutrition practitioner at the end of each consultation. 
3. Personalised health follow-up questionnaire – this aims to measure any changes 
to the client’s health after intervention. This questionnaire is for the client to complete 
before their return consultation. 
4. Achievement record – this aims to capture which interventions the client complied 
with. This tool is designed to be completed by the nutrition practitioner at the outset 
of each return consultation. 
Aims of Round 3 
The aims of Round 3 were to: 
• review the health questionnaire to see which questions can be eliminated in order to 
reduce its overall size; 
• review a follow-up questionnaire to see which questions should be repeated in order 
to capture changes to the client’s health and weight; 
• review the intervention record to gather consensus on questions/approaches and 
wording; 
• review the achievement record to see which questions from the intervention record 
should be repeated in order to capture client compliance to intervention 
recommendations; and 
• identify areas for further development. 
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Objectives were for nutrition practitioners to review these tools from a clinical perspective: 
that the questions are appropriately phrased, that the questions/approaches correlate with 
question aims, and that the questions/approaches support clinical decision making. This 
round also asked nutrition practitioners if they would be willing to participate in the pilot trail 
of these tools. 
Objectives for academics and researchers were to review these tools from a research 
perspective, i.e. that the questions are appropriately phrased to limit bias and support 
statistical analysis; that the questions/approaches correlate with question aims and that 
assessment and reassessment at six months, one year, two years etc. would allow for 
meaningful statistical analysis. 
Objectives for clients were to review tools from the client perspective and determine if they 
were satisfied the wording of the questions/approaches was clear and enabled them to give 
a suitable answer; that they were satisfied the wording of the questions/approaches was 
appropriate and free of emotional charge, and that they would, as clients seeking weight loss 
support, be willing to provide this information. 
Qualtrics (2012) software was used to develop and undertake the online survey. Each Delphi 
survey was pilot trialled and reviewed by the research supervisors, then updated as a result 
of feedback. Each survey round was online for two weeks and reminder emails were sent to 
participants after one week and before the deadline. Round 3 was completed in September 
2016. 
Keeney et al. (2011, p. 72) suggest Burnard’s (1991) 14-stage process method of content 
analysis, but this approach seemed overly complex and Keeney et al. (2011, p. 72) also 
states that a simple approach to content analysis works well. A simpler approach was 
therefore undertaken by recording the results in spreadsheets so that group collective 
opinion and consensus could be more easily analysed. Results from each round were used 
to construct new tools as well as formulate the objectives and requirements for feedback for 
the next round. Informal literature reviews were used to support tool construction. 
Responses were summarised between rounds and fed back to the participants through a 
process of controlled feedback (Hasson, Keeney and McKenna, 2000). 
The spreadsheet data was manually analysed. Infrequently occurring development 
suggestions/statements may have been omitted to keep new tool construction manageable. 
Consensus was equated at the majority (51%) agreement among respondents, e.g. if the 
majority of nutrition clients were willing to provide information, then consensus on whether 
an assessment should be included was equated at the majority stating yes, as opposed to 
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no. The ‘maybe’ responses were not counted in the overall weighting as to whether an 
assessment should be included in the construction of new tools. 
3.10.6 Pilot trial 
A pilot study of the newly developed tools was undertaken between 11 October 2016 and 30 
September 2017. Tool pilot testing aimed to achieve face validity and measure feasibility and 
utility for each of the four tools. Objectives were: 
• practitioner and client completion of face validity surveys; 
• assessment on practitioner and client experience of using these tools; and 
• assessment on what reliable and valid data the tools provide. 
Nutrition practitioners were invited to participate. This invitation was disseminated via email 
targeting, CNELM and BANT social media, networking and word-of-mouth. The aim was for 
the invitation to reach as many practitioners as possible, and practitioners were asked to get 
in contact should they be willing to participate. Strategies for enhancing participation in the 
pilot trial, such as personalised email contact, were also undertaken from the outset. 
Nutrition practitioners listed on LinkedIn, the freelance dietitian website, the nutritionist 
resource website, the BANT website and the Zest4Life website were personally emailed and 
invited to participate. Two follow-up emails were sent to these practitioners in an effort to 
increase engagement. Participation invitations and responses were tracked on a 
spreadsheet (see appendix 15). 
Sample size was based on the number of practitioners willing to trial tools multiplied by the 
number of obese patients in their clinic willing to participate. In total, 51 practitioners 
responded to the invitation as willing to participate. They were sent the pilot trial protocol 
(see appendix 6) and participation sheets (see appendices 4 and 5). These practitioners 
received an initial phone call to address any queries and discuss participation. During 
participation they were provided with email and telephone support to address any queries 
and they were sent copies of all completed documentation and guided through each stage. 
The inclusion criteria stated that: each practitioner must trial all four tools on a minimum of 
two clients, all tools and review surveys must be completed by 31 July 2017, and clients 
should be seeking nutrition intervention for weight loss. Practitioners who had agreed to 
participate but were not engaging were contacted to promote engagement and offer support. 
The following adaptations and activities were undertaken based on practitioner feedback and 
guidance provided by Prescott et al. (1999), to support engagement: 
• PDF versions of the tools were disseminated to practitioners so they could review 
them; 
• the pilot trial protocol was simplified; 
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• consent procedures were embedded so this was not a separate additional activity; 
• a seven-minute video was recorded and disseminated to explain the process, 
importance and purpose of the pilot trial2; 
• the client information sheet was reworded to remove references to obesity and to 
change the inclusion criteria from ‘clients with BMI >30’ to ‘clients seeking to lose 
weight’; 
• telephone meetings were offered and arranged to address any questions and help 
overcome any barriers to engagement; 
• deadline dates for pilot trial completion were extended by three months and then 
another three months; 
• reassurance around confidentiality was provided; and 
• reassurance that the impact to the practitioner’s normal practice would be limited was 
provided. 
A considerable amount of effort was invested over the course of 11 months to ensure 
practitioners were able to engage with the pilot trial. A total of three practitioners did finally 
participate. The importance of pilot and feasibility studies has been explored by Van 
Teijlingen and Hundley (2001). Identifying if the proposed tools are appropriate or too 
complicated was important. Insight into the fidelity and usability of the tools was essential for 
further tool development. Pilot trialling also intended to determine whether the tools were 
adequate for larger studies, which could have, for example, assessed the impact of different 
layouts and construction to response sets. If participation numbers had been much higher, it 
may have been possible to utilise common factor analysis and principal component analysis 
to help reduce the number of questions on the tools and simplify them. 
For those that did engage, data was collected via the online survey software, Qualtrics. 
Practitioners were asked to send their clients the participant information sheet for clients to 
establish if they were happy to participate. If so, the practitioner was able to send them the 
link to complete Tool 1 – the health history questionnaire – via the online research software 
Tool, Qualtrics. Each client had to be given a unique identification number to maintain their 
confidentiality. 
Practitioners were able to undertake client consultations at a time that suited them. When 
the client had completed Tool 1, the practitioner was sent a copy and prompted to ask their 
client to complete the QQ-10 face validity survey (Moores, Jones and Radley, 2012). At the 
end of the first consultation practitioners were requested to complete Tool 2 – the 
                                               
2 https://www.youtube.com/watch?v=CCXmh7sJXfc&t=3s 
72 
interventions record (via the online link) – which aimed to capture all the recommended 
interventions. 
Once enough time had elapsed to allow the client to implement the recommendations, 
practitioners were requested to send their client the online link to Tool 3, the follow-up 
questionnaire. Again, the practitioner was sent a copy of the completed questionnaire and 
prompted to ask the client to complete the QQ-10 face validity survey. At the end of a follow-
up consultation practitioners were requested to complete Tool 4, the achievement record, 
with the aim of capturing which interventions the patient had complied with. 
Once a practitioner had gone through this process with a minimum of two clients they were 
asked to complete adapted versions of the QQ-10 face validity survey for each of the tools. 
The pilot trial protocol explained the process for practitioners (see appendix 6). 
Analysis focused on the validity of survey responses rather than questionnaire responses. It 
was not necessary to analyse the health issues and interventions undertaken by the few 
clients who responded. Rather, practitioner and client feedback on the use of the tools was 
assessed to determine issues with the tools and/or pilot trial that may have presented 
barriers to engagement. 
A mix of multiple-choice and open-ended questions in the face validity surveys gathered 
quantitative and qualitative data. Results of the validity surveys were exported to a 
spreadsheet for analysis. The small number of responses meant that statistical analysis was 
unachievable. 
3.10.7 Survey of NTs 
This survey was conducted by a group of undergraduate students at CNELM and supervised 
by myself and the programme leader for the BSc (Hons) Nutritional Science programme. 
These students were required to create and administer social research within a community, 
analyse the data and justify a strategy for implementing a sustainable health culture within 
the given community. These students were presented with two important queries that arose 
as a result of the pilot trial: 
1. Do obese (BMI>30) individuals seek out nutritional therapy support? 
2. Do NTs have the resources to reach or adequately engage with the growing obese 
population? 
With supervision, these students conducted a survey titled: 
Do nutritional therapists have the resources to reach or adequately engage with the 
growing obese population within various locations? 
(Gordon et al., 2017) 
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The aim of this survey was to identify potential opportunities to enhance engagement 
between obese population groups and NTs. The survey was conducted via the online tool 
SurveyMonkey (Finley, 1999). The survey was pilot tested with both supervisors before the 
link to the online survey was distributed to NTs in August 2017 via the BANT members’ 
Facebook page and the CNELM Facebook page. 
When the survey closed on 14 August 2017, a total of 49 NTs had completed the survey. 
Social media reminders were sent to increase response rates. A mix of multiple-choice and 
open-ended questions in the surveys gathered quantitative and qualitative data. Survey 
Monkey has a number of data analysis features; all response data was downloaded so the 
results could be analysed and evaluated. 
3.10.8 Interview nutrition practitioners 
The aim of the interview was to gather practitioner views on the barriers that may prevent 
nutrition practitioners from embedding standardised tools in personalised nutrition practice 
and exploring potential approaches to overcoming these barriers. Objectives included to: 
• evaluate barriers which may have prevented them (or other practitioners) from being 
able to participate with the pilot trail;  
• evaluate barriers which may prevent other practitioners from embedding 
standardised tools into personalised nutrition practice; 
• identify barriers of engagement with tools provided by clinic clients; 
• discuss potential ethical issues which may contribute as barriers to using 
standardised tools; 
• explore strengths and limitations of the NT profession which may impact on the 
utilisation of standardised tools; and 
• evaluate approaches to overcoming any barriers. 
Kvale’s (1996) seven-step interview approach was utilised, as with previous interviews. 
Participants were selectively sampled from the pilot trial process: they were nutrition 
practitioners who had been willing to participate in the pilot trial stage but did not engage. A 
mix of open-ended, semi-structured questions were included to facilitate conversational 
dialogue. The interview guide (see appendix 16) included the aims and objectives as well as 
the main questions. This was sent to interviewees at least five days in advance to ensure 
that they had time to prepare. The interviews were held via online Zoom meeting at a time 
convenient to the interviewee. Between 25 April 2017 and 23 May 2017 six interviews with 
nutrition practitioners were conducted, with: 
• three NTs who specialise in weight loss programmes; 
• one Bariatric nutritionist; 
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• one NTs and MSc Personalised Nutrition Programme Leader; 
• one naturopath and weight loss coach. 
The contents of the interviews were transcribed verbatim, uploaded to Nvivo and then a 
word frequency query was conducted to identify the following themes: tools, 
questionnaire/questions/question, standardised, clients/people, consultation, 
practitioner/practitioners/practice and profession. 
 
Figure 122 Nvivo word frequency cloud diagram 
Transcripts were then analysed and coded using these themes. Kvale’s (1996, p. 187) five-
step interview analysis methods was then utilised as per the previous interviews and the 
results were verified by triangulation with literature. 
3.11 Advantages, disadvantages and critical analysis of the 
methodology 
The tool-gathering approach was informed by MacDermid et al. (2009), who highlight the 
complications in searching the literature for outcome measures and difficulties obtaining and 
getting permission to use tools. Broad search terms were used in order to capture a wide 
range of potential papers and tools for inclusion. Bias could have been introduced when the 
results from the first search were used to frame the second search, which may have limited 
the breadth of the results. This data-collection approach also involved a degree of subjective 
judgement regarding the extent to which any study or tool met the inclusion criteria and was 
deemed relevant for clinical nutrition practice to gather individual health history data, support 
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clinical decision making or analyse clinical outcomes. However, requesting further tools for 
inclusion through practitioner surveys and interviews helped overcome these limitations. The 
search description forms, search results tracker spreadsheet and tool categorisation 
spreadsheet were designed to make the methodology transparent and replicable. 
Conducting surveys via online survey applications was low in cost and provided functionality 
which eased data analysis. Anonymity meant that when reminding potential participants to 
complete the survey, they could not be targeted because it was impossible to tell who had 
already done it. Survey development was difficult due to the limited number of features in the 
online survey software, which meant that a number of the surveys were quite lengthy. 
Biemer (2010, p. 28) highlights a range of strengths and limitations relating to survey quality. 
Surveys were designed with multiple objectives and were therefore complex and multi-
dimensional. The advantage of using and developing surveys within the project’s 
methodology meant that I was able to experiment with design and layout as well as learn 
from the analysis of surveys conducted which then influenced new tool development. An 
increased awareness of the issues affecting design, reliability, validity and analysis was 
achieved through this process. 
The use of CNELM’s and my own contacts for interview sampling introduced selection bias 
in terms of the target population. However, a minimum of three interview participants did 
allow for triangulation of the data. The semi-structured approach was advantageous in terms 
of gathering specific data, increasing comparability of the results, and being able to have a 
flexible and open discussion. The issue with the open discussion element was that I found it 
difficult not to become engaged with the conversation, and therefore I may have unwittingly 
influenced responses by expressing agreement or my own views as part of the conversation. 
Again, the use of CNELM and my own contacts, and identifying “who is an expert” will have 
introduced a level of selection bias for the Delphi participants (Keeney et al., 2011). The 
Delphi method has had a number of criticisms, which are explored by Keeney et al. (2011, p. 
20), including a lack of universal guidelines (and therefore a single definition of the 
approach), with no guidance on the number of participants required for a representative 
sample. Due to the sample size for each of the three perspectives (clinical utility, research 
utility and client acceptance), it was not possible to gain consensus. Although the results 
were aggregated and that informed new tool development, there was a level of subjective 
interpretation for tool development. 
It was clear from the surveys and interviews that tools should be simple and easy to use. 
However, the Delphi process did not allow for the tools to be narrowed down or simplified. 
With each survey round there was more feedback to incorporate, and although the feedback 
included calls to simplify the tools, participants were unable to sufficiently eliminate 
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questions in Round 3 in order to reduce the overall length of the tools. The length of the final 
tools was likely too large and complex, which may have added to the lack of practitioners 
willing to engage in the pilot trial. 
Failure to achieve recruitment targets for the pilot trial is a well-known issue among 
researchers. Treweek (2015) highlights that more than 50% of clinical trials fail to achieve 
their recruitment targets. Barriers to clinician and patient participation in clinical trials were 
thoroughly explored by (Prescott et al., 1999), as well as the length and complexity, barriers 
that appeared to be an issue in this pilot trial include: lack of time (for both practitioners and 
patients); stigma associated with obesity; perceived lack of importance of the trial; the 
difficulty of practitioners admitting to patients/clients they did not know the relevance of some 
of the questions in the tools; incompatibility of the trial protocol with “normal” clinical practice, 
lack of suitable patients and lack of practitioner research experience. 
Bias is an issue when recruitment numbers are low. Selection bias is problematic because 
the majority of practitioners that did engage were more likely to have been associated with 
CNELM, either as students or staff. This pre-existing relationship would likely mean they 
were more willing to put the time and effort into engaging with the research. Severity of 
illness or case complexity was also an issue that led practitioners to exclude certain clients 
from participating. So, when practitioners were considering which of their clients to ask to 
participate they were making a subjective choice based on whether they thought the client 
was likely to be willing and able to engage with the process and documentation. 
The fact that the tools are designed to measure the efficacy of nutritional interventions could 
be interpreted by practitioners as tools which measure how effective they personally are in 
practice, which may have also been a barrier to participation. 
Tool questions had initially been developed on paper and questions were then transferred to 
the online survey software Qualtrics to be able to undertake the pilot trial with online versions 
of the tools. During the transfer of questions from paper to the online software it was not 
possible to keep the same format of all questions – some had to be adapted to work in the 
software. Although using online survey software has advantages over paper tools, the reality 
is that the software is cumbersome. The vision for these tools is to develop them as online 
platforms which can be accessed via multimedia methods. The advantages for developing a 
bespoke application for these tools would mean that the access, design and flow of the tools 
could be enhanced. It would also give practitioners more control; they would be able to 
check if their clients had completed the tools and print off the documents for themselves, and 
that may provide more practitioner ownership and engagement. It is beyond the remit of this 
project to develop the tools via a bespoke online application. 
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The decision-making process within this project has aimed to be transparent, replicable and 
rigorous to ensure research quality as well as facilitate ease of participation. Although the 
universal definition of quality has not been clearly defined (Reeves & Bednar 1994, 
Jacobson 1998) it is recognised that different research paradigms and research 
stakeholders may interpret quality differently. Conventional research values were applied to 
this project including: rigour, verisimilitude, an objective research approach and transparent, 
systematic and reproducible research methods. 
3.12 Chapter summary 
This chapter has outlined the project’s ontological and epistemological position, research 
design and methodology, and it explores how the research methods may produce results 
that address the research questions. The processes for data collection and analysis were 
described and critically analysed. My own role as an insider and outsider researcher was 
also explored and will be reviewed again as part of the reflexive account in Chapter 7. The 
next chapter builds on this account of the overall methodology and various methods used in 
the project to explore the practical aspects of the project’s activities.  
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Chapter 4: Project Activity 
This chapter aims to describe and analyse the project activities undertaken for the 
methodologies described in Chapter 3. It explores the practical activities undertaken to 
develop and complete the research methods, surveys and interviews used throughout the 
project and draws significantly on my research journal. 
4.1 Overall activity 
Although the project was funded by my workplace, this research was not about my 
workplace and did not take place within my workplace. This project does however support 
strategic vision of my workplace: 
steering the integration of personalised nutrition and nutritional therapy to become an 
accepted mainstream healthcare option, and contributing meaningfully to the 
development of an evidenced-based approach to support personalised nutrition 
interventions by using advanced statistical techniques known as statistical machine 
learning (SML) to overcome the limitations of randomised controlled trials (RCTs) 
(CNELM, 2017) 
As Head of Education, investing in my professional development is also advantageous to my 
workplace as their business culture aims to: 
Engender commitment, accountability, integrity and partnership among staff and 
students in line with our Vision and Mission. Promote excellence, consistency and 
commitment in our teaching. 
(CNELM, 2017) 
My workplace provided me with access to use their resources, such as email and online 
conference call facilities and access to clients coming through the supervised student clinic. 
They gave me time off from work to focus on writing this report and they continue to be 
supportive of my professional development. Factors which determined the project activities 
included: access to resources, time constraints and access to research participants. The 
positive professional reputation of my workplace may have helped gain participants from the 
nutritional therapy profession, but it may also meant that participant self-selection was 
biased, it is likely that NTs would wish to support the development of the profession by 
supporting researchers wishing to demonstrate the efficacy of nutritional therapy practice. 
4.2 Data collection and analysis 
The first activity undertaken was to complete several literature reviews which aimed to 
critically review, prior to undertaking data collection, a range of ideas and theories relevant to 
the project, as well as explore how personalised nutrition practice could be transformed with 
the development of a new case-by-case evidence base. As described in Chapters 2 and 3, 
an extensive online search was conducted to identify, categorise and evaluate existing tools 
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which support individual health history data collection, clinical decision making and clinical 
outcome analysis suitable for nutrition practice in the management of obesity. 
In February 2014, during the literature reviews and gathering of existing tools, I progressed 
from using folders and a highlighter pen to undertake manual coding, to using Nvivo 10 
software. Nvivo 10 is a data handling software package that enables storage, organisation 
and analysis of qualitative research data. Loading the documentation into Nvivo felt, at the 
time, like a major change in the project’s activities. It was not just the analysis capabilities of 
the software, but the fact that I was checking again during data entry, that allowed me to be 
confident in the robustness of the data. The ease of coding using the software was helpful. It 
is interesting to note that before using Nvivo I wanted to go back and check my work 
manually. However, moving to the Nvivo package had a significant impact on time 
constraints. The time it took me to learn the software and input the data seemed worthwhile 
for the ease of analysis. 
Before completing the searches and undertaking the analysis I compared the tool 
categorisation spreadsheet with the nodes of categorised data in Nvivo. I updated the 
categorisation spreadsheet so that the categories and Nvivo nodes corresponded. This 
highlighted a number of tools that I had not identified through the manual paper method. 
Nvivo therefore appears to have provided more rigour in data collection and analysis. 
The large volume of existing tools identified that were suitable for nutrition practice in the 
management of obesity impacted on the development of the practitioner survey. I was aware 
that participants could become overwhelmed by the time commitment required to complete a 
long survey. My concern was that participant overwhelm could impact on participation later 
in the project as well as directly affect participant withdrawal and/or provide incomplete 
survey results. On the other hand, I also felt I had to include all the tools identified because 
that would be a direct reflection of the data gathered and if I excluded any that would be 
adding my subjective bias. I aimed to be rigorous and transparent. Finally, it was the quality 
analysis of each tool that allowed for exclusion of some tools, which reduced the volume and 
size of the survey. Different approaches to developing the survey were considered and 
piloted with practitioners to help analyse how to best cut the survey down to an appropriate 
size before it was conducted. 
Integrating a number of valid, robust and reliable tools into an online format and then 
establishing validity may have presented a solution for meeting the research outcomes. 
However, the majority of the tools identified were developed purely for research purposes 
and appeared to provide minimal clinical utility. Initially it was also difficult to determine how 
the data provided by these tools could inform clinical decision making. Consideration was 
given to developing a clinician’s guide so that the aim and purpose of each question could 
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be understood, but that was not possible because of the complexity of potential responses to 
questions. The idea to group questions under pathophysiological mechanisms to support 
clinical decision making did not emerge until after Round 1 of the Delphi surveys. I kept good 
records throughout the project, and this certainly helped my analysis and project report 
writing. 
Over the whole project, 18 semi-structured interviews were undertaken. Towards the final 
few interviews I became concerned that I was leading the interviewees. I had made a 
concerted effort not to lead when I was asking questions, but in some cases I did consider 
the need to explain my thinking about the research. I thought that because participants had 
given their time to do the interviews with me, and because pilot trial participation was 
minimal, I should explain my views and findings around that. Once I had this realisation, I 
aimed to explain my view after participants had answered interview questions in a bid not the 
lead them. 
At the time of starting to transcribe my interviews I had just attended a Middlesex University 
seminar on qualitative interviews which highlighted the importance of transcription for 
analysis purposes. However, my project is not about gathering depth of meaning, as in 
social research, so I reviewed the value of self-transcription versus the time it takes to 
transcribe and outsourced transcription via a professional and confidential service. I was 
then able to review the transcription and start the coding process, which was significantly 
more efficient. 
Data analysis for all activities took considerably longer than anticipated in my proposal. My 
research journal was also extensive, and I added entries regularly. I am motivated by 
robustness and spent a lot of time checking and rechecking my work, which was time-
consuming. I also wanted to triangulate data where possible, for example between 
interviews and surveys. 
4.3 Tool development 
Delphi Round 1 reviewed a range of tools and approaches, and questions for inclusion in 
new tool development, as per the methodology described in Chapter 3. Where possible, 
questions for inclusion in new tools were based on questions already included in validated 
tools from the following sources. The identification/development of questions for each 
category was therefore based on the following approach: 
1. Search for suitable question in Jeor (1997); if none identified 
2. Search Allison (1995); then 
3. Search Bowling (1995); then 
4. Search Bowling (2005); then 
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5. Search Weatherby (2004); then 
6. Search validated tools identified in categorisation spreadsheet; then 
7. Search practitioner tools provided after the survey with permission to use in this 
research project; then 
8. Search online for relevant questions and approaches. 
Round 2 aimed to gain feedback and consensus on satisfaction with the included questions. 
The decision for developing tools before Round 2 of the Delphi surveys was discussed with 
my research supervisors and it was felt that it would be better to have a visual representation 
and choices of questions for participants to give their opinion on, rather than have them 
imagine tools and make recommendations. I used the Round 1 Delphi survey results to 
develop the Round 2 survey questions. If the Round 1 survey results highlighted that 
practitioners did not use an assessment method then I excluded the assessment. This 
started to cut back on the size of the new tool. The need to keep the tool concise outweighed 
the value of including assessments that the majority of practitioners did not use. 
It was clear from the interview results that I had to further simplify tools and assessment. It 
was therefore decided to exclude already well established and validated tools for dietary 
intake and physical activity assessment as part of this project. Although these assessments 
are clearly important, they did not need to be newly constructed; the existing validated 
approaches could be integrated with new tools. I therefore focused on developing the tools 
that had not yet been robustly developed or validated: the health history and family history 
tools. 
What was useful in using existing validated tools to develop new tools for Round 2 was that 
the questions included in existing tools had already been validated. I therefore used the 
following hierarchy for formulating the new tools questions: 
• first choice: question was taken verbatim from one of the validated tools; 
• second choice: question was researched for any consensus about the best way to 
formulate the question; 
• third choice: the majority of tools (across those listed) that pose the question in the 
same way; and then 
• fourth choice: question from non-validated tools – these were highlighted for further 
consideration by the Delphi group. 
After a review of existing tools it appeared that questions grouped under headings such as 
“health issues” “symptoms” “hormone health”, appeared helpful for practitioners to be able to 
undertake clinical decision making and prioritise intervention strategies. A literature review 
was then undertaken to identify pathophysiological mechanisms of obesity, signs and 
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symptoms of those mechanisms and tools and tests assessing those mechanisms, so that 
questions could be grouped under headings of pathophysiological mechanisms. 
During the development of questions related to mechanisms there were numerous problems. 
For example, all mechanisms interrelate: mechanisms like dyslipidaemia and oxidative 
stress do not necessarily have clinical signs and symptoms. This led me to search, review 
and understand that validating clinical tools which explicitly enable pathophysiological 
mechanistic reasoning for personalised nutrition practice has not been done before. 
Although it was possible to find tools which had clustered questions around physiological 
functions, none of them were validated and validated tools identified during this search did 
not provided a pathophysiological reasoning approach. 
I had to make some educated guesses about signs and symptoms of mechanisms so that I 
could develop relevant questions. Many of the signs and symptoms which formed questions 
related to mechanisms were therefore created, but they are not evidenced. There were 
mechanisms, such as oxidative stress, that were not explicitly included in new tool 
development because of this issue. It would therefore be essential that the results from 
these mechanism questions are validated against laboratory test data on oxidative stress, 
inflammation, dyslipidaemia and other proposed mechanisms. 
Mechanism question development: 
1. Mechanisms and diseases identified from online literature searches; then 
2. Mechanisms and disease questions identified from existing tools; then 
3. Brainstorming questions with colleagues; and then 
4. Ask practitioners at next Delphi round if: 
• the range of obesity mechanisms, proposed for inclusion in new tools, is 
appropriate and comprehensive; and if 
• the questions and approaches for each mechanism correlates with it, and/or if 
further questions are required. 
After Round 2 and before Round 3, the new tool questions were entered into an online 
survey application called Qualtrics, so they could be pilot trialled via an online system rather 
than on paper. However, the Qualtrics software does not have the functionality to present 
the questions in the same way as the format the Delphi group agreed on (appendices 17 and 
18). Other software packages such as SurveyMonkey and Google Tools were reviewed at 
length, but Qualtrics possessed the best functionality. It was therefore decided to carry on 
developing the tools in Qualtrics. 
Moving the questions from the paper formats to an online format meant that the formatting of 
the tools changed, and it also meant some of the questions had to be adapted. Any 
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questions that were adapted were changed as little as possible, staying true to original 
question. Any changes that were made also prioritised reducing the overall size or length if 
the tool and increasing clarity. 
During this development, I realised tool development had focused on health data collection 
which supported clinical decision making, but there was a lack of intervention tracking to 
enable clinical outcome analysis. This led me to develop Tool 2 (the intervention tracking 
tool) (appendix 19), which aims to capture the interventions that were recommended by the 
nutrition practitioner; Tool 3 (the follow-up questionnaire) (appendix 20), which aims to 
measure any changes to the client’s health after intervention; and Tool 4 (the achievement 
record) (appendix 21), which aims to capture the interventions the client complied with. 
These were developed based on existing tool analysis and on the results of Delphi Round 1 
and practitioner surveys. This meant that tools 2, 3 and 4 only went through one Delphi 
round before being pilot trialled. However, it was anticipated that feedback would be 
received during the pilot trial and a final Delphi round would be conducted after further 
changes had been made based on feedback from the pilot trial. 
4.4 Pilot testing 
The methodological approach and the activities undertaken for the pilot trial are described in 
Chapter 3. After several months of promoting the pilot trial I managed to get 52 practitioners 
willing to participate, but only 3 of them actually engaged with the pilot trial process. I 
undertook various activities to promote engagement, which are discussed in section 3.9. 
Changing the inclusion criteria from obese clients (BMI>30) to clients seeking weight loss 
broadened the number of clients who could participate in the pilot trial. At this point I thought 
that would help increase engagement, but it did not. The adapted QQ10 validation survey 
questions were about the client and practitioner views of using the tools, whether the tools 
were too long, too complex and easy enough to use, and allowed them to express their 
health concerns, so changing the inclusion criteria did not affect the validation data gathered 
for the tools. 
I discussed the pilot trial with BANT (the Nutritional Therapy Professional Body) and they 
agreed if I recorded a request for participation on camera that I could disseminate the 
participation request on the BANT website and social media. I did this, and also recorded a 
video for those practitioners who had already agreed to participate in order to explain the 
changes, the purpose and value of the study in an effort to increase engagement. 
I had feedback from practitioners that the barrier was in recruiting clients – that the clients 
did not understand the purpose and the value of the research, even though the purpose was 
outlined in the participant information sheet (appendix 4). Asking practitioners, who may also 
not have fully understood the purpose and value of the research, to explain this quite 
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complex research study to their clients was problematic. On reflection, it may have been 
easier to organise a group of obese participants myself, then validate the tools directly with 
the group, and then present the validated tools to the practitioners for use. 
The pilot trial outcome led to a change of focus for the project: to explore the barriers that 
may have contributed to this outcome, to explore obstacles that may prevent practitioners 
from embedding standardised tools in personalised nutrition practice and to identify potential 
approaches to overcoming these barriers. 
I also started to wonder what numbers of obese individuals engaged with nutritional therapy. 
There was a dearth of research available on this theme. In January 2017 a group of students 
at my workplace were seeking a research project. I met with them and discussed my 
concerns. The students conducted a survey of nutritional therapy practitioners which I 
supervised. The survey aimed to identify the number of obese individuals’ practitioners were 
seeing in nutritional therapy practice, how those therapists engaged with the obese 
population and identify any barriers with a view to identifying potential opportunities to 
enhancing engagement between obese population groups and NTs. 
I was always aware that this project was complex, however it emerged that each of the 
following had depths of complexity which were not anticipated: 
• obesity – all individuals come to obesity through their own unique set of 
circumstances, beliefs, genetics, lifestyle and environment; 
• nutrition practice – all practitioners approach practice individually, based on their own 
unique set of values, approaches to the therapeutic relationship, personality and 
experience; and 
• clinical tools – the range and variety as well as how integral they are to the process 
of clinical practice. 
4.5 Professional development activities 
In addition to the described methodological activities I undertook numerous professional 
development activities throughout the project, including: 
• attending lectures and seminars; 
• attending BANT AGMs and keeping track of professional body updates; 
• presenting at: 
o Middlesex University Research conferences; 
o the Nutrition Society Postgraduate Conference; 
o the University of West London Research Conference; 
o an Organisation Studies Network (OSN) seminar; and 
o the 20th Dilemmas in Human Services International Research Conference. 
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• having a paper published on leadership3; 
• supporting student research and publication.4 
Some of these influenced my approach to the project more than others. For example, I went 
to an inspirational event at Oxford University called Big Data Science in Medicine. It raised a 
number of questions that I had already been thinking about and had included in my interview 
questions, e.g. how can existing online tools be integrated with newly developed paper 
tools? There is now a plethora of data-gathering applications measuring daily diet intake, 
exercise, sleep etc. that people use through their smartphones. These tools may be the best 
way to track compliance and outcomes of nutrition interventions because of ease of use and 
real-time tracking. This event highlighted the future moves towards data tracking and 
analysis which enabled me to probe deeper on these considerations via practitioner 
interviews. 
It has been critically important that I remained engaged with professional development 
activities. The insights gained from other researchers has been particularly useful in helping 
to identify opportunities to enhance the project’s activities. 
4.6 Chapter summary 
This chapter reviewed the key activities undertaken as part of this project and presented 
some of the numerous considerations and reflections that presented themselves through 
undertaking these activities. Managing the range of complexities, as well as time constraints, 
impacted on all aspects of the project’s outcomes. The next chapter will report on and 
discuss the project’s results and findings.  
                                               
3 Michelle Barrow, BSc, MSc, QTLS. Dr. Gordon Weller. Dr. Celia Bell, PhD. Dr Linda Bell, PhD. 
(2017) Leadership Development: reflective insights from a female Head of Education. Work Based 
Learning e-Journal International. 
4 Miles, H., & Barrow, M. (2018). Committed to Weight Loss: an IPA Analysis Into the Experiences of 
Individuals Who Lost Weight Through Nutritional Intervention. Current Research in Food and 
Nutrition, 6(1). 
86 
Chapter 5: New Tool Construction Findings 
This chapter presents the analysis of research findings for each of the research methods 
undertaken to construct new clinical tools for individual health data collection and clinical 
outcome analysis which support clinical decision making. The approach for undertaking the 
interviews, surveys, the Delphi method, and pilot trial are described in chapters 3 and 4. This 
chapter critically analyses the results from each research method in turn. The overall 
discussion of findings assimilates and summarises the results, and aims to interpret the 
findings within the context of existing literature, the scope of the project and construction of 
new tools. 
5.1 Findings from online search for existing tools 
A broad and extensive online search to identify existing tools which support individual health 
history data collection, clinical decision making and clinical outcome analysis was conducted 
between November 2013 and January 2014. A total of 3,334 papers were considered for 
inclusion, and a total of 46 papers met the final inclusion criteria (appendix 2). These papers 
have already been discussed in the literature review (section 2.5). 
Reviewing these results and the tools provided by participants of the survey and interviews 
allowed for the identification of broad categories of assessments related to the development 
and management of obesity and the identification of some specific obesity-related measures 
and tools. This enabled the development of the tools categorisation spreadsheet (appendix 
11). Categories included: general, diet and nutrition, psychology, physical activity, genetics 
and family history, physiological, sociocultural, body composition, test results, goals and 
outcomes and intervention tracking. 
 
Figure 133 Results of searches for tools related to each category 
As discussed in section 3.9, further searches were then conducted to identify tools related to 
each of these categories. These results allowed for the tool categorisation spreadsheet 
(appendix 11) to be updated with tools and measures that were identified in this second 
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round of searches. In total, as a result of both sets of searches, 11 categories, 65 measures 
and 34 tools were recorded. 
The results highlighted a gap between tools identified via online searches and tools used in 
clinical practice, such as online dietary assessment applications. Five online applications 
(Dietplan6, Nutritics, CRON-O-Meter, SELFnutritiondata and myfitnesspal) as well as three 
clinical tools (Measure Your Medical Outcome Profile – MYMOP, pedigree chart and 
functional matrix) were therefore added to the tool categorisation spreadsheet. MYMOP is a 
validated tool (Hourigan et al., 2014) which measures health outcomes the patient considers 
most important, but it does not correlate changes of health outcomes to interventions. 
After quality assessment, a final total of 11 categories, 44 measures and 29 tools were 
included. 
Table 5 Final categorisation of tools identified which support individual health history data collection, 
clinical decision making and clinical outcome analysis suitable for nutrition practice in the 
management of obesity 
Category Measures Tools 
Diet and 
Nutrition  
diet intake food frequency questionnaire 
eating habits food diary/record 
eating styles, behaviours and 
habits 
24-hour recall 
diet history 14-item Mediterranean 
assessment tool 
  three-factor eating 
questionnaire (TFEQ) 
  eating habit questionnaire 
(EHQ) 
Dietplan6 
Nutritics 
CRON-O-Meter 
SELFnutritiondata 
myfitnesspal 
Health History 
medication   
medical conditions 
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weight history 
health history 
Risk Factors obesity risk factors   
Psychology 
psychological wellbeing 
assessment 
general wellbeing schedule 
perceived body image EEQ emotional eating 
questionnaire 
emotional eating emotions and stress 
questionnaire 
emotions and stress Larocque obesity 
questionnaire 
eating behaviour eating disorders in obesity 
questionnaire 
eating disorder   
addiction 
motivation 
depression 
Physical activity 
physical activity undertaken activity recall 
barriers to physical activity Baecke questionnaire 
sedentary behaviour IPAQ (sort 7-day) 
Body 
Composition 
BMI   
anthropometrics 
Basal metabolic rate 
resting heart rate/pulse 
blood pressure 
waist circumference 
waist-hip ratio 
Family History family history pedigree chart 
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Quality of life  
  IWQOL lite 
Moorhead-Ardelt quality of 
life questionnaire 
obesity-related wellbeing 
(ORWELL 97) 
obesity and weight loss 
quality of life instrument 
(OWLQOL) 
short form – 12 
short form – 36 
World Health Organization 
Quality of Life questionnaire 
Sleep quantity, patterns, quality   
Sociocultural 
self-efficacy self-efficacy questionnaire  
personal or social pressures   
patient perspectives /beliefs 
self-care 
relationships 
Goals and 
Outcomes 
patient goals MYMOP 
patient’s expected outcomes   
patient-defined outcomes 
satisfaction with intervention 
programme 
self-reported weight loss 
clinical decision making 
intervention compliance, dietary 
habits, physical activity and health-
related life quality  
user satisfaction of using tool to 
enable ongoing review 
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interventions recommended 
The next stage of the research was to identify which tools clinicians used for data collection. 
This was undertaken through an online survey. 
5.2 Findings from survey of nutrition practitioners 
A total of 98 practitioners were emailed to complete a survey about the data they gather in 
clinical practice with an obese population and how they gather the data. When the survey 
closed on 1 January 2015 a total of 32 questionnaires had been completed. Of the 32 
respondents 29 were practitioners with experience of working with obese (BMI +30) adults. It 
was these 29 practitioners who met the inclusion criteria; those excluded did not have 
experience of working with obese (BMI +30) adults. 
 
Figure 144 Quantity of nutrition practitioners who participated with the survey and their professions 
5.2.1 Diet and nutrition 
Across the tools used to assess diet intake, the most frequently used assessments were 
eating style, behaviour and habits (19 out of 27 = 70.39%), with food frequency assessments 
and food diaries coming joint second. Sixteen out of 28 (57.14%) respondents always use 
food frequency assessment and 16 out of 27 (59.26%) always use food diaries in clinical 
practice, while only 5 out of 27 (18.52%) always use 24-hour diet recall. Eating styles, 
behaviour and habit assessment as well as food diaries were perceived to identify factors 
that may contribute to the client’s obesity, while the most frequently mentioned strength of 
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food frequency assessment, 24-hour diet recall and dietary analysis software was ease of 
use. The most frequently given weakness was that the client did not always give accurate 
information. 
The online application myfitnesspal was the most frequently used dietary analysis software 
(8 out of 21 = 38%). This application lets the client enter food diary data as opposed to the 
other programmes, which require the practitioner to enter the data on behalf of the client. 
Just over half of respondents (14) always, or sometimes, used dietary analysis software 
while many never (10) or rarely (3) used it. The limited use of online software applications for 
dietary analysis may be due to the lack of user friendly applications, and that their use ‘takes 
too long’ was cited as the main weakness. 
Practitioners mostly utilised their own questionnaires and food diaries. Only two respondents 
stated they used validated food assessment questionnaires. Three practitioners solely 
gathered data through interview in consultation and three had their clients enter data online, 
while one gave their client the option to track dietary intake online. 
Food diaries and follow-up consultations and interviews with the client were the most 
frequently cited methods of assessing diary compliance. Dietary assessment tools not used 
in clinical practice, such as the Mediterranean diet assessment, were excluded from 
consideration for new tool development. 
5.2.2 Health history and risk factors 
Twenty out of 27 respondents (74.07%) always assessed weight in obese (BMI 30+) clients, 
4 sometimes assessed it (17.81%) and 3 never assessed weight (11.11%). The majority of 
practitioners collected weight data through interview in consultation (22 out of 23 = 95.65%). 
Responses highlight that weight history analysis is useful to assess weight throughout the 
client’s lifespan because it: 
“gives rich clinical information about aetiology and current behaviour and its origins” (EBS) 
Tracking weight loss was also considered essential to track compliance and/or the efficacy 
of interventions by 10 out of 20 respondents (50%). 
Twenty out of 26 respondents (76.92%) assessed both health history and obesity risk factors 
while 5 (19.23%) assessed health history only and 1 (3.85%) assessed obesity risk factors 
only. The majority of practitioners (16 = 66.67%) assessed these throughout the lifespan, 5 
(20.83%) since childhood, 2 (8.33%) since adulthood and 1 (4.17%) since adolescence. 
Most practitioners (22 = 85%) gathered this data through interview at the consultation and 
asked clients to complete a non-validated questionnaire (9 = 34%). 
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The most commonly perceived strength of assessing individual health history and risk 
factors was that it identifies factors that may have contributed to the client’s obesity (15 = 
68.18%) while the most perceived weakness was that clients do not always give accurate 
information (13 = 86.67%). 
5.2.3 Psychology 
Twenty-one of 26 (80.77%) respondents assess perceived stress, addiction and motivation 
of their obese clients. One dietitian and one nutritionist only assessed motivation. One 
weight loss specialist and one NT only assessed motivation and perceived stress. The 
majority (12) gathered this data through interview at consultation only. Eight respondents 
gathered this data via interview in consultation and had the client complete a questionnaire. 
Six respondents just have the client complete a non-validated questionnaire. When asked 
how respondents assess or measure changes to the client’s stress, addiction and/or 
motivation, the majority (9) responded that this was done through questioning and interview. 
Other answers included: 
• “through observed behaviour and changes in coping and management skills, eating 
and weight change” (EBS) 
• “online diaries or journals” (NT) 
• “goal setting” (D) 
• “food diary, weight change and self-reported changes.” (N) 
• “repeat completion of the questionnaire at intervals: start, then at 6 months, then at 
12 months” (D) 
• “changes not measured” (WMS) 
• “careful and continuous monitoring” (EBS). 
When asked if participants assess perceived body image in nutrition practice with obese 
clients, of the 22 respondents 9 always or sometimes assessed body image and 8 (3.33%) 
never assessed it. Out of 24 who answered, the majority (18 = 75%) did not use any of the 
psychology tools identified in online searches. Four had used the emotional eater 
questionnaire and 2 had used the general wellbeing schedule. 
Of 24 respondents, 8 always (33.33%) and 7 (29.17%) sometimes assessed eating 
disorders in obesity, compared to 3 (12.50%) who rarely assessed it and 6 (25.00%) who 
never assessed it. Of 17 responses, 12 gathered the data through questioning at interview. 
Individual respondents stated that they assess for signs of eating disorders by: 
“talking to [the] client in consultation” (NT) 
“look for red flags which may indicate an eating disorder” (N) 
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“careful questioning at the consultation” (N) 
One stated they only assessed for eating disorders if it was raised as an issue by the 
referrer. Of the 24 who answered the question, 7 always (29.17%) and 6 (25.00%) 
sometimes assessed depression in obesity clients compared to 4 (16.67%) who rarely 
assessed it and 7 (29.17%) who never assessed it. Of 16 responses, 10 gathered the data 
through questioning at interview. Individual respondents stated they used: 
“a mixture of questionnaire and face-to-face questions” (NT) 
“consultation and medical history” (WMS) 
“[if signs of depression are observed then] a referral [would be made]” (N) 
When asked if respondents used any other method or tools for psychological assessment in 
obese individuals, 25 respondents skipped the question, suggesting they do not. Three 
specifically stated ‘no’, with 1 adding: 
“as am not qualified” (NT) 
Other responses include: 
“Not specifically. I am trained in assessing obese patients multi-dimensionally including 
possible night-eating syndrome” (EBS) 
“I am piloting our own pre-intervention questionnaire to assess readiness and expectations 
of weight management intervention” (D) 
When asked how they assessed or measured changes to depression, emotional eating, 
disordered eating or perceived body image, practitioners responded: 
“[It] varies from client to client… [the] client and I will work out a programme that works for 
client.” (NT) 
“talking to the client during consultation” (NT) 
“in-person questioning” (N) 
“through discussion, client compliance” (NT) 
“questioning” (EBS) 
“careful monitoring” (EBS) 
5.2.4 Physical activity 
Twenty responded when asked if they use physical activity recall in nutrition practice with 
obese individuals. Thirteen (65.00%) stated always, 5 (25.00%) stated sometimes and 2 
(10.00%) stated never. Of 16 responses, the most frequently highlighted strength was ease 
of use (10 = 62.50%), while out of 13 responses the most frequently highlighted weakness is 
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that the client does not always give accurate information (11 = 84.62%). When asked which 
tool they used most frequently to assess physical activity (the international physical activity 
questionnaire [IPAQ] or the Beacke questionnaire), 21 stated neither, 10 skipped the 
question and 1 weight management specialist responded that they used the IPAQ 
questionnaire. 
Out of the 21 who responded, 18 (85.71%) assessed both barriers to physical exercise and 
sedentary behaviour. None just assessed sedentary behaviour, 2 (9.52%) – one NT and one 
weight management specialist – just assessed barriers to physical exercise and one (4.76%) 
NT stated neither. Fifteen stated that the data was gathered through questioning and 
interview at the consultation, 1 of whom used this in combination with a questionnaire. 
Physical activity recall, barriers to physical exercise and sedentary behaviour appear to be 
frequently assessed. The survey failed to assess data-collection methods for these. It is 
likely that physical activity recall data is gathered via interview in consultation, as this was 
the most frequent method for assessing barriers to physical exercise and sedentary 
behaviour. Questionnaires, online journal and applications such as myfitnesspal also allow 
for exercise tracking, but these data-collection methods were not mentioned. 
5.2.5 Body composition 
Twenty-two responded on the use of BMI in the assessment of obese clients. Thirteen 
(59.09%) responded that BMI is always taken into account, 5 (22.73%) responded 
sometimes, 2 (9.09%) responded rarely and 2 (9.09%) responded that they never assess 
BMI. One NT response stated they used: 
“fat percentages using [the] Tanita scale and clothes size.” (NT) 
When asked how height and weight data was gathered, 14 (70.00%) responded that they 
measured the client for height and weight and 6 (30%) responded the client reports their own 
height and weight. 
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Figure 155 Gathering height and weight data chart 
Of the 22 that responded to whether they use waist circumference or waist-to-hip ratio, 9 
(40.91%) stated they used both, 5 (22.73%) stated they used waist circumference only, 1 
(4.55%) stated waist-to-hip ratio only and 7 (31.82%) stated they used neither. Twenty 
(90.91%) respondents never use callipers. One NT stated rarely and one nutritionist stated 
sometimes. One stated: 
“During my training as a nutritional therapist I pinched a volunteer’s nerve with callipers so I 
know that it can cause problems. Also, I assume clients may not want this type of physical 
contact.” (NT) 
Seventeen (77.27%) respondents never assess the basal metabolic rate or resting heart 
rate. Two (9.09%) practitioners, one eating behaviour specialist and one weight 
management specialist assessed resting heart rate only. Ten (45.45%) did not assess blood 
pressure or pulse. Six (27.27%) assessed just blood pressure and 6 (27.27%) assessed 
both, while no respondents assessed only pulse. Nine (75%) collected the data by 
measuring the client while 3 (25%) have the clients report their own measurements. 
5.2.6 Family history 
Twelve (57.14%) out of 21 who responded stated they always ask obese clients about the 
health of family members. Five (23.81%) said they sometimes ask, 2 (9.52%) said they 
rarely ask and 2 (9.52%) stated they never ask about the health of family members. Fifteen 
(78.95%) gather this data through interview at consultation. Seven (36.84%) have the client 
complete a form or questionnaire. One (5.26%) practitioner completes a pedigree chart and 
none ask the client to enter the data online. 
30% (6) 
70% (14) 
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5.2.7 Quality of life 
Eighteen responded to the use of validated clinical tools in quality of life assessment. 
Sixteen used none of the tools named. One eating behaviour specialist uses the ORWELL 
97 obesity-related wellbeing tool and the WHO Quality of Life questionnaire. One Weight 
management specialist also uses the WHO Quality of Life questionnaire. 
 
Figure 166 Results for use of validated quality of life assessments 
5.2.8 Sleep 
Twelve out of 19 respondents assessed sleep quantity, patterns and sleep quality. One 
nutritionist, 1 dietitian and 1 weight management specialist did not assess any of these. One 
NT assessed sleep quantity and patterns only, 1 dietitian assessed quality only, 1 dietitian 
assessed quantity only and 1 nutritionist assessed sleep patterns only. One dietitian stated: 
“We discuss how inadequate sleep can impact obesity in group and one-to-one sessions.” 
(D) 
5.2.9 Sociocultural 
In the management of obese clients, 7 practitioners assess all of the sociocultural influences 
named in the chart below. 
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Figure 177 Results for assessment of sociocultural influences 
One eating behaviour specialist who assessed all of these stated: 
“I am trained to assess all of these and work with all of these.” (EBS) 
No other comments were given, suggesting other sociocultural factors should be assessed. 
When asked how the data was collected, 6 (31.58%) gathered the data through interview at 
consultation and have the client complete a questionnaire. Twelve gather the data through 
interview at consultation only and none ask the client to complete only a questionnaire. 
5.2.10 Goals and outcomes 
Out of 20 respondents, only 1 nutritionist did not assess whether the client met their 
expected outcomes/goals as a result of nutritional intervention and did not assess the client’s 
satisfaction with the intervention programme. The majority (16 = 80%) assessed both of 
these. Two NTs and 1 dietitian only assessed whether the client met their expectations, 
while 1 NT only assessed the client’s satisfaction with the intervention programme. When 
asked how the data was collected, 12 stated they gather the data through interview at 
consultation, 2 had the client complete a questionnaire or feedback form while 5 stated they 
used both methods. 
Nineteen responded when asked if they use the MYMOP to assess the outcomes of 
nutritional interventions in obesity management. Of the 19, 14 responded ‘never’ and 5 
responded ‘sometimes’. An open-ended text option was given for respondents to comment 
on whether and how they measure or assess any other outcomes of nutritional interventions 
in obesity management: 
“clinical interview [because it] fosters rapport and wellbeing of patient [without] just [focusing 
on] weight” (EBS) 
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“progress reports in clinic journals/diaries from client, whatever reporting log we have elected 
to use in clinic” (NT) 
“overall improvements in health [assessed through] interview” (D) 
“sometimes functional tests…allow reassessments and helps in clinical decision making” (N) 
“Reviewing lab data, GP-patient summaries, self-reported feedback from individuals or 
carers” (D) 
“Improvements in these areas can be very powerful: they demonstrate the worth of 
intervention to GPs, carers, patients and remind participants that their commitment and 
actions have made a tangible difference to their health” (D) 
However, “Sometimes the differences are not significant enough at that point in the process 
to make an impact.” (D) 
5.2.11 Discussion of survey results 
Results highlight varying and inconsistent clinical assessment and data-collection 
approaches in nutrition practice. The majority of nutrition practitioners used their own 
approach to gather data through the use of their own non-validated questionnaires or 
through interview within the consultation setting. Only a few practitioners used a few 
validated tools. It is assumed that this is due to a lack of validated tools and applications to 
support clinical nutrition practice. There is also a variation in data gathered by practitioners, 
on sleep for example, which is likely due to: the individual approaches used to gather data, 
the varying levels of clinical skill, training and knowledge of practitioners, and varied 
understanding of the clinical relevance of contributing factors, such as sleep. 
The strength ‘ease of use’ was the most frequently cited across all assessments, and was 
the most significant strength in at least 20 different assessments. It may be that ‘ease of use’ 
plays a role in the choice of assessment methods for practitioners. ‘Ease of use’ was 
followed by ‘identifies factors that may be contributing to the client’s obesity’, which was the 
main strength across 9 different assessments, except in the use of MYMOP and blood 
pressure and pulse assessment. The assessment ‘allows you to re-assess and monitor 
client progress’ was also considered to be a strength across all assessment methods except 
for family history assessment, and it was the most significant strength of the MYMOP 
assessment. The ‘data informs clinical decision making’ was considered a strength across all 
assessment methods, while “accuracy of data gathered” was considered a strength in all 
assessments except sleep and the MYMOP assessment. “Reliability and validity of 
assessment” scored the lowest in terms of strengths suggesting a need for reliable and 
validated tools in nutrition practice. 
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This is supported by an assessment of the weaknesses which highlights “the assessment 
lacks reliability and validity” was frequently cited as a weakness across most assessment 
methods. Although, “the client does not always give accurate information” was the highest 
scoring, most frequently cited weakness. It is not clear in the literature whether client/patient-
reported data may be more accurate when recorded electronically or when a practitioner 
gathers the data via interview. It seems logical that certain body composition assessments 
may be more accurate when measured by the practitioner, especially where “difficulty getting 
accurate measure” is cited as the main weakness. “Takes too long” was cited as a weakness 
across numerous assessment methods, highlighting practitioner time constraints. The 
majority (23 = 73%) of participants, irrespective of their profession, were self-employed in 
private practice, which may impact these findings. Independent practice may contribute to 
time pressures, economic uncertainty, case load uncertainty and excessive workload issues 
(Nash, Norcross and Prochaska, 1984). 
It is more time effective for the client to enter diet data directly into software rather than have 
the client give the data to the practitioner to enter. Currently, there appears to be a lack of 
client facing diet applications for professional use. Nutritics are developing an application in 
order to provide a shared client and practitioner tool which can provide detailed dietary 
analysis to support professional clinical decision making. A new application, 
CheckYourNutrition, came to market in 2017. CheckYourNutrition assesses food frequency 
via food diaries, but does not appear to include explicit information about eating style, 
behaviour and habits. It would be beneficial if food diary/journal applications allowed clients 
to upload food photographs, enabling practitioners (or a software application) to undertake 
nutrient analysis directly. 
Health history and obesity risk factors are essential to help identify pathophysiological 
mechanisms that may be contributing to client obesity and to identify further red flags and 
comorbidities, such as Type 2 diabetes, sleep apnoea and other conditions or medications 
that may contribute to or result from obesity (Aronne, 2002). There appears to be a lack of 
standardised clinical tools to gather and assess this type of data in an obese population. 
Overcoming the limitations of accurate client information is difficult when the information 
relates to other people (Ginsburg & Willard, 2009). A family history questionnaire or checklist 
is a tool used in research or general practice, while the pedigree chart is more likely used by 
geneticists. 
With regards to clinical outcome analysis, many of the body composition measures, such as 
BMI and waist-to-hip ratio, can be used as outcome measures to evaluate the effectiveness 
of a weight loss programme, even though there are a number of strengths and limitations to 
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each of the assessment methods, which are clearly described in the literature (Beechy et al., 
2012; Silva et al., 2013; Switzer, Mangat and Karmali, 2013; Lindsay et al., 2014). 
Outcome analysis is also about keeping in touch regularly with the patient (Velentgas et al., 
2013). However, there was a lack of outcomes analysis which correlates to actions or 
interventions the clients may have implemented. 
The meaning and purpose of measuring quality of life has broad considerations (Bowling, 
1995, p. 1). The measurement of health outcomes is essential to researching effectiveness 
of clinical interventions and disease-specific scales are considered more clinically and 
socially significant than generic quality of life (QOL) scales (Bowling, 1995, p. 16). QOL 
measures frequently overlap with measuring psychological wellbeing, exercise ability and 
sociocultural support. It would be important to limit repetition but also capture red flags, 
potential comorbidities and broader health status. Measurement of health outcomes should 
be tied to measures for exercise, sedentary behaviour, diet intake and psychological mood 
(Wolf, 2002). 
There are a number of tools available for measuring social networks and support. Social 
roles and relationships in relation to obesity have primarily focused on marital status, but 
ethnicity, cultural factors and relationships also play a role (Crawford, Jeffery, Ball, & Brug, 
2010 p. 106). The mechanisms by which sociocultural factors are associated with obesity 
are not well understood (Crawford et al., 2010, p. 107) probably because they are numerous 
and complex (Crawford & Jeffery, 2005 p. 37–53). Developing a case-by-case evidence 
database may allow for correlation analysis which further explores the influence of 
sociocultural factors in obesity. This data could also help to highlight or limit the number of 
confounding factors when data mining such a database. 
A number of outcome analysis methods are used in clinical practice but each practitioner 
uses their own approach. Standardisation of intervention and outcome analysis tracking may 
allow for CER. The MYMOP (Paterson, 1996) is a validated and frequently used tool that 
allows for reassessment and monitoring of client progress. However, it is limited because it 
utilises client-reported outcomes and therefore has limited comparative capacity. Tracking of 
obesity-specific outcomes alongside client-reported outcomes provides more robust clinical 
outcome analysis (Wolf, 2002). 
What has not been assessed by the survey, and was not reported by the respondents, was 
the identification of potential pathophysiological contributors to obesity, such as 
inflammation, insulin resistance and hormone imbalance, to support clinical decision making. 
New tools which link data on sleep patterns to eating habits may also be able to identify 
associations between sleep and eating for individuals and stratified cohorts. This could help 
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to personalise intervention decisions and potentially motivate change of lifestyle and 
behaviour in individuals. 
Some respondents shared their own clinical tools as a result of this survey. These were 
reviewed and compared to validated tools to inform new tool development. A number of the 
practitioner’s self-developed health history questionnaires do gather health data where 
questions are clustered in physiology groupings e.g. cardiovascular system questions, 
nervous system questions, circulatory questions etc. 
Signs and Symptoms Analysis from a Functional Perspective by Weatherby (2004) includes 
a nutritional assessment questionnaire that takes this grouping approach. It also provides a 
guide to the significance of the question, what responses may indicate and potential clinical 
recommendations for consideration. The questionnaire and approach by Weatherby (2004) 
is not validated, and the connections made from the questions to the clinical 
recommendations made in the book are not referenced or linked to research, but the 
approach appears useful for clinical practice. Analysing health data when it is grouped in this 
way may support practitioners’ pathophysiological reasoning and clinical decision making. 
Although the survey was useful for gathering information to inform new tool development, 
results did not identify frequently used validated tools that could be integrated into an online 
format. These results highlighted that there are currently no standardised data-collection 
methods in clinical nutrition practice, and each practitioner is gathering data in their own 
unique way. Therefore, enabling robust, standardised data-collection methods could 
transform personalised nutrition practice. 
5.3 Findings from interviews 
Twelve interviews with nutrition practitioners (6), academics (5) and a statistician (1) were 
conducted and transcribed between February and June 2015. Their comments below are 
coded with their initials and P for practitioner, A for academic and S for statistician. The 
interviews with practitioners aimed to gather views on clinical tools, assessment and 
decision making, as well as evaluate views on the ethics and implications of standardising 
approaches to personalised nutrition. The aim of the interviews with academics and 
statistician was to evaluate their experience and views on tool development and validation 
and/or data set management to inform new tool development. 
Results from all 12 interviews are presented under 14 headings, which were the themes 
identified from the data during transcription and analysis. The following combines both 
practitioner and academic results, as a number of academics also have clinical experience 
and some practitioners were in academia. They also discussed a number of overlapping 
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themes; therefore analysis enables a comparison of the differences and similarities between 
practitioner and research responses. 
5.3.1 Standardised approaches 
All six practitioners responded positively when asked about their views on the use of 
standardised data collection approaches or questionnaires in personalised nutrition practice. 
Consistency, structure, reliability and getting comparable information were seen as benefits: 
“They provide a structure really, a practice for all kinds of practitioner whether they be 
dietitian, public health therapist, or GP, other health profession, to gather basic data, that is 
consistent.” (CC-P). 
Practitioners also highlighted potential limitations: 
“I’m unconvinced that some of the questionnaires don’t just distort the information as much 
as they give [sic].” “It’s very, very hard to get somebody to tell you the truth about what they 
really eat,” and “what becomes reported on a piece of paper becomes an instrument for 
being judged.” “It becomes some kind of interrogation around food.” “My way of getting 
around that is a very unstructured, very relaxed sort of interview.” (RJ-P) 
“There is a small risk of putting the practitioner’s agenda over and above the patient’s 
agenda, which means that before a patient comes to you, you already know the set of 
questions you are going to ask so from that point of view the practitioner’s agenda becomes 
more of the priority and there is a risk of losing the patient-centred approach.” (DT-P) 
A way to overcome these concerns was also proposed: 
“So long as the practitioner is using the tool alongside the consultation the tool will not 
replace the individualised conversation.” (DT-P) 
5.3.2 Ethical issues 
When practitioners were asked about ethical issues arising from using standardised 
approaches to personalised nutrition practice, there were some concerns, including: 
“…maintaining and protecting the patient’s autonomy.” (DT-P) 
“Legal and ethical implications of storing personal data is probably one of the biggest 
challenges.” (AJ-S) 
Inclusivity and tool validity were also raised as ethical considerations: 
“people who can’t read or write can’t go away to a complete questionnaire in their own time.” 
(AJ-S) 
“Patients for whom English is not their first language [may be excluded]” (JS-A). 
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“Because we live in a multiple society [sic] and you know, you wouldn’t want your [tools] to 
put people off who come from slightly different cultural backgrounds.” (MA-A) 
“You will also want to see how non-obese people respond.” (JN-A) 
Another important issue was identified: 
“From an ethical perspective we can’t demand questions to be answered.” (CR-A) 
5.3.3 Patient/client-centredness 
Patient- and client-centredness was a recurring theme throughout the interviews, for 
example: 
 “What’s important with a professional is when they get to speak to somebody kind of face-
to-face about the issue, is to be able to be patient, patient-led and patient- kind of directed”. 
(JS-A) 
“I think a lot of achieving weight loss is about wanting to do it in a way that suits you.” “Every 
case is very, very different, so I think a lot of it is very much linked to recognition in the 
individual of what’s caused the problems and their engagement with addressing it.” (CR-A) 
“Let them lead the way in terms of them deciding what the priorities are and what the 
strategies will then be.” “The key thing is helping them unpick their relationship with food, 
what have you tried in the past, what’s worked well and what doesn’t work well.” (RJ-P) 
“A lot of it is very much about getting people involved in their own self-help.” (CR-A) 
5.3.4 Health history collection 
Practitioners were asked how they determine the main issues contributing to obesity for their 
individual clients: 
“Looking at the diet, looking at the family history and looking at certain factors that are going 
to be influencing things such as sleep and stress and hormones.” “From a tool point of view I 
guess by the time I’m meeting with them it’s all verbal.” (HL-P) 
“[This information] comes more from speaking to the client and understanding at that initial 
appointment how we’re going to get them on the right track as quick as possible”. “The 
reality is the majority of us don’t know who is going to walk through the door… so you need 
to know everything about everything.” (NM-P) 
This also highlights that gathering health details before consultation is useful: 
 “Dietitians will have access to people’s medical records, and so you don’t actually need to 
get the patient to spend a lot of time actually telling you about their medical history because 
you know a lot of it.” (JS-A) 
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“Initially before I see anyone usually, I get a GP-patient summary, which will tell me all of 
their current active problems and any recent blood test they have had. And then the rest of it 
really comes directly from the patients, when they sit in front of me.” (CC-P) 
The importance of triangulating data was also discussed: 
“If they say that they are a gym member can we go back and see how often they have 
scanned into their local suite of their local gym.” However, “rather than challenge them about 
it, just try to sort of understand the reasons why they’re misreporting in those ways or 
question them in different ways so that we get more precise data.” (CR-A) 
5.3.5 Clinical decision making 
Practitioners were asked in which ways the questionnaires and tools help them make clinical 
decisions: 
 “The tools that we are currently using are not able to help practitioners decide what 
intervention is better for patients.” (DT-P) 
“You make clinical decisions on the day… based on the evidence that you have.” (NM-P) 
From the questionnaires and tools “you are able to get some baseline data, be it physical 
activity levels, their eating pattern, and things like that. You can use that information as a 
basis to discuss where they may be struggling. For instance, if you realise that a patient is 
not eating regularly and the problem is that they don’t apportion time to have breakfast, then 
you can fill up the conversation around time management. So from that standpoint, if you 
have a tool that can identify the difficulties then you can use that as a basis to, to direct your 
conversation with the patient.” (DT-P) 
“It’s about really just understanding what, what’s getting in the way for them and helping 
them through the often practical ways of overcoming that”. (AG-P) 
Results highlight that clinical decisions can also be patient-led: 
“When I say ‘how can I help?’ that question is nearly always answered with a key clinical 
outcome.” (RJ-P) 
5.3.6 Clinical outcomes analysis 
Although the interviews failed to ask specific questions about clinical outcomes analysis, it 
was discussed, and results were closely related to patient-centredness: 
“[It is a] tool to capture the baseline data, like these how much fruits and vegetables they 
were eating, how much physical activity they were doing, how often they were eating 
breakfast and things like that,” and then assess “the data [again in] six months’ time.” (DT-P) 
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 “I have more touch points with that client on obesity management. So it might be that I have 
a weekly touchpoint, it might be that if they are local I will see them each week and the follow 
ups might only be 15 minutes, 30 minutes but there will be an allowance probably once a 
month for a longer session. I’ll do the intervening touch points by Skype or by phone and 
then as I progress with a client then the gaps between having contact with me will probably 
get longer, assuming it’s all going well, (obese clients) definitely need more care and hand-
holding and more support and most of that is around motivation.” (AG-P) 
“What’s really missing at the moment is before and after interventions [analysis]” (RJ-A) 
“You need to [understand] from one consultation to the next as to what’s working, what isn’t 
working, what progress is being made” (HL-P) 
“Capturing data now and then we will follow up and see the trend of that data maybe six 
months’ time. I think that is the missing link the fact that the tool that we are using was not 
able to help practitioners decide what intervention is better for patients.” (DT-P) 
5.3.7 Engagement with the evidence base 
Practitioners were asked ‘In what ways do you use the scientific literature to support your 
clinical decision making?’ As well as, ‘In what ways do you analyse the client data you have 
gathered against scientific literature?’ 
“Within the NHS most people will base the decision making on existing guidelines more so 
than individual pieces of evidence and the hope is that these guidelines are based on 
evidence, so most people use that as useful clinical decisions rather than sourcing evidence 
and all.” (DT-P) 
“I’ll look at guidelines for particular illnesses”; “pinning down the guidelines”; “we’ve got too 
many guidelines”; “I would look at NICE quite a lot” (RJ-P) 
The dietitian and the naturopath referred to guidelines when asked about engagement with 
the evidence base. Other practitioners engaged with the evidence base to explore their 
client’s health condition if it was complex or beyond their clinical experience. They also 
engaged with the evidence to: 
• “check drug, nutrient interactions” (RJ-P); 
• “research about medications” (NM-P); and 
• “look at the mechanism or action of the pathophysiology of the disease”; “mechanism 
of action of interventions” (JN-A). 
Time constraints were also frequently cited as a barrier to engaging with the evidence base. 
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5.3.8 Linking new tools to the evidence base 
Practitioners were asked ‘if a tool or questionnaire was devised that that linked to supporting 
research literature, how would that be useful for your clinical practice?’ 
“Fabulously useful. It would, it would make the difference between using it and not using it”. 
(RJ-P) 
Unfortunately, there were no solutions offered by practitioners in terms of how that could 
work. Academics responded cautiously to the idea of linking new tools to the evidence base: 
“That is a huge amount of work, I mean that is a lot of work. I think if you can, make that 
recommendation” (MA-A) 
“I guess that’s quite a long way down the road in terms of tool development, isn’t it? Because 
you wouldn’t really want to do that, until you have got your own substantive database. 
Because you know, if you – for example if you develop a tool and you use that tool, and say, 
hundred people who are obese, you don’t know how representative your sampling is, of the 
general population or about clinical population. So, actually linking that to evidence in terms 
to improve clinical decision making, I think you will probably need to be fairly far down the 
road in terms of your tool development before you can actually do that. Because, you know, 
making these kind of links on the basis of a limited evidence base. I am not sure how helpful 
that would be.” (VS-A) 
5.3.9 Case studies 
Three practitioners highlighted the value of case studies when discussing engagement with 
the evidence base: 
“What I respond to the most is reading other case studies.” (HL-P) 
“[Research data] kind of has to be case study-based really because it’s the practical clinical 
side that we are looking at not the research theory. It’s not the theory of what happens when 
rats are fed with something, it’s actually what happens with real people”; “It’s a great way of 
keeping up to date.” (AG-P) 
Practitioners were also asked ‘what are the advantages and disadvantages of sharing case 
data with researchers to create an evidence database for nutrition practice?’ The 
advantages for sharing case data include: 
“It makes you look at yourself a bit when you listened to other people’s ways of doing 
things.” (CC-P) 
The considerations or limitations for sharing case data: 
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“At the moment [sharing case data is] not that useful because I think it’s so individual and it’s 
so out of any format, I think that’s the problem. I think giving a format that could be followed 
so there could be some level of uniformity, I think would be essential.” “I absolutely would 
[share case data] if I completely trusted them, I knew how it was going to be used and how 
they were asking you to submit the information wasn’t too time-consuming.” “[What’s 
required is] a repository that is a bit more structured, if you were uploading a case that you 
would be forced to put it into a certain format, so that you collected all of the essential stuff 
that was important for clinical decision making.” (HL-P) 
5.3.10 Priority considerations for developing new tools 
Practitioners and academics were asked what they thought were the most important 
considerations for the use or development of questionnaires/tools in clinical practice. There 
appears to be a conflict of views between practitioners and academics on using tools. The 
practitioners were interested in narrative medicine: 
“I don’t think it’s appropriate to tick a box about ‘do you feel anxious often?’ I think that that 
comes out in the narrative.” (RJ-P) 
“Sometimes the best thing you can do is actually put the pen down and… just let people’s 
feelings and thoughts and anxieties about doing this come to the fore, just a series of flexible 
and open questions to keep the dialogue going is sometimes all you need.” (JS-A) 
“You can look through a questionnaire and really get a good understanding what you think 
you are going to want to work on with that client, but often, it’s actually when you speak to 
them, you uncover a lot more information.” (NM-P) 
The academic view is: 
“Free text answers are deeply problematic [from the point of view of statistical analysis], 
you’ve got to code them up. If we are going to develop a tool that is useful and statistically 
validated then the free text answers may be of clinical utility but they are not really given 
statistical utility.” (JN-A) 
“So tools need to be developed so that they are useful for research purposes”; “proper 
statistical analysis”; “to be able to pull that (data) out (into a spreadsheet) and then we can 
analyse it in a standard piece of software… like SPSS.” “[and to be able to] look for before 
and after efficacy, do time series analysis, see how people on different diets are responding 
similarly or differently.” (JN-A) 
Tools also need to be useful for clinical purposes: 
 “Usability, practicability, striking the balance between getting as much information as 
possible but doing it within a context of it not being demotivating.” (AG-P) 
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“You need [the tool] to be flexible: not all people come to obesity via the same route.” (JS-A) 
“[There are] very different kind of histories and so any tool needs to be able to capture the 
sort of richness and depth” (JS-A) 
“Anything that’s sort of relatively easy to do is not going to capture the complexity” (HL-P) 
“Your main concern is if this tool going to be an add-on or is it going to help me save or 
manage time”; “Time is the huge factor.” (DT-P) 
It was felt by one practitioner that tools are about: 
“Making sure that we are showing a degree of competency as a profession so, we are using 
the questionnaire to help us make sure we’ve covered red flags, family history, the 
medications are the client is taking, the GP details, consent from the client… it covers quite a 
lot of admin and important clinical audit aspects, as well as giving us some basic information 
around their physiology” (NM-P) 
Having a client without a questionnaire: “[is] like a comfort blanket taken away from me, but 
also it, it does, prevent me from being able to make sure I’ve covered all the, the major areas 
that might not necessarily come up in a general chit chat conversation style of, of 
questioning.” (NM-P) 
Clinical tools appear to have numerous applications, one (as above) is in providing security, 
but practitioners also thought it was about: 
• “getting as much background information as possible” (AG-P); and 
• “[getting] a client thinking because what we offer is quite a different sort of approach 
that they’ve probably had before. A lot of people have forgotten their whole health 
history and if you just go in without a questionnaire or anything, asking them some of 
the questions we ask, - they wouldn’t remember. So by having the health 
questionnaire it gets them thinking, it gets them talking to family members to jog their 
memories and that enables us to get much more complete information on the day.” 
(HL-P) 
5.3.11 Desired from new tools 
A number of suggestions were made throughout the interviews for the desired functionality 
of newly developed tools: 
“Electronic data capture is vital”; “Combine these tools with mechanistic information”; “To 
have questions that are clearly tied to pathophysiology”; “Linking each question to a 
particular mechanism.” (JN-A) 
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“Objective evidence-based measures that are quick”; “Probabilistic flowcharts for clinical 
decision making that were evidence-based”; “I want to be able to keep electronic records in 
the clouds for all my clients”; “Easy to use.” (RJ-P) 
“Really easy to use and not easy to misinterpret” (NM-P) 
“Evidence-based so it gets us more accepted in mainstream medicine” (HL-P) 
“Wouldn’t it be great if you had, if there was a fabulous easy access repository of data” (AG-
P) 
5.3.12 Tool validation 
Academics were asked about their views on validating tools: 
“The tool needs to be statistically validated” (JN-A) 
“We [have] got to [be able] to pool our data, especially in the UK, it’s ridiculous, how 
everyone is doing something slightly different and it’s not comparable and then all that 
information is completely waste.” (MA-A) 
Validation techniques discussed include: 
“Face validity is one of the most important things” (MA-A) 
“The advantage of using the existing ones [questionnaires] is that you’re hopefully at least 
starting with questions that make sense and pass the face validity test.” (AJ-S) 
“Go back to people with obesity, go back to your patients and make sure that what you are 
asking them is, what you think you are asking them because we often think, we are asking 
something, and people respond differently because they don’t quite understand what we are 
trying to get at.” (MA-A) 
“Things like reading age are important. So, readability, using lay language, a lot of 
psychological tools are pretty awful in terms of the questions they ask and tend to ask the 
same questions.” (VS-A) 
“Very standard techniques [as well as more complex analysis]”; “principle component 
analysis or PCA which is very typically used to validate questionnaires or understand the 
responses that particular groups of people have to questionnaires” (JN-A) 
It was thought that the pilot trials would provide an opportunity to undertake validity 
assessment. 
5.3.13 Data sets 
Academics were also asked about the management of data sets: 
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“Possibly some of the best data you could get is if you are getting good quality longitudinal 
data, so you are following up the same subjects over a period of time, and if they are 
changing their diet patterns during that time, then you are starting to get some potentially 
useful data on the physiological parameters at any rate, that’s not going to help you so much 
with the long-term outcomes”; “That’s a lot more reliable than looking at between person 
facts as you have got cross-sectional data, all you can do is compare the person who eats 
12 sausages with the person who eats tofu burgers”; “Missing data is always a big problem. 
Well, I say it’s always a big problem often in questionnaires if people filling the questionnaire 
tools, they often do fill in all the questions”; “You will usually get a small amount of missing 
data... if you are unlucky, you might get lots of missing data and statistically that can be quite 
tricky to handle.” (AJ-S) 
“You always going to get some people who report good and some who report bad 
deliberately, if you like, and I think it’s just a question being aware of that. I mean, there are 
other biases.” (VS-A) 
“The more important thing is how you get people to honestly complete the measures.” (MA-
A) 
5.3.14 Database research 
The implications and ethical issues of building a case-by-case evidence base was discussed 
with both practitioners and academics: 
“There is the challenge of knowing what you are going to do with the data before you start 
building your database for research purposes, you want to be really clear about what your 
research hypothesis is and making sure that the data is going to be able to answer that”; 
“Even if you think really carefully about that build of wonderful database and get a great 
sample size and everything, it may still not be completely convincing”; “That’s why potentially 
using longitudinal data could be beneficial because that cuts out a lot of the confounding 
[factors], but it certainly won’t cut out all of it.” (AJ-S) 
“Even in the general population sample, you can’t assume that that is representative 
because it may be that the kind of people who consult nutritional therapists, they are not 
representative in a general population. I think when you get into the stage of building up a 
clinical database, within that you are going to have lots of subsets of people, with different 
characteristics, and I think it might be dangerous to make to draw inferences on the basis of 
a database, of say a thousand people but where those thousand people have vastly different 
characteristics. So, for example, maybe different health conditions or different age group or 
different socioeconomic groups. So, I think you have to be very careful, not to draw 
inferences that are not representative, of the population you are working with.” (VS-A) 
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“I think, it’s very difficult thing when you think about data mining because people can’t give 
that consent to things that they don’t, you know, you might not know what purpose you want 
to use your database for. So you can’t ask people to give consent.” “People may be happy to 
give general consent but they don’t know who’s going to be using the data. Can you 
guarantee for example, it’s not going to be used for commercial purposes? People may not 
want that, they may be happy to give it to the health consultant but not for commercial 
reasons. So, I think the ethics of this is really important. And then of course, it’s the whole 
data protection issues as well. You have to be really careful of that.” (VS-A) 
5.3.15 Discussion of interview results 
One of the main research questions this project is designed to answer was “is it possible and 
ethical to standardise a personalised approach to nutrition practice?” It appears from the 
interviews results that standardised data-collection approaches, such as questionnaires, are 
important and beneficial, and could contribute to the development and dissemination of best-
practice case reports. The perceived benefits included enabling the development of a 
repository of data and evidence development for personalised nutrition practice. There were 
limited ethical concerns relating to standardising data-collection methods, although ensuring 
patient-centredness and inclusivity were key, as was ensuring tools do not replace the 
consultation process because of the value placed on client narrative and centredness. The 
results do highlight that ethically, the use of tools and questions cannot be made compulsory 
in practice and the value of undertaking ongoing population and cross-cultural validity 
assessments is necessary to address the ethical concerns raised (Beaton et al., 2000; 
Zumbo and Chan, 2014). 
The ethical concerns and validity of data mining from a case-by-case evidence base are 
more problematic, and highlight the importance of data storage, consent and the issues of 
gaining consent for data mining when it may not be possible to be exact about its purposes. 
Solutions for overcoming key issues for data mining electronic health records are discussed 
in the literature (Blumenthal and Tavenner, 2010; Jensen, Jensen and Brunak, 2012; Ross, 
Wei and Ohno-Machado, 2014). The value of knowing the purpose of the evidence base 
before building it was seen as key. The primary purpose of building a case-by-case evidence 
base for nutrition practice is to allow for the probabilistic prediction of the outcomes of 
interventions. This is the key goal. Missing data was also identified as an issue, although 
there are statistical methods for overcoming this. 
The results highlighted the value of ongoing feedback from the users of the tools in order to 
further shape them and ensure compliance. Trialling tools with diverse representation groups 
may also help identify sensitivity to cultural differences as well as around questioning of 
obesity, to avoid questions becoming an interrogation of food intake or an instrument of 
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judgement (Hannah et al., 2009). As a result, obese individuals were invited to engage with 
the development of new tools via the Delphi process, as well as provide feedback on 
completing new tools after pilot trialling. 
The results support the perception that practitioners engage with the evidence base in 
different ways. Some practitioners are using public health guidelines such as NICE, as 
discussed in Chapter 2. Other practitioners are using the primary literature in order to 
explore the client’s health history when it is complex, unique or is something they have not 
experienced in clinic before. Whether this allows for a more personalised approach than the 
use of public health guidelines is debatable. Clinical decisions can be patient-led, and this 
may help with client engagement and compliance. Case studies were cited as more helpful 
for practitioners in terms of insight than other research studies, but it was felt case studies 
could be improved if the information was presented in a standardised format. 
Flexibility of new tools is required to suit individualised approaches to practice by a range of 
practitioners including dietitians, nutritionists and NTs. Electronic data capture would provide 
a more flexible approach than paper tools. Online tools are considered important for a 
number of reasons, not just for practitioner ease but also as a tool for clients to self-monitor 
their real-time food intake and behaviour. The use of information technology to improve 
dietary assessment and tackle obesity has been assessed by Carter et al. (2012). The 
development of online applications is beyond the remit of this project; instead the project will 
seek opportunities for online tool development with existing online tool providers. 
Relating new tools to the existing evidence base was met positively by practitioners, but the 
volume of work required to achieve something meaningful to inform clinical practice was 
highlighted by academics as something to approach cautiously and is in any case beyond 
the remit of this research project. This will instead become a recommendation for 
postdoctoral development. 
The development of new tools needs to consider both clinical and research approaches. 
Considering the results from the survey and these interviews, new tools are needed to: 
• highlight obesity risk factors and red flags; 
• ensure tools stay in the remit of nutrition practice; 
• offer a choice of assessment measures but not make tracking all of them 
compulsory; 
• relate questions to pathophysiological mechanisms of disease to support 
pathophysiological reasoning; 
• enable analysis to identify associations between intervention compliance and health 
and weight outcomes; 
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• gather data which may help to limit the number of confounding factors when data 
mining; 
• track obesity-specific outcomes alongside client-reported outcomes; and 
• allow for frequent measuring of outcomes measures at regular intervals. 
The ways in which new tools could provide reliable and statistically validated data were 
discussed with academics. The conflict between the academics’ responses and the 
practitioners’ value of narrative medicine highlighted that more than one data-collection 
approach is required to meet each of these needs. New tools therefore aimed to include: 
• statistically analysable baseline and follow-up measures – e.g. physical activity 
levels, food intake, measuring before and after interventions; 
• recommended interventions and compliance tracking; 
• administrative data such as GP details and consent; and 
• free text but structured case study forms providing a uniformed format. 
Structured case study development is not an aim for this project but was considered during 
tool development. Only the first two points above are required for development to meet the 
aims of this project. Ideally, individual health data gathered by the tools should be 
anonymised to manage data protection risks (Graham, 2012). Practitioners could continue to 
use their methods for administrative data gathering, such as GP details, which are not 
required for analysis and add to the complexity of ethical issues including confidentiality, 
privacy and data protection. 
5.4 Findings from Delphi Survey 
Three rounds of Delphi surveys were conducted between October 2015 and June 2016. 
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Figure 188 Delphi survey participants, and their perspective and profession 
The overall aim of the Delphi method is to collaboratively construct new clinical tools which 
assess the efficacy of personalised nutrition practice in obesity management. Due to the 
word count restrictions of this report it is not possible to present an in-depth analysis of each 
round, although this was conducted. The following discussion provides an overview of the 
Delphi survey results, feedback and research utilised for the development of four new clinical 
tools. 
The majority of nutrition client/patient (C/P) participants were willing to provide information 
for the various assessments. Therefore, it can be assumed in the discussions below that 
nutrition clients/patients are happy to provide the information unless otherwise stated. 
Comments followed with (R) were from participants from the research perspective. 
Comments followed with (C) were from participants from a clinical perspective. 
115 
In Round 1 participants reviewed and ranked a range of tools and assessment methods, as 
described in Chapter 3. The results of Round 1 helped to develop new tool categories and 
questions for tool development. Round 2 aimed to gain feedback and consensus on 
satisfaction with the included questions. The results from Round 2 were used to construct 
four new tools: 
1. Tool 1: Personalised health history questionnaire 
(https://mdxl.eu.qualtrics.com/SE/?SID=SV_78MODoa9LvgWDKB) – this aims to 
collect health history and family history data around mechanisms of obesity, as well 
as collect a range of baseline health measurements. This questionnaire is for the 
patient to complete before the first consultation. 
2. Tool 2: Intervention record 
(https://mdxl.eu.qualtrics.com/SE/?SID=SV_2rdbdwQkaKAMqTX) – this aims to 
capture which interventions were recommended by the nutrition practitioner. The 
practitioner should complete this at the end of each consultation. 
3. Tool 3: Personalised health follow-up questionnaire 
(https://mdxl.eu.qualtrics.com/SE/?SID=SV_8IxX3qhW1nUQb0p) – this aims to 
measure any changes to the client’s health measurements after intervention. This 
questionnaire is for the patient to complete before their return consultation. 
4. Tool 4: Achievement record 
(https://mdxl.eu.qualtrics.com/SE/?SID=SV_eDvG2CfybY4hMrP) – this aims to 
capture which interventions the patient complied with. This tool is completed by the 
nutrition practitioner at the outset of each return consultation. 
Feedback at the end of Round 2 highlighted the health questionnaire was: 
“much too long” (R) 
“length / detail required likely to affect compliance” (R) 
Round 3 of the Delphi surveys aimed to review the content and reduce the overall size and 
complexity of the health history questionnaire as well as gain feedback and consensus on 
satisfaction with the questions proposed for inclusion in Tool 2, the intervention record and 
Tool 4, the achievement record. Tool 4 was originally named the ‘compliance record’ but, 
based on Round 3 feedback it was renamed the ‘achievement record’. 
5.4.1 Diet and nutrition 
The first round of the Delphi survey reviewed the use of various dietary assessments 
including food frequency tracking, food diaries, 24-hour diet recall and online dietary 
assessment tools. 
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The results of the previous survey, together with the results of the Delphi Round 1 highlight 
that practitioners engage with numerous validated food frequency questionnaires as well as 
numerous online applications for assessing food frequency, eating styles and dietary habits. 
These existing tools can be utilised and there was no need to develop new diet and nutrition 
intake assessment tools as part of this project. Diet and nutrition assessment does however 
need to be tracked before, during and after intervention so that changes to food intake can 
be measured against health and weight outcomes. This was therefore included in tools 2 
and 4. 
5.4.2 Health history and risk factors 
In Round 1, 10 participants’ considered health and family history should be gathered by a 
questionnaire/tool before the consultation. One clinician stated it should be gathered in the 
consultation setting. Multiple-choice questioning was the preferred data-collection method, 
with seven participants highlighting multiple-choice and four highlighting free text as a data-
collection method. Seven participants stated that a symptoms checklist should also be 
included. 
No validated health history tools were identified, but practitioner questionnaires included a 
range of approaches to gathering this data. Validated tools such as the Stanford health 
assessment (Pecoraro et al., 1979; Bruce and Fries, 2003) exist, and although they are not 
focused on obesity, their content and approaches did inform new tool development. Medical 
health history questionnaires were also reviewed and considered. 
Seven participants stated that a symptoms checklist should also be included in the 
tool/questionnaire and that it should include red flag symptoms. Some validated symptom 
checklists do exist, such as the Rotterdam checklist (Hardy et al., 1999) and the Edmonton 
symptom assessment system (Richardson and Jones, 2009), but these were designed for 
use in palliative care. There do not appear to be any similar validated symptom checklists for 
use in obesity, although numerous measures of QOL in obesity do exist (Chambers & 
Swanson, 2010; Forhan, Vrkljan, & MacDermid, 2010; Mannucci et al., 1999). There are also 
generic health-related QOL assessments such as the medical outcomes study (SF12 and 
SF36) (Wee, Davis and Hamel, 2008), which informed the development of new tools. 
New health questionnaires (tools 1 and 3) aim to relate symptoms and health history 
questions to pathophysiological mechanisms of obesity. This should support a 
pathophysiological reasoning practice paradigm. A literature review was undertaken to 
identify a range of pathophysiological mechanisms, ‘other diseases’, health conditions and 
red flags associated with obesity and tools and tests/measures assessing those 
mechanisms, as described in Chapter 3. The results identified a range of pathophysiological 
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mechanisms (see Table 6), and results were used to inform categories and questions for tool 
development. 
Table 6 Pathophysiological mechanisms contributing to obesity 
Mechanism Reference 
Addiction Kenny and Shaw (2011) 
Dietary intake   
Dysbiosis 
Dimitrov (2011) 
Dyslipaemia 
Eder, Baffy, Falus, and Fulop, 
(2009); Piva et al., (2011) 
Energy expenditure   
Epigenetics 
Campión, Milagro, and Martínez, 
(2009); Javier Campión, Milagro, 
and Martínez, (2010); Tammen, 
Friso, and Choi (2013) 
Early onset obesity 
Lillycrop and Burdge, (2011); 
Martínez, (2012); Rhee, Phelan, 
and McCaffery, (2012) 
Genetics 
Bouchard and Drake (2010); Guo et 
al., (2006); Herrera, Keildson, and 
Lindgren, (2011) 
Hormonal imbalance Kushner (2012) 
Hyperglycaemia 
Choi et al., (2013); Fuentes, 
Roszer, and Ricote, (2010); Kurpad 
and Aeberli, (2012); Lu et al., 
(2008); Yang et al., (2010) 
Infections origin 
Bassols, Moreno, Ortega, Ricart, 
and Fernandez-Real, (2010); 
Pasarica and Dhurandhar, (2007)  
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Inflammation 
Benozzi, Perruzza, and 
Pennacchiotti, (2012); Choi et al., 
(2013); Clària, Titos, López-Vicario, 
and González-Périz, (2010); 
Deepali, Thomas, and Gupte, 
(2013); Eder et al., (2009); Fain, 
(2010); Fuentes et al., (2010); Kim, 
Shin, Moon, and Chung, (2011); Tai 
and Ding, (2010); Yang et al., 
(2010) 
Insulin resistance 
Fuentes et al., (2010); Lu et al., 
(2008) 
Medication related 
mechanisms 
Benozzi et al., (2012) 
Other diseases (diabetes, 
cancer etc) 
Kishida, Funahashi, and 
Shimomura, (2013) 
Oxidative stress 
Choi et al., (2013); Piva et al., 
(2011) 
Pregnancy Kushner, (2012) 
Psychological factors (e.g. 
depression, beliefs, 
motivation) 
Grossniklaus et al., (2012); Karasu, 
(2012); Kushner, (2012) 
 
Satiety disruption/leptin 
resistance 
Erez et al., (2011); Orbetzova et al., 
(2012) 
Sleep disturbance Clària et al., (2010) 
Smoking cessation Fuentes et al., (2010) 
Socio economic factors 
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Stress/adrenal 
dysfunction 
Bloomgarden, (2009); Greenfield 
and Marks, (2009); Grossniklaus et 
al., (2012); Karasu, (2012); 
Kushner, (2012) 
During Delphi Round 2 clinicians were asked if they considered the proposed range of 
mechanisms (listed in Table 6) to be comprehensive. Six participants said yes and two were 
unsure. 
In Round 3 of the Delphi survey, participants were asked which of the mechanism headings 
should be deleted, included or adapted. Out of the 12 respondents who completed the 
Delphi survey, if at least half of them (6 or more) stated the heading should be deleted or 
adapted then this change was made, for example: dysbiosis was changed to digestive 
issues, while insulin resistance and hyperglycaemia were changed to blood sugar regulation. 
A list of ‘other diseases’, health conditions and red flags associated with obesity was also 
developed based on a literature review utilising the term “obesity-related diseases” (see 
appendix 2) (Browning, 2003b; Martin, Qasim and Reilly, 2008; Michael I Goran, 2008; 
O’Rourke, 2009; Horng and Hotamisligil, 2011; Mathew, Okada and Sharma, 2011; Na et al., 
2011; Yamauchi and Kadowaki, 2013b; Doron et al., 2013; Ohashi et al., 2014; Reilly T. 
Enos, Velázquez and Murphy, 2014; Nigro et al., 2014; Choi and Snider, 2015; Sarah C. 
Ferrante et al., 2015; Zhang et al., 2015; Lee et al., 2015). Health conditions included were 
associated with obesity and/or correlated to the above mechanisms of pathophysiology. 
Results were used to develop a table of health conditions for health history analysis (see 
Table 7), which was presented to the Delphi group for inclusion in Round 2. 
Table 7 Health history question on new tool 
  Question 1  Question 2 
Condition 
Please Tick please provide more 
details e.g. type of 
condition Current Past 
Alzheimer’s disease       
Asthma       
Atherosclerosis       
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Attention deficit 
hyperactivity disorder 
(ADHD)       
Autism spectrum disorder       
Binge-eating disorder       
Bulimia       
Cancer       
Cardiovascular / heart 
disease       
Celiac disease       
Chronic fatigue syndrome       
Chronic venous disease       
Chronic viral condition       
Depression       
Eating disorder       
Epstein Barr virus       
Fibromyalgia       
Gallbladder disease       
Glaucoma       
Gout       
Hepatitis (A, B or C)       
Herpes virus       
High blood pressure       
Hypertension       
Insomnia        
Kidney disease       
Mononucleosis (mono)       
Mood or anxiety disorder       
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Night-eating syndrome       
Non-alcoholic fatty liver 
disease       
Osteoarthritis       
Peripheral vascular disease       
Polycystic ovarian 
syndrome (PCOS)       
Post-traumatic stress       
Respiratory disorders       
Shingles       
Sleep apnoea       
Steatohepatitis       
Thyroid disease       
Thyroiditis       
Type 1 diabetes       
Type 2 diabetes       
Practitioners and clients were asked to rate their satisfaction with the list of conditions 
proposed for inclusion. All who answered were satisfied except one practitioner who stated 
there are: 
“too many conditions and many clients would not know what they all mean. Could they be 
reduced to a smaller list of higher level conditions, using names that clients would 
understand?” (C) 
Another stated: 
 “terminology quite medical” (C) 
Numerous changes were made based on feedback, for example: insomnia was swapped to 
disturbed sleep, thyroiditis was deleted and thyroid disease was changed to thyroid disease 
or condition, to support use client-focused language. 
In Round 2, all clinicians were satisfied or moderately satisfied these questions would 
support clinical decision making. All academics who responded were satisfied or moderately 
satisfied these questions would support meaningful statistical analysis. 
122 
5.4.3 Medication 
A medication category was added after Round 1. The questions aim to identify if the 
medication has side effects which may be contributing to obesity and to enable checking of 
drug nutrient interactions. Three approaches to collecting this data were elucidated from 
practitioner questionnaires. Participants were asked to rate their preferred choice. 
 
Figure 199 Proposed approaches to gather data on medication intake 
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Each of the approaches was the preferred choice of six different of respondents. Overall, 
Approach 1 had a marginally higher preference score. Approach 1 had the least number of 
participants scoring it as their least preferred choice. Approach 3 overall came out with the 
highest score in terms of satisfaction that the approach assesses current use of medication 
and Approach 1 had the worst score. Therefore, Approach 3 has been included in new tools 
and updates based on feedback provided. For example, supplements were included, 
instructions included examples, and some of the questions were altered. 
5.4.4 Smoking history 
A smoking history category was added after Round 1. The aim of the questions is to identify 
if smoking cessation, or history of smoking cessation, is a potential contributing mechanism 
of obesity and to consider if smoking indicates other mechanisms of obesity such as 
oxidative stress and addiction. Questions on smoking were based on Jeor (1997 p. 662 and 
p. 811). During Round 2 all clinicians were satisfied or moderately satisfied these questions 
would support clinical decision making. All academics who responded were satisfied or 
moderately satisfied that these questions would support meaningful statistical analysis. 
Individual feedback helped to improve clarity of the final questions: 
“I like the approach, but I think that more formatting and direction will be needed to make 
sure people answer the questions correctly” (R) 
5.4.5 Pregnancy 
A pregnancy category was added to identify if pregnancy had been a contributing factor to 
individual obesity. On the questionnaire, clients are asked to describe their weight, before, 
during and after pregnancy. All practitioners and academics who responded, except 1 
academic, were satisfied with the questions which assess pregnancy as a contributing factor 
to individual obesity. All clinicians were satisfied or moderately satisfied that these questions 
would support clinical decision making. All academics who responded were satisfied or 
moderately satisfied that these questions would support meaningful statistical analysis. All 
clients were willing or moderately willing to answer these questions, except the male client 
who did not respond to this question. The tool was updated to clarify these questions were 
for females only. 
5.4.6 Hormone balance 
A hormone balance category for females was added. Questions aim to identify if: length of 
cycle is an indicator of hormone imbalance, and if the menopause, hormone replacement 
therapy (HRT), contraceptive intake or other female sex hormone imbalances and conditions 
may be potential contributors to obesity. All clinicians and academics except one academic 
were satisfied the questions assess length of hormone cycle, menopause and hormone 
imbalance. Overall, three academics were unsatisfied the questions assess use of HRT and 
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the contraceptive pill and three were unsatisfied the questions assess if female hormone 
balance may be a contributor to obesity in an individual. Feedback helped to further develop 
the clarity of the questions for the final tool: 
“should include other forms of contraception” (NT) 
5.4.7 Inflammation 
An inflammation category was added after Round 1 to identify if it is a potential contributing 
mechanism to obesity. Results of Round 2 highlighted all clinicians and two academics were 
satisfied that the questions correlate to the mechanism and aims. However, feedback 
highlighted the: 
“Question [was] not sufficiently sensitive or specific for inflammation” (R) 
The literature was reviewed to overcome this issue, but no clear solution was found. No 
validated tools exist for inflammatory assessment, the original questions had been derived 
from the WHO QOL assessment (WHO, 1998). Further research on inflammatory conditions 
led to rosacea and psoriasis also being included as part of this assessment. The language 
was considered too technical, so adaptations were made based on feedback to simplify the 
questions and reduce any replication with questions in health history category. Suggestions 
question for inclusion were added: 
“Non-coeliac gluten sensitivity, inflammatory skin conditions” (C) 
“iritis, eczema” (C) 
An example box was also added for clarity. All clinicians were satisfied or moderately 
satisfied these questions would support clinical decision making. All academics who 
responded, except one, were satisfied or moderately satisfied these questions would support 
meaningful statistical analysis. All clients were willing or moderately willing to answer these 
questions. 
5.4.8 Behaviour and food 
This category was added to assess if satiety hormone disruption, such as leptin resistance, 
may be a potential contributing mechanism to obesity and, if in combination with dietary 
assessment, food addiction may be a potential contributing mechanism to obesity and the 
potential need to include the validated food addiction scale. Feedback highlighted: 
“This is impossible by the nature of the questions, unless you have biomarkers and/or 
validation tools in place” (R) 
This raises an important point: the aim of the project is to develop and validate news tools. 
Undertaking laboratory testing and gathering data on biomarkers of clients could be used to 
corroborate the validity of responses related to mechanisms such as satiety hormones. 
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5.4.9 Digestive issues 
This category was added after Round 1 to identify if dysbiosis is a potential contributing 
mechanism to obesity. Questions relate to gastrointestinal function. Overall satisfaction the 
questions correlate to the mechanism and question aim was achieved. An academic 
suggested: 
“Give some likely tick-box options for question 3 and also an ‘other’ option. This would make 
analysis easier.” (R) 
This was implemented. All clinicians were satisfied or moderately satisfied these questions 
would support clinical decision making. All academics who responded were satisfied or 
moderately satisfied these questions would support meaningful statistical analysis. All clients 
were willing or moderately willing to answer these questions. 
5.4.10 Blood sugar regulation 
The aim of this category was to identify if insulin resistance or hyperglycaemia are potential 
contributing mechanisms for obesity and to assess potential red flags for diabetes. All 
academics and clinicians except one were satisfied or moderately satisfied that the 
questions correlate to the mechanism and aim. Overall satisfaction was achieved in relation 
to clinical decision making and statistical analysis and all clients were willing or moderately 
willing to answer these questions. Changes were made based on feedback. 
5.4.11 Blood fats 
The aim of this category was to identify if dyslipidaemia is a potential contributing 
mechanism to obesity for the individual patient. All academics and clinicians, except one 
clinician and one academic were satisfied or moderately satisfied that the questions assess 
dyslipidaemia as a potential contributing mechanism to obesity. One clinician stated: 
“Dyslipidemia is a metabolic consequence of obesity, not the other way round, so [it is] 
difficult to see how it would be a potential mechanism to obesity” (C) 
Although this is a valid point, questions which help to identify dyslipidaemia may help to 
guide clinical decision making. This section was included in Round 3, which asked 
participants to eliminate sections in order to reduce the overall size of the tool. The results 
highlight this section should continue to be included. 
5.4.12 Psychology 
Clinicians highlighted that self-perceived stress (five participants), addiction (four 
participants), motivation (four participants), eating disorders (five participants), depression 
(five participants) should be data gathered by new tools. Feedback highlights: 
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“There are several validated questionnaires available to choose from but [a] free text option 
also needed if [the] client wants to expand on anything” (C) 
Stress assessment for obesity management is important (Cohen, Janicki-Deverts and Miller, 
2007; Torres and Nowson, 2007; Ozier et al., 2008; Greenfield and Marks, 2009) and the 
perceived stress scale is a validated tool (Cohen, Kamarck, & Mermelstein, 1983) that has 
been used to assess the relationship between stress and obesity (Stewart-Knox et al., 
2012). Several versions of the perceived stress scale have been validated. The four-item 
version appears to be the shortest version and therefore easiest to complete, so this was 
included in new tool construction. 
A food addiction scale has been validated (Gearhardt, Corbin and Brownell, 2009; Pursey et 
al., 2014) and was considered for inclusion, however it is a 25-item questionnaire and this 
may need to be shortened to be of clinical utility. As well as food addiction, determining other 
addictions would be important for clinical decision. Feedback highlights: 
 “The client may be more likely to admit their addictions in a questionnaire; however, if the 
practitioner has the right skills to get the truth from the client then asking them in the 
consultation may be more accurate”. (C) 
“Suggest asking both in the tool pre-consultation and also in the face-to-face. Depending on 
the person, they may respond more honestly in one situation or the other, so this covers all 
bases” (R) 
“This can be sensitive” (R) 
so questions on addiction: 
“need to be phrased in a way so the client does not feel judged or ashamed” (C) 
Motivation assessment tools were reviewed (Ceccarini et al., 2015). The National Obesity 
Forum provides a four-item patient motivation and readiness to change tool which was 
included in new tool development which was included in new tool development. 
By Round 2, the aims of psychological assessment had developed to include: 
• epigenetic changes as a potential contributing mechanism to obesity; 
• psychological factors as a potential contributing mechanism to obesity; 
• QOL; 
• sleep disturbance as a potential contributing mechanism in obesity; 
• self-perceived stress as a potential contributing mechanism to obesity; 
• individual motivation and readiness to change; 
• the need to undertake further assessment using validated tools e.g. sleep disorder 
scale, depression scale; and 
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• the need to refer individuals for psychological support. 
Two practitioners and two academics were unsatisfied with questions which assess 
epigenetic changes as a potential contributing mechanism to obesity. Feedback stated: 
“a more in-depth questioning needed to tease out the epigenetic contribution” (C) 
This was not possible because the literature does not link epigenetic change to signs and 
symptoms. 
One practitioner and one academic were unsatisfied with questions assessing psychological 
factors as a potential contributing mechanism to obesity. One academic was unsatisfied with 
questions assessing QOL and sleep disturbance as a potential contributing mechanism in 
obesity and self-perceived stress as a potential contributing mechanism to obesity. All who 
responded were satisfied with questions which assessed individual motivation and readiness 
to change. One academic was unsatisfied with questions which assess the need to 
undertake further assessment using existing validated tools e.g. the sleep disorder scale and 
the depression scale, and two academics were unsatisfied with the questions which 
assessed the need to refer individuals for psychological support. The feedback stated: 
“Psychological questions are not diagnostic just indicators” (R) 
All clinicians who responded were satisfied or moderately satisfied these questions would 
support clinical decision making. All academics were satisfied or moderately satisfied these 
questions would support meaningful statistical analysis. All clients were willing or moderately 
willing to answer these questions. This section was developed as a result of feedback and 
presented for elimination or inclusion in the final tools at Round 3 of the Delphi survey which 
resulted in this section being included in the final questionnaire. 
5.4.13 Physical activity 
As with diet and nutrition intake, there are numerous validated physical activity assessments, 
questionnaires and online applications that nutrition practitioners had already engaged with. 
Physical activity data-collection methods therefore do not require new tool development. 
Changes to physical activity levels should be tracked before, during and after intervention, 
so that change can be measured against health and weight outcomes, this was therefore 
included in tools 2 and 4. 
5.4.14 Body composition 
Although the limitations of BMI have been thoroughly explored in the literature (Kok, Seidell 
and Meinders, 2004; Daniels, 2009; Shah and Braverman, 2012), it is the most frequently 
used assessment of body size and it provides nationally recognised parameters of 
overweight and obesity (Lindsay et al., 2014). Assessments will need to ask clients for their 
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weight and height in order to calculate BMI. Six clinicians stated it should be measured by 
the practitioner using scales in the consultation setting. Researchers felt this measure was 
important to ensure an accurate baseline. However, clinicians feedback highlighted that this 
was a sensitive subject and should be a patient dependant decision: 
“Excess body weight is a sensitive subject, this information should be collected face-to-face” 
(C) 
“Many clients do not want to weigh themselves so asking them to do so could be upsetting 
for them” (C) 
“Some clients estimate their weight” (C) 
Checking accuracy during the consultation is therefore important: 
“The initial consultation could be used to teach them best practice so future ‘weigh ins’ could 
be recorded in the tool” (R) 
Clinician feedback stated waist circumference was: 
“needed only in rare cases and can be measured at the consultation” and “is easy to give the 
answer but someone would wonder about the accuracy and consistency in methodology” (C) 
This was therefore excluded in new tool development. Proposed questions for gathering 
data on individual weight history across lifespans where there have been weight changes, 
were presented in Delphi Round 2. The questions were developed based on a weight history 
questionnaire from the University of Iowa. Early onset obesity as a contributing mechanism 
for obesity (Lillycrop and Burdge, 2011; Martínez, 2012; Rhee, Phelan and McCaffery, 
2012). Feedback highlighted retrospective weight assessment over a lifetime “will be 
incredibly difficult for people to recall” (C). 
Two academics and one practitioner were unsatisfied that the questions meet their aim. The 
reasons given are: 
“You are putting a lot of reliance on participants’ memor[ies]” (R) 
However, all clinicians were satisfied or moderately satisfied these questions would support 
clinical decision making and all academics who responded were satisfied or moderately 
satisfied these questions would support meaningful statistical analysis. This assessment was 
therefore included but adjusted to enhance clarity based on the feedback provided. 
5.4.15 Family history 
Ten clinicians considered health history and family history should be gathered by the 
questionnaire/tool before the consultation. Multiple-choice was the preferred data-collection 
method, however research feedback highlighted: 
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“There might be an argument for using free text while developing such a tool, as that might 
help determine what terms are commonly used. But ultimately a categorical assessment will 
be much easier to analyse” (R) 
Seven clinicians considered family history should be recorded via a pedigree chart before 
the consultation, however a pedigree chart is not a specific assessment but an approach to 
collating FHH data. 
No validated family history tools were identified, but practitioner questionnaires did include a 
range of approaches to gathering this data. Validated tools such as the Stanford health 
assessment (Pecoraro et al., 1979; Bruce and Fries, 2003) do exist and their content and 
approaches were reviewed for new tool development. Three approaches to collecting this 
data were taken from clinical tools and suggested for inclusion in Delphi Round 2. 
Participants were asked to rate their preferred choice: 
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Figure 20Proposed approaches to gather data on family health history 
Approach 1 was the most preferred choice by twelve respondents. Two academics stated 
that this approach was “easier for optical mark recognition and hence analysis” (R). 
Feedback also highlighted: 
“perhaps numbers would be more useful than X’s as there may be more than one 
sister/brother/daughter with the same diseases” (R) 
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“It’s not clear if the lack of an X means that the family member definitely didn’t have the 
condition or if the participant doesn’t know. Perhaps instruct participants to put a Y in the box 
if the family member had the condition, N if they didn’t, and leave it blank if they don’t know” 
(R) 
These suggestions were incorporated into the final tool. Feedback also highlighted that: 
“other weight categories need to be added (underweight and anorexia in particular) and 
disease will be added, and the examples are just for instruction” (R) 
An underweight column was added, although anorexia is quite specific, so an additional 
column of “Other health condition: Please insert name or description” was included instead. 
Three practitioners and two academics were satisfied that Approach 1 assessed family 
history of obesity and disease. Two clinicians were somewhat dissatisfied these questions 
would support clinical decision making while one academic was somewhat dissatisfied these 
questions would support meaningful statistical analysis. Although clients were willing to 
provide this information, it relies on recall and is about family members, so their perception is 
likely inaccurate. One respondent stated: 
“people need simple questions” (C) 
Further analysis is required to determine the validity of this assessment. 
5.4.16 Sociocultural 
Sociocultural factors aim to assess baseline gender, date of birth, marital status and 
occupation data, as well as potential sociocultural factors contributing to obesity in individual 
patients, including socioeconomic status, ethnicity, changes in marital status, changes in 
occupation and history of food insecurity. Feedback from an academic suggested using 
census questions on marital status. Question were therefore updated to replicate the 
census. Proposed questions for each of these were presented in Delphi Round 2. 
One academic was unsatisfied that the questions measured a range of sociocultural 
mechanisms which may have contributed to obesity or weight gain in individual clients. 
Feedback from the research perspective highlights: 
“I’d be surprised if the questions you ask are the only relevant sociocultural mechanisms that 
could contribute to weight gain” (R) 
“exclude some life event factors – e.g. moved house and childbirth” (R) 
Childbirth is assessed later in the questionnaire. Moving house was not included to keep the 
questionnaire brief, although it could be relevant as a major life event and should therefore 
be explored in the consultation. 
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All but one practitioner was satisfied or moderately satisfied these questions would support 
clinical decision making. All academics who responded were satisfied or moderately satisfied 
these questions would support meaningful statistical analysis. All clients were willing or 
moderately willing to answer these questions. 
Practitioners suggested the following questions should be included: 
• household income 
• mobility / disability 
• distance to shops 
• migrant status 
• how many people in household 
• highest level of education 
• amount (of money) available to spend on food 
• location 
• social class 
• social isolation 
• job seniority 
Household income and highest level of education were suggested by more than two 
respondents and are therefore to be included in new tool development. The ‘highest level of 
education question’ was taken from the UK census. The other questions were not included in 
an effort to keep the questionnaire short and easy. 
5.4.17 Goals and outcomes 
The interventions record (Tool 2) and the achievement record (Tool 4) were introduced to 
the Delphi group in Round 3. These tools were created based on a review of stage three 
Round 1 Delphi results and a review of applications such as myfitnesspal and MBODY360. 
Dietary approaches were developed from Wills’ (2008) book The Diet Bible, and my own 
ideas. Exercise approaches were developed from myfitnesspal application. The laboratory 
assessments section was developed from a review of various laboratory websites. 
In Round 3, practitioners were asked to rate their overall satisfaction with the 
wording/phrasing of each of the questions in the interventions record (Tool 2) and the 
achievement record (Tool 4). Academics were asked to “rate their satisfaction that the 
wording/phrasing of each of the questions limits potential bias and statistical analysis” and 
clients were asked to “rate their satisfaction that the wording/phrasing of each of the 
questions is clear and enables you to give a suitable answer” and whether questions are 
“appropriate and free of emotional charge”. Most respondents were either satisfied or 
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somewhat satisfied with the wording/phrasing of each of the questions. Changes were made 
as a result of feedback. For example, one practitioner commented: 
“I would like an option to put quantities into the Q2 table i.e. increase by x amount.” 
It is agreed that the quantification of responses would enhance the tool and analysis, so 
quantities were included. 
In Round 3 clients, practitioners and academics were asked about which of the Tool 1 health 
questionnaire questions should be repeated at follow-up consultations to assess changes to 
the client’s health and weight after nutrition intervention. This method was used to create 
Tool 4, the follow-up questionnaire. There were a number of questions that did not need to 
be repeated (e.g. sex) and that was apparent from the outset. It has been worthwhile to get 
consensus on which questions should not be repeated on the follow-up questionnaire. A 
recurring comment was that questions can be asked at the consultation and although this is 
true, free text in a consultation setting is difficult data to analyse and measure. The benefit of 
keeping the questions on an initial and follow-up tool is that they are all asked in the same 
way. If a client does not wholly complete the questionnaire tool then the questions should be 
asked in the consultation setting in order to close any data gaps. 
Based on the feedback in Round 3 on Tool 1, the health questionnaire, changes were 
implemented to reduce the overall size or length of the tool. Most respondents indicated all 
questions should be kept. Some sections were combined to reduce overall size and increase 
simplicity. At the end of Round 3 participants were asked if they had any other comments or 
suggestions, practitioners responded: 
“looks like it will be a very useful tool - still concerned about how long it will take to complete 
though” (C) 
“I feel almost all of the questions are relevant if you want to obtain a true picture of the client, 
their current health situation, thoughts, feelings, contributory factors etc. As long as this is 
explained to the client and they understand that this is the best way to help them then I don’t 
think they would have a problem filling it in” (C) 
“I think some of this depends on the term your client has been with you for example woman’s 
bodies change fast and you could have a woman who start with you in January of 2016 who 
is still menstruating however, it could have all changed by June therefore it’s probably a 
good idea to repeat some of the questions from time to time but not weekly or monthly. You 
could also have someone in full time employment when they start and they could be made 
redundant while they are with you” (C) 
In response to the above comments it is good feedback that a practitioner felt the tool will be 
very useful. It is agreed that a practitioner can explain the value of these tools to the client 
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and that should increase the comprehensiveness of data the client provides in the tools. The 
follow-up tool should be completed regularly so that the practitioner can assess any changes 
before meeting the client at the consultation. 
5.4.18 Discussion of Delphi survey 
This Delphi survey approach did succeed in the development of new tools which aim to 
enable individual health history data collection and clinical outcome analysis in nutrition 
practice which may support clinical decision making for the management of obesity. They 
include statistically analysable baseline and follow-up measures. The health questionnaires 
should enable clients to effectively communicate their health issues and support practitioner 
clinical decision making by enabling pathophysiological reasoning because questions relate 
to, and are clustered in, pathophysiological mechanisms of obesity. The tracking of 
recommended interventions and client compliance/achievement should enable practitioners 
to analyse the impact of interventions in relation to the client’s weight and health outcomes 
as a result of compliance behaviour. These will be assessed in the pilot trial. 
New tools allowing frequent measuring of outcomes measures at regular intervals and 
gather data which allow for the assessment of confounding factors when data mining. New 
tools do not make any question or measure compulsory, as highlighted with psychological 
assessment, the willingness of clients to provide this data, or the ability of clients to provide 
data, may vary from client to client. This may prove problematic however as it is not possible 
to analyse the impact of this until sufficient data has been gathered to undertake statistical 
analysis. 
What had not been anticipated during tool development was that the tools would themselves 
determine the consultation process, for example that tools 1 and 3 should be completed by 
the client before the consultation and tools 2 and 4 should be completed by the practitioner 
after the consultation. It may be that my own clinical approach biased tool development 
towards this process. However, it appeared to emerge from developing the tools. It would 
have helped to gain consensus on the tools being used in this way, or gain opinion on how 
the tools could more flexibly fit with a range of practitioner approaches clinical practice and 
data collection. 
The Delphi survey method did not succeed in reducing the size or complexity of these tools. 
This may be a consequence of individual practice approaches where practitioners have 
varied views on what data should be gathered to inform clinical decision making, hence 
adding more questions, rather than reducing them. However, it was anticipated that the pilot 
trial feedback may lead to further adaptations based on feedback which would help to 
simplify the tools. 
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5.5  Findings from pilot trial 
The pilot trial with practitioners in clinical practice aimed to achieve face validity and 
measure feasibility and utility for each of the four tools. Fifty-one practitioners responded to 
the invitation willing to participate, however only 3 practitioners engaged with the full pilot 
trial process. 
 
Figure 21Pilot trial participant recruitment and number of completed new tools during the pilot trial 
process 
Lack of engagement with the pilot trial is analysed and discussed in Chapter 6. This chapter 
is focused on new tool construction and this section therefore reports on the results and 
feedback from participants who did engage with the pilot trial. 
Table 8 Number of completed pilot trial tools and validity surveys 
Tool/Survey Number completed 
Tool 1 – health questionnaire 13 client records 
Tool 1 – validity survey for clients 6 client records 
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Tool 1 – validity survey for 
practitioners 
3 practitioner records 
Tool 2 – intervention record 10 records completed by 5 
practitioners 
Tool 2 – validity survey for 
practitioners 
3 practitioner records 
Tool 3 – follow-up questionnaire 8 client records 
Tool 3 – validity survey for clients 4 client records 
Tool 3 – validity survey for 
practitioners 
3 practitioner records 
Tool 4 – achievement record 6 records completed by 3 
practitioners 
Tool 4 – validity survey for 
practitioners 
3 practitioner records 
The following analysis focuses on validity survey responses rather than data gathered by 
new tools. It was not necessary at this point to analyse the individual health history and 
interventions recommended, or other data reported in new tools, because that does not meet 
with the purpose of this project. It would have been useful to undertake an analysis of which 
questions were completed by participants, but due to the low response numbers it was also 
not possible to conduct any statistical analysis on questionnaire responses. Due to the low 
number of respondents it was also not possible to assess face validity or measure feasibility 
or utility for any of the tools. Rather, an analysis of practitioner and client feedback on the 
use of the tools was undertaken to determine further changes that could enhance the 
development new tools. 
5.5.1 Tools 1 and 3 – health questionnaires 
Tool 1, the personalised health questionnaire, aims to collect health history and family 
history data around mechanisms of obesity, as well as a range of baseline health 
measurements. Tool 3, the follow-up questionnaire, aims to measure any changes to the 
client’s health measurements after intervention. This questionnaire is a repeat of the majority 
of questions from Tool 1, in the same format. Therefore, this analysis reviews the feedback 
on both of these tools simultaneously. Tabled results of the validity surveys can be seen 
below (tables 9 and 10). 
All practitioners and clients felt the new tools allowed clients to effectively communicate their 
health issues. All practitioners felt the language was appropriately client-centred. One client 
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disagreed that Tool 1 was easy to complete but all clients agreed Tool 3 was easy to 
complete. Only two clients enjoyed filling in the health questionnaires, three did not agree or 
disagree, and one did not enjoy filling in the first health questionnaire. Client feedback 
stated: 
“As the English is not my mother language it was a little bit more difficult to understand it”; “I 
found some of the instructions difficult to follow and could be simplified” (C/P) 
“The section on medication is difficult to complete as you have to keep scrolling back up to 
see the headings and then back down to the condition. otherwise I thought it was ok.” (C/P) 
The issue with scrolling was due the Qualtrics software functionality. Feedback from one 
practitioner stated: 
“The layout was visually confusing and too restrictive” (C) 
All practitioners felt tools 1 and 3 were easy to interpret, with two out of three stating 
“strongly agree”. This may be due to the arrangement of questions in categories of 
pathophysiological mechanisms. All respondents felt the questionnaire was relevant to the 
health issues of the client, and that it included all aspects of health issues that concerned 
them, except one for the follow-up questionnaire who did not agree or disagree. Client 
feedback highlighted: 
“remembering history of ailments of grandparents quite difficult” (C/P)
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Table 9 Results of validity assessments on Tool 1 – The health questionnaire 
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Table 10 Results of validity assessments on Tool 3 – The follow-up questionnaire 
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One practitioner felt tools 1 and 3 were not an improvement on the questionnaires they had 
previously used in their own practice. Two agreed that Tool 1 was an improvement although 
one did not agree or disagree that Tool 3 was an improvement. One practitioner stated: 
“I would like to see a question such as: What is the main reason you are seeking nutritional 
support? And, what is most important for you to achieve from your consultation? I would also 
like to see more questions relating to social network to get an understanding about 
loneliness, friendships, available support etc. I think the question on “How often do you 
experience negative feelings” should have been left entirely open and not exemplified 
with...’such as depression, despair and anxiety’ which may lose some clients, who are none 
of those, but feel negative in their thinking” (C) 
This is useful feedback which should be implemented to enhance the questionnaire. Another 
practitioner stated: 
“I did not see any questions on exercise? Or sexual health? Or diet?” (C) 
The exclusion of dietary and exercise analysis was explained to participants in the pilot trial 
introduction video. No sexual health category was included because this was not identified 
as a contributing factor to individual obesity development. There were specific questions on 
the herpes virus in the health history section, birth control in the hormone section, as well as 
pelvic inflammatory disease and the prostate gland in the inflammation section. 
Four out of six clients felt the first health questionnaire was too long, two out of three 
practitioners felt it could be shortened. Only one client agreed Tool 3 was too long and two 
out of three practitioners felt the follow-up could be shortened. Practitioner feedback stated: 
“There were too many questions at the beginning on ethnicity, marital status and education 
and income brackets. It could feel rather intruding and such questions may be better left to 
the end once the person has settled into answering questions about themselves. I personally 
would never ask about income brackets. I do understand that for research purposes such 
questions are very relevant.” (C) 
All clients agreed they would be happy to complete the questionnaires again as part of their 
routine care, except one who neither agreed or disagreed. Two practitioners were also 
happy to use Tool 1 in their routine clinical practice, but one strongly disagreed. By the 
return questionnaire only one practitioner was happy to use it in their practice. Not one client 
found the questionnaires embarrassing but one practitioner stated there were aspects which 
were inappropriate. One practitioner also stated: 
“I would never make decisions based on a questionnaire and I aim to use a questionnaire 
only to guide my questions in the consultation where appropriate. In my view a questionnaire 
runs the risk of preconceived ideas prior to meeting the client, which may drive the questions 
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and consultation in an unfavourable way for the client. It can however be an aid in exploring 
certain areas and as a tool for monitoring progress if partially repeated at a later stage in the 
process.” (C) 
New tools are not meant to replace the consultation process but are used as a tool for 
tracking progress robustly. 
5.5.2 Tools 2 and 4 – intervention tracking 
Tool 2, the intervention record, aimed to capture which interventions were recommended by 
the nutrition practitioner. Tool 4, the achievement record, aimed to capture which 
interventions the client/patient complied with. Tool 4 is almost a replicate of Tool 2 and 
therefore this analysis reviews the feedback on these tools simultaneously. The practitioner 
completes these tools, therefore only practitioners were invited to complete the validity 
surveys and provide feedback on this tool. The results of the validity surveys can be seen in 
tables 11 and 12 below. 
Two practitioners agreed, and one did not agree or disagree, that Tool 2 enabled them to 
capture all the recommended interventions and that it was easy to complete. Two 
practitioners agreed, and one disagreed that Tool 4 enabled them to capture whether their 
clients complied with the recommendations and the extent to which their clients complied 
with the recommendations. 
One agreed, one disagreed, and one neither agreed or disagreed that Tool 2 could be 
shortened and simplified. The same responses were received for Tool 4 being shortened but 
two also agreed it could be simplified. Two disagreed and one agreed the intervention tool 
was an improvement on their previous approach to recording prescribed interventions, while 
one agreed, one disagreed and one did not agree or disagree, that Tool 4 was an 
improvement on their previous approach. Feedback stated: 
“This tool did not quite capture my interventions of cPNI as the psychological and social and 
coaching aspect was missing in the reporting, use of questionnaires for say ACEs (adverse 
childhood events) and some other interventions I often use – intermittent living, so the tool 
could be developed.” (C) 
The achievement tool could be updated with a ‘reasons’ free text box as feedback 
highlighted: 
“My client suffered emotional trauma between the two consultations and there was nowhere 
to record why she was non-compliant.” (C) 
Feedback also stated: 
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“It was too time-consuming to complete the supplements with names and brands etc. It 
would have been great to simply leave space to paste say the supplement prescription that 
the client has received.” (C) 
Another aspect of feedback was: 
“psychological and social steps taken - I do a lot of coaching and the tool lacks ways of 
monitoring steps taken to implement ideas from the coaching and progress/perceived 
progress.” (C) 
Only one practitioner would be happy to use these tools in their clinical practice, feedback 
stated they are: 
“not user friendly and quite restrictive.” (C) 
Only one agreed the intervention tool improved their clinical decision making, however two 
felt the achievement tool improved their clinical decision making. Only one agreed (one 
disagreed and one neither agreed or disagreed) that these tools are useful in clinical 
practice. 
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Table 11 Results of validity assessments on Tool 2 – The intervention record 
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Table 12 Results of validity assessments on Tool 4 – The achievement record 
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5.5.3 Discussion of pilot trial 
There is insufficient data provided by the pilot trial to undertake meaningful or statistical 
analysis. However, the feedback further corroborated some of the earlier findings, such as 
the value of undertaking population and cross-cultural validity assessments for new tools and 
not making questions compulsory. The restriction of the online software also highlights the 
need to develop a tailored online assessment which can provide the appropriate 
functionality, which can also positively impact on increasing the simplicity of assessment and 
therefore save time. 
Data on patient income sources was not meant to support clinical decision making, but 
rather allow for an analysis of confounding factors when data mining. The clarity of the 
purpose of each question needs to be made clear so practitioners can differentiate between 
the research and clinical perspectives of the tools. 
Data on the clinical utility of these tools was lacking. There were still further suggestions 
being made on what else the tools needed to be included by various practitioners, which 
would further grow the tools, rather than simplify them. It may better to break the tools down 
into smaller tools so that they are less time-consuming to complete. Questions which gather 
more intrusive data can then be gathered later during the consultation process, on a 
separate tool or in person, once the practitioner and client have built up rapport and trust. 
For example, there could be one tool for health history assessment, another for family history 
assessment, another for tracking progress. Having numerous, small, quick to complete 
validated tools may give practitioners an opportunity to pick and choose when clients 
complete tools, this could also be client-led and may enable a more personalised data 
collection approach using numerous standardised tools. 
Feedback on the need to include coaching measures not only raises a valid point for adding 
therapeutic interventions to these tools but also supports the idea that the outcomes of 
nutritional interventions are not just due to dietary, supplement and exercise interventions 
(Karasu, 2012; Miles and Barrow, 2018). New tools lack appropriate therapeutic relationship 
measures which should have been evaluated for inclusion. There is, without doubt, the 
practitioner element and therapeutic intervention. This raises some important questions: 
1. How can the benefits of nutrition intervention be teased out from the practitioner’s 
therapeutic intervention? 
2. Can we measure the therapeutic alliance in nutrition practice? 
3. Is nutritional therapy more about the therapy than the nutrition? 
These are further addressed in the chapters 6 and 8. 
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5.6 Overall discussion of findings 
This project aimed to evaluate the ethics of standardising data-collection methods in 
personalised nutrition practice, and although patient autonomy, inclusivity, data management 
and data mining consent concerns were raised there was overall support for standardising 
data-collection methods as long as that does not impact on the practitioner being able to 
make personalised intervention decisions and recommendations. Standardised data-
collection methods do not need to limit the scope of personalised nutrition practice but could 
support clinical decision making, as well as enabling practitioners to pool data and develop a 
case-by-case evidence base that allows for analysis and comparison on the efficacy of 
interventions that further supports clinical decision making. 
The online search for tools identified numerous validated tools for assessing dietary intake, 
physical activity levels, body composition, QOL and psychological factors in obesity. Many of 
these tools were developed for research rather than clinical purposes and the survey of 
nutrition practitioners highlighted that only a few practitioners use validated tools. Although 
some of these tools may lack clinical utility, others are well established and useful and could 
be utilised by all nutrition practitioners to standardise data-collection methods. 
There is a gap in tools which gather data on individual health history, family history, 
sociocultural influences on obesity as well as goals and outcomes. The survey of nutrition 
practitioners and the interviews highlighted that the majority of practitioners are developing 
and using their own questionnaires to gather this data. In a review paper, Snyder et al. 
(2012) compare the advantages and disadvantages of methods for gathering data, including 
paper questionnaires, interviews and via computer technology. Snyder et al. (2012) highlight 
the advantages of interviews and the potential requirement to train clients on how to use 
both paper questionnaires and internet applications. The consultation interview should not be 
replaced by internet applications but rather be used in conjunction with them to enhance 
efficient data collection (Snyder et al., 2012). 
Another finding is that none of the current outcome assessments used in practice, including 
the validated MYMOP tool, appear to robustly consider or enable those outcomes to be 
measured against the client’s compliance to implementing dietary and nutritional 
interventions. Findings of the survey results highlight measurements on health outcomes that 
can be tied to measures for exercise, sedentary behaviour, diet intake and psychological 
mood. The new tools created for this project specifically aim to enable the analysis of 
intervention compliance on the client’s health and weight outcomes. 
Practitioners are currently using their own tools for clinical practice and there is currently no 
standardised clinical approach to data collection. The results of the survey also demonstrate 
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that, through the use of their own tools, there is a large variation in data gathered by 
practitioners – on sleep for example. Nutrition practitioners are currently undertaking clinical 
reasoning and making intervention decisions based on varied data sets. It could therefore be 
assumed that, even when using clinical guidelines to make recommendations, if one patient 
saw two nutrition practitioners independently, the interventions given to that patient from 
each practitioner could vary because the intervention decisions have been made on different 
data sets from the same individual. 
Current tools do not appear to enable the identification of contributing pathophysiological 
mechanisms of obesity. Clustering questions in groups of pathophysiological mechanisms 
associated with obesity may enable mechanistic reasoning. This new approach is not without 
its limitations (Pizzorno and Jr, 2012), but practitioner feedback on new tools does suggest 
this approach could help to improve clinical decision making. 
Practitioners value tools which are easy to use and that help them to identify factors that 
contribute to the client’s obesity. A number of other developmental considerations were 
identified from the survey and interviews, and the Delphi method allowed for collaborative 
development of four new clinical tools for health data collection and clinical outcome 
analysis, which aim to support clinical decision making and can be used to standardise case 
data-collection methods in personalised nutrition practice. 
The pilot trial of the four new collaboratively developed clinical tools gained interest from 
practitioners but was unsuccessful in engaging and retaining them. The reasons for the lack 
of engagement and retention are explored in the next chapter. The feedback from 
practitioners and clients that did engage in the pilot trial process highlight the need to re-
evaluate the construction of the tools and further consider the impact of the therapeutic 
relationship on the outcomes of nutritional practice. There was a conflict of feedback across 
the research methods, between keeping tools streamlined, easy and user-friendly as well as 
comprehensive, thorough and robust. 
5.7 Chapter summary 
This chapter has explored the results for each of the research methods undertaken to 
construct new clinical tools for health data collection and clinical outcome analysis. The 
findings were summarised in the overall discussion. The conclusions and recommendations 
that arise from these results are discussed further in Chapter 8.  
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Chapter 6: Integrating Standardised Data-Collection Methods 
Findings 
This chapter presents the analysis of research findings for each of the research methods 
undertaken to evaluate the limitations and opportunities for integrating standardised data-
collection methods in personalised nutrition practice. The approach for undertaking the pilot 
trial, survey and interviews were described in Chapters 3 and 4. The overall discussion of 
findings assimilates and summarises the results, and aims to interpret the findings within the 
context of existing literature, the scope of the project and standardising data-collection 
methods in personalised nutrition practice. 
6.1 Findings from pilot trial – lack of engagement 
Results from participants who did engage with the pilot trial were reported in the previous 
chapter. These findings explore the lack of engagement with the pilot trial. Of the 46 
practitioners who responded to emails invitations to participate with the pilot trial the 
following reasons were cited for declining to participate: 
Table 13 Reasons nutrition practitioners gave for declining to participate in the pilot trial 
Reasons for declining to participate: Number of 
practitioners 
No reason stated 15 
Not working with obese population 11 
Too busy 7 
Works with children or adolescents 3 
Not seeing clients at this time 2 
Would need to apply for ethics approval at their 
clinic 
1 
Withdrew after seeing information 1 
New practitioner - just starting out 1 
Not comfortable asking client to give more info 1 
Practitioner does not have enough clients 1 
Concern about confidentiality 1 
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Cannot find suitable clients 1 
Has not yet qualified 1 
The most frequently cited reason to decline from participation with the pilot trial was that 
nutrition practitioners were not engaged with an obese population. Of the 11 practitioner that 
stated they were not working with an obese population, 10 were NT and 1 was a naturopath. 
Of the 51 practitioners who responded willing to participate 44 were nutritional therapy 
practitioners, 6 were dietitians and 1 was a naturopath. This is likely due to the request to 
engage reaching more NTs than other practitioner groups, like dietitians. Practitioners 
engaged with BANT and CNELM social media are more likely to be NTs. Direct emailing 
also targeted more NTs than dietitians or other practitioners. 
6.1.1 Discussion of pilot trial – lack of engagement and retention 
These results raise at least two important queries: 
1. Do obese (BMI>30) individuals seek out nutritional therapy support? 
2. Do NTs have the resources to reach or adequately engage with the growing obese 
population? 
A review of the literature was undertaken to address these questions, however there was no 
data available and research to assess these questions should be undertaken. These 
questions were therefore raised with a group of CNELM undergraduate students seeking to 
undertake a research project, who went on to survey NTs (Gordon et al., 2017). These 
results are reported in Chapter 6.3. 
Initial recruitment of 51 practitioners for this pilot trial suggests retention was a bigger issue 
than recruitment. The biggest barrier from my perspective was asking practitioners to recruit 
their clients to engage with the tools. Many practitioners may have struggled to explain the 
purpose of the trial to their clients and therefore disengaged. Engaging directly with the 
target population to undertake research to validate tools may be one way to overcome this 
barrier. 
It may have also been a concern for practitioners to have the outcomes of their interventions 
recorded and assessed. These tools not only record the outcomes of interventions but 
directly report the intervention decisions and outcomes successes of practitioners. This level 
of reporting may have provided another barrier to engagement, if practitioners have self-
doubt about their ability they may not wish to report on the outcomes of the interventions 
they recommended. 
In a 6-month mixed methods study of GP’s (n=11) which assessed GP confidence and self-
efficacy before and after implementing weight management programmes found that those 
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who engaged with the pilot intervention had an increase in confidence and self-efficacy when 
managing obesity (Sturgiss et al., 2017). They concluded that a structured obesity 
management tool can improve practitioner self-efficacy and confidence in managing obesity 
(Sturgiss et al., 2017). Further highlighting the benefits of this research projects to 
practitioners and limiting any concerns may help to overcome this barrier. 
To identify and explore these concerns, and any other barriers, interviews were conducted 
with practitioners who had been willing to participate in the pilot trial stage, but did not 
engage, to evaluate barriers which may have prevented them, or other practitioners from 
being able to participate with the pilot trail or embed standardised tools into their own 
practice. These results are reported in Chapter 6.4. 
6.2 Findings from survey of nutritional therapists 
This survey, conducted by CNELM research students (Gordon et al., 2017) under my 
supervision, aimed to identify potential opportunities to enhance engagement between obese 
population groups and NTs. A total of 49 nutritional therapy practitioners had completed the 
survey. The survey was conducted to meet the aims of these student’s research projects. 
Not all results of the survey are reported here. Only the results which are directly relevant to 
this project are reported here. 
In response to the question “What percentage of your total number of clients per month are 
obese (BMI >30)”? 69% (34) stated less than 25% and 8% (4) stated more than 50%. 
 
Figure 22Survey results chart of the percentage of total number of obese nutritional therapy clients 
per month 
When asked “Within your marketing do you specifically state weight loss management is part 
of your practice?” 61% (30) responded they did not and 31% (15) responded they did. 
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Figure 23Survey results pie chart of NT’’s who do and do not have marketing which specifically states 
weight loss management 
The survey also asked, “do you experience any barriers engaging with an obese 
population?” 53% (26) stated they did not and 47% stated they did experience barriers. 
When asked to specify these barriers, 12 cited barriers for individual clients such as: 
“embarrassment, shame, denial, perception of friends/relatives/others” 
“difficulties committing to change”. 
[They are] “very focused upon how others perceive them and believe others think they are 
constantly eating”. 
“they are not commonly the demographic that seeks nutrition advice”. 
Interesting, there were also responses such as: 
“they are entrenched in slimming world and Weight Watchers ethos”, “so many people want 
to follow high street clubs” 
“I feel the likes of Weight Watchers and Slimming World have convinced the obese and 
overweight population that their programmes are the only ones likely to help clients achieve 
their weight loss goals” because “group type initiatives more aggressively market to this 
audience”. 
In response to the question “What strategies do you use for marketing your practice? Tick all 
that apply” 90% (44) stated via their own website and 88% (43) stated by word-of-mouth. 
Other responses included: 
154 
“networking meetings, referrals, and newsletters”.
 
Figure 24Survey results bar chart of strategies used by NT’’s to market their practice 
When asked “Do you have any suggestions on how NTs might improve their engagement 
with an obese population?” numerous responses gave actions for individual practitioners, 
such as: 
“run talks and classes” 
“volunteer at a local community event” 
undertake “further training in counselling” 
“get more involved in group programmes” 
 “work as part of a multi-disciplinary team” 
A number of other suggestions should also be considered at a professional level: 
“it’s about awareness of NT more than anything.” 
“by describing how nutritional therapy supports each individual to achieve wellness” 
“group formats, Facebook/email support advertising the personalised approach” 
“online programmes with regular NT contact” 
“getting GPs on board to refer to NTs” 
“contact GP’s, bariatric consultants, counsellors etc.” 
 “Integrated education with GPs who would be willing to work with us” and “more promotion 
from GP’s”. 
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6.2.1 Discussion of the survey 
This survey was targeted directly to NTs. Whereas the surveys and interview participants 
results reported earlier in this research project (see Chapter 5) engaged a range of 
nutritional practitioners already working with an obese population. It was therefore not until 
the lack of engagement with the pilot trial that concerns were raised about the broader 
engagement of obese populations with nutritional therapy. 
The survey results suggest the stigma related to obesity is a challenge for clients wanting to 
engage with nutritional intervention. The impact of the stigma of obesity has been well 
explored in the literature (Karasu, 2012; Puhl & Brownell, 2001; Puhl & Heuer, 2009, 2010). 
This research did not explore the potential stigma of nutritional therapy practitioners working 
with obese individuals. A comparative analysis of dietetic and non-dietetic students using a 
validated fat-phobia scale highlighted that dietitians exhibit moderate negative attitudes 
towards obesity (Berryman et al., 2006). Although the authors acknowledge numerous 
limitations with this research, they concluded that educational programmes which explored 
bias towards obesity helped to reduce negative attitudes (Berryman et al., 2006). It may 
therefore be worthwhile to undertake similar research with NTs to raise awareness and 
minimise barriers to engagement. 
The results also highlight the limitations of NTs marketing themselves individually when 
compared to weight loss brands like Weight Watchers and Slimming World who have a 
global reach and engage with numerous marketing activities including TV advertising. The 
comments on how NTs may improve engagement with an obese population varies from 
individual activities which NTs can undertake and activities which can be undertaken at the 
level of the professional body. Some of these responses point to actions that are already 
undertaken by the nutritional therapy professional body, BANT, for example in 2013 BANT 
launches a programme to inform GPs about nutritional therapy (BANT, 2013). 
There are also other actions which could be considered by the NT’s professional body, 
BANT: large scale advertising to raise awareness of NTs, nationwide online nutritional 
therapy group and individual consultations, developing collaborative relationships with other 
professional bodies e.g. bariatric surgeons, counsellors and other health care professions, 
and integrated education and CPD events for other health professionals. 
6.3 Findings from interviews 
Six interviews were conducted with nutrition practitioners who had been willing to participate 
in the pilot trial, but did not engage, to further explore practitioner views on the barriers that 
may prevent them and other nutrition practitioner from embedding standardised tools in 
personalised nutrition practice. This included strengths and limitations of the profession 
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which may impact on the utilisation of standardised tools, and approaches to overcoming 
barriers. Results are presented under these nine headings which are themes that emerged 
from analysis: engagement barriers, time constraints, invasiveness, compliance, flexibility, 
health complexity, tools guide practice, practice approach and potential solutions. 
6.3.1 Engagement barriers 
Participants were asked “what are the barriers engaging clients with standardised tools? 
Either for this pilot trial or more generally.” Each participant described different barriers to 
engagement and it was therefore not possible to identify any single issue affecting all 
participants. 
“One has to come, come across so professional as a, as a nutritional therapist because, 
because we aren’t [yet accepted] …  if I was sitting there in a GP practice, I’ve already won 
the respect of those people. But as a nutritional therapist, it’s my responsibility to win the 
respect of those people, so, I’ve got to be pretty sure about what I’m saying and, and coming 
across as, as professional”; “so, if I’m then, getting somebody to take part in any study right 
at the outset, I suppose I have to be very clear” (CB) 
“I wonder if the, the professional base isn’t used to participating in research either. So they 
didn’t” (RJ) 
“I think the main barrier for me was, [clients] just weren’t interested, you know, they just, they 
didn’t get anything back from it… they were more concerned about their weight loss than 
helping to participate in some trial” (MC) 
Asking practitioners to engage their clients on a pilot trial appears to have been a barrier to 
participation for at least two practitioners. 
“I guess it was the fact that it was a sort of third-party sort of set-up I think possibly had 
something to do with it” (LO) 
“It’s probably easier to work on a practitioner-only side; than to get the practitioner and the 
patient to do it together” (RJ) 
6.3.2 Time constraints 
Time constraints were mentioned by all participants – either their own time constraints to 
engage with the process or the time constraints that prevented their clients from completing 
the tools: 
“Time-consuming, I think that would be a major, major factor” (CS) 
“If you’re busy and you’re rushed for time and you’ve got to take time aside to discuss it with 
the client; that might have been another hurdle.” (RJ) 
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“There’s a lot of sort of chasing up, often, to get these things back from people.. I know 
particularly the pilot trial... I remember looking at your questionnaire initially and I think it 
said.. this may take up to an hour to fill in... I will often look at that and go ‘well I don’t have 
an hour now, I won’t, I can’t do it now. I’ll come back to it.’ And then you just never come 
back to it. I think, sort of, time is a big thing for people and, you know, they think, ‘I’ll do that 
when I have a bit more time’, and they never have a bit more time”; “and possibly… I wasn’t 
as hot on following up with them to make sure that they did it? You know, it wasn’t sort of a 
top priority for me to kind of follow up with them to make sure that they’d done it: If I’m 
honest, that was probably part of it.” (LO) 
Aside from the pilot trial, participants were asked: “Have you received any feedback from 
your clients on their experience of filling out questionnaires?” 
“A lot of people have commented that the six page questionnaire that I give them is, is quite 
long and takes a long time to fill out.” (CB) 
[A client may say} “Gosh, that’s a big document to fill out… but [that’s] not really [a barrier] 
most people seem to have been fairly happy to do that” (CS) 
“They want some streamlined… nowadays everyone’s busy and people want to be given 
information in as simple and quick a form as possible” (CS) 
There were opposing opinions on streamlining the tools: 
“It’s impossible to make your questionnaire shorter. If it’s, if it’s shorter then it doesn’t collect 
all the data. So, you either make it proper, and long... or you don’t make it at all. I mean, 
because you still have to ask these questions.” (NG) 
6.3.3 Invasiveness 
One participant commented on the potential of obesity stigma being a barrier to 
engagement: 
“I can imagine that stigma would be quite a big thing, where people wouldn’t want to get too 
involved with being part of a trial because, I guess, it’s the whole feeling like a bit like a 
guinea pig, might not appeal to them. So, it is quite a sensitive delicate area; I think people 
feel quite a lot of, self-blame, possibly for being overweight… it’s not the same as some 
other health conditions that people might feel is out of their control. So I guess 
embarrassment and shame might be one of the reasons.” (CS) 
“I think weight loss is such a delicate area anyway, because there’s so much stigma around 
it.” (CS) 
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“It’s very in-depth, it’s very straightforward; it’s very invasive… you’re asking a lot of very 
pointed, very sharp questions.  Sometimes some people don’t want to answer…” (NG) 
The invasive nature of the questionnaire may therefore have presented another barrier to 
some clients: 
“If you don’t know the practitioner and you don’t sort of quite know what you’re signing up for, 
I think maybe you, yes, would, there would be a little sort of barrier of sharing information 
with someone that you don’t know anything about” (LO) 
“If you give a questionnaire that’s got quite a lot of personal, in-depth consultation, or you’re 
going through somebody’s life history in depth, then it can feel quite threatening in some 
ways” (CB) 
“Until you’ve been working with somebody for a while, you have not achieved with them, this 
trusted adviser status, so any profession, whether you’re talking about accountancy, law, has 
this concept of trusted adviser status that you build up with a client… So, we’re almost on a 
back step for trusted adviser status because we’re not part of the National Health Service, 
and at that point we haven’t developed this trusted status, adviser status” (CB) 
Building up a trusting therapeutic relationship is important for client engagement: 
“I call my work coaching. I do. Because that’s what it is; it, it’s training and coaching... 
therapy... because that, that’s the most important part in this thing… you have to kind of get 
a rapport; you have to get some understanding... he or she feels comfortable disclosing a lot 
of data to you.” (NG) 
“At first there’s a little bit coldness in relationships... then there comes out a crisis; then that 
person feels like, okay, well, there’s somebody who’s finally listening, finally understanding, 
and then it runs for, this warmth of relationships, therapeutic relationships, runs for maybe a 
couple of consultations, and then... they come to some barrier, and very often... they despair, 
and they don’t come back, because - it’s not like something isn’t working, it’s because they 
can’t overcome the psychological part of it.” (NG) 
The psychological and coaching element of nutritional therapy is an important part of 
supporting clients to make healthy changes to their lifestyle. Building a trusting relationship 
may also support client compliance which was another recurring theme. 
6.3.4 Compliance 
“In an ideal world, I’d love to be able to send a client a form that they fill in beforehand, and 
that gets sent back to me and I get to review it before I see the client and then we sort of, 
you know, that then leads you on to what happens in the consultation. But I just think – I’ve 
had so many troubles with getting people to do things before you’ve established a 
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relationship with them or something, you know? I think after the initial contact they’d be more 
willing to follow it through?” (LO) 
“I’ve tried on various occasions to sort of send them through to a client for them to fill in 
beforehand and they either haven’t read the instructions or they just don’t get it and so 
they’ve filled it in wrong. And so, it’s completely useless.” (LO) 
“I now will do those forms with someone sitting in front of me so I can guide them through 
[it]– It’s a very simple form… but people still get it wrong.” (LO) 
“Overwhelmingly, the key issue that I’m gonna have to deal with is compliance. It doesn’t 
matter what the information is; it’s all about compliance and the better relationship I can 
build, the better my chances of compliance, the better my chances are that people will be 
honest with me around food.” (RJ) 
6.3.5 Flexibility 
With a personalised approach there also has to be a willingness to meet individual needs: 
“Some people love writing everything down and some people forget. I don’t think they’re 
opposed. It’s just life gets in the way, and, you know, they’re not as, possibly as organised as 
others.” (MC). 
“many people like hard copies” (NG) 
“Some of them don’t have computers because they have tablets; some of them don’t have 
tablets or computers: they have telephones. It’s impossible to fill in questionnaire” (NG) 
“When you integrate Asian cultures; when you integrate Indian, Pakistani cultures, true, true 
cultures – I mean not, not people who are born here – they sometimes, they don’t even know 
what that question means, whatever that question is, because they never actually thought 
about it.” (NG) 
Cultural validity analysis would need to be undertaken to meet various needs. However, in 
order to achieve a standardised data-collection approach, such as through an online 
application, it will not be possible to overcome some of these barriers: 
“There’s a lot of apps out now, with tools for weight loss now, all using the same tools. But, I 
think when you’re seeing somebody personally every week, it’s because you’re not doing 
that – you want that personal intervention and you want that personal care.” (MC) 
An approach should incorporate both of these facets; it should include personalised 
coaching and care with the client, and data-gathering which can be done online. 
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6.3.6 Health complexity 
“The biggest barrier to me, personally taking part in this was the fact that this [was] very 
much geared to obesity, and of course I wasn’t having anyone saying, ‘I want to deal with 
obesity’ and ‘not having enough flow of clients at this point in time.’” (CB) 
“Lots of people come [for nutrition therapy] and they’ve got complex [health] issues, and 
they’re not mentioning… obesity” (CB) 
Clients come for nutritional therapy for health reasons, and weight loss may not the primary 
concern: 
“Nutritional therapy’s so complicated just because we’re dealing with living, human people –
every single one of them is different.” (CS) 
“The issue with that is that… somebody with high weight is not the only thing we look at… 
they have so many other issues… so, if you give them obesity questionnaire, you might… 
miss out things?” (NG) 
“There are different questionnaires, like stress questionnaire, a weight loss questionnaire; I 
had thyroid questionnaire; I had a stress questionnaire; I had specific questionnaires for 
childhood obesity… but then I stopped using them because I thought… it’s almost like going 
into very single track.” (NG) 
6.3.7 Tools guide practice 
Participants were asked about methods they use when assessing their clients. Again, all 
participants were using their own tools and methods, but these results could also indicate 
that some practitioners may be adapting their data-collection methods depending on their 
patient and on their own clinical experience: 
“The questionnaire was developed over time really. So I started off with a questionnaire… 
but edited it, so I added in bits, took away bits… so it’s just been edited according to what 
use.” (CS) 
“I’m sort of following, loosely following a Zest4Life kind of intake form. But I’ve kind of 
adapted that to be my own intake form.” (LO) 
“I use timelines to help myself think, but in terms of, it’s a very unstructured interview. I’ve got 
some standard questions, like where do you think this all began?” (RJ) 
“I do have two questionnaires. One questionnaire is Dicken’s questionnaire...The second 
questionnaire was developed by myself from some medical questionnaires... I created my 
questionnaire the way I think.” (NG) 
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“I don’t really have anything concrete… a food diary, emotional diary, and weigh-in: they’re 
probably the main tools. And then I track that through a sheet that I have where it’s – just 
looking at it now – it’s in chronological order: they have their goals, what they want to 
achieve.” (MC) 
“I’ve sort of tried different questionnaires, we obviously had a questionnaire when I 
graduated, so that was the one I used for a number of years, and then there was an update 
and I tweaked it myself, and I’ve used the CNELM questionnaire as well to see how that 
panned out; when I was with Nuffield, then I used their questionnaire.” (CB) 
This highlights the fact that practitioners are also developing their own questionnaires to suit 
their practice approach: 
 “[A] questionnaire is not just a tool: [a] questionnaire is a way of thinking.” (NG) 
“The health questionnaire… dictates my thoughts before the consultation and, which sort of 
questions I want to ask the client - what additional information I want to get out of them. So 
that gives me clues as to what, you know, where I think needs probing further.” (CS) 
This highlights another barrier for the pilot trial: 
“When they are faced with a new tool and it’s perhaps structured in a way that they’re not 
accustomed to using, that then they have to reconfigure their whole consultation to fit that 
tool into it. And they have to make a decision as to whether they abolish their existing tool or 
whether they use this tool as a replacement, and then they have to question whether the 
new tool includes all the other things that they had previously, and so there’s quite a lot of 
complex thinking that someone has to engage in before including those tools.” (CB) 
“If you’re asking questions on marital status, past pregnancies, this sort of thing, which can 
appear to be quite invasive sort of information, you have to feel comfortable that you can act 
on that information. And if you don’t know whether you’re going to do anything with that 
information, then you almost feel uncomfortable about asking it.” (CB) 
“When I look through a questionnaire that I made and the people filled it in, I don’t need to 
read every line. I just see where these marks are on the page - I know what we’re talking 
about. So I’m used to it, you see? It’s my comfort zone. So we’ve basically have to retrain 
ourselves to use [the pilot trial tools] …” (NG) 
6.3.8 Practice approach 
“The process of nutritional therapy in itself is quite complex, because it can mean different 
things to different people.” (CB) 
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The various approaches to gathering client data and the use of questionnaires to guide the 
consultation process highlights that nutritional therapy practitioners all take their own 
approach to practice. There were even opposing views about the impact of this: 
“Every practitioner works very, very differently … and I think that is a strength” (LO) 
“Lack of standardised practice is a massive weakness, I think, in the profession. So, I know 
that if I go to a doctor or a GP anywhere in the country, that at least I’m going to be assessed 
in, in a certain way and that if I’m at risk, for example, of getting diabetes that there’s certain 
algorithms behind the analysis. And it doesn’t matter if I go to this clinic or that clinic, that 
those things are in place to, to pick that up. And that gives me, as an individual, a certain 
amount of assurance.” (CB) 
“We do lots and lots of different things; we do them in lots and lots of different ways… the 
way that we apply evidence is really very… variable” (RJ) 
“I think the trouble is everyone works so differently… we are so varied in the way that we are 
looking and working with clients, it, I think it’s hard to standardise the process. But then on 
the flip side of that, I get that it would be really useful and in terms of being able to validate 
what we do –particularly if we are wanting to communicate with the medical profession – you 
know, I totally get that it would be [a] really useful thing to do, but how you come up with that 
sort of structured standard thing that people use, I don’t know.” (LO) 
“The profession as it exists, is so very… atomised, I would say, in that each practitioner does 
things in their own way. So that... is one barrier and I think it’s also a barrier to us developing 
perhaps a common language and... collaboration.” (CB) 
“I think [standardised practice] must happen, not just should happen, must happen. We all 
should have standardised approach – I mean personalised in terms of patients but 
standardised in terms of what, how we understand things”; “It has to happen. Because 
otherwise, if there, there’s no standards in the industry, that’s rubbish.” (NG) 
“I think historically we’ve been very bad at structuring our consultation process” even the 
“different [nutritional therapy] training providers [are] teaching students in different ways.” 
(CB) 
“Tools have to really be asking questions that are absolutely vital in terms of the way that the 
consultation goes.” “If the tools really helped to guide practitioners to embed perhaps a more 
structured approach to their practice, then, perhaps they would start to use standardised 
tools a bit more.” (CB) 
There was discussion about the wider impact of various practice approaches on the 
profession: 
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“I work in a hospital up north... doctors… [have] asked, ‘So you’re a nutritional therapist? We 
used to have another nutritional therapist here… could you tell us about your profession, ‘cos 
we’re, we’re not quite sure; are you all guys doing the same thing?’ That question was 
asked.” (LO) 
“People don’t necessarily know what... nutritional therapy’s going to involve when they, when 
they rock up to see a nutritional therapist; it’s still a sort of slightly unknown process, to a lot 
of people, ‘cos it will be the first time that they’ve come across someone, and they’re used to 
having that sort of seven minutes with their doctor, where they don’t go into as much detail 
about their health, and past medical history, and lifestyle, and all that kind of stuff. So I think 
that the way we work is, is quite… novel, to most clients.” (LO) 
“[Clients] might not come back if they don’t know why they’re coming back or how that 
process is structured.” (CB) 
“I think the industry, with nutrition, functional medicine, naturopathy, is very confusing for lots 
of people and you could do a one-month qualification, a degree, a post-degree, a post-grad 
qualification, but at the moment it’s dietetics, isn’t it? That’s the only kind of recognised… 
and nutritionists. But nutritional therapy, I think, has a, a still quite a slanted view.” (MC) 
“The training colleges aren’t standardised either, you know, are they? There’s such a huge 
variation in the training of nutritional therapists. So I mean, I guess it’s got to sort, you know, 
really, that’s where we need to start: is in terms of the kind of training, qualifications.” (LO) 
“There is such a varying degree of how the core curriculum is being interpreted.” (CB) 
“There’s such a huge variation in the training of nutritional therapists. So I mean, I guess 
that’s where we need to start.” (LO) 
6.3.9 Potential solutions 
As well as highlighting barriers to the pilot trial and implementing standardised data-
collection methods into personalised nutrition practice, participants were asked “What could 
be done to encourage the use of standardised tools (or standardised data collection) in 
personalised nutrition practice?” 
“Structuring our consultation process… I think that’s crucial to the success of the profession”. 
“A more staged approach because they’re dealing with the fundamentals of that first 
consultation allows them to really focus on, on fundamentals and diet, and it builds trust with 
the client so that they’ve found that they’ve got a much higher rate of, of clients returning as 
a consequence of that.” (CB) 
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“I think there should be some process in place but I’m not sure whether it’s the same tool 
that everyone should be using…I think there should be a system in place but I think… people 
are different.” (MC) 
“Maybe have something where the standardisation would be, there are certain areas that 
should be covered by every practitioner but then that can be built on, you know, those areas 
can then be extended on, rather than, you know, an exact standardised tool.” (CS) 
“If we had some tools which were centralised tools that everybody had available to them, I 
think that would be an excellent thing, and I think it would help to standardise nutritional 
therapy”; “a collective of standardised tools that you could apply in practice.” (CB) 
“I feel… nutritional practice that could be dealt in a fairly algorithmic way… So, it’s about 
finding a way that standardises perhaps some certain core assessments, with a capacity to 
go deeper into certain other aspects, if you’re perhaps a specialist in that area. For example, 
if you’re a specialist in gut health, or, or obesity, then you would perhaps want additional 
tools on top of a, an overriding tool to, to, to dig further into those areas.” “What are the really 
essential questions that they have to be in there? So, things about medication, things about 
red flags, things, the diet is obviously crucial… and certain symptoms. So, again, this comes 
back to how then one structures the process.” (CB) 
“New tools should not take not more than half an hour of somebody’s time probably… 
otherwise it just becomes stressful and that’s what you are trying to avoid in the first place.” 
(CS) 
“Raise awareness, or at least make people comfortable in terms of how to use the tools and 
things.” (LO) 
“Probably just general education on… what a positive outcome would be. So,.. what’s the 
importance of it… and really sort of targeting thinking of how that… importance with clientele 
and also for practitioners … how would those outcomes improve their practice.” (CS) 
These comments give insight into some potential solutions for implementing standardised 
tools into personalised nutrition practice. 
6.3.10 Discussion of interview findings 
NTs and their participants may not have experience of participating in such research and 
they may not have felt, or considered themselves, sufficiently confident about explaining the 
purpose and value of the trial. If the purpose and benefits of the pilot trial were not 
adequately explained to the clients, it would be difficult to engage them. This is a complex 
project, therefore making the benefits of engaging with these tools clearer to both 
practitioners and their clients may have increased engagement with the pilot trial. In order to 
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validate clinical tools, they need to be used with the population group. These results support 
my concern that practitioners may have struggled to recruit participants for the pilot trial. It 
may have been better to work directly with an obese population only, rather than through 
practitioners. 
When developing clinical tools there clearly needs to be a balance in terms of efficiency and 
completeness to support robust data gathering. Shorter but more frequent data collection 
approaches may allow further flexibility and help overcome barriers of time constraints, 
engagement and compliance. It may also be possible for practitioners to better support 
population groups who are unable to access or engage with online tools if the tools are 
shorter and quicker to complete. 
It is also important to build the therapeutic relationship prior to requesting personal and 
invasive data. A consultation process may need to be developed alongside online tools, 
where data is collected in stages along with a staged consultation approach. The aims of 
each consultation and/or outcomes of data sets can determine which further tools are 
required for completion. Initially a smaller baseline questionnaire (medication, red flags, 
presenting issues) is required, then more invasive data could be collected personally during 
the consultation process. This could include trauma and adverse events that an individual 
might find it difficult to share until a much later stage in the consultation process. Then a 
questionnaire to assess pathophysiological mechanisms and laboratory data. Then 
assessment of barriers to compliance, motivation, food addition, behaviour or personality 
assessments could be undertaken, depending on the client’s individual requirements at any 
given time. Meanwhile collecting ongoing dietary analysis, exercise and lifestyle data through 
real-time application would allow for compliance/achievement monitoring. Developing a 
range of short, validated, standardised tools may therefore help to overcome a number of the 
barriers presented and enable a more personalised data collection approach, which could be 
client-led. 
These results also highlight the incongruence with creating tools for personalised nutrition 
practice that focuses on a condition such as obesity. Focusing on obesity is a disease-
oriented approach rather than a personalised approach. The complexity of client health 
issues means clients rarely present with obesity or any other disease in isolation, meaning it 
may be better to have personalised health questionnaires that do not focus on obesity, but 
can be used for all clients. 
Practitioners use their clinical tools to guide their consultation process. They have been 
trained to use their tools and have developed them over time to suit their needs within the 
consultation process. Engaging them with new clinical tools requires a significant time 
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commitment and this has likely impacted on engagement with the pilot trial, especially as the 
majority of nutrition practitioners who have engaged with this research are self-employed so 
time issues, case load uncertainty and excessive workload issues (Nash, Norcross and 
Prochaska, 1984) may have presented additional barriers to engagement. For any new 
approach to be successful it is clear that training practitioners to use new tools is necessary. 
The variation of programmes delivering nutritional therapy across different training providers 
should be further investigated by the NTEC. The NTEC did undertake an online survey of 
NTs (n=408) exploring their working profiles to support the development of the core 
curriculum, which was insightful in terms of identifying the number of NTs trained at various 
academic levels and what sources of evidence informed their clinical practice, with continued 
professional development (89.2%), scientific journals (80.6%), industry events (67.2%) and 
internet forums (55.9%) coming out on top (Benbow et al., 2017). Interestingly, word-of-
mouth marketing was identified as the most successful marketing method by 80.7% of 
respondents. Further research to identify how NTs can raise their profile through 
professional marketing strategies could be useful. 
NTEC reported that 68.2% of participants suggested the medical professional has poor 
regard for NTs, although some reported that this was improving along with an overall 
improvement of the public perception of nutritional therapy (Benbow et al., 2017). The 
authors conclude that advances for professional development, and the perception of NTs by 
medical professionals and the public, could be improved by setting the qualification level at 
academic level 6, which is the same as nutritionists and dietitians (Benbow et al., 2017). 
Further comparison of clinical training provided by nutritional therapy education providers, as 
well as a comparison of practice approaches as taught and practised, would be insightful. 
Benbow et al., (2017) explored clinical practice, with 66.9% of respondents stating they use 
functional medicine to inform clinical decisions and 73% using a systems biology approach, 
although the clinical approaches to these were not described. Performance criteria is 
specified in the National Occupational Standards (NOS) for nutritional therapy, but there is 
little guidance given in terms of practice approach other than: 
“Conduct a nutritional and overall health assessment and plan the therapy” 
(Skills for Health, 2010) 
The NT core curriculum provides further description: 
“Nutritional therapy practitioners use a wide range of tools to assess and identify 
potential nutritional imbalances and understand how these may contribute to an 
individual’s symptoms and health concerns. This approach allows them to work with 
individuals to address nutritional balance and help support the body towards 
maintaining health” 
(NTEC, 2015) 
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NTEC and BANT also state: 
“Nutritional Therapy is the application of nutrition science in the promotion of health, 
peak performance and individual care. Health is defined by the World Health 
Organisation as “a state of complete physical, mental and social wellbeing and not 
merely the absence of disease or infirmity”. Nutritional therapy embraces this 
definition and professional practice is underpinned by a set of fundamental principles 
which support optimal health outcomes, i.e. 
• biochemical individuality: understanding and appreciating the importance of 
variations in metabolic function deriving from genetic, epigenetic and environmental 
differences among individuals. 
• person centred: emphasising individual care rather than disease care, following Sir 
William Osler’s admonition that “It is more important to know what patient has the 
disease than to know what disease the patient has” 
• dynamic balance of internal and external factors: understanding that resilient 
homeostasis (the buffering capacity to respond to a perturbation) is important for 
physiological equilibrium; 
• web-like interactions: understanding that human physiology functions as an 
orchestrated network of interconnected systems, rather than individual systems 
functioning autonomously and without effect on each other; and 
• promotion of organ reserve: as the means to enhance health span by maintaining 
genomic stability and mitochondrial capacity so decreasing morbidity.” 
(BANT, 2017a; NTEC, 2018) 
These synthetically describe nutritional therapy and its underpinning philosophies to a 
degree but they do not analytically describe the process or practice approach. The BANT 
Professional Practice Handbook (2018) provides further description of the boundaries of NT 
practice but does not detail a practice approach. 
The BDA (2015) on the other hand provides a model and process for dietetics practice which 
includes: 
• the use of structured records to improve quality of care; 
• structured reporting and communication of clinical reasoning; 
• information sources for clinical data gathering using a systematic and standardised 
structure; 
• methods for assessment and reassessment; 
• approaches to clinical reasoning; 
• definitions of what constitutes nutrition and dietetic interventions; 
• implementation of intervention approaches as well as monitoring; and 
• reviewing and evaluating intervention approaches. 
These all provide clarity in terms of what can be expected from dietetic practitioners. 
The BDA describes this process as: 
“an important step in the development of consistent high standards of dietetics 
practice” 
(BDA, 2015). 
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Although the BDA model and process are client-centred and include consideration of social, 
cultural, lifestyle and economic factors, they take a differential diagnosis approach where 
signs, symptoms and aetiology are used to determine a nutrition and dietetics diagnosis and 
then evidence-based guidelines are used to determine an intervention. This approach fits 
with the EBM paradigm but cannot be considered personalised nutrition practice because it 
does not allow for consideration of the broader complexities of health and disease, including 
genetics, genomics, epigenetics, physiology, pathology and toxicology, as explored in 
Chapter 2. 
The interview results highlight that the varying practice approaches were a barrier to 
implementing standardised tools. Using a computer technology analogy: when the operating 
systems are different one cannot implement standard applications. In order to be able to 
implement standardised tools into clinical practice there may first need to be a more 
standardised practice approach. Further research should be conducted to understand the 
implications of developing a more structured process for undertaking personalised nutrition 
practice and how this can be achieved without limiting the scope of practice. Personalised 
nutrition practice may not need to be standardised, its process may just need to be better 
defined. 
6.4 Overall discussion of findings 
The pilot trial of the four new collaboratively developed clinical tools gained interest from 
practitioners but lacked engagement from practitioners during the pilot trial. The interviews 
with practitioners that followed identified some of the reasons why the pilot trial was 
unsuccessful and aimed to identify ways in which standardised tools could be integrated into 
personalised nutrition practice. 
Rather than having one large health questionnaire, it seems smaller, more frequent data-
collection points would better engage clients and enable a more flexible and less invasive 
practice approach. It could also allow for the development of a therapeutic relationship 
before whole life histories or invasive assessments are undertaken. Having a selection of 
short standardised tools and data-gathering techniques may also allow practitioners to 
consider which assessment methods are best suited to their clients, which could support a 
personalised nutrition practice approach. 
The lack of clarity around the nutritional therapy process is likely contributing to the varying 
practice approaches undertaken by nutritional therapy practitioners. Variation of practice 
approaches has consequences for how clinical decisions are made and how clients are 
managed. Variation of practice approaches also seems to be impacting how the profession 
is perceived by other health professionals and how the profession is able to describe and 
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promote itself. Clarification of a personalised nutrition practice approach appears to be 
essential for developing standards in nutritional therapy and promoting its acceptance in 
mainstream health care. However, developing a clear message which describes nutritional 
therapy in a meaningful way which can be understood by other health care professionals and 
the general population, is challenging. 
This project also aimed to evaluate the ethics of standardising data-collection methods in 
personalised nutrition practice, and although patient autonomy, inclusivity, data management 
and data mining consent concerns were raised, there was overall support in standardising 
data-collection methods as long as that does not impact on the practitioner being able to 
manage the consultation in their own way and making personalised intervention decisions 
and recommendations. Standardised data-collection methods do not need to limit the scope 
of personalised nutrition practice but could enable us to pool data and develop a case-by-
case evidence base that allows for analysis and comparison on the efficacy of interventions 
which supports, rather than standardises, clinical decision making. 
6.5 Chapter summary 
This chapter has explored the results from each research method in turn to explore the 
implementation, analysis and outcomes of this project. The overall discussion of findings 
summarised the main results and project outcomes. The conclusions and recommendations 
that arise from these results are further discussed in Chapter 8.  
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Chapter 7: Reflexive Account 
Continual reflection was undertaken throughout the project to assess the influence of my 
position within the research, as explored in Chapter 3. This chapter is a retrospective 
reflective account which draws on my reflective learning diary and explores my 
developmental transformation throughout the project as well as the impact of my self-
development and the outcomes of this project on professional environments such as my 
workplace and the nutritional therapy profession. Theories of reflection, such as Johns’ 
(2000) model of structured reflection, Brookfield’s (1995) four critical lenses and Gibbs 
(1988) reflective cycle, were reviewed, and their approaches utilised to advance and deepen 
my reflective thinking. 
7.1 Self-development 
The DProf, and this project, were undertaken part-time over six years while I maintained a 
part-time (three days per week) working role as Head of Education at CNELM. My work is 
complex and encompasses a number of roles. I am a senior manager in a middle-leadership 
position (Bryman, 2007). Managing my workload alongside the project (two to three days per 
week) while also taking care of my family has developed my time management skills, 
especially the ability to compartmentalise: focused working on specific roles at one time, 
isolating issues, planning and moving forward in incremental steps, closing one compartment 
to focus on another (Blair, 2012). Compartmentalisation has been essential to be able to 
juggle numerous roles and responsibilities and this has also required a considerable amount 
of forward planning and organising to achieve successfully. 
In essence there have been three selves: worker, student, parent/family member. Being a 
parent/family member meant that I had to take time away from working and studying, which 
impacted positively on my emotional health. I am fortunate that I did not experience any 
major personal or familial issues during the project. I have an incredibly supportive spouse, 
family and work environment. There were times over the course of the programme when I 
was deeply unhappy about the burden of the workload and the impact of that on my 
availability for my child. A number of qualitative research studies have explored the 
experience of female doctoral students and identified that being a mother has profound 
implications (Brown and Watson, 2010). Although I had anticipated the amount of work 
involved, I had not anticipated the level of emotional fluctuation that I experienced. Similar 
experiences are described by female doctoral students in the phenomenological study by 
Schmidt and Umans (2014). Being a mature student in a supportive environment meant I did 
not experience some of the stressors explored by Schmidt and Umans (2014), such as: 
financial difficulties, peer pressure and low status. Nonetheless, the times of stress and 
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emotional turbulence, whether created by my own expectations or by external influences, 
have deepened my empathy for students I work with. As a result, I am better placed to 
provide guidance and support to the students in my workplace who are also juggling many 
roles with families and finding that stressful. This empathy and support may have a positive 
impact on student retention (Lillis, 2011) in my workplace. 
Setbacks with my project included an intense feeling of failure due to the lack of engagement 
with the pilot trial, and the barriers to publishing the leadership research paper were at times 
overwhelming, but I kept going. During setbacks I am quick to undertake self-assessment 
reflection. I consider that I responded appropriately to feedback and broke through the 
barriers that presented themselves. Overcoming these research barriers has made more 
resilient, reflexive and adaptable. I am proud of myself for keeping going in times of adversity 
and I am better able to manage and accept overwhelm as a result. I consider my strength 
throughout the project has been persistence. In a series of experiments described by 
McFarlin et al. (1984), it appears that self-esteem is key for increased persistence following 
initial failure. Although persistence is essential for goal attainment, numerous skills have 
been required at various stages of the project to achieve success. 
Below is an extract from my reflective journal which demonstrates the changing of my 
perceptions about myself and reflective insights about potential research bias: 
I have been having a lot of thoughts about the value of the professional doctorate and 
the limitations of myself and my research. Clearly simplification is important, limiting 
complexity and making things easy, which I don’t always do, could have been further 
applied in terms of the tools. I realise hindsight is a wonderful thing but if I had 
interpreted the initial interviews in another way could I have come to these answers 
about keeping forms simple earlier? Was my bias in terms of meeting the outcomes 
of the research aims and objectives preventing me from seeing that the tools are too 
complex and practitioners/the profession are not ready or is that the result of my 
research and I would never have come to that if it hadn’t been for the lack of 
engagement with the pilot trial? A confusing time. 
Barrow (2016) 
These types of reflexive insights occurred throughout the project. My learning was non-linear 
and heuristic. The learning from a professional doctorate cannot be designed or predicted. 
Hopwood’s (2010) qualitative research highlights that my academic job role influences my 
self-development choices and my project activities are shaped by self-development 
intentions. On reflection, my self-development intentions were in response to the demands of 
both my research project and my work role. I am highly motivated in self-development 
activities and that is influenced by my work environment which encourages staff self-
development and delivers student development opportunities (Ryan and Deci, 2000). 
My writing has been prolific, not just about the project and the research outcomes but my 
reflective diary and my research journals are extensive. I have become highly reflective. 
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When I was unable to undertake project tasks I read academic and self-development study 
skills books and this further guided my writing. Self-development was one reason for 
undertaking professional doctoral studies; to me it is as meaningful as accomplishing the 
research. Reflective writing allowed me to develop academic self-regulation including self-
motivation, self-monitoring and goal attainment (Siebert and Walsh, 2013). I have learnt that 
I am more determined, self-reliant and adaptable than expected. These attributes have not 
only brought me to the completion of this project but are essential for effective leadership. 
As a result of completing the project I have found my confidence has grown, which has 
changed the perception I have of myself. I left school with few academic qualifications. 
During my 30s I achieved two degrees, a diploma to teach and numerous CPD awards; 
imminently this professional doctorate. Imposter syndrome, an internal feeling of academic 
and intellectual self-doubt (Clance and Imes, 1978), at the outset of the doctoral studies and 
the outset of my job role as Head of Education made me more determined to prove myself. 
Self-doubt has been replaced with resilience and confidence. Professional identity 
development has been achieved in numerous ways: enhanced understanding of workplace 
cultures, utilisation of theory in complex work environments, development of reflective and 
ethical practice, raised critical awareness and personal epistemological development (Hofer, 
2008; Trede, Macklin and Bridges, 2012). 
Certainly, knowledge and skills such as research skills, writing and getting published were 
achieved during the course of the project. The project was highly complex, and managing it 
developed my adaptability, collaboration, communication and leadership skills. The self-
development aspects of undertaking the project were what I most enjoyed, because it felt 
like I was making progress. Most surprisingly, my feminist and broader political views also 
developed during the project, maybe from the insights and knowledge gained, maybe from 
the development of critical analysis, or maybe from the political developments that took place 
during the course of the project – including Brexit – as I am European, not British. 
All of the self-developments discussed in this section have fed into my work and the 
contribution I make within my workplace and within the profession in ways I am now able to 
recognise and ways that I have yet to recognise. Self-development will continue as I reflect 
post-project, post-doctorate and as a part of lifelong learning. 
7.2 Development in my work role 
I have already explored some of the influences of my self-development on my work roles, 
such as drawing on my student status to empathise with the students at my workplace. Self-
development has also enhanced my ability to think critically about problems, identify 
solutions and create new knowledge as well as my ability to plan, manage and deliver work 
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projects, which has benefitted my organisation. For example, I instigated a research-based 
approach to undertaking projects and surveys within my own organisation, which allows us 
to better measure the effects of change and make evidence informed decisions. Publishing 
research (Barrow et al., 2017) and contributing to academic conferences also helps to raise 
the profile of my institution and to meet the organisation’s vision: 
 …to be viewed as a centre of excellence 
(CNELM 2017) 
I am very grateful that my institution has been supportive of my studies in a number of ways: 
funding, encouragement, time away from work to write, and much more. Working in an 
academic environment has positively influenced my research in numerous ways. Prior to 
undertaking the DProf, working at my institution had socialised me to academia and 
scholarly practice (Antony, 2002; Weidman and Stein, 2003). During the project I was 
surrounded by other academics who were available for ideas and support. This 
“developmental network” (Sweitzer, 2009) has been essential for doctoral progress and 
success. It has provided me with opportunities to reflect and self-appraise as well as 
enhance my understanding of my collaborative network and my position to undertake 
effective resource management. 
My professional development also impacted on the professional development activities I 
provide as a part of my job role, positively affecting students, staff, my institution and 
indirectly, the professions into which graduates will move. I very much enjoy teaching and I 
have utilised my learning to enhance and broaden my teaching practice in numerous ways, 
including: the development of reflective practice, teaching ethics to enhance the student’s 
ability to consider ethical issues and undertake ethical reasoning, as well as teaching 
research methods at my institution and another institution. 
I have also fed my learning into staff development in numerous ways: I have given staff 
workshops on my learning, promoted the integration of reflection and ethical reasoning into 
teaching and learning activities across taught programmes, and supported the development 
of the CNELM research agenda. My job role has evolved during my time working on the 
project. I have been training other staff to take on the module leading which I used to 
manage. I have focused more on developing the Head of Education role as a consequence 
of the insights afforded to me by engagement with professional doctoral studies. The new 
module leaders under my leadership have made excellent progress and I consider this a 
result of my ability to communicate complex issues effectively, as these modules include 
complex nutritional topics. 
My confidence grew with research supervision. I am now helping students to publish papers 
(Miles and Barrow, 2018), which has a positive effect on my institution, the students and the 
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nutritional therapy profession. My ideas for research projects, how to design them and 
manage the complexities of ethical issues that surround them have developed as a result of 
my studies, and that impacts positively on student research – both in scope and quality. I am 
now keen to support my institution in facilitating the provision of doctoral research 
supervision at CNELM in collaboration with an awarding institution. It is CNELM’s mission to: 
Provide globally accessible high quality education and training in nutritional science 
and personalised nutrition” and to “promote lifelong learning and provide 
opportunities for continuing professional development 
(CNELM, 2017) 
Although I enjoy a good level of autonomy in my working role, my research supervisors 
allowed me to work more independently, and although at times I craved more direction, the 
level of autonomy provided by the doctoral research has allowed for significant growth and 
self-development. Autonomy in work influences job satisfaction, self-esteem, work-related 
motivation, attitudes and behaviours (Schwalbe, 1985; Pierce and Gardner, 2004). Group 
autonomy also positively influences group cohesiveness and effectiveness (Langfred, 2000). 
This insight has led me to review and reconsider the management strategies within my 
workplace by seeking to support staff development, individual autonomy and group 
autonomy. 
The overwhelm of managing the workload of work and studies, within time restrictions, led to 
feelings of not being able to do anything well; not my research, my job role or my family role. 
The project did take my time, and sometimes my focus, away from my work. Accepting the 
limitations of time resources was not always easy, but this has honed my time management 
skills and my research and project planning. Being realistic about expectations, breaking 
down tasks into manageable sizes, and understanding what I can achieve within time frames 
helped to take the stress out of feeling overwhelmed. 
When pressured by time constraints I have a tendency to focus on task-orientation and I can 
lose focus on strategic oversight. I have learnt that I must make time in my working and 
research roles to consider wider contexts of the tasks at hand and that collaboration and 
reflection are good ways of providing the space required for enhancing strategic oversight 
and planning. Although there has been critical discourse of the use of reflection in 
workplace-based learning (Siebert and Walsh, 2013), development of reflection and 
academic self-regulation has also benefitted my organisation because it has allowed for a 
deeper analysis and evaluation of workplace issues, as well as the self (Siebert and Walsh, 
2013). 
Costley et al. (2010) undertook a grounded theory approach, utilising open-ended interviews, 
to study the impact of professional doctorates in the workplace of ten candidates who had 
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completed their studies and identified that personal attributes, skills, professional 
effectiveness are outcomes of undertaking a professional doctorate project, as well as 
enhanced credibility and status in their professional community, enhanced personal 
capability and that the process of undertaking a professional doctorate continues to make an 
impact after the project has been completed. Costley et al. (2010) conclude that the DProf 
programme offers many benefits for the individual, their workplace and their professional 
environment and, although time-consuming, the benefits hugely outweigh the impact of time 
and focus away from work to undertake it. 
7.3 Project outcomes 
The project’s outcomes are highlighted throughout this report and expand beyond the 
construction of four new clinical tools for health data collection and clinical outcome analysis. 
The use of the term ‘personalised nutrition practice’ within the project aims and research 
questions, and the research methods outcomes led me to explore what personalised 
nutrition practice means. Uncovering the limitations of the descriptions and approaches to 
nutrition practice has been a significant finding. However, it cannot be claimed that all 
dietitians use only evidence-based guidelines and do not undertake pathophysiological 
reasoning, in the same way that it cannot be claimed all NTs undertake pathophysiological 
reasoning and do not make evidence-based recommendations, mainly because the results 
only represent a small sample of nutrition practitioners. By describing what constitutes 
personalised nutrition practice, a new model and approach for nutrition practice has 
emerged. Pathophysiological clinical reasoning is a model for personalised nutrition practice 
which has emerged from combining the personalised, person-centred, evidence-based and 
systems biology philosophies. Although similar to the functional medicine model, 
personalised nutrition practice should extend beyond it by: more explicitly taking a 
mechanistic approach, building validated and evidence-based tools that support 
pathophysiological reasoning, further encompassing cPNI and biopsychosocial model, 
collating and data mining case-by-case data sets, and by enabling the outcomes of 
interventions to be predicted. 
Having come to these realisations as a result of the project, the benefit of hindsight has 
provided valuable insight into how standardised clinical tools can be developed to support 
pathophysiological reasoning and further develop a personalised practice approach. The 
vision for developing a case-by-case evidence for personalised nutrition practice remains. 
The need to develop standardised data collection tools for personalised nutrition practice 
also remains. However, because the research results pointed to a lack of process for 
personalised nutrition practice, one of the project outcomes has therefore been to propose a 
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definition of personalised nutrition practice, which has not previously been done by 
professional bodies or within existing research. 
This project has therefore moved me into a position for leading transformation in 
personalised nutrition practice by further defining, developing and disseminating its 
approach. I am now ideally positioned to further develop standardised validated personalised 
practice tools to support a pathophysiological clinical reasoning approach, through my own 
postdoctoral research but also through my research supervision role. Development of a 
case-by-case evidence database is also achievable through postdoctoral research and 
collaboration with software developers. 
7.4 Nutritional therapy profession 
The nutritional therapy profession is in a state of flux. It is relatively new compared with 
dietetics practice. It was important that I kept abreast of changes in the profession to identify 
opportunities to influence change and to inform the project and its activities. I had invited the 
British Association of Nutrition and Lifestyle Medicine (BANT) to participate with the Delphi 
method, and was disappointed that directors and managers of BANT did not choose to 
participate as this could have been of benefit to the profession. I did however engage with 
BANT’s Centre of Excellence. In this context I reviewed the Nutrition Evidence Database that 
BANT developed and gave feedback on how to enhance it, thinking about how it could feed 
into a case-by-case evidence base in the future. 
In a members’ newsletter dates November 2017, the BANT chair discussed the development 
of a “standard consultation questionnaire” (BANT 2017) which I have requested to be 
involved with. It is positive that the professional body recognise the value of developing 
standardised clinical tools and the need to share standardised case study reports in order to 
share practice approaches. Although the directors and managers of BANT were not directly 
involved in this research project, several BANT members were, and that provided an 
opportunity to hear their voices of how practitioners would like a standardised data-collection 
approach to develop. My concern with BANT implementing standardised tools to current 
practice is that it would likely have limited engagement and uptake by practitioners, as this 
project experienced. It is therefore my recommendation that any new tools are best 
embedded in the training of NTs, to develop a new wave of practitioners who can use them, 
and to offer existing practitioners CPD training on the use of standardised tools. It is also a 
recommendation that any newly developed tools undergo numerous validity assessments 
otherwise it could push the profession further away from acceptance and collaboration with 
mainstream health care. 
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I had preconceived issues with the nutritional therapy profession: about the varying 
approaches to practice, the lack of standardised data-collection methods and the lack of 
assessment methods to determine the efficacy of interventions. This project was borne out of 
these observations. I consider the lack of engagement with the pilot trial as a reflection of 
issues within the nutritional therapy profession: the lack of a clearly defined practice process, 
practitioners defining their own practice approach and how implementing standardised tools 
disrupts that approach, how obesity management is difficult, lack of engagement with these 
clients and lack of understanding of nutritional therapy relative to nutritionists and dietitians 
among the public. It seems that the research results support my observations, but the risk is: 
did my preconceived ideas lead to bias? With critical analysis and regular reflection 
throughout the project I am satisfied that sufficient bias limitation was undertaken during the 
research process and that the project outcomes could not have been predicted. 
The results indicate that because practitioners earn income from their client work and word-
of-mouth is their best advertisement, disrupting the consultation process could have a 
negative impact on their livelihoods. The results did not fully explore that practitioners may 
see the tools as a measure of their own efficacy rather than a measure of the efficacy of the 
interventions they recommended. This was my own interpretation. However, this led me to 
consider how these tools measure the therapeutic relationship and if that can be separated 
out from the nutritional interventions, which is an important and complex consideration. 
Another insight regarding the lack of engagement with the pilot trial came from a discussion 
with a peer which made me reflect on the results of the practitioner survey and interviews. I 
had originally taken the results from the first round of surveys and interviews that 
practitioners were not using standardised tools, instead using their own tools, as a sign that 
developing a standardised tool was essential. What I had not fully considered was that one 
of the things that a questionnaire does is to set up the expectations of the consultation 
process both from the client and the practitioner perspective. As such I think that 
practitioners consider that they need to have an intimate understanding of a questionnaire 
and the directions in which each question can take them. I thought one of the reasons for the 
resistance in uptake from practitioners is that it deviates from their existing questionnaire and 
therefore influences and potentially changes the patterns and process of their consultation. 
This concern was therefore explored further with practitioners following the pilot trial. 
In terms of my development, I had not anticipated the level of insight into professional 
nutrition practice that I have achieved over the course of the project. This insight was gained 
as a result of a lack of engagement with the pilot trial, which I had initially perceived as a 
failure. However, had the pilot trial succeeded and had I produced and analysed results of 
the new tools created I may not have gained insight into the complexities of engaging 
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practitioners with such tools. This outcome may have been found much later, increasing risk 
to the profession. This outcome also places me in an excellent position to be able to advise 
BANT on how to develop and integrate standardised tools into clinical practice. This outcome 
also resulted in the interviews which explored approaches to practice that led me to identify 
the limitations of the current descriptions of nutrition practice. It is this outcome that bought 
out many valuable outcomes and should therefore be perceived as a key result. Ultimately, 
undertaking the development of these tools and highlighting the value of building a case-by-
case evidence base for personalised nutrition practice has been blazing a trail for other 
researchers, practitioners and the profession to transform personalised nutrition practice. 
There are currently no opportunities to undertake PhD research with providers of nutritional 
therapy training. Facilitating the provision of doctoral research opportunities for the 
profession would be a significant enhancement. Few NTs have doctorates. As an NT myself, 
my DProf attainment may also contribute to raising the standards of the profession. 
Developing doctoral research opportunities within the profession could also support my own 
postdoctoral research opportunities. 
The nutritional therapy profession as a whole does not market itself for weight loss. 
Individual practitioners may advertise themselves as such, but that does not compare to the 
marketing strategies of brands such as Weight Watchers, Slimming World or Lighter Life. 
The NHS does not refer obese individuals to seek out nutritional therapy. Nutritional therapy 
is paid for privately and can be costly in comparison to other weight loss programmes. There 
are so many reasons why I question whether obesity as a focus for this project had actually 
been a good choice, because of the stigma and complexity related to it. However, obesity is 
a growing epidemic which can hugely benefit from nutrition intervention at a personal level. 
Increasing the opportunities for this population group to engage with practitioners and 
increasing the evidence for the efficacy for interventions at a personal level continues to be a 
worthwhile pursuit. 
7.5 Chapter summary 
The value of reflection in and on action (Schon 1983, p. 68) throughout my doctoral 
development has highlighted numerous benefits to a range of stakeholders, most notably my 
work environment and my ability to identify areas for enhancement within my working role, 
within my organisation and development opportunities for staff.  
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Chapter 8: Conclusions and Recommendations 
This chapter summarises the project and identifies the achievements of the project in relation 
to its aims. It evaluates the project outputs and their potential impact on the profession and 
further explores the vision for transforming personalised nutrition practice.  
Recommendations are recapped, and dissemination of the findings are discussed, followed 
by a conclusive discussion. 
This research project aimed to evaluate, construct and validate standardised clinical data-
collection tools for obesity management in personalised nutrition practice. The main 
questions the project was designed to answer are: 
1. Is it possible and ethical to standardise a personalised approach to nutrition practice? 
2. If so, what tools can be constructed and validated to help individual health history 
data collection, clinical decision making and clinical outcome analysis to enable the 
development of a case-by-case evidence base for personalised nutrition practice in 
the management of obesity? 
A clear distinction was made in Chapter 2 that this project did not seek to standardise 
personalised nutrition practice through the development of clinical guidelines. It has sought 
to standardise health data-collection methods from individual clients’, so the data can be 
statistically analysed and compared. Clinicians should use standardised, validated and 
reliable measures to evaluate their intervention decisions and clinical outcomes (MacDermid, 
Grewal, & MacIntyre, 2009). In order to provide a comprehensive personalised nutrition 
practice approach, data-collection methods should aim to capture as many influences on 
disease expression as possible, including: genetic, genomic, physiological, pathological, 
biochemical, dietary, behavioural, lifestyle, cultural and the social aspects of care, as well as 
the client’s own values and views regarding their outcomes. 
There were ethical concerns with utilising standardised data-collection methods related to 
issues of validity, inclusivity and non-compliance. However, standardising data-collection 
methods may enable better auditing and analysis of intervention efficacy and therefore help 
to minimise the risk of harm. There were also numerous ethical considerations in relation to 
the development of a case-by-case evidence base. Chalmers et al. (2013) pointed out the 
blurred lines between the benefits of research and providing clinical care, issues included: 
privacy and sharing/pooling of data, consent, discrimination and comprehensiveness of 
reporting. These issues need to be fully considered within a governance framework for the 
development of a case-by-case evidence base. 
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It has been possible to construct new tools which aim to standardise individual health history 
data collection and clinical outcome analysis to support clinical decision making, but it has 
not possible to validate these tools. This complex project has been the first of its kind in 
trying to pull together various nutritional practice approaches to support the development of 
robust translational bioinformatics tools using a pathophysiological reasoning approach, and 
it has been ambitious from the outset. Although there were setbacks in terms of pilot trialling 
and validating these tools, the learnings provided by these findings have been insightful for 
understanding what further work needs to be done in order to achieve standardisation of 
data-collection methods to enable the vision of transforming personalised nutrition practice 
and the development of a case-by-case evidence base. 
8.1 Standardising data-collection methods in personalised nutrition 
practice 
One of the aims of the project was to evaluate the ethics, limitations and opportunities of 
standardising data-collection methods in personalised nutrition practice. Results highlighted 
that participant practitioners were using their own methods to assess individual health data 
through interview at the consultation setting and through the use of health questionnaires 
they had developed themselves or adapted from other sources. Subsequent interviews 
highlight that practitioners developed their own clinical data-collection methods to support 
their own clinical practice approaches. 
Variations in data gathering and practice approaches increases the variation of data 
available to support clinical decision making among practitioners. This is clearly problematic 
and undermines an evidence-based approach. When clinical decisions are widely divergent 
clinical outcomes suffer and patient safety may be compromised (Rozich et al., 2004). 
Standardisation of data-collection tools is therefore required to increase data quality and 
uniformity of practice, reduce practice variation and improve patient safety (Rozich et al., 
2004). 
Intervention effects are variable (Zeevi et al., 2015, Whelan, Hollar, Agatston, Dodson, & 
Tahal, 2010) so in order to make evidence-based personalised nutrition a reality we need to 
utilise standardise health data-collection methods which enable the data to be stratified into 
subgroups where it can be analysed and compared. Interventions can then be validated, and 
efficacy predicted for various subgroups. Limiting the ethical concerns associated with 
nutritional categorisation, including discrimination and ‘healthism’, needs to be further 
considered as a possible unintended consequence of developing this approach. 
An unexpected outcome of the Delphi method was that, through the development of the 
tools, a consultation approach emerged. It was also clear from practitioner interviews that 
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clinical tools are utilised to support and guide the practice approach. There were barriers in 
trying to implement standardised tools into a range of practice approaches during the pilot 
trial. Varying practice approaches may be a consequence of various data-collection 
approaches. Structured data-collection methods may therefore help to develop a more 
uniform practice approach for personalised nutrition practice. 
Interview results highlight that the range of practice approaches has far-reaching implications 
in terms of how the nutritional therapy profession is perceived and understood by 
mainstream health care and the public. Interview results suggest variations in practice 
approaches could be due to variations of training provision, which should be further 
investigated by NTEC. A review of the NOS and core curriculum on what constitutes a 
nutritional therapy practice did identify a lack of clarity in what constitutes a nutritional 
therapy model and process in comparison to dietetics practice, which may explain the 
variations in clinical training provision. 
It is difficult to encapsulate a succinct description that gives clients and potential 
collaborative professionals a firm grasp of what can be expected from nutritional therapy. If 
this was achieved it may enable the profession to communicate more directly and succinctly 
with the public to build engagement and ease the ability to further undertake large scale 
advertising, nationwide intervention programmes, the development of collaborative 
relationships, integrated education and CPD events and help facilitate acceptance of 
nutritional therapy in mainstream health care. I plan to undertake postdoctoral research to 
develop the description, model and process for NT practice as this fits with my ambition to 
make nutritional therapy accessible through mainstream health care. 
The therapy element of nutritional therapy is another consideration raised by feedback on 
the tools which highlighted that the therapeutic intervention element of practice has an 
impact on the outcome of any intervention programme. There is a lack of appropriate 
therapeutic relationship measures for nutrition practice and it may never be possible to 
completely tease out the benefits of nutrition intervention from the practitioner’s therapeutic 
intervention. Nutrition practice is about both the interpersonal therapeutic intervention and 
the nutritional interventions themselves, and the influence of these are likely to be as unique 
as each individual practitioner and each individual client. Until we have appropriate tools and 
methods to measure them robustly, we cannot properly address questions which ask: what 
works, for whom, and in whose hands. 
This project stemmed out of the observation that nutrition and health care practitioners do 
not routinely assess data on the outcomes of their patients, and even less frequently 
compare the outcomes of similar patients (Kurtin & Stucky, 2009) in any meaningful, robust 
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or standardised way. New tools appear to enable analysis on the outcomes of interventions, 
but the pilot trial was too small to draw any firm conclusions. Zeevi et al. (2015) 
demonstrated that robust analysis of numerous data outcomes can inform intervention 
decisions in personalised nutrition practice, leading to predictive, preventative, personalised 
and participatory (P4) practice. 
It also appears possible to create the tools which enable standardised data-collection 
methods that do not detract from personalised nutrition practice. With further development, 
new clinical tools in personalised nutrition practice could enable a standardised personalised 
approach to nutrition practice and support the development of a new case-by-case evidence 
database. The results of the literature review and interviews highlight limited ethical concerns 
with the utilisation of standardised data-collection methods – in fact they may help to 
increase data quality and uniformity of practice, reduce practice variation and improve 
patient safety (Rozich et al., 2004). 
As discussed, ethical issues in relation to the development of a case-by-case evidence base 
and data mining are broader and would need to be addressed with the collaborative 
development of a governance framework alongside the development of the evidence 
database. Some of the issues of privacy, confidentiality and data protection can be 
overcome by anonymised data collection and ensuring GDPR compliance. Clarity and 
transparency related to ownership, trustworthy intermediaries and legal protection are also 
essential (Harvey et al., 2012). There are also problems with larger scale data analysis, such 
as sampling bias, which would need to be further examined by statisticians and data 
analysts. 
Addressing these does not help overcome the concern that the increase of data to support 
clinical decision making through the increased power of prediction may increase the 
authority of the practitioner and promote paternalism (Gefenas, Cekanauskaite, Tuzaite, 
Dranseika, & Characiejus, 2011). Nor does it address discrimination issues for those who 
cannot afford to pay for this approach, or how such an approach might successfully be 
integrated into NHS practice. Of course, acceptance of nutritional therapy into mainstream 
health care provision may help to address the issue of inequality of access. The issues of 
patient ability to access, read, complete and interact with complex tools are hurdles that can 
be overcome with practitioner support. 
Making questions and tools non-compulsory was seen as an ethical requirement. Clinical 
data is often inconsistent, inaccurate and incomplete, so any data integration approach must 
have a method for separating non-validated or poor-quality data from accurate, complete 
and standardised data (Sheldon & Ou, 2013). Quality and completeness of data sets are 
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essential. Smaller, easier, more frequent questionnaires may aid client compliance and data 
completeness. However, there is a need for continued quality control and re-analysis of the 
validity of the data gathered by new tools (Sheldon & Ou, 2013). 
Zeevi et al. (2015) demonstrated that it is possible to gather complex health behaviours and 
related influences through comprehensive, standardised profiling and smartphone 
applications. Real-time assessment of diet intake, through the use of repetitious and ongoing 
analysis over long time periods, is helping to overcome the issues associated with 
retrospective dietary analysis (Gibson, Ferrucci, Tangrea, & Schatzkin, 2010; Michels, 2003). 
However, the burden of having to constantly input diet and physical activity can affect the 
validity of the data. It would be beneficial if food diaries/journals allowed clients to upload 
food photographs rather than input data. It appears the development of applications and 
online assessments which allow for nutrient analysis of content from photos to be analysed 
has already begun (Martin, Kaya, & Gunturk, 2009). 
In order to enable standardised data-collection methods in personalised nutrition practice 
there has to be training provided to students and practitioners on the use of tools and 
practice approaches. This training should be embedded into the NOS and core curriculum 
with clear recommendations, naming specific robust and validated data tools for use in 
practice. The results highlight that practitioners are not researchers and may not be clear 
about the purpose and value of the data being collated, further emphasising the need for 
training. Hannah et al. (2009) recognise that in order to successfully engage practitioners in 
the use of standardised health records and to achieve successful transformation of clinical 
practice processes, managing cultural change and highlighting the benefits to the patient and 
their own practice are key. 
8.2 New tool construction 
One of the aims of the project was to construct new clinical tools for health data collection, 
clinical decision making and clinical outcome analysis which standardises case data-
collection methods and enables the assessment of the efficacy of interventions. Initially, it 
was thought, through collation and evaluation of existing tools and the practitioner survey on 
the use of tools in clinical practice, that the most frequently used validated tools could be 
integrated into an online format, and then validated. Instead the results highlighted that 
validated tools were not frequently used in nutrition practice and that there were no 
standardised data-collection methods; each practitioner who participated was gathering data 
in their own unique way. 
Results from gathering and analysing existing tools highlighted the need to focus tool 
development on statistically analysable baseline and follow-up measures – before and after 
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interventions – and tracking of client interventions compliance. The tools should include the 
broader considerations of health and disease and should include social, cultural, lifestyle, 
environmental and economic factors. The tools should also enable the data to be stratified 
into subgroups where it can be analysed and compared, and then interventions can be 
validated for various subgroups. The Zeevi et al. (2015) flagship study was the first to use 
this systems biology, P4, personalised nutrition approach. 
The literature reviews highlighted that a personalised approach needs to understand 
mechanisms of pathophysiology, that mechanistic reasoning has the ability to make 
inferences from the knowledge to inform clinical decision making (Nardini, Annoni, & 
Schiavone, 2012), and although mechanistic reasoning is not without limitations (DeBusk, 
Sierpina, & Kreitzer, 2011), mechanism of actions of interventions which target underlying 
pathophysiological mechanisms facilitate a personalised rather than disease-centred 
practice approach. Assessments and approaches for undertaking mechanistic reasoning in 
clinical practice are currently lacking. Results from the Delphi surveys highlight new tools 
created measure a comprehensive range of pathophysiological mechanisms affecting 
individual aetiology of obesity to enable mechanistic reasoning. Chapter 4 explored the 
issues with the development of questions related to pathophysiological mechanisms and the 
need to validate the questions against laboratory test data. Further research is required to fill 
the gaps in current mechanistic understanding of obesity which CNELM is currently 
undertaking. CNELM has developed a mechanism review research method which students 
undertake for their research projects. This is developing mechanistic insight and enhancing 
the understanding of its value to nutrition practice and clinical reasoning. 
Results from the categorisation and evaluation of existing tools, practitioner survey and 
Delphi method highlighted that the only validated assessments frequently used in practice 
were those used to assess diet intake (e.g. 24-hour diet recall) and physical activity recall. 
However, the limitations of retrospectively remembering dietary intake and exercise activities 
(Michels, 2003) can be overcome with real-time, repetitious and ongoing assessment 
(Gibson et al., 2010; Michels, 2003), through the use of online real-time smartphone 
applications which already exist for dietary intake and physical activity assessment. There 
was therefore no need to construct these tools as part of this project. 
The results also highlighted that there was a gap in tools which gather data on individual 
health history, family history and sociocultural influences on obesity and that, although some 
practitioners undertaking outcome analysis did use validated tools, such as the MYMOP, the 
assessment of clinical outcomes was not measured against intervention compliance. It has 
therefore not been possible to measure the outcomes in relation to interventions in any 
robust manner. To enable CER a number of patient-centred outcomes need to be compared 
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to assess the impact of interventions on symptoms, QOL and biomarker changes (Greenfield 
& Kaplan, 2012). Tool development focused on these areas, which led to the creation of four 
new clinical tools: 
1. Tool 1: Personalised health history questionnaire – which aims to collect health 
history and family history data around mechanisms of obesity, as well as collect a 
range of baseline health measurements. This questionnaire is for the patient to 
complete before the first consultation. 
2. Tool 2: Intervention record – which aims to capture which interventions were 
recommended by the nutrition practitioner. The practitioner should complete this at 
the end of each consultation. 
3. Tool 3: Personalised health follow-up questionnaire – which aims to measure any 
changes to the client’s health measurements after intervention. This questionnaire is 
for the patient to complete before their return consultation. 
4. Tool 4: Achievement record– which aims to capture which interventions the patient 
complied with. This tool is completed by the nutrition practitioner at the outset of each 
return consultation. 
Tools need to further include client values, preferences, abilities, objectives, values, self-
expressed needs, economic resources and anthropometric data, biomarker and laboratory 
analysis (including genomic and genetic tests), real-time diet (food intake, quality, quantity, 
habits, preferences etc.) and lifestyle assessment (exercise/sleep quality and amount etc.), 
and social, psychological, personality and behavioural dimensions of disease, but this was 
beyond the capacity of this project at this time. There was conflict in participant feedback 
between keeping tools streamlined, easy and user-friendly as well as comprehensive, 
thorough and robust. It was clear from the Delphi responses that it is incredibly difficult to 
prioritise what health data should be collected in personalised nutrition practice, because it is 
all important due to the complex nature of factors influencing individual obesity development 
and clinical decision making. The ability to comprehensively capture all the influences on 
health outcomes over a lifetime is not achievable through these tools and may never be 
achievable due to the huge number of complex combinations and permutations of genetic, 
epigenetic, lifestyle, diet and environmental factors and, in reality from a clinical perspective, 
there are issues of invasiveness, ability, time constraints and compliance to manage. Yet, 
the tools constructed do provide a good start. 
For example, health risk data in combination with FHH data to support clinical decision 
making is considered to be a critically important step in the advancement of personalised 
health care (Ginsburg & Willard, 2009). Historically FHH has not been well utilised because it 
has lacked standard and valid collection methods (Ginsburg & Willard, 2009). Numerous 
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assessments to establish the validity and reliability of these tools still need to be undertaken, 
including the validity of mechanistic clusters of questions. They should be undertaken 
directly with the target population to limit the barrier of engaging client participation through 
practitioners. Validity, quality and accuracy of data provided is clearly key to avoid 
misleading patients and practitioners (Finnegan, 2009). Inaccurate and unreliable data is not 
useful in guiding clinical decision making. 
These tools assess a huge range of clinical outcomes, although the clarity of the purpose of 
each question needs to be made clear so practitioners can differentiate between the 
research and clinical perspectives of the tools. These tools appear to support analysis of the 
impact of interventions on clinical outcomes. However, like Zeevi et al., (2015) real-time 
physical activity, sleep and food intake measures using smartphone applications in 
combination with comprehensively profiling is required. It is recommended that practitioners 
use existing online and smartphone tools for dietary analysis and tracking. I have been 
working with one student on a research project which aims to evaluate and compare the 
functionality and validity of online dietary assessment applications in order to offer 
practitioners a comparative analysis of these tools. Relationships have been forged with 
software developers and it may be possible to work with existing online tool application 
organisations to develop a more robust method for assessing health changes as a result of 
nutritional intervention. 
The results demonstrated an incongruence with creating tools for personalised nutrition 
practice that focused on a condition such as obesity. Focusing on obesity is a disease-
oriented approach rather than a personalised approach. The complexity of client’s health 
issues (clients rarely present with obesity or any other disease in isolation) means it would 
be better to have baseline tools that do not focus on obesity but can be used for all clients. 
In terms of further developing comprehensive profiling that is suitable from a clinical 
perspective than the development of numerous, small, quick and easy to complete validated 
tools appear to provide a solution. For example, single tools for each of the following that 
should not take more than half an hour, preferably less, to complete: 
• administrative data (address, GP address); 
• patient goals and outcomes; 
• presentation, risk factors and red flags; 
• health history, health currently and ongoing real-time analysis; 
• family history; 
• food behaviour, dietary influences and intakes over a lifespan, currently and ongoing 
real-time analysis; 
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• lifestyle history, lifestyle currently and ongoing real-time analysis; 
• exercise history, exercise currently and ongoing real-time analysis; 
• weight history, weight currently and ongoing real-time analysis; 
• history of medical interventions, current medical interventions and ongoing analysis; 
• history of other interventions (e.g. supplements), currently and ongoing real-time 
analysis; 
• patient/client values, preferences, abilities, motivation, objectives, self-expressed 
needs; 
• history of economic resources and sociocultural influences, current influences and 
ongoing analysis; 
• psychological, personality and behavioural assessments and ongoing behavioural 
analysis; 
• self-perceived stress; 
• QOL assessments; 
• therapeutic alliance assessment; 
• anthropometric assessments; 
• smoking and addiction history, currently and ongoing analysis; and 
• female pregnancy and contraception history. 
These represent the categories and findings discussed in Chapter 5. Like health data, all 
tools should all interrelate. These tools already gather data on physiological mechanisms 
contributing to obesity including, addiction, pregnancy, medications, stress and smoking (see 
Table 6). There should also be tools which cluster questions to a range of evidence-based 
physiological functions involved in disease expression, such as: 
• digestion, assimilation and elimination; 
• immune system function; 
• hormonal function; 
• neuronal function; 
• energy production; 
• structural integrity; 
• repair functions; 
• detoxification function; 
• psychological and emotional management; and 
• transport and bioavailability. 
Signs and symptoms clustered within each of these physiological functions suggest 
pathophysiological mechanisms such as: dysbiosis, dyslipidaemia, hormonal imbalance etc. 
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and the need for further investigation into their influence on disease expression with 
biomarker and laboratory analysis. Tool development requires further underpinning 
mechanistic insight. It may be possible to validate these tools against biomarker and 
laboratory analysis. Independent cohort studies are also required to validate the statistical 
prediction models of mechanisms of actions of intervention targeted to these mechanisms to 
support these physiological functions. This would help to provide an evidence-based 
approach to pathophysiological reasoning and personalised nutrition practice. 
This approach would also support the pathophysiological reasoning paradigm. Numerous 
tools may enable practitioners to gather standardised health data for numerous individuals 
via a variety of practice approaches. Over time, it may be possible to develop long and short 
versions for some of these tools, similar to the SF-36 and short SF-12 health status survey 
tools, allowing practitioners to discuss, negotiate and agree with their clients which 
assessment methods are best suited to the client at any given time. It gives practitioners an 
opportunity to build rapport before requesting completion of more invasive questions or tools. 
This approach should also be client-led; clients determine which range of non-compulsory 
tools or ongoing analysis they engage with at different stages of the consultation process. 
This would enable a more personalised data-collection approach using numerous 
standardised tools and therefore support personalised nutrition practice. Clearly, only fully 
completed tools should be used for data mining and substantiating evidence to inform clinical 
practice. 
Evidence-based personalised nutrition practice needs to be rooted in the use of validated 
tools in the same way other health professions accessible through mainstream health care 
do. Postdoctoral research will aim to develop and validate each of these tools. Evaluation of 
their impact on the practice process is also required, and the analysis of multiple tools by 
functional medicine practitioners could be insightful. Again, this research fits well with my 
ambitions. I believe this would provide an opportunity to make personalised nutrition practice 
a unique practice approach, which could attract a range of health care practitioners, 
including NTs, nutritionists and dietitians who are keen to develop their health care practice 
and professional development in this way. 
8.3 Transforming personalised nutrition practice 
One of the aims of the project was to enable the development of a new case-by-case, 
evidence base for personalised nutrition practice in obesity management. This discussion 
expands on the vision for transforming personalised nutrition practice through the 
development of an online application which gathers data via these bioinformatics tools and 
collates them to develop a case-by-case evidence base. 
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Bereczki (2012) argued that PM is an upgrade of EBM, because PM allows for the use of a 
range of sources of evidence, including patient preferences and individual expertise. It is not 
one approach, or the other, it is plurality of evidence that should form the basis of basis of 
modern day health care practice (A. Miles, Loughlin, & Polychronis, 2008). Systems biology 
offers the approach to analysing and comparing this complex health data, including the 
outcomes of interventions, which can translate findings to inform clinical practice, hence 
making it translational (Feldman, 2015). The risks of nutritional categorisation/stratification 
raised by Fierz (2004) and the issues of healthism and the medicalisation around food do 
require further exploration (Görman, 2007). 
Zeevi et al. (2015) have led the way in demonstrating that machine learning algorithms can 
be used to integrate and compare complex data from a range of individual, multi-dimensional 
health influences in order to make predictions on the outcomes of interventions, and use 
independent cohort studies to validate the statistical prediction models, to achieve a 
personalised nutrition approach that extends beyond stratification based on genetic tests and 
beyond personalisation, meaning tailoring interventions to the individual’s preferences and 
needs. 
The literature review highlighted the value of developing bioinformatics tools in promoting the 
practice of personalised and systems medicine, because these tools can integrate clinical 
and laboratory data and also enable the development of case-by-case evidence base that 
would allow for data mining and knowledge discovery (Yan, 2012). The literature review 
justified why these tools should enable pathophysiological reasoning. As discussed, new 
tools should collate health data that helps to uncover individual functional imbalances in 
physiological mechanisms that underpin disease development. Physiological mechanism 
research is currently limited because the EBM paradigm ranks it as low value, however 
understanding pathophysiological mechanisms is essential for clinical decision making 
because it allows for consideration of mechanisms of action of interventions to be targeted to 
ameliorating mechanisms of pathophysiology. It was clear from tool development in this 
project that this approach to collecting health data has not previously been undertaken. 
Further research is required to fill the gaps in mechanistic understanding. 
Developments in complex computational network analysis are enabling the modelling of 
genomic, genetic, epigenetic, biochemical, metabolic and proteomic pathways. Systems 
biology seeks to integrate this knowledge and study their interactions for a thorough 
understanding of disease (Yan, 2012). Modelling mechanisms of actions of therapeutic 
interventions, such as food and nutrients, could also be integrated to understand how they 
impact numerous physiological mechanisms both short- and long-term. 
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In the future, new tools could triangulate clinical data gathered with other sources, such as 
real-time food intake, supplement ordering, sleep and exercise tracking, supermarket loyalty 
card shopping data, social network data, gym membership data etc. It would be beneficial if 
the food diaries/journals allowed users to upload photographs. Numerous data-collection 
methods are important for improving the validity of data (Golafshani, 2003). The 
development of the internet of things (physical devices, home appliances, smartphones, 
vehicles etc.) and technologies for big data analysis may enable this. This data can be 
continually analysed and monitored against changes in biomarkers (cholesterol, PPGR, 
cholesterol etc) to determine how they affect individual physiological and pathophysiological 
mechanisms. SML is then utilised to predict the efficacy of lifestyle, dietary and exercise 
adaptations, as well as medications and nutritional supplements, which can be utilised to 
ameliorate underlying mechanisms of pathophysiology and promote optimal physiological 
function. It may even be able to provide data to a range of devices to inform real-time 
decisions on food intake, exercise and sleep and alert practitioners to contact individuals 
who have red flag issues. 
Kawamoto et al. (2005) identified that clinical decision support which provides actionable 
recommendations that are delivered automatically, at the time of decision making, have 
significantly improved patient care. Therefore, a case-by-case evidence base which 
translates data to create personalised clinical decision support tools should deliver it at the 
time of decision making utilising interactive technology (Sheldon & Ou, 2013). The approach 
by Villa et al. (2012) suggests a system which presents a range of evidence-based practice 
options which can be discussed with patients in terms of their needs and preferences and 
therefore also enables person-centred tailoring to individual needs. This system should also 
alert practitioners to relevant updates as a result of new knowledge (Sheldon & Ou, 2013). 
A case-by-case evidence base may enable the dissemination of personalised nutrition 
research, and not just structured case studies but longitudinal evidence for the outcomes of 
groups of stratified cases. Data collected from practitioners on their management 
approaches, for example, time spent on lifestyle coaching, teaching cooking skills, 
developing self-awareness, mindfulness, stress management skills etc. may allow further 
assessment of the influence of practice approach and determine what works, for whom and 
in whose hands. 
Collaboration with laboratories may also allow for the integration of patient test results. Data 
from the database could not only inform patients and practitioners, it could potentially inform 
clinical pathology laboratories about the development of new tests and physiological 
functional assessment. Tools can link to the evidence-based literature in numerous ways, 
including interpretive guides on test results provided by laboratories. 
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An online data-collection and data provision system, accessible for a range of health 
practitioners and consumers, should save practitioner time in researching and evaluating 
evidence-based recommendations. Allowing time for incorporating coaching strategies 
alongside nutritional interventions to support behavioural change can positively influence 
client’s engagement, confidence and compliance with personalised weight loss programmes 
(Miles & Barrow, 2018). The application could also host forums or communities where 
groups of patients can chat, and practitioners can post information. Social support with 
internet communities can play a pivotal role with compliance. The development of such an 
application is clearly ambitious, labour-intensive and costly. 
8.4 Problems with the feasibility of the mission of the project 
The mission of the project are its long terms aims: to centralise the data gathered by a range 
of short, standardised and validated clinical tools that have been created to enable the 
develop a case-by-case evidence base.  It aims to apply statistical machine learning to these 
new data sets to facilitate probabilistic predictions on the outcomes of interventions; and to 
enable new research to be undertaken to determine the efficacy of a range of nutrition 
interventions for personalised nutrition practice.   
 
Ogden (2016) highlights the gaps inherent in the translation process from protocol to 
individual behaviour as well as the issues with patient variability in terms of their adherence 
to interventions.   The variability of the data reported and collated underpin the issues with 
measuring interventions (independent variable) and outcomes (dependent variable). 
Ultimately, it is the quality of the data input that determines the quality of the data output.  
Enforcing data standards and quality would be a significant challenge. Adjustment for 
differences in individual variables would be critical in the assessment and comparison of 
client’s outcomes data to inform intervention decisions for future clients (Krousel-Wood 
1999).    
 
Nutrition interventions require behaviour change (diet, exercise supplements etc). Behaviour 
changes comes from the individual client not the intervention. The differences in practitioner 
approaches and their unique therapeutic relationship with each client can make a significant 
difference to the client’s experience, their behaviour change and ultimately their health 
outcomes (Kelley at al 2014, Pan, Luie 2016). Although we may be able to identify these 
variables and potentially measure these experiences we cannot limit or solve the issue of 
patient variability, their behaviour or adherence to interventions, in future clients.   Ogden 
(2016) highlights benefits of variability in practice, how practice variability offers flexibility and 
a richer professional environment than one that is standardised or systematised.  The 
192 
variability of individual clients requires variability in practice approaches in order to support 
effective behaviour change but it is exactly these variations that provides issues with 
measuring and extrapolating data from case-by-case data sets. 
    
The problems with the feasibility of the mission of the project lie in the limitations due to the 
numerous gaps and quality of the data collected.  It may never be possible to measure the 
numerous gaps or the nuances of the therapeutic relationship.  Variability in behaviour and 
compliance of clients exists and cannot be ignored.  There lies value in variability of practice 
and the art of the therapeutic relationship which aims to enhance the consultation process 
and client experience.  Developments in the standardisation of data collection in nutrition 
practice should therefore support freedom and flexibility in the consultation process and 
where possible adjust for differences in individual variables.  
8.5 Recommendations 
This section aims to recap all the recommendations made throughout the project. 
Dissemination of the project findings will include: teaching at my academic institution and 
other institutions, publication in peer-reviewed scientific journals, presentation at academic 
and industry events and conferences as well as research supervision. The results of this 
project highlighted the importance of publishing data on the validity and reliability of new 
tools across a range of journals as well as promoting them through professional bodies and 
CPD events. 
CNELM is in the process of changing the name of the Nutritional Therapy Practice Diploma 
to the Personalised Nutrition Practice Diploma as a result of my recommendation. 
Pathophysiological reasoning to support clinical decision making will be further embedded 
into the syllabus and learning outcome content for this programme. The name change for the 
practice diploma may attract prospective, or already qualified, nutrition practitioners such a 
dietitians and nutritionists who wish to develop their professional skills with a personalised 
nutrition practice pathophysiological reasoning approach. This may, in time and with other 
developments, enable CNELM to pursue accreditation of its personalised nutrition 
programmes with the Health Professions Council (HPC) and/or the Association for Nutrition 
(AfN). 
Postdoctoral research will aim to develop and validate numerous online tools as discussed, 
to support personalised nutrition practice and pathophysiological reasoning, and to enable 
the vision for developing a case-by-case evidence base. This may be achievable through my 
own research and research supervision within my role at CNELM. Fulfilling those goals also 
requires further research to develop valid clinical questions around mechanisms of 
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pathophysiology, develop mechanistic reviews and mapping, research to integrate and 
compare the complex data mechanistic insight provides, developing robust therapeutic 
relationship measures for nutrition practice, research to enable triangulation of health data 
with other sources such as real-time data tracking, studies to validate statistical prediction 
models and numerous ongoing validity assessments for tools. 
Postdoctoral research will also focus on developing the description, model and process for 
personalised nutrition practice and nutritional therapy practice. I will continue to seek 
opportunities for acceptance of nutritional therapy practice in mainstream health care 
provision. Research should also be undertaken to identify how NTs can raise their 
professional profile through professional marketing strategies and successfully achieve 
nationwide online nutritional therapy consultations. 
Further research is also required to explore the potential stigma of nutritional practitioners 
working with obese individuals and how nutrition practice can better engage with an obese 
population as well as identify actions to help limit wider social stigma for this population 
group. 
Some of the tools reviewed as a part of this project were utilised in clinical trials of anti-
obesity drugs or after bariatric surgery, so utilising those tools in clinical trials of nutrition 
interventions may allow for a comparison of nutrition intervention to drugs and surgery, which 
would provide valuable CER. 
In terms of developments within my work and professional environments, I will continue to 
teach personalised nutrition and support CNELM with the development of its programmes to 
help provide integrated education and CPD events for a range of health professionals, as 
well as support their aim to: 
Build a Research Centre, with active postdoctoral, PhD and MSc researchers 
focusing on an integrated approach to evidence based personalised medicine… our 
aim is also to build bridges between academic communities: bringing together 
researchers in statistical machine learning and systems biology with practitioners in 
nutritional therapy and functional medicine. 
(CNELM 2017) 
As discussed, I am keen to support CNELM with the development of a PhD research 
programme, in collaboration with an awarding institution, which would attract researchers to 
help undertake this research. There appears to be an interest among graduates and 
students. There is funding available for research into nutrition and obesity from the National 
Institute for Health, the Medical Research Council and the UK government for developing 
personalised health technologies that better target interventions to patients. With funding, 
CNELM may be able to build its research centre. PhD students can also support delivery of 
academic content to CNELM’s undergraduate and postgraduate programmes. 
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I also aim to continue to develop my own teaching on: developing research methods for 
nutrition practice, ethical reasoning, robust clinical outcome analysis and the use of 
electronic health records and standardised tools to support practice, as well as undertaking 
supportive obesity analysis and management in practice. Teaching at other institutions would 
also help to raise awareness of my research findings and support a movement towards a 
personalised practice approach, as well as raise the profile of CNELM. 
I aim to work with existing online tool application organisations to develop a more robust 
method for assessing health changes as a result of nutritional intervention for existing diet 
and exercise tracking applications. As discussed, research supervision is already underway 
to evaluate the functionality of existing applications, which may enable identification of the 
most suitable software organisations to collaborate with. 
I aim to work directly with professional bodies to support the development of collaborative 
relationships with other professional bodies e.g. bariatric surgeons, counsellors and other 
health care professions. I aim to support NTEC with any investigation on the variation of 
clinical training education delivered across different training providers and any updates they 
may wish to make to the NOS and core curriculum to better define what constitutes a 
nutritional therapy practice approach. I also aim to help the development of clear 
recommendations for, and naming specific, robust and validated data tools for use in 
nutritional therapy practice. 
I aim to work with BANT to continue the development of their centre of excellence, to support 
the development of large scale advertising to raise awareness of NTs and the development 
of nationwide online nutritional therapy consultation programmes. In order to achieve these, 
the development of a cohesive and succinct explanation of the nutritional therapy approach 
is essential. 
8.6 Conclusions 
This collaborative research project has been committed to enabling the development of a 
new, case-by-case, evidence base for personalised nutrition practice in obesity 
management. It has constructed four new clinical tools which: take a pathophysiological 
mechanism approach to data collection and analysis. These tools aim to be meaningful to 
different nutritional perspectives as well as suitable and interpretable by any mainstream 
health care practitioners. It has identified barriers and complexities for integrating 
standardised tools into clinical practice and provides recommendations for how standardised 
tools can be successfully integrated into practice. 
This project met with its objectives, it: explored potential ethical issues relating to the use of 
standardised tools in nutritional therapy practice and collated, categorised and evaluated 
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existing tools which support individual health history data collection, clinical decision making 
and clinical outcome analysis in nutrition practice. It identified the practitioners’ and clients’ 
experience of using existing tools, their strengths and weaknesses, to inform new tool 
development and explored the views and experience of academics and statisticians on 
robust tool development to inform new tool development. It collaboratively constructed new 
tools and pilot trialled them with a small number of practitioners and their clients. The project 
then evaluated ways in which standardised tools could be implemented into nutritional 
therapy practice. 
Key stakeholders have included CNELM, Middlesex University, professional nutrition bodies 
such as BANT and NTEC as well as research participants including a variety of nutrition 
practitioners, and their clients seeking who were seeking to lose weight. Feedback on the 
use of the new clinical tools highlighted, for those that engaged with it, experienced raised 
awareness and understanding of the factors contributing to obesity. Practitioners, 
academics, statisticians and researchers are stakeholders who were brought together to 
contribute to the development of new clinical tools. The results of the project have created 
new knowledge in terms of understanding, defining and developing an evidence-based 
personalised nutrition practice approach which can lead to major change initiatives and 
enhance and strengthen the nutrition profession, particularly the nutritional therapy 
profession. 
This project has positively impacted on further research in terms of supervising student 
research projects and achieved publication of research, which raises the profile of CNELM. It 
has positively impacted staff development. Recommendations for further research and 
professional developments have been described. Research success is also important for 
Middlesex University in order to meet their aims and objectives as well as demonstrate it can 
fulfil the requirements and expectation for other doctoral candidates. The project meets the 
Level M and Level D descriptors as described in the projects module handbook. 
My own skill development was explored in Chapter 7, my plans are to continue on the 
journey of lifelong learning, to enable other student’s success on their journey, to continue to 
enhance the nutritional therapy profession and to strive for the development of a new, case-
by-case, evidence base for personalised nutrition practice and the integration of nutritional 
therapy in mainstream health care provision. 
8.7 Chapter summary 
This chapter has summarised the project and drawn conclusions and recommendations from 
the project’s findings. It has addressed the research questions the project was designed to 
answer and evaluated the project outputs and its impact on the profession.  
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Appendix 1 Example literature review search description form 
Review 1: Search Description Form 1 
Student Name:  Michelle Barrow Student Number:  M00118142 
SEARCH TERMS: 
‘Evidence based medicine’  
AND ‘personalised’  
 
INCLUSION CRITERIA: 
Topic related to evidence based practice in general 
Dates ranged from 2003 to present 
EXCLUSION CRITERIA: 
Topic related to specific disease/health condition or intervention 
Repeat findings 
Topic not related 
Foreign Language Papers 
OTHER INFO: 
SEARCH ENGINES USED:      Summon 
 
SEARCH DATE:  12th October 2013 
SEARCH NUMBER:  1 
 
in title and abstract 
Excluded newspaper articles and book 
reviews 
NUMBER OF RESULTS:  0 NUMBER OF RESULTS INCLUDED:  0 
Comments: 
 
SEARCH ENGINES USED:      Google 
Scholar 
 
SEARCH DATE:  12th October 2013 
SEARCH NUMBER:  2 In the title 
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NUMBER OF RESULTS:   2 
 
NUMBER OF RESULTS INCLUDED:  2 
Comments: 
 
SEARCH ENGINES USED:      PubMed 
 
SEARCH DATE:  12th October 2013 
SEARCH NUMBER:  3 
 
Title and abstract 
NUMBER OF RESULTS:   8 
 
NUMBER OF RESULTS INCLUDED:  2 
Comments: 3 excluded related to specific diseases or treatments, 1 was in Russian 
except for the abstract, 1 was in Italian except for abstract,  1 was repeat finding 
 
SEARCH ENGINES USED:      Cochrane 
Library 
 
SEARCH DATE:  12th October 2013 
SEARCH NUMBER:  4 
 
abstract 
NUMBER OF RESULTS:   5 
 
NUMBER OF RESULTS INCLUDED:  0 
Comments: all related to specific conditions 
 
SEARCH ENGINES USED:      Science 
Direct 
 
SEARCH DATE:  12th October 2013 
SEARCH NUMBER:  5 
 
In the abstract  
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NUMBER OF RESULTS:   8 
 
NUMBER OF RESULTS INCLUDED:   
Comments: 7 on specific conditions, 1 in Spanish.  
 
SEARCH ENGINES USED:      RSM all 
Databases 
 
SEARCH DATE:  12th October 2013 
SEARCH NUMBER:  6 
 
In the abstract 
NUMBER OF RESULTS:   341 
 
NUMBER OF RESULTS INCLUDED:  24 
Comments: most excluded due to not being related, discussing a specific treatment or 
condition or foreign language paper. A number of articles were on the pharmaceutical 
industry and how they were using pharmacogenetics in clinical medicine but that was 
deemed not relevant.  
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Appendix 2 Literature reviews keywords, inclusion and exclusion criteria and number of 
results table. 
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Appendix 3 Literature and tool search results tracker spreadsheet - example sheet. 
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Appendix 4 Participant information sheet for nutrition clients 
 
 
 
 
 
 
PARTICIPANT INFORMATION SHEET FOR NUTRITION CLIENTS  
 
Study title: Constructing validated clinical tools to enable the development of a new evidence 
base for personalised nutrition practice in weight management. 
Invitation Paragraph 
You are invited to take part in a research study.  Before you decide whether to take part it is 
important for you to understand why the research is being done and what it will involve.  
Thank you for reading this. 
What is the purpose of the study? 
The aim of this pilot trial is to assess tools used for case history collection and clinical 
outcome analysis.  You will be asked to complete a health history questionnaire online, by 
your nutrition practitioner, and a similar questionnaire after you have implemented the 
nutritional interventions. You will then be invited to complete a short 10 question survey to 
assess your experience of using these online tools.    
Why have I been chosen? 
You are someone who is seeking, nutritional intervention and have been asked to participate 
because you meet the selection criteria.  
What will happen to me if I take part? 
The aims, duration and outcome of the nutrition consultation will remain the same. The way 
we collect your health information and interpret it may be different from the way we collect 
data from other clients. You will continue to have the same support from your practitioner 
and receive personalised nutrition interventions to meet your needs. Nutrition and lifestyle 
interventions are determined by the nutrition practitioner and agreed and arranged between 
you. 
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What do I have to do? 
Please book a consultation with your practitioner or clinic manager at a time that suits you.  
Please complete the online questionnaires and surveys when requested to do so.  
What are the possible benefits of taking part? 
We hope that participating in a nutrition consultation will benefit you. The study is focused on 
improving the ways in which your health information is collected and analysed.  Your views 
on completing the questionnaires are extremely valuable and help to further develop the 
tools.   The outcomes of this study may enable nutrition practitioners to collect and analyse 
client health information more effectively. 
What are the possible disadvantaged and risks of taking part? 
There are no known risks of participating in this study. 
Do I have to take part? 
No. It is up to you to decide whether or not to take part.  If you decide to take part, you are 
still free to withdraw at any time and without giving a reason.  A decision to withdraw at any 
time, or a decision not to take part, will not affect the standard of care you receive. 
Will my taking part in this study be kept confidential? 
All information that is collected about you during the course of the research will be kept 
strictly confidential.  Any information about you that is used will have your name and address 
removed so that you cannot be recognised from it. 
All data will be stored, analysed and reported in compliance with the Data Protection 
Legislation. 
What will happen to the results of the research study? 
The results of the research will be published as part of the postgraduate dissertation which 
will be completed by the end of 2018 – you will not be identified in any report or publication. 
You can contact michelle@cnelm.co.uk to request a copy of the published results.  
Who has reviewed the study?  
The Middlesex University, School of Health and Education, Health Studies Ethics sub-
Committee. 
Contact for further information 
Michelle Barrow 
Centre for Nutrition Education and Lifestyle Management 
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2 Edward Court 
Wellington Road 
Wokingham  
Berks RG40 2AN 
Tel: 0118 979 8686 
Email: michelle@cnelm.co.uk 
 
Dr. Celia Bell & Dr. Linda Bell 
Middlesex University 
The Boroughs 
Hendon 
London NW4 4BT 
Tel: 0208 411 5555 
Email: c.bell@mdx.ac.uk  l.bell@mdx.ac.uk  
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Appendix 5 Participant information sheet for nutrition professionals 
 
 
 
 
 
PARTICIPANT INFORMATION SHEET FOR NUTRITION PROFESSIONALS 
 
Study title: Constructing validated clinical tools to enable the development of a new evidence 
base for personalised nutrition practice in obesity management 
Invitation Paragraph 
You are invited to take part in a research study.  Before you decide whether to take part it is 
important for you to understand why the research is being done and what it will involve.  
Please take time to read the following information carefully and discuss it with others if you 
wish.  Please do ask if there is anything that is not clear or if you would like more 
information.  Take time to decide whether or not you wish to take part. Thank you for reading 
this. 
What is the purpose of the study? 
The aim of this research project is to assess whether it is possible and ethical to standardise 
a personalised approach to nutrition practice. It will assess current approaches to the 
nutritional management of obesity and tools used for case history collection, clinical decision 
making and clinical outcome analysis. It will assess participants’ experience of using these 
tools and their views on the ethics and implications of standardising approaches to 
personalised nutrition practice.  This project aims to integrate or improve existing tools in 
order to provide new, statistically validated tools which relate to the current evidence base. 
This is undertaken to assess the possibility for developing a new, case by case, 
personalised nutrition evidence base for the management of obesity. 
Why have I been chosen? 
This research project aims to incorporate knowledge and expertise from a variety of 
professionals. You have been selected as a potential participant because of your knowledge 
and skills. At least 30 other individual participants, including: practitioners, representatives of 
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educational establishments and professional bodies, students, academics and researchers 
have been asked to participate.  
Do I have to take part? 
No. It is up to you to decide whether or not to take part.  If you do decide to take part you will 
be given this information sheet to keep and be asked to sign a consent form. If you decide to 
take part you are still free to withdraw at any time and without giving a reason.  If you do not 
wish to participate you do not have to do anything in response to this request. 
What will happen to me if I take part? 
There are number of different research methods to this study.  You may be asked to take 
part in one or more of the following; surveys, interviews, workshops, focus groups, Delphi 
survey and tool testing trials. You will be asked after each contribution if that is your final 
contribution or if you are happy to contribute again.  
Questionnaires will take between 5 and 20 minutes to complete and the deadline for 
completion will be two weeks from the date they are dispatched. You will be sent a form or 
an online link containing the survey or questionnaire which you can complete and submit in 
your own time.  
Interviews will take between 30 minutes and 90 minutes. They will be semi structured and 
informal with the topics for discussion sent to you in advance.  The actual date, time and 
duration you are available will be agreed with you in advance. Interviews will be audio 
recorded for ease of transcription unless you request otherwise.  
Workshop or focus groups – This is when a few participants get together with the researcher 
in order to assess or develop ideas. Their duration varies from 1 to 4 hours. The dates and 
duration will be made available in advance.  
New data collection tools will be trialled. This means you are a practitioner or student 
working with clients in a clinic setting and may use these tools during the consultation 
process. Consultations will be audio or video recorded. Written consent from the client will 
also be obtained before collecting data from them. The aims and duration of the nutrition 
consultation should remain the same. The way you collect and interpret health information 
from your client may be different from the way you have previously collected and assessed 
data. You will still determine, agree and arrange any appropriate personalised nutrition 
interventions with your client to meet their needs. A follow-up consultation will need to be 
arranged 6-8 weeks after the initial consultation where you will collect further data on your 
client’s progress. 
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Please note that in order to ensure quality assurance and equity this project may be selected 
for audit by a designated member of the committee.  This means that the designated 
member can request to see signed consent forms.  However, if this is the case your signed 
consent form will only be accessed by the designated auditor or member of the audit team. 
What do I have to do? 
Complete the consent forms and return to michelle@cnelm.co.uk  
Michelle will then contact you with the relevant options for participation.  
What are the possible disadvantaged and risks of taking part? 
There are no known risks of participating in this study. 
What are the possible benefits of taking part? 
There is no intended benefit to the participants taking part in this study.  The outcomes of 
this study may enable nutrition practitioners to collect and analyse client health information 
more effectively which could strengthen the evidence base for nutritional intervention and 
better inform the management of obesity in the future.  
Will my taking part in this study be kept confidential? 
All information that is collected about you during the course of the research will be kept 
strictly confidential.  Any information about you which is used will have your name and 
address removed so that you cannot be recognised from it. 
All data will be stored, analysed and reported in compliance with the Data Protection 
Legislation. 
What will happen to the results of the research study? 
The results of the research will be published as part of the postgraduate dissertation which 
will be completed by the end of 2017 – you will not be identified in any report or publication. 
You can contact michelle@cnelm.co.uk to request a copy of the published results.  
Who has reviewed the study?  
The Middlesex University, School of Health and Education, Health Studies Ethics Sub-
Committee. 
Contact for further information 
Michelle Barrow 
Centre for Nutrition Education and Lifestyle Management 
2 Edward Court 
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Wellington Road 
Wokingham  
Berks RG40 2AN 
Tel: 0118 979 8686 
Email: michelle@cnelm.co.uk 
 
Dr. Celia Bell & Dr. Linda Bell 
Middlesex University 
The Boroughs 
Hendon 
London NW4 4BT 
Tel: 0208 411 5555 
Email: c.bell@mdx.ac.uk  l.bell@mdx.ac.uk  
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Appendix 6 Pilot Trial Protocol 
Pilot Trial Protocol 
Background: 
Four new clinical tools have been developed through a series of expert panel reviews as part 
of a doctoral research project.  The project aims to develop and validate robust clinical tools 
which can assess the efficacy of personalised nutrition practice in obesity management. The 
data from these tools may allow for the development of a new, case by case, evidence base 
for personalised nutrition practice.   The tools have all been developed for online access 
using research software called Qualtrics.  The 4 new tools include: 
1. Personalised health history questionnaire – this aims to collect health history and 
family history data around mechanisms of obesity, as well as collect a range of 
baseline health measurements. This questionnaire is for the client/patient to 
complete before the first consultation.  
2. Intervention record – this aims to capture which interventions were recommended 
by the nutrition practitioner.  The practitioner should complete this at the end of each 
consultation. 
3. Personalised health follow-up questionnaire – this aims to measure any changes 
to the client’s health measurements after intervention.  This questionnaire is for the 
client/patient to complete before their return consultation. 
4. Achievement record – this aims to capture which interventions the client/patient 
complied with. This tool is completed by the nutrition practitioner at the outset of each 
return consultation.  
Pilot Trial aims: 
This pilot trial aims to achieve face validity and measure feasibility and utility for each of the 
4 tools. 
• Clients/Patients will be asked to completed a 10 question face validity survey (the 
QQ-10 instrument) after tool 1 (personalised health history questionnaire) and tool 3 
(personalised health follow-up questionnaire) have been completed.   
• Practitioners will be asked to complete adapted versions of the QQ-10 face validity 
survey for each of the tools after they have completed the pilot trial process.   
• An analysis of face validity, feasibility and utility will be undertaken once all pilot trials 
have been completed. 
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Parameters: 
• Each practitioner must trial all 4 tools on a minimum of 2 clients.   
• All tools and review surveys must be completed by 31st July 2017.  
• The clients are seeking nutrition intervention for weight loss.   Please assess your 
client meets this parameter before sending them the online link to the personalised 
health history questionnaire to complete. 
• All participants (clients and practitioners) are free to withdraw from participating in 
this research at any time and this must not affect the service or care the patient/client 
is given. If you or your client wish to withdraw please inform michelle@cnelm.co.uk.  
• All information must be kept confidentially. 
• If you have any queries or concerns, please contact Michelle Barrow on 07879 
403321 or michelle@cnelm.co.uk  
Method: 
Please send your client the participant information sheet for clients an establish if they are 
happy to participate.  If so, please send them the link to complete tool 1 (the health history 
questionnaire) via the online research software tool Qualtrics (the link to the questionnaire is 
given below).  You will need to give the client a unique identification number to maintain their 
confidentiality, and inform michelle@cnelm.co.uk of the client identification numbers, so you 
can be sent a copy of the completed questionnaire before you conduct the initial 
consultation.   
Each day (Monday to Fridays) Michelle Barrow will check to see if any new questionnaires 
have been completed and forward them to the relevant practitioners.  When the client has 
completed tool 1, Michelle will send it to you and prompt you to ask the client/patient to 
complete the 10 question face validity survey to assess their views on tool 1.  The survey’s 
used to assess face validity are also online via the research software Qualtrics.  The survey 
link will be sent to you with your client’s completed questionnaire. 
You can conduct the initial consultation at a time that suits you. At the end of the first 
consultation you should complete tool 2, the interventions record (via the online link below) 
which aims to capture all the recommended interventions. 
Prior to the return consultation, please remind the client of their unique identification number 
and send them the link to tool 3, the follow-up questionnaire (see below for link).  Again, you 
will be sent a copy of the completed questionnaire and prompted to ask the client/patient to 
complete the 10 question survey to assess their views on tool 3.  
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You can conduct the return consultation at a time that suits you.  At the return consultation 
please complete tool 4, the achievement record (link below), so that you can assess which of 
the recommended interventions the client was compliant with. At the end of the return 
consultation you should complete tool 2, the interventions record again if further 
interventions were recommended.  
Once you have conducted all of the pilot trials (a minimum of 2 clients are required) please 
inform michelle@cnelm.co.uk  then you, the practitioner, will be asked to complete the face 
validity surveys for each of the 4 tools. Links to face validity surveys for completion will be 
sent to you via email.  The pilot trial process is due to end on 1st May 2017. 
The flow-chart below aims to visually clarify this process.  If you have any queries, please do 
contact Michelle on 07879 403321 or michelle@ cnelm.co.uk 
Links to tools: 
Tool 1 FOR CLIENT COMPLETION - Personalised health history questionnaire: 
https://mdxl.eu.qualtrics.com/SE/?SID=SV_78MODoa9LvgWDKB 
Tool 2 FOR PRACTITIONER COMPLETION – Interventions record: 
https://mdxl.eu.qualtrics.com/SE/?SID=SV_2rdbdwQkaKAMqTX 
Tool 3 FOR CLIENT COMPLETION -  Follow-Up Questionnaire: 
https://mdxl.eu.qualtrics.com/SE/?SID=SV_8IxX3qhW1nUQb0p  
Tool 4 FOR PRACTITIONER COMPLETION – Achievement record: 
https://mdxl.eu.qualtrics.com/SE/?SID=SV_eDvG2CfybY4hMrP 
Your participation in this research project and your feedback on these tools is much 
appreciated.  Thank you. 
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Prior to initial 
consultation
• Send clients/participants (adults seeking weight loss) the client information sheet 
to establish if they are willing to participate. 
• If so, please give your client a unique identification number and ask them to 
complete tool 1, personalised health questionnaire (link provided above)
• Please inform Michelle f your client's unique identification number.
• Michelle will send completed questionnaites to you and you will also be prompted 
to ask the client to complete the 10 question validity survey.  
• If you have not received your client/patient questionnaire, or if you have a query, 
then please do contact michelle@cnelm.co.uk or call her on 07879 403321
Initial consultation
• Please undertake the initial consultation at a time that suits you.
• At the end of the initial consultation please complete tool 2, the interventions 
record (link provided above)
Prior to return 
consulation
• Please arrange a follow-up consultation with the client.
• Remind your client of their participant identification number and ask them to 
complete tool 3, follow-uphealth questionnaire (link provided above).
• Each day (Monday to Fridays) Michelle Barrow will check to see if any new 
questionnaires have been completed and forward them to the relevant 
practitioners, you will also be prompted to ask the client to complete the 10 
question survey.  
• If you have not received your client/patient questionnaire, or if you have a query, 
then please do contact michelle@cnelm.co.uk or call her on 07879 403321
Return consultation
• At the outset of each return consultation please complete tool 3- the achievement 
record (link provided above). 
• Undertake the return consultation
• At the end of the consultation please complete a second tool 2, the interventions 
record, if more recommendations are given (link provided above)
After return 
consultation
• Once all tools have been completed and submitted, the clients have completed 
the survey’s reviewing the tools, and the practitioner has completed a minimum 
of 2 clients the pilot trial is complete.  Please do use this process for as many 
clients as possible. 
• At the end, the practitioner will be prompted to complete the face validity 
survey's for each of the tools.
• Your participation and feedback on the tools is much appreciated.  Thank you.
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Appendix 7 Ethics committee permission 
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Appendix 8 Ethics committee change approval 2015 
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Appendix 9 Ethics committee change approval 2017 
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Appendix 10 Participant consent form 
 
Version Number 2 (June 15) 
Participant Identification Number:  
CONSENT FORM 
Title of Project: Constructing validated clinical tools to enable the development of a new 
evidence base for personalised nutrition practice in obesity management. 
Name of Researcher: Michelle Barrow BSc (Hons), MSc, QTLS.    
                  Please initial box 
1 I confirm that I have read and understand the information sheet                       
dated ...................……………..…for the above study and have had the 
opportunity to ask questions. 
 
2 I understand that my participation is voluntary and that I am free to    
      withdraw at any time, without giving any reason. 
 
3 I agree that this form that bears my name and signature may be seen              
by a designated auditor.  
 
4 I agree that my non-identifiable research data may be stored in National  
Archives and be used anonymously by others for future research.  I am  
assured that the confidentiality of my data will be upheld through the removal  
of any personal identifiers. 
 
5 Delete 5 and or 6 if not applicable: 
I understand that sections of any of my medical notes may be looked at by  
1 
2 
3 
4 
5 
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responsible individuals from [company name] or from regulatory authorities  
where it is relevant to my taking part in research.  I give permission for these  
individuals to have access to my records. 
 
6 I understand that my interview may be taped and subsequently transcribed. 
 
 
7. I agree to take part in the above study. 
 
___________________________ _______________ ______________  
Name of participant Date Signature 
 
 
___________________________ _______________ ________________ 
Name of person taking consent Date Signature 
(if different from researcher) 
 
___________________________ _______________ ________________ 
Researcher Date Signature 
 
1 copy for participant; 1 copy for researcher; 
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Appendix 11 Tool categorisation spreadsheet – example sheet 
Category: diet and nutrition 
Measure tool 
Identified 
in 
aim of 
tool 
measure
ment 
target 
popul-
ation 
permission 
to use tool 
Content 
Application 
e.g. self-
reported, 
expert  
outcome 
measures 
feasibility 
(cost, time 
burden) 
diet 
intake 
24 hour 
diet 
recall 
Review 5 
search 1 
line 8  
retrospect
ive 
assessme
nt of 
dietary 
intake 
all  N/A` 
subjects 
are 
asked to 
recall all 
foods 
and 
estimatin
g portion 
sizes for 
a 
particular 
time 
period.   
can be self-
reported or 
taken by 
interviewer 
who can ask 
more 
probing 
questions 
nutritional 
intake over 
1 day 
quick with 
minimal 
burden, 
simpler 
than 
keeping a 
diary but 
less 
accurate.  
diet 
intake 
multi 
pass 
method 
Review 5 
search 1 
line 8  
form of 
diet recall 
with a 3 
or 5 stage 
approach 
all 
to be 
determined 
1. quick 
list of 
foods 
eaten or 
drunk. 2.  
collection 
of 
detailed 
info OR 
forgotten 
food list 
(5 cycle). 
3. a 
recall 
review 
(time and 
occasion 
when 
they 
were 
eaten). 4. 
detail 
cycle of 
foods 
and 
amounts 
5. the 
final 
review 
expert asks 
but can be 
automated 
coding of 
food intake 
3 steps is 
less work 
than 5 
steps. 
Could the 
same be 
achieved 
with an 
online tool 
already in 
existence. 
Needs to 
be 
conducted 
by 
interviewer
. 
diet 
intake 
food 
frequen
cy 
questio
nnaire 
review 5 
search 9 
line 7 
checklist 
of foods 
consume
d - 
usually 
used in 
conjunctio
n with 24 
hour diet 
recall and 
a 3 day 
food 
record 
all 
must use 
validated 
tool - e.g. 
1999 EPIC. 
there is no 
standard 
FFQ. Each 
questionnair
e should be 
judged for its 
ability to 
provide the 
information 
for which it 
was 
list of 
foods 
and 
frequenc
y of 
eating 
them, 
portion 
size also 
important 
either 
coding of 
food intake 
- good for 
assessing 
average 
log-term 
diet intake 
inexpensiv
e, quick 
and easy 
to 
standardis
e if not too 
many 
questions 
are 
included. 
Not all 
foods can 
be 
included. 
Validity 
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intended. 
Tool for 
obesity is 
ideal.  the 
online 
Food4Me 
FFQ has 
good 
agreement 
with the 
validated 
printed 
EPIC-Norfolk 
FFQ  
must be 
established 
diet 
intake 
willett 
FFQ 
Nvivo 
as above 
- food 
frequency 
questionn
aire with 
153 
items. Old 
from early 
90's 
all      
diet 
intake 
Food 
dairy / 
record 
Nvivo 
diaries 
are meant 
to record 
all food 
ingestion 
after it 
has 
occurred.  
all N/A` 
record of 
date and 
time, 
describe
d food 
eaten, 
portion 
size, 
where 
eaten 
and 
estimate
d calories 
self-reported 
assessmen
t of food 
intake 
provide 
rich detail, 
subject to 
errors but 
better than 
food recall. 
Can be 
quire 
demanding 
in terms of 
time. 
deterioratio
n of record 
quality 
occurs with 
lack of 
motivation 
diet 
intake 
visual 
estimati
on of 
dietary 
intake 
Nvivo 
using 
pictures 
to get a 
visual 
estimatio
n 
all 
lots of work 
developing 
pictures 
photos of 
foods 
expert 
assessmen
t of food 
intake in 
conjunction 
with food 
recall or 
frequency 
significant 
set-up 
burden 
diet 
intake 
eating 
styles 
questio
nnaire 
Nvivo 
stratify 
participan
ts into 
eating 
style 
groups 
such as 
"emotiona
l eater"' 
"food 
fretter", 
"social".   
      
270 
diet 
intake 
14 item 
Mediter
ranean 
assess
ment 
tool 
review 5 
search 1 
line 9 
assesses 
quality of 
food 
intake, 
Irrespecti
ve of 
calorie 
intake 
all not yet 
14 food 
frequenc
y 
questions 
related to 
healthy 
foods 
either 
food 
frequency 
of healthy 
foods 
short 
questionna
ire, easy 
eating 
habit 
question
naire 
eating 
habit 
questio
nnaire 
(EHQ) 
review 5 
search 14 
line 1 
assesses 
food 
consumpt
ion 
patterns - 
another 
food 
frequency 
approach 
all not yet 
includes 
food 
frequenc
y 
question
naires 
which 
stratify 
subjects 
into 
groups to 
support 
clinical 
decision 
making 
either 
food 
frequency 
short 
questionna
ire, easy 
eating 
style 
your 
person
al 
eating 
style 
profile 
review 5 
search 9 
line 6 
       
eating 
style & 
hunger 
assessm
ent 
three 
factors 
eating 
questio
nnaire 
TFEQ 
R18 or 
R21 
review 5 
search 9 
line 7 
assesses 
food 
intake 
behaviour 
Obese 
popula
tion 
but 
has 
been 
validat
ed for 
genera
l 
popula
tion 
not yet - 
need to 
request to 
look ta 
questionnair
e - no 
example 
online 
R18 is 51 
questions 
that 
measure 
3 
dimensio
n of 
eating 
behaviou
r 
including 
1. 
cognitive 
restraint 
of eating, 
uncontrol
led 
eating 
and 
hunger. 
Scored 
with 
Likert 
scale. 
R21is 
only 21 
questions 
self-reported 
insight into 
cognitive, 
behavioura
l and 
emotional 
aspects of 
eating 
which may 
help direct 
NLP or 
behavioura
l support 
programm
es 
51 
questions 
is long but 
the R21 is 
only 21 
questions 
and has 
shown 
good 
reliability 
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diet 
history 
Diet 
history 
questio
nnaire 
Nvivo 
assessme
nt of food 
intake. 
can be 
combinati
on of food 
intake 
and 
frequency 
all N/A` 
interview
er 
questions 
responde
nt about 
usual 
eating 
patterns. 
Used to 
cross 
check 
against 
diaries 
and 
meals 
expert 
interview but 
also self-
administered 
tools 
available 
elaborate 
picture of 
quality and 
quantity of 
food intake 
more 
complete 
than food 
records or 
food recall, 
careful 
interviewin
g is 
required. 
Still 
retrospecti
ve 
analysis. 
Can be 
time 
consuming 
(Allison 
1995) 
eating 
behavio
ur 
 
review 5 
search 2, 
line 10 
already 
assessed 
above 
      
software 
analysis 
diet 
plan 6 
my own 
knowledg
e        
software 
analysis 
nutritics 
my own 
knowledg
e 
diet diary 
which 
links to 
food 
database
s in order 
to provide 
dietary 
analysis 
 not yet 
uses UK 
and Irish 
database 
data and 
compare
s intakes 
to 
national 
DRV's 
expert enters 
details 
provided by 
client - it 
would be 
better if the 
client 
entered their 
details 
instead. 
  
software 
analysis 
cron-o-
meter 
my own 
knowledg
e 
diet diary 
analysis  
not yet 
   
free 
application 
software 
analysis 
Self-
nutritio
n data 
my own 
knowledg
e 
diet diary 
analysis  
not yet 
    
applicati
on 
MyFitn
essPal 
my own 
knowledg
e 
diet diary 
analysis 
all not yet  
self-reported 
and can be 
shared 
 
burden in 
client 
adding the 
info.  We 
would 
need the 
info 
anyway so 
they would 
still have to 
provide it 
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Appendix 12: Survey of nutrition practitioners search and send tracker spreadsheet - 
anonymised 
Date 
Source 
searched 
Search 
terms Results 
Included job roles Excluded Contact Details  
date 
chased 
date 
chased 
27/10
/2014 
linked in = 
my own 
contacts 
obese 8 4 
weight 
management 
specialist, 
dietician, 
prodimed 
director, 
nutritionist 
working with 
children, not 
stated they 
practice 
nutrition with 
obese 
individuals on 
their profile 
ALL EMAIL 
ADDRESSES 
AND CONTACT 
DETAILS 
REMOVED TO 
KEEP 
PARTICIPANTS 
ANONYMOUS  
11/11/2
014 
 
27/10
/2014 
linked in = 
my own 
contacts 
obesity 49 31 
specialist obesity 
dietician x 5, 
health 
improvement 
practitioner x 2, 
physician, 
dietician x 2, 
eating & 
behaviour 
specialist, ION 
nutritional 
therapist x 4, 
CNELM NT x2,  
nutritionist, UW 
NT, weight 
management 
specialist, 
nutrition 
consultant, 
clinical 
psychologist, NHC 
NT, obesity 
practitioner, 
addiction 
counsellor 
journal 
publisher,  
non-
practitioners, 
clinical nurses 
in obesity 
surgery.   
11/11/2
014 
 
27/10
/2014 
CNELM 
contacts, 
emailed 
top level 
managem
ent to ask 
for their 
contact 
recomme
ndations 
 15 14 
CB, RJ, Professor 
RT, HL 
(anonymised)  
Professor Roy 
Taylor is a 
diabetes 
researcher 
and not an 
obesity 
practitioner 
11/11/2
014 
 
03/11
/2014 
BANT 
Members 
   
emailed BANT 
admin and asked 
for contacts of 
practitioners 
specialising in 
obesity 
 11/11/2
014 
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03/11
/2014 
http://ww
w.freelanc
edietitians
.org/searc
h/Search_
profile_pri
vate.asp  
area of 
interest: 
obesity.  
Profile 
description: 
DOM 
5 4 
DOM = dieticians 
working in 
obesity 
management.  I 
emailed all 
dieticians listed as 
such on this 
website.  
1 duplicate 
(susan@nutrit
ionu.co.uk) 
21/11/2
014 
01/12/2
014 
03/11
/2014 
http://ww
w.domuk.
org/viewp
age.php?c
at=7&pag
e=45  
DOM  3 3 
DOM = dieticians 
working in 
obesity 
management.  
British Obesity 
and Metabolic 
Surgery Society 
(BOMSS) 
dietitians. 
 21/11/2
014 
01/12/2
014 
03/11
/2014 
google 
UKVRN 
Obesity 
5 5 
included the first 
5 nutrition 
practitioners who 
state they work in 
obesity or weight 
management 
 21/11/2
014 
01/12/2
014 
03/11
/2014 
google 
nutritionist 
obesity  
5 4 
included the first 
5 nutrition 
practitioners who 
state they work in 
obesity or weight 
management 
mostly 
websites not 
practitioners 
21/11/2
014 
01/12/2
014 
03/11
/2014 
google 
nutrition 
practitioner 
weight loss 
5 0 
included the first 
5 nutrition 
practitioners who 
state they work in 
obesity or weight 
management 
 21/11/2
014 
01/12/2
014 
03/11
/2014 
google 
nutrition 
practitioner 
obesity 
0 0 
included the first 
5 nutrition 
practitioners who 
state they work in 
obesity or weight 
management 
 21/11/2
014 
01/12/2
014 
03/11
/2014 
google 
obesity 
weight loss 
nutrition 
London 
5 5 
included the first 
5 nutrition 
practitioners who 
state they work in 
obesity or weight 
management 
 21/11/2
014 
01/12/2
014 
03/11
/2014 
nutrition 
society 
members 
   
emailed office 
and asked for 
contacts of 
practitioners 
specialising in 
obesity 
 21/11/2
014 
01/12/2
014 
03/11
/2014 
Associatio
n for 
Nutrition 
   
emailed chief 
executive rand 
asked for contacts 
of practitioners 
specialising in 
obesity 
 21/11/2
014 
01/12/2
014 
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03/11
/2014 
dieticians 
in obesity 
managem
ent 
   
emailed DOM UK 
and asked for 
contacts of 
dietitians 
 21/11/2
014 
01/12/2
014 
03/11
/2014 
Associatio
n for the 
Study of 
Obesity  
   
emailed office 
manager and 
asked for contact 
details 
 21/11/2
014 
01/12/2
014 
10/11
/2014 
weight 
watchers 
 1 1   
21/11/2
014 
01/12/2
014 
10/11
/2014 
Rosemary 
Connolly 
 1 1   
21/11/2
014 
01/12/2
014 
10/11
/2014 
slimming 
world 
 1 1   
21/11/2
014 
01/12/2
014 
10/11
/2014 
obesity 
society 
     21/11/2
014 
01/12/2
014 
10/11
/2014 
British 
nutrition 
foundatio
n 
    told me to 
contact AfN 
21/11/2
014 
01/12/2
014 
10/11
/2014 
nutritionis
t resource 
 126 15 
aimed for 
dietitians 7 
nutritionists to 
avoid weighting 
to nutritional 
therapy 
those who 
had no easy 
to find email 
address 
21/11/2
014 
01/12/2
014 
10/11
/2014 
IFM find a 
practition
er 
database 
obesity 8 7  
those who 
had no easy 
to find email 
address 
21/11/2
014 
01/12/2
014 
10/11
/2014 
PNI 
practition
er 
weight 6 3   
21/11/2
014 
01/12/2
014 
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Appendix 13 Example academic interview guide 
Interview Guide Academics 
Study title: Constructing validated clinical tools to enable the development of a new evidence base for 
personalised nutrition practice in obesity management 
Contact: 
Email: michelle@cnelm.co.uk,  
Tel: 07879 403321 
 
Consent form: 
You will have been sent a consent form to complete and participant information sheet.  The 
information sheet states interviews will take between 30 minutes and 90 minutes. They will be 
semi structured and informal.  The topics for discussion are below so you can see these in 
advance.  The actual date, time and duration has been agreed and is stated below. Interviews 
will be audio recorded for ease of transcription unless you request otherwise. If you have not 
done so already please return the signed consent forms.  
 
Aims & Objectives of Interview: 
The aim of the interviews is to evaluate your experience/ views on tool development and 
validation and/or data set management.  Objectives include: 
1. Evaluate ways in which new tools can provide reliable and statistically validated data 
2. Identify ways in which new tools can relate to the existing evidence base 
• Evaluate ways in which tools can best be pilot tested/trialled 
• Identify implications and ethical issues of building a case by case evidence base 
 
Interview data sheet 
Participant name:  AJ 
Job title/ speciality: Senior Principal Statistician  
Email:  ANON 
Further contact details:  None provided 
Date agreed to participate: 17th February 2015 
Interview date, time & 
duration:  
21st February 2015 11am to 12.15pm 
Type of interview: GoToMeeting 
Audio Recording: yes 
Consent forms signed: yes 
Participant info sheet 
provided: 
Yes on 15th February 2015 
Transcription Date:  
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Transcription source:  Nvivo 
Circumstances booking interview: 
 
 
 
 
Circumstances during interview: 
 
My laptop crashed half way through the interview.  I had to reboot and email Adam and send 
him new online meeting details but he did return to complete the interview.  
 
I was unable to take any motes during the interview because the sound volume was low and 
my typing would have meant I may not have been able to hear the responses.   
 
Interview questions: Interviewer observations: 
Welcome. Would you like me to quickly 
review the purpose of this interview 
and/or my research aims? 
 
 
There are 16 questions and we have up to ?? minutes to discuss each one.  
In your view, what are the most important 
considerations when developing a health 
questionnaire/tool to enable the creation 
of an individual case by case database 
on the health status and nutritional 
intakes of an obese population?  
 
 
If you had a mix of existing 
questionnaires (some validated, some 
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not, some used for research, some used 
in practice).  How would you use these 
existing questionnaires be used to 
develop new questionnaires or tools? 
 
How would you use existing online tools 
for data gathering, such as apps which 
measure food intake, exercise and sleep, 
to support the creation of new tools?  
 
 
What assessments of validity would you 
seek for new questionnaires and/or tools? 
 
  
Questions and scales in the newly 
constructed questionnaires/tools – in 
what ways would you assess their quality 
before the tool is piloted? 
 
 
Have you participated in a Delphi consensus 
before? What are your views on this 
methodology. 
 
 
Comparing the new tools with other similar 
tools- which method do you consider is 
the best approach?  
• Have 2 practitioners in a room 
completing the tools for the same 
client? 
• Have the client see two practitioners 
consecutively? 
• test-retest trial of the tool? 
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What are the best ways to track individual 
responses and response sets?   
 
What are the best ways to identify response 
set answers to the questionnaire?  If these 
are identified how should the questionnaire 
be adapted? 
 
 
What are the ways you manage incomplete 
data sets? 
 
 
Are there any other issues I should consider 
for the development of new tools?  This 
would involve ranking questions, measures 
and tool approaches.  
 
 
I would like to relate specific questions on 
the tool (and their responses) to the existing 
evidence base to help inform clinical decision 
making.  How could this be done? 
 
 
What do you consider to be the obstacles to 
clinical database research? 
 
 
What do you consider to be ethical issues 
when building clinical database for data 
mining?  
 
 
Would you be willing to participate in Delphi 
group surveys?   
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Do you have any further comments? 
 
 
Interviewer reflections post interview: 
 
Many valuable insights were shared by the interviewee.  Mainly that the purpose of what the 
tool should do and what data we want to elicit from it should be absolutely clear at the 
outset. 
 
 
 
Interviewee additions post interview: 
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Appendix 14 Example practitioner interview guide 
Interview Guide Practitioners 
Study title: Constructing validated clinical tools to enable the development of a new evidence base for 
personalised nutrition practice in obesity management 
Contact: 
Email: michelle@cnelm.co.uk  
Tel: 07879 403321 
 
Consent form: 
You will have been sent a consent form to complete and participant information sheet.  The 
information sheet states interviews will take between 30 minutes and 90 minutes. They will be 
semi structured and informal.  The topics for discussion are below so you can see these in 
advance.  The actual date, time and duration has been agreed and is stated below. Interviews 
will be audio recorded for ease of transcription unless you request otherwise. If you have not 
done so already please return the signed consent forms.  
 
Aims & Objectives of Interview: 
The aim of the interview is to gather your views on clinical assessment and decision making, as 
well as your views on standardising approaches to personalised nutrition practice.  Objectives 
include: 
3. Evaluate practitioner views on standardising approaches to personalised practice 
4. Identify ways in which practitioners use clinical assessment to make clinical decisions 
5. Identify ways in which practitioners engage with the evidence base 
• Evaluate implications for building new  tools 
• Discuss potential ethical issues of building a case by case evidence base 
 
Interview data sheet 
Participant name:  DT 
Job title/ speciality: Obesity Dietitian – clinical advisor at diabetes UK 
Email:  ANON 
Further contact details:   
Date agreed to participate: 13/3/15 
Interview date, time & 
duration:  
21/3/15 
Type of interview: GoToMeeting 
Audio Recording: yes 
Consent forms signed: yes 
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Participant info sheet 
provided: 
yes 
Transcription Date:  
Transcription source:   
Circumstances booking interview: 
 
Booked over email.   
 
 
Circumstances during interview: 
 
Very quiet speaker, it was quite hard to hear what he was saying. 
 
 
 
Interview questions: Interviewer observations: 
Welcome. Would you like me to quickly 
review the purpose of this interview 
and/or my research aims? 
 
 
What are your views (strengths and 
weaknesses) on standardising approaches 
to personalised nutrition practice? For 
example, using a standardised 
questionnaire.  
 
Keeping the patient’s agenda rather than 
having the practitioner as the priority.  
Alongside not replace conversation and 
consultation.  
In your view, what ethical issues arise from 
using standardised approaches to 
personalised nutrition practice? 
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What are the most important 
considerations when using a 
questionnaire/tool in clinical practice?   
 
Time is the main factor, as dietician only gets 
30 minutes.  It needs to be web-based, user 
friendly and time saving 
The questionnaires/tools you use - were 
they developed by yourself or someone 
else? 
 
If self-developed - how did you go about 
developing the tool? 
If developed by someone else - who 
developed it/where did you get it? 
 
Used a tool that was developed across 
departments 
Through clinical assessment, how do you 
determine which are the main issues 
contributing to obesity for that individual? 
 
Depends on the patient, some can be patient 
led.  
In which ways do the questionnaires and 
tools help you make clinical decisions?  
 
Outcome and target focused and protocol 
driven.  
What further data or questions could help 
support your clinical decision making? 
 
 
The client data you have gathered, in what 
ways do you analyse this against scientific 
literature? 
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In what ways do you use the scientific 
literature to support your clinical decision 
making? 
 
 
If there were no time constraints, In what 
other ways could you use the scientific 
literature to support your nutrition practice?   
 
 
If a tool or questionnaire was devised 
that that linked to supporting research 
literature. How would that be useful for 
your clinical practice? 
 
 
Do you assess any of the following: 
• Case history questionnaire Life line?  
• Motivation questionnaire / 
motivational interviewing? 
• Exercise ability? 
Uses motivational interviewing 
Assesses exercise ability by oxygen 
measure in researcher rather than clinical 
practice.  
Under which circumstances would you 
ask clinical clients to use online data 
recording or mobile phone apps to 
measure their food intake, exercise, 
sleep etc? 
 
 
What are the advantages and 
disadvantages of sharing case data with 
researchers to create an evidence 
database for nutrition practice?  
 
Would this be something you are willing 
to do? 
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Apart from having to gain client 
permission, what other considerations 
arise from creating a case by case 
evidence base for nutrition practice? 
 
 
Would you be willing to participate in Delphi 
group surveys?   
 
 
Do you have any further comments? 
 
 
Interviewer reflections post interview: 
 
I was conscious to take notes of thoughts that occurred to me but then realised that if 
something occurred in my head, a question, then I asked it.  It was all audio captured.  
 
 
 
Interviewee additions post interview: 
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Appendix 15 Pilot trial participation request tracker – anonymised 
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291 
Appendix 16 Example post pilot trial practitioner interview guide 
Post Pilot Trial Practitioner Interview Guide 
Study title: Constructing validated clinical tools to enable the development of a new evidence base 
for personalised nutrition practice in obesity management 
Contact: 
Email: michelle@cnelm.co.uk,  
Tel: 07879 403321 
Consent form: 
You will have been sent a consent form to complete and participant information sheet.  The 
information sheet states interviews will take between 30 minutes and 90 minutes. They will 
be semi structured and informal.  The topics for discussion are below so you can see these 
in advance.  The actual date, time and duration has been agreed and is stated below. 
Interviews will be audio recorded for ease of transcription unless you request otherwise. If 
you have not done so already please return the signed consent forms.  
Background: 
Four new clinical tools were developed through a series of expert panel reviews as part of 
this doctoral research project. Despite reaching out to hundreds or practitioners, and interest 
from numerous practitioners, there was unfortunately little to no engagement with the pilot 
trial of these tools.  This project now wishes to explore the barriers that may have 
contributed to this outcome and explore idea for overcoming these barriers.  
Aims & Objectives of Interview: 
The aim of the interview is to gather your views on the barriers that may prevent practitioner 
from  imbedding standardised tools in personalised nutrition practice and explore potential 
approaches to overcoming these barriers.  Objectives include: 
6. Evaluate barriers which may have prevented you, or other practitioners from being 
able to participate with the trail or embed standardised tools into your own practice.  
7. Evaluate barriers which may prevent other practitioners from embedding 
standardised tools into personalised nutrition practice  
8. Barriers of engagement with tools provided by clinic clients  
9. Discuss potential ethical issues which may contribute as barriers to using 
standardised tools 
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10. Explore strengths and limitations of the Nutritional Therapy profession which may 
impact on the utilisation of standardised tools 
11. Evaluate approaches to overcoming any barriers 
12. Explore size/ duration/ approaches in which standardised tools could be easily 
imbedded into practice.  
 
Interview data sheet 
Participant name:  LO 
Job title/ speciality: Naturopath and nutritional therapist 
Email:  Anonymised 
Further contact details:   
Date agreed to participate: 4/5/17 
Interview date, time & 
duration:  
19/5/17 10.30am 
Type of interview: Zoom online conference call 
Audio Recording: yes 
Consent forms signed: yes 
Participant info sheet 
provided: 
yes 
Transcription Date:  
Transcription source:   
Circumstances booking interview: 
All communication by email 
Circumstances during interview: 
Nothing out of the ordinary 
 
 
 
Interview questions: Interviewer observations: 
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Welcome. Would you like me to quickly 
review the purpose of this interview and/or 
my research aims? 
 
 
There are 10 questions.  
Please do tell me a little about yourself and 
your nutritional practice. 
naturopath 
Roughly, what percentage of your clients 
are obese or seeking weight loss? (less 
than 5 %, less 25%, less than 50%, more 
than 50%) 
 
What tools, or other methods, are you 
currently using when assessing your clinic 
clients? 
How were the tools developed? 
 
Bioimpedance machine 
Zest for life intake – adapted 
Health and blood sugar questionnaire 
MSQ for other clients – introduced 
through that via nutri seminars 
How does the content & structure/layout of 
your existing tools impact on your 
evaluation of the client and the process of 
the consultation? 
Trained on using tools 
Do you think nutritional therapy 
professionals should use standardised tools 
in clinical practice? 
 
Prompt: Currently practitioners use their 
own tools.  Standardised = all practitioner 
using the same tools.   
 
Embedding standardised tools into your 
own practice, either for this pilot trial, or 
more generally: How do you think this 
would this impacts your evaluation of the 
client, or the process of the consultation? 
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Prompt: How many questions, or how long, 
should a standardised tool be to make it 
easy to embed into practice? 
What are the barriers engaging clients with 
standardised tools? either for this pilot trial 
or more generally.  
 
Prompt: Have you received any feedback 
from your clients on their experience of 
filling out questionnaires?  
Do you think we need questionnaires?   
What facets, e.g. strengths and limitations, 
of the nutritional therapy profession may 
impact on the utilisation of standardised 
tools in practice?   
 
What could be done to encourage the use 
of standardised tools (or standardised data 
collection) in personalised nutrition 
practice? 
 
Do you have any further comments?  
Interviewer reflections post interview: 
I feel as though I have got to the nub of most issues at this point (4 interviews in) but I 
have another 2 interviews booked on Tuesday so will see it through to 6 and then stop this 
part of the data collection. 
 
Interviewee additions post interview: 
Participant followed up by sending me the tools she referred to in the interview 
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Q6. Have you changed jobs within the 
following time periods (select all that apply): 
 
N/A 
 
Within 
last 6 
months   
 
Within 
last 
year  
 
Within 
last 2 
years  
 
Over 
2 
years 
ago 
 
Q7. Have you been made redundant or 
stopped working within the following time 
periods (select all that apply):  
 
N/A 
 Within 
last 6 
months   
 Within 
last year  
 Within 
last 2 years  
 Over 
2 years 
ago 
 
     Appendix 17 Tool 1 Questionnaire paper format 
Personalised Nutrition Health Questionnaire 
Client Identification:  name/address/ID number/email address/ other contact details as appropriate. 
 
Socio-cultural:  
Q1. I identify my gender as (please select) 
 Male  
 Female  
 Other _______________________ (please state) 
 
Q3. What is your legal marital or same-sex civil partnership status (please select): 
 Never married and never registered a same-sex civil partnership (please skip to question 5) 
 Married 
 In a registered same-sex civil partnership 
 Separated, but still legally married or in civil partnership 
 Divorced or formerly in a same-sex civil partnership which is now legally dissolved 
 Widowed or surviving partner from a same-sex civil partnership 
 
Q4. Have there been any changes to your marital or same-sex civil partnership status in the 
following time periods? (please select) 
Married or registered in same-sex 
civil partnership. 
 
N/A 
 Within 
last 6 
months   
 Within 
last year  
 Within 
last 2 
years  
 Over 2 
years ago 
Separated, but still legally married 
or in civil partnership 
 
N/A 
 Within 
last 6 
months   
 Within 
last year  
 Within 
last 2 
years  
 Over 2 
years ago 
Divorced or formerly in a same-sex 
civil partnership which is now 
legally dissolved 
 
N/A 
 Within 
last 6 
months   
 Within 
last year  
 Within 
last 2 
years  
 Over 2 
years ago 
Widowed or surviving partner from 
a same-sex civil partnership 
 
 
N/A 
 Within 
last 6 
months   
 Within 
last year  
 Within 
last 2 
years  
 Over 2 
years ago 
 
Q5. Last week, were you (tick all that apply) 
 working as an employee 
 working self-employed or freelance 
 away from work ill, on maternity leave or temporarily laid off 
 on a training scheme 
 in full time or part time education 
 retired 
 looking after home or family 
 long-term sick or disabled 
 other (please state) ____________________________ 
Q2. Date of Birth: 
__________________(DD/MM/YY) 
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Ethnicity: Q8. What is your ethnic group? Choose one section from A to E, then tick one box to 
best describe your ethic group or background: 
• White 
 English/Welsh/Scottish/N. Irish/British 
 Irish 
 Gypsy or Irish Traveller 
 Any other white background  
Please state _______________ 
C. Asian/Asian British 
 Indian 
 Pakistani 
 Bangladeshi 
 Chinese 
 Any other Asian background  
Please state _______________ 
 
Food Security: 
Q9. Have you ever used food aid systems, such as food stamps, food banks or other food support 
initiatives?  (please select)O 
 N/A  Within last 6 
months   
 Within last 
year  
 Within last 2 
years  
 Over 2 years 
ago 
 
Q10. if yes, how frequently have you used food aid systems during that period (please select) 
 N/A  1-5 times  6-10 times  11-20 times  More than 20 
times 
 
Education & Income: Q11. Which of these qualifications do you have? (tick every box that applies 
if you have any of the qualifications listed): 
 1-4 O levels/CSEs/GCSEs (any grades), Entry level, Foundation Diploma 
 NVQ Level 1, Foundation GNVQ, Basic Skills 
 5+ O levels (passes)/CSEs (grade 1) GCSEs (grades A8-C), School certificate, 1 A level/2-3 AS 
levels/VCE’s, Higher Diploma 
 NVQ Level 2, Intermediate GNVQ, City and Guilds Craft, BTEC First/General Diploma, RSA 
Diploma 
 Apprenticeship 
 2+ A levels/VCEs, 4+ AS levels, Higher School Certificate, Progression/Advanced Diploma 
 NVQ Level 3, Advanced GNCQ, City and Guilds Advanced Craft, ONC, OND, BTEC National, 
RSA Advanced Dip. 
 Degree (for example BA, BSc), Higher degree (for example MA, PhD, PGCE) 
 NVQ Level 4-5, HNC, HND, RSA Higher Diploma, BTEC Higher Level 
 Professional qualifications (for example teaching, nursing, accountancy) 
 Other vocational/work-related qualifications 
 Foreign qualifications 
 No qualifications 
 
B Mixed/multiple ethnic groups 
 White and Black Caribbean 
 White and Black African 
 White and Asian 
 Any other mixed/multiple ethic background  
Please state _______________ 
D. Black/African/Caribbean/Black British 
 African  
 Caribbean 
 Any other Black/African/Caribbean 
background: Please state _______________ 
E. Other ethnic group 
 Arab 
 Any other ethnic group:   
Please state _______________ 
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 £35,000 to £49,999 
 £50,000 to £74,999 
 £150,000 to 199,999 
 £200,000 or more 
 £75,000 to £99,999 
 £100,000 to 
£149,999 
 
Least:  
In Stone and pounds:_______ stone_______ lbs 
Or in Kilogram: _______________ kgs 
Lowest weight:  
In Stone and pounds:_______ stone_______ lbs 
Or in Kilogram: _______________ kgs 
Q12. Which category best describes your total annual household income before taxes (please 
select) 
 Less than £25,000 
 £25,000 to £34,999  
 
Weight Assessment:  
Q13 what is your height?  
In feet and Inches: _______ foot _______ inches  
Or in meters: ________________  m 
 
Q15. How would you best describe your weight during the following periods if your life? (please 
select) 
Age 0-5  Underweight  Average weight  Overweight  Obese 
Age 6-10  Underweight  Average weight  Overweight  Obese 
Age 11-14  Underweight  Average weight  Overweight  Obese 
Age 15-18  Underweight  Average weight  Overweight  Obese 
Age 19-25  Underweight  Average weight  Overweight  Obese 
 
Q16. What is the most and least you have weighed as an adult?  
Most :  
In Stone and pounds:_______ stone_______ lbs 
Or in Kilogram: _______________ kgs 
 
Q17. Describe how much your weight has fluctuated in the past year: 
Highest weight:  
In Stone and pounds:_______ stone_______ lbs 
Or in Kilogram: _______________ kgs 
Q 18 Family health and weight history:  
Please Y to all appropriate boxes for the family members who have, or have had, each condition.   
Please add numbers (1, 2, 3 etc.) if you have more than 1 sister, brother, daughter etc. with the 
same condition. 
Please add N to all appropriate boxes for family members who have not, or have never had, each 
condition. 
Please leave boxes blank for the instances where you do not know, are unsure or do not have such 
a relative. 
 Exampl
e 
column 
Under
- 
weight 
Norma
l 
Weigh
t 
Over- 
weight 
Obese Bariatri
c 
surgery 
Diabete
s type 1 
Diabete
s type 2 
Other health 
condition. Please 
insert name or 
description (e.g. 
stroke, cancer, mental 
health issues, gout, 
arthritis): 
Your 
Father 
Y         
 
Q14. What is your current weight? 
In Stone and pounds:_______ stone_______ 
lbs 
Or in Kilogram: _______________ kgs 
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Paternal 
Grandfather 
Y         
 
Paternal 
Grandmother 
N         
Father’s 
brothers 
N         
 
Father’s 
sisters 
1         
Your 
Mother 
N         
 
Maternal 
Grandfather 
         
Maternal 
Grandmother 
         
Mother’s 
brothers 
         
Mother’s 
sisters 
2         
Your  
brothers 
N         
 
Your  
sisters 
N         
 
Your  
sons 
1 and 2         
 
Your 
daughters 
1         
 
Personal health history:  
Q19. Please select if you are have experienced any of these in the last 3 months: 
 unexplained 
pain 
 blurred vision 
or dizziness 
 difficulty 
swallowing 
 paralysis  unexplained 
bruising 
 bleeding from 
nipple 
 breast lumps  discharge from 
vagina 
 persistent 
cough 
 unexplained 
rash 
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 blood in 
sputum 
 calf swelling  headaches  persistent nose 
bleeds 
 unexplained 
weight loss 
 blood in urine  change in 
nature of moles 
 loss of appetite  shortness of 
breath 
 unexplained 
heavy periods 
 blood in vomit  chest pain  numbness  slurred speech  unexplained 
loss of periods 
If you are currently experiencing any of these conditions please make an appointment to see your 
primary health care provider such as your G.P.  
 
Q20. The following table aims to identify your history of disease and other health conditions. Please 
complete providing as much information as possible. Please use another sheet of paper if 
necessary: 
 
Condition: 
Please Tick 
Leave blank if 
not applicable please provide 
more details  e.g. 
type of condition 
When did this 
condition 
start? (date) 
Duration (months 
or years, e.g. 6 
months, 2 years) 
How was/is it 
managed/treated? 
(medication, 
surgery, therapy 
etc.) Current Past 
addiction 
       
 
arthritis: 
rheumatoid, 
osteoarthritis 
etc.      
 
attention deficit 
hyperactivity 
disorder (ADHD)      
 
autism  
       
 
cancer 
       
 
chronic fatigue  
       
 
Dementia e.g. 
Alzheimer’s 
       
 
depression 
       
 
disturbed sleep 
or insomnia       
 
eating disorder 
e.g. binge eating 
disorder/bulimia      
 
eye disease e.g. 
glaucoma       
 
food allergy, e.g. 
celiac, peanut, 
dairy etc.      
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gall bladder 
disease       
 
Gout 
       
 
heart disease or 
vascular disease       
 
        
       
Continued.. 
Please Tick 
Leave blank if 
not applicable please provide 
more details  e.g. 
type of condition 
When did this 
condition 
start? (date) 
Duration (months 
or years, e.g. 6 
months, 2 years) 
How was/is it 
managed/treated? 
(medication, 
surgery, therapy 
etc.) Current Past 
hepatitis ( A, B or 
C) 
      
 
herpes virus, 
including  
Epstein Barr or 
shingles      
 
high blood 
pressure       
 
kidney disease 
       
 
liver disease 
       
 
mood or anxiety 
disorder       
 
night eating 
syndrome       
 
Polycystic 
Ovarian 
Syndrome 
(PCOS)      
 
post-traumatic 
stress       
 
respiratory 
disorders e.g. 
asthma, sleep 
apnoea      
 
thyroid disease 
or condition       
 
type 1 diabetes 
       
 
type 2 diabetes 
       
 
Any other 
disease or 
condition:  
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Medication and Supplementation 
Q21.Please list below all the medications, drugs or supplements you took in the PAST MONTH. For 
each one you list please answer the questions below as best as you can.  Medications include 
prescriptions, over the counter medicines, cold remedies, painkillers, contraceptives, creams, 
injections, eye drops etc. Supplements include vitamins, minerals, herbs, probiotics etc. Please use 
another sheet of paper if necessary: 
Medication, 
drug or 
supplement  
name or 
type 
Dose/strength 
e.g. mg, ml 
etc.  
For what 
reason 
were you 
taking it? 
 
How many 
days did 
you take 
it? 
How many 
times did 
you take 
each day? 
How many 
times did 
you miss 
taking it? 
How well 
does it 
work for 
you? 
1 = well 
2 = okay 
3= not well 
4= unsure 
 
___________  ____________  __________  __________  _________  ___________  __________ 
 
___________  ____________  __________  __________  _________  ___________  __________ 
 
___________  ____________  __________  __________  _________  ___________  __________ 
 
___________  ____________  __________  __________  _________  ___________  __________ 
 
___________  ____________  __________  __________  _________  ___________  __________ 
 
___________  ____________  __________  __________  _________  ___________  __________ 
 
 
Smoking history 
Q22.  Please answer 1 and 2.  You only need to answer 3,4 and 5 if you have a history of smoking.  
1. Do you currently 
smoke tobacco (e.g. 
cigarettes, cigars, pipes 
etc.)  or e-cigarettes? 
 No. 
 
 Daily.   
How many cigarettes 
per day? _________ 
 Less than daily.  
How many cigarettes per month? 
_________ 
2. Have you smoked 
tobacco or e-cigarettes 
in the past? 
 No 
please skip to 
Q23.  
  Yes. 
at what age:________ 
For how long: 
 
___________ 
How many 
cigarettes per 
day? 
_____________ 
3. How does smoking 
affect your weight? 
  Keeps my 
weight down 
 No effect   Keeps my 
weight up 
  I don’t know 
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4. How many times 
have you stopped 
smoking for more than 
3 months? 
  1-2 times   3-6 
times 
  7-14 
times 
  15-20 times   More than 20 
times 
5. If you have smoked 
and stopped. Did you 
gain weight as a result 
of stopping smoking? 
 No   Yes If yes, how 
much weight did 
you gain?  
How many times did you 
gain weight as a result of 
stopping smoking? 
 
Pregnancy  Men please skip to Q29. For females only:   
Q23. Are you pregnant now?  No.  Maybe.  Yes, How many weeks pregnant are 
you_________? 
 
Q24.  Have you ever been pregnant?   
 Yes, how many times?________   How many children have you given birth too?________     
 No, please skip to Q25.  
 
If yes, please answer where possible: Child 1 Child 2 Child 3 Child 4 Child 5 
Sex of each child -  M/F      
Date of birth for each child -  DD/MM/YY      
Vaginal delivery for each child -  Yes/No      
Did you experience gestational diabetes -  
Yes/No 
     
On average, how much weight did you put on 
during each pregnancy?  - Lbs or Kgs 
     
How much pregnancy weight did you lose 6 
months after each pregnancy?  - Lbs or Kgs  
     
 
Q24.  Please describe your weight, before, during and after pregnancy 
Before pregnancy (1st)  Underweight  Normal 
weight 
 Overweight  Obese 
During pregnancy (1st)  Underweight  Normal 
weight 
 Overweight  Obese 
6 months after pregnancy 
(1st) 
 Underweight  Normal 
weight 
 Overweight  Obese 
Before pregnancy ((2nd )  Underweight  Normal 
weight 
 Overweight  Obese 
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During pregnancy (2nd )  Underweight  Normal 
weight 
 Overweight  Obese 
6 months after pregnancy 
(2nd ) 
 Underweight  Normal 
weight 
 Overweight  Obese 
Before pregnancy (3rd)  Underweight  Normal 
weight 
 Overweight  Obese 
During pregnancy (3rd)  Underweight  Normal 
weight 
 Overweight  Obese 
6 months after pregnancy 
(3rd) 
 Underweight  Normal 
weight 
 Overweight  Obese 
Please use another sheet of paper if necessary.  
 
Hormone Balance Men please skip to Q29. For females only:   
Q25. Are you still menstruating?  
 No,   when did your periods cease and why?_______________________________________ 
(please skip to Q26.) 
 Yes,  are your periods regular?  Yes.   No, if no please give further 
details_____________________________ 
 
On average, what is the length of time between periods?;  
 Less than 20 
days 
 20-30 days  30-40 
days 
 More than 40 
days 
 
Q26. Please highlight any of the following that apply to you and highlight if they apply currently or in 
the past: 
Hot flushes 
(past/current) 
Insomnia 
(past/current) 
Night sweats 
(past/current) 
Menopausal 
symptoms 
(past/current) 
Ovarian Cysts 
(past/current) 
PMT 
(past/current) 
PCOS 
(past/current) 
Endometriosis 
(past/current) 
Fibroids 
(past/current) 
Fertility problems 
(past/current) 
Breast cysts 
(past/current) 
Loss of libido 
(past/current) 
Facial hair 
(past/current) 
Swollen/tender 
breasts 
(past/current) 
Mood swings 
(past/current) 
Other:  
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Q27. Are you, or have you ever been, on HRT or bio-identical hormones?  No,     Yes,  please 
give further details:  
__________________________________________________________________________ 
 
 
Q28. Have you ever taken: 
Birth control pills? Yes, No 
Birth control implants?  Yes, No,  
IUD coil?  Yes, No. 
 
Inflammation 
Q 29. Please rate: 
How often do you feel aches and pains? 
Such as back pain, neck pain, 
headaches or general soreness. 
 almost 
every day 
 at least 
once a 
week 
 once or 
twice a 
month 
 a few 
times a 
year 
 never 
What are the most common causes of 
pain your experience?  E.g. back ache, 
head ache, period pain etc. 
 
How often do you take anti-inflammatory 
or anti-pain medication such as 
ibuprofen, aspirin or prescription drugs? 
 almost 
every day 
 at least 
once a 
week 
 once or 
twice a 
month 
 a few 
times a 
year 
 never 
 
Q30. Please circle any of the following that apply to you and highlight if they apply currently or in the 
past: 
Example: 
Acne, eczema, 
rosacea, psoriasis 
(past/current) 
Allergies or 
Hypersensitivities 
e.g. hay fever, food 
allergies, rhinitis 
(past/current) 
Asthma 
(past/current) 
Autoimmune 
diseases e.g. 
systemic lupus, 
vitiligo, Hashimoto’s 
Addison’s disease. 
(past/current) 
Please give 
further details 
of conditions 
you have 
circled: 
Celiac Disease 
(past/current) 
Cystitis 
(past/current) 
Inflammation of the 
prostate gland (men 
only) 
(past/current) 
Inflammatory 
kidney condition 
(past/current) 
Inflammatory skin 
conditions e.g. 
acne, eczema, 
rosacea, psoriasis 
(past/current) 
Inflammatory bowel 
disease e.g. 
ulcerative colitis, 
Crohn’s,  
(past/current) 
Non-coeliac gluten 
sensitivity 
(past/current) 
Pelvic inflammatory 
disease 
(past/current) 
Any other inflammatory condition? 
How long did you use these contraception?  
 6 months-2 years 
 2-5 years 
 more than 5 years 
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Satiety hormone disruption and food addiction 
Q31. Please highlight which of the following best applies to you: 
I frequently think about food Not at all Occasionally  Sometimes Frequently Always 
I frequently crave food Not at all Occasionally  Sometimes Frequently Always 
I continue to eat after I feel full Not at all Occasionally  Sometimes Frequently Always 
I feel hungry no matter what I 
eat 
Not at all Occasionally  Sometimes Frequently Always 
I cannot go long periods 
without eating 
Not at all Occasionally  Sometimes Frequently Always 
I always feel hungry Not at all Occasionally  Sometimes Frequently Always 
 
Dysbiosis 
Q32. Please highlight any of the following that apply to you and indicate if they apply currently or in 
the past: 
Example: 
Indigestion 
(past/current) 
Indigestion  
(past/current) 
Heartburn 
(past/current) 
Bowel movements 
shortly after eating 
(past/current) 
Frequent stomach 
upset or pain 
(past/current) 
Nausea or vomiting 
(past/current) 
Constipation or 
hard to pass stools 
(past/current) 
Diarrhoea or 
urgency to go 
(past/current) 
Blood in stools / 
black stools 
(past/current) 
Undigested food in 
stools 
(past/current) 
Stools are not well 
formed (loose) 
(past/current) 
Excessive foul 
smelling gas 
(past/current) 
Cramping in lower 
abdomen 
(past/current) 
Mucus in stools 
(past/current) 
Pain between 
shoulder or under 
the rib cage 
(past/current) 
Irritable bowel 
syndrome (IBS) 
(past/current) 
Offensive stool 
(past/current) 
Pale, bulky stool 
(past/current) 
Stools that float 
(past/current) 
Stools that sink 
(past/current) 
Haemorrhoids 
(past/current) 
Anus itching 
(past/current) 
Thrush 
(past/current) 
Fungal or yeast 
infections e.g. 
athletes foot, ring 
History of parasites 
(past/current) 
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 most of my weight is above the waist (apple) 
 most of my weight is below the waist (pear) 
 I am not sure 
 other. Please describe: -
____________________________________________ 
 
Q.38 When did you last have your cholesterol tested: 
 Never.  In the last 6 months.  In the last year.  In the last 3 years.  
 In the last 5 years. 
worm 
(past/current) 
 
Q33. How often do you have a bowel movement?  
 More than once a day.    Once a day.   Once every few days.  Other:-
________________________________ 
 
Q34. Have you noticed any recent changed in your in bowel habits 
 No.  Yes - please give details:-
__________________________________________________________________  
 Other 
______________________________________________________________________________ 
 
Insulin resistance and hyperglycaemia 
Q35. Please tick which of the following best applies to you: 
I urinate more than I feel is normal  Never   Seldom  Often  Always 
I feel I urinate at night more frequently than is normal    Never   Seldom  Often  Always 
I feel very thirsty more frequently than normal  Never   Seldom  Often  Always 
I feel very tired more frequently than normal  Never   Seldom  Often  Always 
I have experienced unexplained weight loss  Never   Seldom  Often  Always 
I have itching around the penis or vagina  Never   Seldom  Often  Always 
I have episodes of thrush  Never   Seldom  Often  Always 
I have skin tags  Never   Seldom  Often  Always 
I experience cuts or wounds that heal slowly  Never   Seldom  Often  Always 
I experience blurred vision   Never   Seldom  Often  Always 
I experience weakness or dizziness after a period of 
fasting or with hunger 
 Never   Seldom  Often  Always 
I can feel extreme hunger  Never   Seldom  Often  Always 
I experience drowsiness   Never   Seldom  Often  Always 
I experience nausea  Never   Seldom  Often  Always 
 
Dyslipidaemia.   
Q36. Do you have difficulty losing weight?  not at all  moderately difficult  extremely difficult 
Q37. Tick which applies to you :    
307 
 
 
Q 39. My cholesterol level is: 
 I don’t know.  
 Low.  
Normal.  
 Raised.   
 
Oxidative stress 
Q40. Please tick which of the following best applies to you: 
I experience shortness of breath 
 Never   
Seldom 
 Weekly  Every 
night 
I snore  
 Never   
Seldom 
 Weekly  Every 
night 
I wake up in the night with a very dry and sore throat 
 Never   
Seldom 
 Weekly  Every 
night 
I wake up with a chocking or grasping sensation 
 Never   
Seldom 
 Weekly  Every 
night 
Q41. Have you ever been diagnosed with sleep apnoea?  
 No - please skip to Q42.   Yes – when were you diagnosed 
(dd/mm/yy)_________________________________  
 
Are you receiving treatment?  No  Yes – Please describe treatment 
__________________________________________________________ 
Epigenetic Changes 
Q42. Please tick which of the following best applies to you: 
Prior to the age of 17  I experienced stress 
or trauma (e.g. death of parent, 
separation, physical, emotional or sexual 
abuse, significant accident) 
 No  I cannot 
remember 
 Yes If yes: please provide 
further information on a 
separate sheet if you wish 
to. 
If yes, on a scale of 1 to 5, how traumatic 
was this? 
 1 
Least 
traumatic 
 2  3 
traumatic 
 4  5 
Extremely 
traumatic 
 
Psychological Factors 
Q43. Please tick which of the following best applies to you: 
Please provide exact cholesterol measure: 
  
Total Cholesterol: _______________ Low Density Cholesterol 
(LDL):______________    
 
Triglycerides:_________________  High Density Cholesterol (HDL): 
_______________ 
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How much do you enjoy life.  Not at 
all 
 A little  A 
moderate 
amount 
 Very 
much 
 An 
extreme 
amount 
To what extent do you feel your life 
to be meaningful? 
 Not at 
all 
 A little  A 
moderate 
amount 
 Very 
much 
 An 
extreme 
amount 
How often do you have negative 
feelings such as depression, 
despair, anxiety? 
 Always  Very 
often 
 Quite often  
Seldom 
  Never 
I feel able to accept my bodily 
appearance 
 Not at 
all 
 A little  A 
moderate 
amount 
 Very 
much 
 An 
extreme 
amount 
On the whole I feel satisfied with 
myself 
 
  
Strongly 
disagree 
  
Disagree 
  Neither 
agree or 
disagree 
  Agree  Strongly 
agree 
I take a positive attitude towards 
myself 
  
Strongly 
disagree 
 
Disagree 
 Neither 
agree or 
disagree 
  Agree  Strongly 
agree 
 
Quality of life 
Q44. Please tick which of the following best applies to you: 
How would you rate your quality of life?   Very 
poor 
  
Poor 
  Neither 
good nor 
poor 
  
Good 
  Very 
Good 
How would you rate your physical 
functioning? 
  Very 
poor 
  
Poor 
  Neither 
good nor 
poor 
  
Good 
  Very 
Good 
How would you rate your general health   Very 
poor 
  
Poor 
  Neither 
good nor 
poor 
  
Good 
  Very 
Good 
How would you rate your emotional 
health?  
  Very 
poor 
  
Poor 
  Neither 
good nor 
poor 
  
Good 
  Very 
Good 
 
Sleep 
Q45. Please tick which of the following best applies to you: 
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How would you rate the quality if your 
sleep? 
  Poor   Neither 
good nor poor 
  Good 
How frequently do you doze during the 
day? 
 Always  Often  Seldom  Never 
How frequently do you wake in the night?  Always  Often  Seldom  Never 
How frequently do you use over the 
counter or prescription sleep aids? 
 Always  Often  Seldom  Never 
On average, how many hours sleep do 
you get per night 
 3 or less  4-5  6-8   9 or more 
 
Stress 
Q46. Please tick which of the following best applies to you: 
In the last month, how often have 
you felt that you were unable to 
control the important things in your 
life? 
 Never  Almost 
never 
 
Sometimes 
 Fairly 
often 
 Very 
often 
In the last month, how often have 
you felt confident about your ability 
to handle your personal problems? 
 Never  Almost 
never 
 
Sometimes 
 Fairly 
often 
 Very 
often 
In the last month, how often have 
you felt that things were going your 
way? 
 Never  Almost 
never 
 
Sometimes 
 Fairly 
often 
 Very 
often 
In the last month, how often have 
you felt difficulties were piling up so 
high that you could not overcome 
them? 
 Never  Almost 
never 
 
Sometimes 
 Fairly 
often 
 Very 
often 
 
 
 
Motivation to change 
Q47. Please tick which of the following best applies to you: 
In the past month, have you been actively trying to lose weight?  
Yes 
 No 
In the past month, have you been actively trying to keep from weight gain?  
Yes 
 No 
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Are you seriously considering trying to lose weight to reach your goals in the 
next 6 months? 
 
Yes 
 No 
Have you maintained you desired weight for more than 6 months?  
Yes 
 No 
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Appendix 18 Tool 1 Questionnaire - download of online format 
Personalised Nutrition Health Questionnaire 
 
 
Start of Block: Socio Cultural: 
 
Q113 PERSONALISED HEALTH HISTORY QUESTIONNAIRE 
  
 Please complete this questionnaire as comprehensively as possible.  It may take up to 1 hour to 
complete the whole questionnaire.  
 
 On completion, the information will be sent to your nutrition practitioner. The aims, duration and 
outcome of the nutrition consultation will remain the same.   
 
The aim of this pilot trial is to assess the way health information is collected and interpreted.  After 
completion you will then be invited to complete a short 10 question survey to assess your 
experience of using this questionnaire. 
 
 
 
 
Q118 Your participation in this study is entirely voluntary and you can withdraw at any time and 
you are free to omit any question. You should be aware that the data you provide may be used for 
analysis and subsequent publication. The researchers will implement procedures to maintain the 
confidentiality of the participant data. Personal information provided will be stored in computer files 
secured by means of passwords or in locked cabinets. Only the researcher and authorised 
supervisors will be able to access the information. Personal information will be destroyed once the 
research is completed. 
  
 Thank you very much and please do get in touch if you have any questions. 
  
 Researcher: Michelle Barrow; Centre for Nutrition Education and Lifestyle Management (CNELM) 
and Middlesex University 
 michelle@cnelm.co.uk 
 Research Supervisors: Dr L Bell (L.bell@mdx.ac.uk); Dr C. Bell (c.bell@mdx.ac.uk) 
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 Study title: Constructing validated clinical tools to enable the development of a new evidence base 
for personalised nutrition practice in weight management. 
 Academic Year: 2016/17 
 
 
 
Q117 Name of your Nutritionist/Dietician/Nutritional Therapist/Practitioner: 
________________________________________________________________ 
 
 
 
Q1 Your Participant Information Number: 
________________________________________________________________ 
 
 
 
Q2 I identify my gender as: 
▢ Male  (1)  
▢ Female  (2)  
▢ Other (please state in box below)  (3) 
________________________________________________ 
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Q115 Date of birth: 
  
Month (1)  ▼ January (1) ...   (150) 
Day (2)  ▼ January (1) ...   (150) 
Year (3)  ▼ January (1) ...   (150) 
 
 
 
 
Q3 What is your legal marital or same-sex civil partnership status: 
▼ Never married and never registered a same-sex civil partnership (1) ... Widowed or surviving partner 
from a same-sex civil partnership (6) 
 
Skip To: Q5 If What is your legal marital or same-sex civil partnership status: = Never married and never registered a 
same-sex civil partnership 
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Q4 Have there been any changes to your marital or same-sex civil partnership status in the 
following time periods?  
▢ N/A  (1)  
▢ Within the last 6 months  (2)  
▢ Within the last year  (3)  
▢ Within the last 2 years  (4)  
▢ Over 2 years ago  (5)  
▢ Please provide further details if you wish:  (6) 
________________________________________________ 
 
 
 
Q5 Last week, you were (select all that apply):  
• working as an employee  (1)  
• working self-employed or freelance  (2)  
• away from work ill, on maternity leave or temporarily laid off  (3)  
• on a training scheme  (4)  
• in full time or part time education  (5)  
• retired  (6)  
• looking after home or family  (7)  
• long-term sick or disabled  (8)  
• other (please state in box below)  (9) 
________________________________________________ 
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Q10 What is your ethnic group? Choose one section from A to E, then tick one box to best 
describe your ethic group or background: 
▼ English/Welsh/Scottish/N. Irish/British (1) ... Any other ethnic group (please state) (18) 
 
 
 
Q11 Have you ever used food aid systems, such as food stamps, food banks or other food support 
initiatives?   
▼ N/A (1) ... Over 2 years ago (5) 
 
Skip To: Q13 If Have you ever used food aid systems, such as food stamps, food banks or other food support initia... = 
N/A 
 
 
Q12 If yes, how frequently have you used food aid systems during that period:  
▼ 1-5 times (1) ... More than 20 times (4) 
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Q13 Which of these qualifications do you have? (tick every box that applies if you have any of the 
qualifications listed): 
• 1-4 O levels/CSEs/GCSEs (any grades), Entry level, Foundation Diploma  (1)  
• NVQ Level 1, Foundation GNVQ, Basic Skills  (2)  
• 5+ O levels (passes)/CSEs (grade 1) GCSEs (grades A8-C), School certificate, 1 A level/2-
3 AS levels/VCE’s, Higher Diploma  (3)  
• NVQ Level 2, Intermediate GNVQ, City and Guilds Craft, BTEC First/General Diploma, 
RSA Diploma  (4)  
• Apprenticeship  (5)  
• 2+ A levels/VCEs, 4+ AS levels, Higher School Certificate, Progression/Advanced Diploma  
(6)  
• NVQ Level 3, Advanced GNCQ, City and Guilds Advanced Craft, ONC, OND, BTEC 
National, RSA Advanced Dip.  (7)  
• Degree (for example BA, BSc), Higher degree (for example MA, PhD, PGCE)  (8)  
• NVQ Level 4-5, HNC, HND, RSA Higher Diploma, BTEC Higher Level  (9)  
• Professional qualifications (for example teaching, nursing, accountancy)  (10)  
• Other vocational/work-related qualifications  (11)  
• Foreign qualifications  (12)  
• No qualifications  (13)  
 
 
 
Q14 Which category best describes your total annual household income before taxes: 
▼ Less than £25,000 (1) ... £200,000 or more (8) 
 
End of Block: Socio Cultural: 
 
Start of Block: Weight Assessment 
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Q15 Weight Assessment 
 
What is your height in feet and inches?  
Feet (1)  
Inches (2)  
▼ 1 (1) ... 7 ~ 11 (84) 
 
 
 
Q16 What is your current weight in stone and pounds?  
  
Stone (1)  
Pounds (2)  
▼ 1 (1) ... 65 ~ 13 (975) 
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Q17 How would you best describe your weight during the following periods if your life?  
 Underweight (1) Average weight (2) Overweight (3) Obese (4) 
Age 0-5 (1)  ▢  ▢  ▢  ▢  
Age 6-10 (2)  ▢  ▢  ▢  ▢  
Age 11-14 (3)  ▢  ▢  ▢  ▢  
Age 15-18 (4)  ▢  ▢  ▢  ▢  
Age 19-25 (5)  ▢  ▢  ▢  ▢  
 
 
 
 
Q18 What is the most you have weighed as an adult?  
Stone (1)  
Pounds (2)  
▼ 1 (1) ... 65 ~ 13 (975) 
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Q19 What is the least you have weighed as an adult?  
Stone (1)  
Pounds (2)  
▼ 1 (1) ... 65 ~ 13 (975) 
 
 
 
Q20 Describe how much your weight has fluctuated in the past year: What is the most you have 
weighed in the past year?  
Stone (1)  
Pounds (2)  
▼ 1 (1) ... 65 ~ 13 (975) 
 
 
 
Q21 What is the least you have weighed in the past year?  
Stone (1)  
Pounds (2)  
▼ 1 (1) ... 65 ~ 13 (975) 
 
End of Block: Weight Assessment 
 
Start of Block: Family health and weight history 
 
Q112 On the table below:  Please add Y to all appropriate boxes for the family members 
who have, or have had, each condition.  Please add numbers (1Y, 2N, 3Y etc.) if you, or your 
parents, have more than 1 sister, brother, daughter etc.  Please add N to all appropriate boxes for 
family members who have not, or have never had, each condition.  Please leave boxes blank for 
the instances where you do not know, are unsure or do not have such a relative.  Use the tab 
button to navigate to each box.     Here is an example: 
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Q21 Click to 
write the 
question 
text 
Underweight 
(1) 
Normal 
Weight 
(2) 
Over-
weight 
(3) 
Obese 
(4) 
Bariatric 
surgery 
(5) 
Diabetes 
Type 1 
(6) 
Diabetes 
Type 2 
(7) 
Other 
health 
condition. 
Please 
insert 
name or 
description 
(e.g. 
stroke, 
cancer, 
mental 
health 
issues, 
gout, 
arthritis 
etc.) (8) 
Your Father 
(1)  
        
Paternal 
grandfather 
(2)  
        
Paternal 
grandmother 
(3)  
        
Father's 
brothers (4)  
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Father's 
sisters (5)  
        
Your Mother 
(6)  
        
Maternal 
grandfather 
(7)  
        
Maternal 
grandmother 
(8)  
        
Mother's 
brothers (9)  
        
Mother's 
sisters (10)  
        
Your 
brothers 
(11)  
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Your sisters 
(12)  
        
Your sons 
(13)  
        
Your 
daughters 
(14)  
        
 
 
 
Page Break  
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Q22 Personal Health History   
  Please select if you are have experienced any of these in the last 3 months: 
• unexplained pain  (1)  
• bleeding from nipple  (2)  
• blood in sputum  (3)  
• blood in urine  (4)  
• blood in vomit  (5)  
• blurred vision or dizziness  (6)  
• breast lumps  (7)  
• calf swelling  (8)  
• changes in nature of moles  (9)  
• chest pain  (10)  
• difficulty swallowing  (11)  
• discharge from vagina  (12)  
• headaches  (13)  
• loss of appetite  (14)  
• numbness  (15)  
• paralysis  (16)  
• persistent cough  (17)  
• persistent nose bleeds  (18)  
• shortness of breath  (19)  
• slurred speech  (20)  
• unexplained bruising  (21)  
• unexplained rash  (22)  
• unexplained weight loss  (23)  
• unexplained heavy periods  (24)  
• unexplained loss of periods  (25)  
If you are currently experiencing any of these conditions please make an appointment to 
see your primary health care provider such as your G.P.  
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Q26 The 
following table 
aims to identify 
your history of 
disease and 
other health 
conditions. 
Please 
complete 
providing as 
much 
information as 
possible. Please 
use box on next 
question to 
provide more 
information if 
necessary: 
Leave blank if 
not applicable. 
Write "current" 
if you are 
currently 
experiencing 
this condition. 
Write "past" if 
you have 
previously 
experienced 
this condition 
(1) 
Please 
provide more 
details e.g. 
type of 
condition (2) 
When did this 
condition 
start? (date) 
(3) 
Duration 
(months or 
years,  e.g. 6 
months, 2 
years) (4) 
How was/is it 
managed/treated? 
(medication, 
surgery, therapy 
etc.) (5) 
addiction (1)       
arthritis: 
rheumatoid or 
osteoarthritis 
etc. (2)  
     
autism (3)       
cancer (4)       
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chronic fatigue 
(5)  
     
dementia e.g. 
Alzheimer's (6)  
     
depression (7)       
disturbed sleep 
or insomnia (8)  
     
eating disorder 
e.g. binge 
eating 
disorder/bulimia 
(9)  
     
eye disease e.g. 
glaucoma (10)  
     
food allergy e.g. 
celiac, peanut, 
dairy etc. (11)  
     
326 
gall bladder 
disease (12)  
     
gout (13)       
heart disease or 
vascular 
disease (14)  
     
hepatitis (A,B or 
C) (15)  
     
herpes virus, 
including 
Epstein Barr or 
shingles (16)  
     
high blood 
pressure (17)  
     
kidney disease 
(18)  
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liver disease 
(19)  
     
mood or anxiety 
disorder (20)  
     
night eating 
syndrome (21)  
     
polycystic 
ovarian 
syndrome (22)  
     
post-traumatic 
stress (23)  
     
respiratory 
disorders e.g. 
asthma, sleep 
apnoea (24)  
     
thyroid disease 
or condition (25)  
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type 1 diabetes 
(26)  
     
type 2 diabetes 
(27)  
     
any other 
disease or 
condition (28)  
     
 
 
 
 
Q27 Please provide more information regarding the previous question if you wish: 
________________________________________________________________ 
________________________________________________________________ 
________________________________________________________________ 
________________________________________________________________ 
________________________________________________________________ 
 
 
Page Break  
Q28 Medication and Supplementation 
Please list below all the medications, drugs or supplements you took in the PAST MONTH. For 
each one you list please answer the questions below as best as you can.  Medications include 
prescriptions, over the counter medicines, cold remedies, painkillers, contraceptives, creams, 
injections, eye drops etc. Supplements include vitamins, minerals, herbs, probiotics etc.  
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Medication, 
drug or 
supplement 
name or 
type (1) 
dose/strength 
e.g. mg, ml 
etc. (2) 
for what 
reason 
were you 
taking 
these (3) 
How 
many 
days did 
you take 
it? (4) 
How 
many 
times 
did you 
take 
each 
day? (5) 
How 
many 
times did 
you miss 
taking it? 
(6) 
How well 
does it 
work for 
you? 
well, 
okay, not 
well, 
unsure 
(7) 
Medication/drug: 
(1)  
       
Medication/drug: 
(2)  
       
Medication/drug: 
(3)  
       
Medication/drug: 
(4)  
       
Medication/drug: 
(5)  
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Medication/drug: 
(6)  
       
Supplement: (7)         
Supplement: (8)         
Supplement: (9)         
Supplement: 
(10)  
       
 
 
 
 
Q30 Please provide more information regarding the previous question if you wish: 
________________________________________________________________ 
________________________________________________________________ 
________________________________________________________________ 
________________________________________________________________ 
________________________________________________________________ 
 
 
Page Break  
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Q29 Smoking History 
 
Do you currently smoke tobacco (e.g. cigarettes, cigars, pipes etc.) or e-cigarettes? 
▼ No (1) ... Less than daily (3) 
 
Skip To: Q33 If Smoking History Do you currently smoke tobacco (e.g. cigarettes, cigars, pipes etc.) or e-cigarettes? = 
No 
Skip To: Q31 If Smoking History Do you currently smoke tobacco (e.g. cigarettes, cigars, pipes etc.) or e-cigarettes? = 
Daily 
Skip To: Q32 If Smoking History Do you currently smoke tobacco (e.g. cigarettes, cigars, pipes etc.) or e-cigarettes? = 
Less than daily 
 
 
Q31 How many per day? 
________________________________________________________________ 
 
 
 
Q32 How many per month? 
________________________________________________________________ 
 
 
 
Q33 Have you smoked tobacco or e-cigarettes in the past? 
▼ No (1) ... Yes (3) 
 
Skip To: End of Block If Have you smoked tobacco or e-cigarettes in the past? = No 
 
 
Q42 At what age did you start smoking? 
▼ 16 (1) ... 75 (60) 
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Q43 For how long did you smoke: 
________________________________________________________________ 
 
 
 
Q44 How many times per day did, or do, you smoke? 
▼ 1-5 (1) ... more than 40 times per day (9) 
 
 
 
Q34 How does smoking affect your weight? 
▼ keeps my weight down (1) ... I don't know (4) 
 
 
 
Q35 How many times have you stopped smoking for more than 3 months? 
▼ Never (1) ... more than 20 times (6) 
 
 
 
Q36 If you have smoked and stopped, did you gain weight as a result of stopping smoking? 
▼ No (1) ... Yes (3) 
 
 
 
Q37 How much weight did you gain as a result of stopping smoking? 
________________________________________________________________ 
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Q38 How many times did you gain weight as a result of stopping smoking? 
________________________________________________________________ 
 
End of Block: Family health and weight history 
 
Start of Block: Pregnancy 
 
Q39 Pregnancy 
  
 Are you pregnant now? 
▢ Yes  (1)  
▢ Maybe  (2)  
▢ No  (3)  
▢ I don't know  (4)  
 
Skip To: Q41 If Pregnancy Are you pregnant now? = No 
Skip To: Q41 If Pregnancy Are you pregnant now? = I don't know 
 
 
Q40 How many weeks pregnant are you? 
________________________________________________________________ 
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Q41 Have you ever been pregnant? 
▢ Yes  (1)  
▢ No  (2)  
▢ I don't know  (3)  
 
Skip To: End of Block If Have you ever been pregnant? = No 
Skip To: End of Block If Have you ever been pregnant? = I don't know 
 
 
Q47 How many times have you been pregnant? 
▼ once (1) ... more than seven times (8) 
 
 
 
Q48 How many children have you given birth too? 
▼ 1 (1) ... More than 6 (7) 
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Q49 Please 
answer where 
possible: 
Child 1 (1) Child 2 (2) Child 3 (3) Child 4 (4) Child 5 (5) 
Sex of each 
child:  M/F (1)  
     
Date of birth 
for each child: 
DD/MM/YY (2)  
     
Vaginal 
delivery: 
Yes/No (3)  
     
Did you 
experience 
gestational 
diabetes: 
Yes/No (4)  
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On average, 
how much 
weight did you 
put on during 
each 
pregnancy? 
please state 
estimated 
weight gain in 
pounds (Lbs) 
(5)  
     
How much 
pregnancy 
weight did you 
lose 6 months 
after each 
pregnancy? 
please state 
estimated 
weight loss in 
pounds (Lbs) 
(6)  
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Q50 Click to write the question text 
 Underweight (1) Normal weight (2) Overweight (3) Obese (4) 
Before pregnancy 
(1st) (1)  ▢  ▢  ▢  ▢  
During pregnancy 
(1st) (2)  ▢  ▢  ▢  ▢  
6 months after 
pregnancy (1st) 
(3)  
▢  ▢  ▢  ▢  
Before pregnancy 
(2nd) (4)  ▢  ▢  ▢  ▢  
During pregnancy 
(2nd) (5)  ▢  ▢  ▢  ▢  
6 months after 
pregnancy (2nd) 
(6)  
▢  ▢  ▢  ▢  
Before pregnancy 
(3rd) (7)  ▢  ▢  ▢  ▢  
During pregnancy 
(3rd) (8)  ▢  ▢  ▢  ▢  
6 months after 
pregnancy (3rd) 
(9)  
▢  ▢  ▢  ▢  
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Q51 Please use this box to provide details for further pregnancies if necessary 
________________________________________________________________ 
________________________________________________________________ 
________________________________________________________________ 
________________________________________________________________ 
________________________________________________________________ 
 
End of Block: Pregnancy 
 
Start of Block: Mechanisms of Pathophysiology 
 
Q53 Hormone Balance.  For females only: 
  
 Are you still menstruating? 
▢ Yes  (1)  
▢ No  (2)  
 
Skip To: Q55 If Hormone Balance.  For females only: Are you still menstruating? = Yes 
 
 
Q54 When did your periods cease and why? 
________________________________________________________________ 
 
Skip To: Q58 If When did your periods cease and why? Is Not Empty 
Skip To: Q58 If When did your periods cease and why? Is Empty 
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Q55 Are your periods regular? 
▢ Yes  (1)  
▢ No  (2)  
 
Skip To: Q57 If Are your periods regular? = Yes 
 
 
Q56 If no, please give further details: 
________________________________________________________________ 
________________________________________________________________ 
________________________________________________________________ 
________________________________________________________________ 
________________________________________________________________ 
 
 
 
Q57 On average, what is the length of time between periods? 
▼ Less than 20 days (1) ... More than 40 days (4) 
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Q58 Please highlight 
any of the following that 
apply to you and 
indicate if they apply 
currently or in the past:  
Currently (1) In the past (2) Unsure (3) 
Hot flushes (1)  ▢  ▢  ▢  
Menopausal symptoms 
(2)  ▢  ▢  ▢  
PCOS (3)  ▢  ▢  ▢  
Fertility problems (4)  ▢  ▢  ▢  
Facial hair (5)  ▢  ▢  ▢  
Insomnia (6)  ▢  ▢  ▢  
Ovarian Cysts (7)  ▢  ▢  ▢  
Endometriosis (8)  ▢  ▢  ▢  
Breast cysts (9)  ▢  ▢  ▢  
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Swollen/tender breasts 
(10)  ▢  ▢  ▢  
Night sweats (11)  ▢  ▢  ▢  
PMT (12)  ▢  ▢  ▢  
Fibroids (13)  ▢  ▢  ▢  
Loss of libido (14)  ▢  ▢  ▢  
Mood swings (15)  ▢  ▢  ▢  
 
 
 
 
Q59 Other: 
________________________________________________________________ 
________________________________________________________________ 
________________________________________________________________ 
________________________________________________________________ 
________________________________________________________________ 
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Q60 Are you, or have you ever been, on HRT or bio-identical hormones?  
▢ Yes  (1)  
▢ No  (2)  
 
Skip To: Q62 If Are you, or have you ever been, on HRT or bio-identical hormones?  = No 
 
 
Q61 Please give further details: 
________________________________________________________________ 
 
 
 
Q62 Have you ever had: 
 Yes (1) No (2) 
Birth control pills (1)  ▢  ▢  
Birth control implants (2)  ▢  ▢  
IUD coil (3)  ▢  ▢  
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Q63 How long did you use these contraception’s? 
▢ 6 months - 2 years  (1)  
▢ 2 - 5 years  (2)  
▢ more than 5 years  (3)  
 
 
 
Q65 Inflammation 
 
almost every 
day (1) 
at least once a 
week (2) 
once or twice a 
month (3) 
a few times a 
year (4) 
never (5) 
How often do 
you feel aches 
and pains? 
such as back 
pain, neck 
pain, 
headaches or 
general 
soreness. (1)  
▢  ▢  ▢  ▢  ▢  
How often do 
you take anti-
inflammatory 
or anti-pain 
medication 
such as 
ibuprofen, 
aspirin or 
prescription 
drugs? (2)  
▢  ▢  ▢  ▢  ▢  
Q66 what are the most common causes of pain you experience? e.g. back ache, head ache, 
period pain etc. 
________________________________________________________________ 
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Q67 Please highlight 
any of the following that 
apply to you and 
indicate if they apply 
currently or in the past:  
currently (1) in the past (2) Unsure (3) 
Allergies or 
hypersensitivities e.g. 
hay-fever, food 
allergies, rhinitis (1)  
▢  ▢  ▢  
Asthma (2)  ▢  ▢  ▢  
Autoimmune diseases 
e.g. systemic lupus, 
vitiligo, Hashimoto's, 
Addisions disease (3)  
▢  ▢  ▢  
Celiac disease (4)  ▢  ▢  ▢  
Cystitis (5)  ▢  ▢  ▢  
Inflammation of the 
prostate gland (men 
only) (6)  
▢  ▢  ▢  
Inflammatory kidney 
condition (7)  ▢  ▢  ▢  
Inflammatory skin 
conditions e.g. acne, 
eczema, rosacea, 
psoriasis (8)  
▢  ▢  ▢  
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Inflammatory bowel 
disease e.g. ulcerative 
colitis, Crohn's (9)  
▢  ▢  ▢  
Non-coeliac gluten 
sensitivity (10)  ▢  ▢  ▢  
Pelvic inflammatory 
disease (11)  ▢  ▢  ▢  
 
 
 
 
Q68 Any other inflammatory condition? 
________________________________________________________________ 
 
 
 
Q69 Please give further details of inflammatory conditions you have experienced: 
________________________________________________________________ 
________________________________________________________________ 
________________________________________________________________ 
________________________________________________________________ 
________________________________________________________________ 
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Q71 Behaviour and Food 
  
 Please highlight which if the following best applies to you: 
 not at all (1) 
occasionally 
(2) 
sometimes (3) frequently (4) always (5) 
I frequently 
think about 
food (1)  
▢  ▢  ▢  ▢  ▢  
I frequently 
crave food (2)  ▢  ▢  ▢  ▢  ▢  
I continue to 
eat after I feel 
full (3)  
▢  ▢  ▢  ▢  ▢  
I feel hungry 
no matter what 
I eat (4)  
▢  ▢  ▢  ▢  ▢  
I cannot go 
long periods 
without eating 
(5)  
▢  ▢  ▢  ▢  ▢  
I always feel 
hungry (6)  ▢  ▢  ▢  ▢  ▢  
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Q73 Digestive Issues 
  
 Please highlight any of 
the following that apply 
to you and indicate if 
they apply currently or 
in the past:  
currently (1) in the past (2) Unsure (3) 
Indigestion (1)  ▢  ▢  ▢  
Heartburn (2)  ▢  ▢  ▢  
Bowel movements 
shortly after eating (3)  ▢  ▢  ▢  
Frequent stomach 
upsets or pain (4)  ▢  ▢  ▢  
Nausea or vomiting (5)  ▢  ▢  ▢  
Constipation or hard to 
pass stools (6)  ▢  ▢  ▢  
Diarrhoea or urgency to 
go (7)  ▢  ▢  ▢  
Blood in stools / black 
stools (8)  ▢  ▢  ▢  
Undigested food in 
stools (9)  ▢  ▢  ▢  
348 
Stools are not well 
formed (loose) (10)  ▢  ▢  ▢  
Excessive foul smelling 
gas (11)  ▢  ▢  ▢  
Cramping in lower 
abdomen (12)  ▢  ▢  ▢  
Mucus in stools (13)  ▢  ▢  ▢  
Pain between shoulders 
or under the rib cage 
(14)  
▢  ▢  ▢  
Irritable bowel 
syndrome (IBS) (15)  ▢  ▢  ▢  
Offensive stools (16)  ▢  ▢  ▢  
Pale, bulky stools (17)  ▢  ▢  ▢  
Stools that float (18)  ▢  ▢  ▢  
Stools that sink (19)  ▢  ▢  ▢  
Haemorrhoids (20)  ▢  ▢  ▢  
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Anus itching (21)  ▢  ▢  ▢  
Thrush (22)  ▢  ▢  ▢  
Fungal or yeast 
infections e.g. athletes 
foot, ring worm (23)  
▢  ▢  ▢  
Parasites (24)  ▢  ▢  ▢  
 
 
 
 
Q74 How often do you have a bowel movement? 
▼ More than once a day (1) ... Once every few days (3) 
 
 
 
Q75 Other: 
________________________________________________________________ 
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Q76 Have you noticed any recent changes in your bowel habits? 
▢ no  (1)  
▢ yes  (2)  
▢ other  (3)  
 
Skip To: Q79 If Have you noticed any recent changes in your bowel habits? = no 
 
 
Q77 Please give details: 
________________________________________________________________ 
________________________________________________________________ 
________________________________________________________________ 
________________________________________________________________ 
________________________________________________________________ 
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Q79 Blood Sugar 
Regulation 
  
 Please tick which 
of the following 
best applies to 
you: 
never (1) seldom (2) often (3) always (4) 
I urinate more than 
I feel is normal (1)  ▢  ▢  ▢  ▢  
I feel I urinate at 
night more 
frequently than is 
normal (2)  
▢  ▢  ▢  ▢  
I feel very thirsty 
more frequently 
than normal (3)  
▢  ▢  ▢  ▢  
I feel tired more 
frequently than 
normal (4)  
▢  ▢  ▢  ▢  
I have 
experienced 
unexplained 
weight loss (5)  
▢  ▢  ▢  ▢  
I have itching 
around the penis 
or vagina (6)  
▢  ▢  ▢  ▢  
I have episodes of 
thrush (7)  ▢  ▢  ▢  ▢  
I have skin tags 
(8)  ▢  ▢  ▢  ▢  
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I experience cuts 
or wounds that 
heal slowly (9)  
▢  ▢  ▢  ▢  
I experience 
blurred vision (10)  ▢  ▢  ▢  ▢  
I experience 
weakness or 
dizziness after a 
period of fasting or 
with hunger (11)  
▢  ▢  ▢  ▢  
I can feel extreme 
hunger (12)  ▢  ▢  ▢  ▢  
I experience 
drowsiness (13)  ▢  ▢  ▢  ▢  
I experience 
nausea (14)  ▢  ▢  ▢  ▢  
 
 
 
 
Q81 Blood Fats 
  
 Do you have difficulty losing weight? 
▼ not at all (1) ... extremely difficult (3) 
 
 
 
353 
Q82 
 
 
 
 
Q83 Which apply to you? 
▢ most of my weight is above the waist (apple)  (1)  
▢ most of my weight is below the waist (pear)  (2)  
▢ I am not sure  (3)  
▢ Other  (4)  
 
Skip To: Q85 If Which apply to you? = most of my weight is above the waist (apple) 
Skip To: Q85 If Which apply to you? = most of my weight is below the waist (pear) 
Skip To: Q85 If Which apply to you? = I am not sure 
Skip To: Q84 If Which apply to you? = Other 
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Q84 Please describe your body weight: 
________________________________________________________________ 
 
 
 
Q85 When did you last have your cholesterol tested: 
▼ Never (1) ... In the last 5 years (5) 
 
Skip To: Q102 If When did you last have your cholesterol tested: = Never 
 
 
Q86 My cholesterol level is: 
▼ Raised (1) ... I don't know (4) 
 
Skip To: Q102 If My cholesterol level is: = Normal 
Skip To: Q102 If My cholesterol level is: = I don't know 
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Q87 Click to write the question text 
 Please provide exact cholesterol measure: (1) 
Total Cholesterol: (1)   
Triglycerides: (2)   
Low Density Cholesterol (LDL): (3)   
High Density Cholesterol Level (HDL): (4)   
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Q102 Quality of Life 
  
 Please select which of the following best applies to you: 
 Very poor (1) Poor (2) 
Neither good 
nor poor (3) 
Good (4) Very good (5) 
How would you 
rate your 
quality of life? 
(1)  
▢  ▢  ▢  ▢  ▢  
How would you 
rate your 
physical 
functioning? 
(2)  
▢  ▢  ▢  ▢  ▢  
How would you 
rate your 
general 
health? (3)  
▢  ▢  ▢  ▢  ▢  
How would you 
rate your 
emotional 
health? (4)  
▢  ▢  ▢  ▢  ▢  
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Q99 Please select which of the following best apply to you: 
 Not at all (1) A little (2) 
A moderate 
amount (3) 
Very much (4) 
An extreme 
amount (5) 
How much do 
you enjoy life? 
(1)  
▢  ▢  ▢  ▢  ▢  
To what extent 
do you feel 
your life to be 
meaningful? 
(2)  
▢  ▢  ▢  ▢  ▢  
I feel able to 
accept my 
bodily 
appearance (3)  
▢  ▢  ▢  ▢  ▢  
 
 
 
 
Q100 Please select which of the following best apply to you: 
 
Strongly 
disagree (1) 
Somewhat 
disagree (2) 
Neither agree 
nor disagree 
(3) 
Somewhat 
agree (4) 
Strongly agree 
(5) 
On the whole I 
feel satisfied 
with myself (1)  
▢  ▢  ▢  ▢  ▢  
I take a 
positive 
attitude 
towards myself 
(2)  
▢  ▢  ▢  ▢  ▢  
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Q89 Sleep 
  
 Please highlight which of the following best applies to you: 
 Never (1) Seldom (2) Weekly (3) Every night (4) 
I experience 
shortness of 
breath (1)  
▢  ▢  ▢  ▢  
I snore (2)  ▢  ▢  ▢  ▢  
I wake up in the 
night with a very 
dry and sore throat 
(3)  
▢  ▢  ▢  ▢  
I wake up with a 
choking or gasping 
sensation (4)  
▢  ▢  ▢  ▢  
 
 
 
 
Q90 Have you ever been diagnosed with sleep apnoea? 
▼ No (1) ... Yes (2) 
 
Skip To: Q105 If Have you ever been diagnosed with sleep apnoea? = No 
 
 
Q91 When were you diagnosed with sleep apnoea? (DD/MM/YY) 
________________________________________________________________ 
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Q92 Are you receiving any treatment? 
▼ Yes (1) ... No (2) 
 
 
 
Q93 Please describe treatment 
________________________________________________________________ 
 
 
 
Q105 How would you rate the quality of your sleep? 
▢ Poor  (1)  
▢ Neither good nor poor  (2)  
▢ Good  (3)  
 
 
 
Q106 On average, how many hours sleep so you get per night? 
▢ 3 or less  (1)  
▢ 4-5  (2)  
▢ 6-8  (3)  
▢ 9 or more  (4)  
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Q104 Please select which if the following best applies to you: 
 Always (1) Often (2) Seldom (3) Never (4) 
How frequently do 
you doze during 
the day? (1)  
▢  ▢  ▢  ▢  
How frequently do 
you wake in the 
night? (2)  
▢  ▢  ▢  ▢  
How frequently do 
you use over the 
counter or 
prescription sleep 
aids? (3)  
▢  ▢  ▢  ▢  
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Q108 Stress 
  
 Please select 
which of the 
following best 
applies to you: 
Never (1) 
Almost never 
(2) 
Sometimes (3) Fairly often (4) Very often (5) 
In the last 
month, how 
often have you 
felt that you 
were unable to 
control the 
important 
things in your 
life? (1)  
▢  ▢  ▢  ▢  ▢  
In the last 
month, how 
often have you 
felt confident 
about your 
abilities to 
handle your 
personal 
problems? (2)  
▢  ▢  ▢  ▢  ▢  
In the last 
month, how 
often have you 
felt that things 
were going 
your way? (3)  
▢  ▢  ▢  ▢  ▢  
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In the last 
month, how 
often have you 
felt difficulties 
were piling up 
so high that 
you could not 
overcome 
them? (4)  
▢  ▢  ▢  ▢  ▢  
How often do 
you have 
negative 
feelings such 
as depression, 
despair, 
anxiety? (5)  
▢  ▢  ▢  ▢  ▢  
 
 
 
 
Q94 Prior to the age of 17 I experienced stress or trauma (e.g. death of parent, separation, 
physical, emotional or sexual abuse, significant accident) 
▢ No  (1)  
▢ I cannot remember  (2)  
▢ Yes  (3)  
 
Skip To: Q110 If Prior to the age of 17 I experienced stress or trauma (e.g. death of parent, separation, physical... = No 
Skip To: Q110 If Prior to the age of 17 I experienced stress or trauma (e.g. death of parent, separation, physical... = I 
cannot remember 
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Q97 On a scale of 1 to 5 how traumatic was this? 
▢ 1. least traumatic  (1)  
▢ 2.  (2)  
▢ 3. traumatic  (3)  
▢ 4.  (4)  
▢ 5. extremely traumatic  (5)  
 
 
 
Q96 Please provide further information if you wish to: 
________________________________________________________________ 
________________________________________________________________ 
________________________________________________________________ 
________________________________________________________________ 
________________________________________________________________ 
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Q110 Motivation to change 
  
 Please select which of the following best applies to you: 
 Yes (1) No (2) 
In the past month, have you 
been actively trying to lose 
weight? (1)  
▢  ▢  
In the past month, have you 
been actively trying to keep from 
weight gain? (2)  
▢  ▢  
Are you seriously considering 
trying to lose weight to reach 
your goals in the next 6 months? 
(3)  
▢  ▢  
Have you maintained your 
desired weight for more than 6 
months? (4)  
▢  ▢  
 
 
End of Block: Mechanisms of Pathophysiology 
 
Start of Block: The end 
 
Q114 Please click save to complete this questionnaire. 
Thank you.  Please do let your practitioner know you have completed it so they can get access 
your data.  Your practitioner will arrange a consultation date and time with you. 
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Appendix 19 Tool 2 Intervention record - download of online format 
Interventions Record 
 
Start of Block: Dietary Recommendations 
 
Q1 INTERVENTIONS RECORD 
  
 This tool should be completed by you, the practitioner, to record which interventions were 
recommended.   Please complete it whenever new recommendations are made. 
 
Q21 The aim of this pilot trial is to assess the way health information is collected and interpreted. 
 
Your participation in this study is entirely voluntary and you can withdraw at any time and you are 
free to omit any question. You should be aware that the data you provide may be used for analysis 
and subsequent publication. The researchers will implement procedures to maintain the 
confidentiality of the participant data. Personal information provided will be stored in computer files 
secured by means of passwords or in locked cabinets. Only the researcher and authorised 
supervisors will be able to access the information. Personal information will be destroyed once the 
research is completed. 
  
 Thank you very much and please do get in touch if you have any questions. 
  
Researcher: Michelle Barrow; Centre for Nutrition Education and Lifestyle Management (CNELM)   
and Middlesex University 
michelle@cnelm.co.uk 
Research Supervisors: Dr L Bell (L.bell@mdx.ac.uk); Dr C. Bell (c.bell@mdx.ac.uk)  
Study title: Constructing validated clinical tools to enable the development of a new evidence base 
for personalised nutrition practice in weight management. 
Academic Year: 2016/17 
 
 
 
Q23 Practitioner Name: 
________________________________________________________________ 
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Q17 Participant Information Number: 
________________________________________________________________ 
 
 
 
 
Q2 Date of record completion: 
  
Month (1)  ▼ January (1) ...   (150) 
Day (2)  ▼ January (1) ...   (150) 
Year (3)  ▼ January (1) ...   (150) 
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Q3 Dietary recommendations   
  Please highlight which of the following dietary interventions are recommended: 
▢ Anti-Candida  (1)  
▢ Fodmaps  (2)  
▢ Intermittent fasting  (3)  
▢ Low fat  (4)  
▢ Low salt  (5)  
▢ Meal replacement  (6)  
▢ Vegan  (7)  
▢ Other: (please state in box below)  (8) 
________________________________________________ 
▢ Balanced glycaemic load  (9)  
▢ Dairy Free  (10)  
▢ Juicing  (11)  
▢ Low glycaemic index  (12)  
▢ Low sugar  (13)  
▢ Nut free  (14)  
▢ Vegetarian  (15)  
▢ Calorie restriction  (16)  
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▢ Gluten free  (17)  
▢ Ketogenic  (18)  
▢ Low histamine  (19)  
▢ Micro matching  (20)  
▢ Nutrient dense  (21)  
▢ Wheat free  (22)  
Q4 Please indicate which of the following food changes were recommended, giving an indication 
of portion size where possible: 
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Increase intake 
(1) 
Decrease 
intake (2) 
Maintain art 
current levels 
(3) 
Avoid (4) 
Not applicable 
(5) 
Alcohol (1)       
Caffeine (2)       
Complex 
carbohydrates 
(3)  
     
Essential fatty 
acids - Omega 
3 (4)  
     
Essential fatty 
acids - Omega 
6 (5)  
     
Fluid - water 
(6)  
     
Fluid -other (7)       
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Fruit (8)       
Prebiotic foods 
(9)  
     
Probiotics 
foods (10)  
     
Protein (11)       
Raw foods (12)       
Salt (13)       
Saturated fat 
(14)  
     
Simple 
carbohydrates 
(15)  
     
Soy foods (16)       
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Sugar (17)       
Vegetables 
(18)  
     
Wholegrains 
(19)  
     
Other (please 
state) (20)  
     
Other (please 
state) (21)  
     
Other (please 
state) (22)  
     
 
 
 
 
Q7 Please describe any other dietary recommendations: (e.g. timing of eating) 
________________________________________________________________ 
________________________________________________________________ 
________________________________________________________________ 
________________________________________________________________ 
372 
________________________________________________________________ 
 
End of Block: Dietary Recommendations 
 
Start of Block: Physical Activity 
 
Q5 Physical Activity   
    
was physical activity recommended? 
▢ Yes  (1)  
▢ No  (2)  
 
Skip To: End of Block If Physical Activity    was physical activity recommended? = No 
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Q6 Please indicate the type and 
duration of exercise, stating the 
number of recommended 
minutes per week 
Minutes per week (1) Further details: (2) 
Aerobics (1)    
Cycling (2)    
Dancing (3)    
Gardening (4)    
Gym classes (state which) (5)    
Running (6)    
Strength Training (7)    
Swimming (8)    
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Team sports (state which) (9)    
Other (please state) (10)    
Other (please state) (11)    
 
 
 
 
Q8 Please describe any other physical activity recommendations: 
________________________________________________________________ 
________________________________________________________________ 
________________________________________________________________ 
________________________________________________________________ 
 
End of Block: Physical Activity 
 
Start of Block: Supplement recommendations 
 
Q9 Supplement recommendations  
  
Were supplements recommended?  
▢ Yes  (1)  
▢ No  (2)  
 
Skip To: End of Block If Supplement recommendations Were supplements recommended? = No 
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Q10 Please indicate 
which supplements were 
recommended and 
provide the product 
brand and name, 
recommended dose and 
duration of 
recommendation: 
Product brand and 
name (1) 
Recommended dose (2) 
Duration of 
recommendation e.g. 1 
week, 1 month, 6 
months, ongoing. (3) 
Multi vitamins and 
minerals (1)  
   
Fatty acids (2)     
Probiotics (3)     
Amino acids (4)     
Herbal products (5)     
Slimming aids (6)     
B vitamin formulas (7)     
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Vitamin C formulas (8)     
Vitamin D formulas (9)     
Vitamin E formulas (10)     
Calcium formulas (11)     
Chromium formulas (12)     
Iron formulas (13)     
Magnesium formulas 
(14)  
   
Specific vitamins (15)     
Specific minerals (16)     
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Brain and nervous 
system support (17)  
   
Cardiovascular products 
(18)  
   
Energy support (19)     
Female health products 
(20)  
   
Gastrointestinal support 
(21)  
   
Glandular formulas (22)     
Immune support (23)     
Inflammatory formulas 
(24)  
   
Joint support (25)     
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Liver support (26)     
Male health products 
(27)  
   
Muscle support (28)     
Other (please state) (29)     
Other (please state) (30)     
Other (please state) (31)     
 
 
End of Block: Supplement recommendations 
 
Start of Block: Test recommendations 
Q11 Test recommendations  
    
Were tests recommended?  
▢ Yes  (1)  
▢ No  (2)  
Skip To: End of Block If Test recommendations   Were tests recommended?  = No 
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Q12 Please indicate which tests 
were recommended, provide the 
test name and from where the 
test was requested: 
Test details e.g. name, 
biomarker (1) 
Source of test e.g. GP, biolab, 
doctors data, Genova 
diagnostics etc. (2) 
Allergy or intolerance testing (1)    
Amino acid analysis (2)    
Biochemistry / haematology 
profile (3)  
  
Cholesterol (4)    
Fasting sugar and haemogolbin 
A1c (5)  
  
Fasting lipid panel (6)    
Fatty acids profile (7)    
Gastrointestinal profile (8)    
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Genetic or genomic assessment 
(9)  
  
Hormone analysis (10)    
Inflammatory markers (11)    
Liver function assessment (12)    
Nutritional profile (13)    
Oxidative stress profile (14)    
Specific minerals (15)    
Specific vitamins (16)    
Thyroid function test (17)    
Toxic metal screen (18)    
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Other (please state): (19)    
Other (please state): (20)    
 
 
End of Block: Test recommendations 
 
Start of Block: Referral recommendations 
 
Q13 Referral recommendations  
    
Were any recommendations made for further support? 
▢ Yes  (1)  
▢ No  (2)  
 
Skip To: End of Survey If Referral recommendations   Were any recommendations made for further support? = No 
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Q14 Please indicate which referrals were made 
• Bariatric surgery  (1)  
• Other health care professional (please stat):e  (2) 
________________________________________________ 
• Other (please state):  (3) ________________________________________________ 
• Counselling/psychological support  (4)  
• Personal trainer/gym  (5)  
• Eating disorder support  (6)  
• General practitioner  (7)  
• Life coaching  (8)  
• Sleep apnoea assessment  (9)  
 
End of Block: Referral recommendations 
 
Start of Block: The end 
 
Q17 Please click save to complete this form. 
 Thank you very much for your involvement in this research project. 
 
Q22 Data may be inspected by the Chair of the Health Studies Ethics  sub-committee and the 
Chair of the School of Social Sciences Ethics  committee of Middlesex University, if required by 
institutional audits  about the correctness of procedures. Although this would happen in  strict 
confidentiality, please write NO if you do not wish this data to  be included in audits. 
________________________________________________________________ 
 
End of Block: The end 
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Appendix 20 Tool 3 Follow-up Questionnaire - download of online format 
Follow-up Personalised Nutrition Health 
Questionnaire 
 
 
Start of Block: Socio Cultural 
 
Q113 PERSONALISED FOLLOW-UP QUESTIONNAIRE 
  
 Please complete this follow-up questionnaire as comprehensively as possible. Many of the 
questions are a repeat from the first questionnaire so that an assessment of changes to your 
health can be made.   It may take up to 1 hour to complete the whole questionnaire.   
 
 On completion, the information will be sent to your nutrition  practitioner. The aims, duration and 
outcome of the nutrition  consultation will remain the same.   
 
The aim of this pilot trial  is to assess the way health information is collected and 
interpreted.   After completion you will then be invited to complete a short 10  question survey to 
assess your experience of using this questionnaire. 
 
 
 
Q118 Your  participation in this study is entirely voluntary and you can withdraw  at any time and 
you are free to omit any question. You should be aware  that the data you provide may be used for 
analysis and subsequent  publication. The researchers will implement procedures to maintain the  
confidentiality of the participant data. Personal information provided  will be stored in computer 
files secured by means of passwords or in  locked cabinets. Only the researcher and authorised 
supervisors will be  able to access the information. Personal information will be destroyed  once 
the research is completed. 
  
 Thank you very much and please do get in touch if you have any questions. 
  
 Researcher: Michelle Barrow; Centre for Nutrition Education and Lifestyle Management (CNELM) 
and Middlesex University 
 michelle@cnelm.co.uk 
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 Research Supervisors: Dr L Bell (L.bell@mdx.ac.uk); Dr C. Bell (c.bell@mdx.ac.uk) 
 Study title: Constructing validated clinical tools to enable the  development of a new evidence 
base for personalised nutrition practice  in weight management. 
 Academic Year: 2016/17 
 
 
 
Q117 Name of your Nutritionist/Dietician/Nutritional Therapist/Practitioner: 
________________________________________________________________ 
 
 
 
Q115 Your Participant Information Number: 
________________________________________________________________ 
 
 
 
Q5 Last week, you were (select all that apply):  
• working as an employee  (1)  
• working self-employed or freelance  (2)  
• away from work ill, on maternity leave or temporarily laid off  (3)  
• on a training scheme  (4)  
• in full time or part time education  (5)  
• retired  (6)  
• looking after home or family  (7)  
• long-term sick or disabled  (8)  
• other (please state in box below)  (9) 
________________________________________________ 
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Q11 Have you ever used food aid systems, such as food stamps, food banks or other food support 
initiatives?   
▼ N/A (1) ... Over 2 years ago (5) 
 
Skip To: Q14 If Have you ever used food aid systems, such as food stamps, food banks or other food support initia... = 
N/A 
 
 
Q12 If yes, how frequently have you used food aid systems during that period:  
▼ 1-5 times (1) ... More than 20 times (4) 
 
 
 
Q14 Which category best describes your total annual household income before taxes: 
▼ Less than £25,000 (1) ... £200,000 or more (8) 
 
End of Block: Socio Cultural 
 
Start of Block: Weight Assessment 
 
Q16 What is your current weight in stone and pounds?  
  
Stone (1)  
Pounds (2)  
▼ 1 (1) ... 65 ~ 13 (975) 
 
End of Block: Weight Assessment 
 
Start of Block: Family health and weight history 
Page Break  
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Q22 Personal Health History 
Please select if you are have experienced any of these since your last nutrition consultation: 
• unexplained pain  (1)  
• bleeding from nipple  (2)  
• blood in sputum  (3)  
• blood in urine  (4)  
• blood in vomit  (5)  
• blurred vision or dizziness  (6)  
• breast lumps  (7)  
• calf swelling  (8)  
• changes in nature of moles  (9)  
• chest pain  (10)  
• difficulty swallowing  (11)  
• discharge from vagina  (12)  
• headaches  (13)  
• loss of appetite  (14)  
• numbness  (15)  
• paralysis  (16)  
• persistent cough  (17)  
• persistent nose bleeds  (18)  
• shortness of breath  (19)  
• slurred speech  (20)  
• unexplained bruising  (21)  
• unexplained rash  (22)  
• unexplained weight loss  (23)  
• unexplained heavy periods  (24)  
• unexplained loss of periods  (25)  
If you are currently experiencing any of these conditions please make an appointment to 
see your primary health care provider such as your G.P.  
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Q26 The 
following table 
aims to identify 
any changes to 
health 
conditions since 
your last 
consultation. 
Please 
complete 
providing as 
much 
information as 
possible. Please 
use box on next 
question to 
provide more 
information if 
necessary 
Leave blank if 
not applicable. 
Write "current" 
if you are 
currently 
experiencing 
this condition. 
Write "past" if 
you have 
previously 
experienced 
this condition. 
Write “new” if 
you have 
developed this 
condition 
since your last 
nutrition 
consultation. 
(1) 
Please 
provide more 
details e.g. 
type of 
condition (2) 
Have there 
been any 
improvements 
or positive 
changes to 
this condition 
or its 
symptoms 
since your last 
nutrition 
consultation? 
(3) 
Has there 
been any 
deterioration 
or negative 
changes to 
this condition 
or its 
symptoms 
since your last 
nutrition 
consultation? 
(4) 
How is it currently 
being 
managed/treated? 
(medication, 
surgery, therapy 
etc.) (5) 
addiction (1)       
arthritis: 
rheumatoid or 
osteoarthritis 
etc. (2)  
     
autism (3)       
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cancer (4)       
chronic fatigue 
(5)  
     
dementia e.g. 
Alzheimer's (6)  
     
depression (7)       
disturbed sleep 
or insomnia (8)  
     
eating disorder 
e.g. binge 
eating 
disorder/bulimia 
(9)  
     
eye disease e.g. 
glaucoma (10)  
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food allergy e.g. 
celiac, peanut, 
dairy etc. (11)  
     
gall bladder 
disease (12)  
     
gout (13)       
heart disease or 
vascular 
disease (14)  
     
hepatitis (A,B or 
C) (15)  
     
herpes virus, 
including 
Epstein Barr or 
shingles (16)  
     
high blood 
pressure (17)  
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kidney disease 
(18)  
     
liver disease 
(19)  
     
mood or anxiety 
disorder (20)  
     
night eating 
syndrome (21)  
     
polycystic 
ovarian 
syndrome (22)  
     
post-traumatic 
stress (23)  
     
respiratory 
disorders e.g. 
asthma, sleep 
apnoea (24)  
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thyroid disease 
or condition (25)  
     
type 1 diabetes 
(26)  
     
type 2 diabetes 
(27)  
     
any other 
disease or 
condition (28)  
     
 
 
 
 
Q27 Please provide more information regarding the previous question if you wish: 
________________________________________________________________ 
________________________________________________________________ 
________________________________________________________________ 
________________________________________________________________ 
________________________________________________________________ 
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Q28 Please list 
below all the 
medications, 
drugs or 
supplements you 
took in the PAST 
MONTH. For 
each one you list 
please answer 
the questions 
below as best as 
you 
can.  Medications 
include 
prescriptions, 
over the counter 
medicines, cold 
remedies, 
painkillers, 
contraceptives, 
creams, 
injections, eye 
drops etc. 
Supplements 
include vitamins, 
minerals, herbs, 
probiotics etc.  
Medication, 
drug or 
supplement 
name or 
type (1) 
dose/strength 
e.g. mg, ml 
etc. (2) 
for what 
reason 
were you 
taking 
these (3) 
How 
many 
days did 
you take 
it? (4) 
How 
many 
times 
did you 
take 
each 
day? (5) 
How 
many 
times 
did you 
miss 
taking 
it? (6) 
How well 
does it 
work for 
you? 
well, 
okay, not 
well, 
unsure 
(7) 
Medication/drug: 
(1)  
       
Medication/drug: 
(2)  
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Medication/drug: 
(3)  
       
Medication/drug: 
(4)  
       
Medication/drug: 
(5)  
       
Medication/drug: 
(6)  
       
Supplement: (7)         
Supplement: (8)         
Supplement: (9)         
Supplement: (10)         
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Q30 Please provide more information regarding the previous question if you wish: 
________________________________________________________________ 
________________________________________________________________ 
________________________________________________________________ 
________________________________________________________________ 
________________________________________________________________ 
 
 
Page Break  
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Q29 Do you currently smoke tobacco (e.g. cigarettes, cigars, pipes etc.) or e-cigarettes? 
▼ No (1) ... Less than daily (3) 
 
Skip To: Q33 If Do you currently smoke tobacco (e.g. cigarettes, cigars, pipes etc.) or e-cigarettes? = No 
Skip To: Q31 If Do you currently smoke tobacco (e.g. cigarettes, cigars, pipes etc.) or e-cigarettes? = Daily 
Skip To: Q32 If Do you currently smoke tobacco (e.g. cigarettes, cigars, pipes etc.) or e-cigarettes? = Less than daily 
 
 
Q31 How many per day? 
________________________________________________________________ 
 
 
 
Q32 How many per month? 
________________________________________________________________ 
 
 
 
Q33 Have you smoked tobacco or e-cigarettes in the past? 
▼ No (1) ... Yes (3) 
 
Skip To: End of Block If Have you smoked tobacco or e-cigarettes in the past? = No 
 
 
Q42 At what age did you start smoking? 
▼ 16 (1) ... 75 (60) 
 
 
 
Q43 For how long did you smoke: 
________________________________________________________________ 
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Q44 How many times per day did, or do, you smoke? 
▼ 1-5 (1) ... more than 40 times per day (9) 
 
 
 
Q34 How does smoking affect your weight? 
▼ keeps my weight down (1) ... I don't know (4) 
 
 
 
Q35 How many times have you stopped smoking for more than 3 months? 
▼ Never (1) ... more than 20 times (6) 
 
 
 
Q36 If you have smoked and stopped, did you gain weight as a result of stopping smoking? 
▼ No (1) ... Yes (3) 
 
 
 
Q37 How much weight did you gain as a result of stopping smoking? 
________________________________________________________________ 
 
 
 
Q38 How many times did you gain weight as a result of stopping smoking? 
________________________________________________________________ 
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End of Block: Family health and weight history 
 
Start of Block: Pregnancy 
 
Q39 Pregnancy 
  
 Are you pregnant now? 
▢ Yes  (1)  
▢ Maybe  (2)  
▢ No  (3)  
▢ I don't know  (4)  
 
Skip To: Q41 If Pregnancy Are you pregnant now? = No 
Skip To: Q41 If Pregnancy Are you pregnant now? = I don't know 
 
 
Q40 How many weeks pregnant are you? 
________________________________________________________________ 
 
 
 
Q41 Have you ever been pregnant? 
▢ Yes  (1)  
▢ No  (2)  
▢ I don't know  (3)  
 
Skip To: End of Block If Have you ever been pregnant? = No 
Skip To: End of Block If Have you ever been pregnant? = I don't know 
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Q47 How many times have you been pregnant? 
▼ once (1) ... more than seven times (8) 
 
 
 
Q48 How many children have you given birth too? 
▼ 1 (1) ... More than 6 (7) 
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Q49 Please 
answer where 
possible: 
Child 1 (1) Child 2 (2) Child 3 (3) Child 4 (4) Child 5 (5) 
Sex of each 
child:  M/F (1)  
     
Date of birth 
for each child: 
DD/MM/YY (2)  
     
Vaginal 
delivery: 
Yes/No (3)  
     
Did you 
experience 
gestational 
diabetes: 
Yes/No (4)  
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On average, 
how much 
weight did you 
put on during 
each 
pregnancy? 
please state 
estimated 
weight gain in 
pounds (Lbs) 
(5)  
     
How much 
pregnancy 
weight did you 
lose 6 months 
after each 
pregnancy? 
please state 
estimated 
weight loss in 
pounds (Lbs) 
(6)  
     
 
 
End of Block: Pregnancy 
 
Start of Block: Mechanisms of Pathophysiology 
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Q58 Hormone 
Balance.  For females 
only:   
    
Please highlight any of 
the following that apply 
to you and indicate if 
they apply currently or 
in the past:  
Currently (1) In the past (2) Unsure (3) 
Hot flushes (1)  ▢  ▢  ▢  
Menopausal symptoms 
(2)  ▢  ▢  ▢  
PCOS (3)  ▢  ▢  ▢  
Fertility problems (4)  ▢  ▢  ▢  
Facial hair (5)  ▢  ▢  ▢  
Insomnia (6)  ▢  ▢  ▢  
Ovarian Cysts (7)  ▢  ▢  ▢  
Endometriosis (8)  ▢  ▢  ▢  
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Breast cysts (9)  ▢  ▢  ▢  
Swollen/tender breasts 
(10)  ▢  ▢  ▢  
Night sweats (11)  ▢  ▢  ▢  
PMT (12)  ▢  ▢  ▢  
Fibroids (13)  ▢  ▢  ▢  
Loss of libido (14)  ▢  ▢  ▢  
Mood swings (15)  ▢  ▢  ▢  
 
 
 
 
Q59 Other: 
________________________________________________________________ 
________________________________________________________________ 
________________________________________________________________ 
________________________________________________________________ 
________________________________________________________________ 
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Q60 Are you, or have you ever been, on HRT or bio-identical hormones?  
▢ Yes  (1)  
▢ No  (2)  
 
Skip To: Q62 If Are you, or have you ever been, on HRT or bio-identical hormones?  = No 
 
 
Q61 Please give further details: 
________________________________________________________________ 
 
 
 
Q62 Have you ever had: 
 Yes (1) No (2) 
Birth control pills (1)  ▢  ▢  
Birth control implants (2)  ▢  ▢  
IUD coil (3)  ▢  ▢  
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Q63 How long did you use these contraception’s? 
▢ 6 months - 2 years  (1)  
▢ 2 - 5 years  (2)  
▢ more than 5 years  (3)  
 
 
 
Q65 Inflammation 
 
almost every 
day (1) 
at least once a 
week (2) 
once or twice a 
month (3) 
a few times a 
year (4) 
never (5) 
How often do 
you feel aches 
and pains? 
such as back 
pain, neck 
pain, 
headaches or 
general 
soreness. (1)  
▢  ▢  ▢  ▢  ▢  
How often do 
you take anti-
inflammatory 
or anti-pain 
medication 
such as 
ibuprofen, 
aspirin or 
prescription 
drugs? (2)  
▢  ▢  ▢  ▢  ▢  
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Q66 what are the most common causes of pain you experience? e.g. back ache, head ache, 
period pain etc. 
________________________________________________________________ 
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Q67 Please highlight 
any of the following that 
apply to you and 
indicate if they apply 
currently or in the past:  
currently (1) in the past (2) Unsure (3) 
Allergies or 
hypersensitivities e.g. 
hay-fever, food 
allergies, rhinitis (1)  
▢  ▢  ▢  
Asthma (2)  ▢  ▢  ▢  
Autoimmune diseases 
e.g. systemic lupus, 
vitiligo, Hashimoto's, 
Addisions disease (3)  
▢  ▢  ▢  
Celiac disease (4)  ▢  ▢  ▢  
Cystitis (5)  ▢  ▢  ▢  
Inflammation of the 
prostate gland (men 
only) (6)  
▢  ▢  ▢  
Inflammatory kidney 
condition (7)  ▢  ▢  ▢  
Inflammatory skin 
conditions e.g. acne, 
eczema, rosacea, 
psoriasis (8)  
▢  ▢  ▢  
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Inflammatory bowel 
disease e.g. ulcerative 
colitis, Crohn's (9)  
▢  ▢  ▢  
Non-coeliac gluten 
sensitivity (10)  ▢  ▢  ▢  
Pelvic inflammatory 
disease (11)  ▢  ▢  ▢  
 
 
 
 
Q68 Any other inflammatory condition? 
________________________________________________________________ 
 
 
 
Q69 Please give further details of inflammatory conditions you have experienced: 
________________________________________________________________ 
________________________________________________________________ 
________________________________________________________________ 
________________________________________________________________ 
________________________________________________________________ 
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Q71 Behaviour and Food 
  
 Please highlight which if the following best applies to you: 
 not at all (1) 
occasionally 
(2) 
sometimes (3) frequently (4) always (5) 
I frequently 
think about 
food (1)  
▢  ▢  ▢  ▢  ▢  
I frequently 
crave food (2)  ▢  ▢  ▢  ▢  ▢  
I continue to 
eat after I feel 
full (3)  
▢  ▢  ▢  ▢  ▢  
I feel hungry 
no matter what 
I eat (4)  
▢  ▢  ▢  ▢  ▢  
I cannot go 
long periods 
without eating 
(5)  
▢  ▢  ▢  ▢  ▢  
I always feel 
hungry (6)  ▢  ▢  ▢  ▢  ▢  
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Q73 Digestive Issues 
  
 Please highlight any of 
the following that apply 
to you and indicate if 
they apply currently or 
in the past:  
currently (1) in the past (2) Unsure (3) 
Indigestion (1)  ▢  ▢  ▢  
Heartburn (2)  ▢  ▢  ▢  
Bowel movements 
shortly after eating (3)  ▢  ▢  ▢  
Frequent stomach 
upsets or pain (4)  ▢  ▢  ▢  
Nausea or vomiting (5)  ▢  ▢  ▢  
Constipation or hard to 
pass stools (6)  ▢  ▢  ▢  
Diarrhoea or urgency to 
go (7)  ▢  ▢  ▢  
Blood in stools / black 
stools (8)  ▢  ▢  ▢  
Undigested food in 
stools (9)  ▢  ▢  ▢  
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Stools are not well 
formed (loose) (10)  ▢  ▢  ▢  
Excessive foul smelling 
gas (11)  ▢  ▢  ▢  
Cramping in lower 
abdomen (12)  ▢  ▢  ▢  
Mucus in stools (13)  ▢  ▢  ▢  
Pain between shoulders 
or under the rib cage 
(14)  
▢  ▢  ▢  
Irritable bowel 
syndrome (IBS) (15)  ▢  ▢  ▢  
Offensive stools (16)  ▢  ▢  ▢  
Pale, bulky stools (17)  ▢  ▢  ▢  
Stools that float (18)  ▢  ▢  ▢  
Stools that sink (19)  ▢  ▢  ▢  
Haemorrhoids (20)  ▢  ▢  ▢  
411 
Anus itching (21)  ▢  ▢  ▢  
Thrush (22)  ▢  ▢  ▢  
Fungal or yeast 
infections e.g. athletes 
foot, ring worm (23)  
▢  ▢  ▢  
Parasites (24)  ▢  ▢  ▢  
 
 
 
 
Q74 How often do you have a bowel movement? 
▼ More than once a day (1) ... Once every few days (3) 
 
 
 
Q75 Other: 
________________________________________________________________ 
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Q76 Have you noticed any recent changes in your bowel habits? 
▢ no  (1)  
▢ yes  (2)  
▢ other  (3)  
 
Skip To: Q79 If Have you noticed any recent changes in your bowel habits? = no 
 
 
Q77 Please give details: 
________________________________________________________________ 
________________________________________________________________ 
________________________________________________________________ 
________________________________________________________________ 
________________________________________________________________ 
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Q79 Blood Sugar 
Regulation 
  
 Please tick which 
of the following 
best applies to 
you: 
never (1) seldom (2) often (3) always (4) 
I urinate more than 
I feel is normal (1)  ▢  ▢  ▢  ▢  
I feel I urinate at 
night more 
frequently than is 
normal (2)  
▢  ▢  ▢  ▢  
I feel very thirsty 
more frequently 
than normal (3)  
▢  ▢  ▢  ▢  
I feel tired more 
frequently than 
normal (4)  
▢  ▢  ▢  ▢  
I have 
experienced 
unexplained 
weight loss (5)  
▢  ▢  ▢  ▢  
I have itching 
around the penis 
or vagina (6)  
▢  ▢  ▢  ▢  
I have episodes of 
thrush (7)  ▢  ▢  ▢  ▢  
I have skin tags 
(8)  ▢  ▢  ▢  ▢  
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I experience cuts 
or wounds that 
heal slowly (9)  
▢  ▢  ▢  ▢  
I experience 
blurred vision (10)  ▢  ▢  ▢  ▢  
I experience 
weakness or 
dizziness after a 
period of fasting or 
with hunger (11)  
▢  ▢  ▢  ▢  
I can feel extreme 
hunger (12)  ▢  ▢  ▢  ▢  
I experience 
drowsiness (13)  ▢  ▢  ▢  ▢  
I experience 
nausea (14)  ▢  ▢  ▢  ▢  
 
 
 
 
Q85  
Blood Fats 
 
When did you last have your cholesterol tested: 
▼ Never (1) ... In the last 5 years (5) 
 
Skip To: Q102 If Blood Fats When did you last have your cholesterol tested: = Never 
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Q86 My cholesterol level is: 
▼ Raised (1) ... I don't know (4) 
 
Skip To: Q102 If My cholesterol level is: = Normal 
Skip To: Q102 If My cholesterol level is: = I don't know 
 
 
Q87 Click to write the question text 
 Please provide exact cholesterol measure: (1) 
Total Cholesterol: (1)   
Triglycerides: (2)   
Low Density Cholesterol (LDL): (3)   
High Density Cholesterol Level (HDL): (4)   
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Q102 Quality of Life 
  
 Please select which of the following best applies to you: 
 Very poor (1) Poor (2) 
Neither good 
nor poor (3) 
Good (4) Very good (5) 
How would you 
rate your 
quality of life? 
(1)  
▢  ▢  ▢  ▢  ▢  
How would you 
rate your 
physical 
functioning? 
(2)  
▢  ▢  ▢  ▢  ▢  
How would you 
rate your 
general 
health? (3)  
▢  ▢  ▢  ▢  ▢  
How would you 
rate your 
emotional 
health? (4)  
▢  ▢  ▢  ▢  ▢  
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Q99 Please select which of the following best apply to you: 
 Not at all (1) A little (2) 
A moderate 
amount (3) 
Very much (4) 
An extreme 
amount (5) 
How much do 
you enjoy life? 
(1)  
▢  ▢  ▢  ▢  ▢  
To what extent 
do you feel 
your life to be 
meaningful? 
(2)  
▢  ▢  ▢  ▢  ▢  
I feel able to 
accept my 
bodily 
appearance (3)  
▢  ▢  ▢  ▢  ▢  
 
 
 
 
Q100 Please select which of the following best apply to you: 
 
Strongly 
disagree (1) 
Somewhat 
disagree (2) 
Neither agree 
nor disagree 
(3) 
Somewhat 
agree (4) 
Strongly agree 
(5) 
On the whole I 
feel satisfied 
with myself (1)  
▢  ▢  ▢  ▢  ▢  
I take a 
positive 
attitude 
towards myself 
(2)  
▢  ▢  ▢  ▢  ▢  
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Q89 Sleep 
  
 Please highlight which of the following best applies to you: 
 Never (1) Seldom (2) Weekly (3) Every night (4) 
I experience 
shortness of 
breath (1)  
▢  ▢  ▢  ▢  
I snore (2)  ▢  ▢  ▢  ▢  
I wake up in the 
night with a very 
dry and sore throat 
(3)  
▢  ▢  ▢  ▢  
I wake up with a 
choking or gasping 
sensation (4)  
▢  ▢  ▢  ▢  
 
 
 
 
Q90 Have you ever been diagnosed with sleep apnoea? 
▼ No (1) ... Yes (2) 
 
Skip To: Q105 If Have you ever been diagnosed with sleep apnoea? = No 
 
 
Q91 When were you diagnosed with sleep apnoea? (DD/MM/YY) 
________________________________________________________________ 
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Q92 Are you receiving any treatment? 
▼ Yes (1) ... No (2) 
 
 
 
Q93 Please describe treatment 
________________________________________________________________ 
 
 
 
Q105 How would you rate the quality of your sleep? 
▢ Poor  (1)  
▢ Neither good nor poor  (2)  
▢ Good  (3)  
 
 
 
Q106 On average, how many hours sleep so you get per night? 
▢ 3 or less  (1)  
▢ 4-5  (2)  
▢ 6-8  (3)  
▢ 9 or more  (4)  
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Q104 Please select which if the following best applies to you: 
 Always (1) Often (2) Seldom (3) Never (4) 
How frequently do 
you doze during 
the day? (1)  
▢  ▢  ▢  ▢  
How frequently do 
you wake in the 
night? (2)  
▢  ▢  ▢  ▢  
How frequently do 
you use over the 
counter or 
prescription sleep 
aids? (3)  
▢  ▢  ▢  ▢  
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Q108 Stress 
  
 Please select 
which of the 
following best 
applies to you: 
Never (1) 
Almost never 
(2) 
Sometimes (3) Fairly often (4) Very often (5) 
In the last 
month, how 
often have you 
felt that you 
were unable to 
control the 
important 
things in your 
life? (1)  
▢  ▢  ▢  ▢  ▢  
In the last 
month, how 
often have you 
felt confident 
about your 
abilities to 
handle your 
personal 
problems? (2)  
▢  ▢  ▢  ▢  ▢  
In the last 
month, how 
often have you 
felt that things 
were going 
your way? (3)  
▢  ▢  ▢  ▢  ▢  
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In the last 
month, how 
often have you 
felt difficulties 
were piling up 
so high that 
you could not 
overcome 
them? (4)  
▢  ▢  ▢  ▢  ▢  
How often do 
you have 
negative 
feelings such 
as depression, 
despair, 
anxiety? (5)  
▢  ▢  ▢  ▢  ▢  
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Q110 Motivation to change 
  
 Please select which of the following best applies to you: 
 Yes (1) No (2) 
In the past month, have you 
been actively trying to lose 
weight? (1)  
▢  ▢  
In the past month, have you 
been actively trying to keep from 
weight gain? (2)  
▢  ▢  
Are you seriously considering 
trying to lose weight to reach 
your goals in the next 6 months? 
(3)  
▢  ▢  
Have you maintained your 
desired weight for more than 6 
months? (4)  
▢  ▢  
 
End of Block: Mechanisms of Pathophysiology 
 
Start of Block: The end 
Q114 Please click save to complete this questionnaire. 
Thank you.  Please do let your practitioner know you have completed it  so they can get access 
your data.  Your practitioner will arrange a  consultation date and time with you. 
 
Q119 Data may be inspected by the Chair of the Health Studies Ethics  sub-committee and the 
Chair of the School of Social Sciences Ethics  committee of Middlesex University, if required by 
institutional audits  about the correctness of procedures. Although this would happen in  strict 
confidentiality, please write NO if you do not wish your data to  be included in audits. 
__________________________________________________________ 
 
End of Block: The end 
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Appendix 21 Tool 4 Achievement record - download of online format 
Achievement Record 
 
 
Start of Block: Dietary achievements 
 
Q1 ACHIEVEMENT RECORD 
  
This tool should be completed by practitioner to record which interventions that the client 
achieved.  This record should be completed at the start of every follow-up appointment to assess 
which interventions the client achieved. 
 
 
 
Q20 The aim of this pilot trial is to assess the way health information is collected and interpreted. 
 
Your participation in this study is entirely voluntary and you can withdraw at any time and you are  
free to omit any question. You should be aware that the data you  provide may be used for 
analysis and subsequent publication. The  researchers will implement procedures to maintain the 
confidentiality of  the participant data. Personal information provided will be stored in  computer 
files secured by means of passwords or in locked cabinets. Only  the researcher and authorised 
supervisors will be able to access the  information. Personal information will be destroyed once the 
research is  completed. 
  
 Thank you very much and please do get in touch if you have any questions. 
  
 Researcher: Michelle Barrow; Centre for Nutrition Education and Lifestyle Management (CNELM) 
and Middlesex University 
 michelle@cnelm.co.uk 
 Research Supervisors: Dr L Bell (L.bell@mdx.ac.uk); Dr C. Bell (c.bell@mdx.ac.uk) 
 Study title: Constructing validated clinical tools to enable the  development of a new evidence 
base for personalised nutrition practice  in weight management. 
 Academic Year: 2016/17 
 
 
425 
 
Q22 Practitioner Name: 
________________________________________________________________ 
 
 
 
Q18 Participant Information Number: 
________________________________________________________________ 
 
 
 
 
Q2 Date of record completion: 
  
Month (1)  ▼ January (1) ...   (150) 
Day (2)  ▼ January (1) ...   (150) 
Year (3)  ▼ January (1) ...   (150) 
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Q3 Dietary recommendations   
  Please tick which of the following dietary interventions were achieved: 
▢ Anti-Candida  (1)  
▢ Fodmaps  (2)  
▢ Intermittent fasting  (3)  
▢ Low fat  (4)  
▢ Low salt  (5)  
▢ Meal replacement  (6)  
▢ Vegan  (7)  
▢ Other: (please state in box below)  (8) 
________________________________________________ 
▢ Balanced glycaemic load  (9)  
▢ Dairy Free  (10)  
▢ Juicing  (11)  
▢ Low glycaemic index  (12)  
▢ Low sugar  (13)  
▢ Nut free  (14)  
▢ Vegetarian  (15)  
▢ Calorie restriction  (16)  
▢ Gluten free  (17)  
▢ Ketogenic  (18)  
▢ Low histamine  (19)  
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▢ Micro matching  (20)  
▢ Nutrient dense  (21)  
▢ Wheat free  (22)  
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Q4 Please 
indicate which 
of the following 
food changes 
were achieved, 
giving an 
indication of 
portion size 
where possible: 
Increase intake 
(1) 
Decrease 
intake (2) 
Maintain art 
current levels 
(3) 
Avoid (4) 
Not applicable 
(5) 
Alcohol (1)       
Caffeine (2)       
Complex 
carbohydrates 
(3)  
     
Essential fatty 
acids - Omega 
3 (4)  
     
Essential fatty 
acids - Omega 
6 (5)  
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Fluid - water 
(6)  
     
Fluid -other (7)       
Fruit (8)       
Prebiotic foods 
(9)  
     
Probiotics 
foods (10)  
     
Protein (11)       
Raw foods (12)       
Salt (13)       
Saturated fat 
(14)  
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Simple 
carbohydrates 
(15)  
     
Soy foods (16)       
Sugar (17)       
Vegetables 
(18)  
     
Wholegrains 
(19)  
     
Other (please 
state) (20)  
     
Other (please 
state) (21)  
     
Other (please 
state) (22)  
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Q7 Please describe any other dietary achievements:  
________________________________________________________________ 
________________________________________________________________ 
________________________________________________________________ 
________________________________________________________________ 
________________________________________________________________ 
 
End of Block: Dietary achievements 
 
Start of Block: Physical Activity 
 
Q5 Physical Activity   
    
was physical activity recommended? 
o Yes  (1)  
o No  (2)  
 
Skip To: End of Block If Physical Activity    was physical activity recommended? = No 
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Q6 Please indicate the type and 
duration of exercise, stating the 
number of minutes achieved per 
week: 
Minutes per week (1) Further details: (2) 
Aerobics (1)    
Cycling (2)    
Dancing (3)    
Gardening (4)    
Gym classes (state which) (5)    
Running (6)    
Strength Training (7)    
Swimming (8)    
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Team sports (state which) (9)    
Other (please state) (10)    
Other (please state) (11)    
 
 
 
 
Q8 Please describe any other physical activity 
achievements:_________________________________________________ 
________________________________________________________________ 
________________________________________________________________ 
________________________________________________________________ 
________________________________________________________________ 
 
End of Block: Physical Activity 
 
Start of Block: Supplement Recommendations 
 
Q9 Supplement recommendations  
  
Were supplements recommended?  
o Yes  (1)  
o No  (2)  
 
Skip To: End of Block If Supplement recommendations Were supplements recommended? = No 
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Q10 Please indicate 
which supplements were 
taken and provide the 
product brand and name, 
recommended dose and 
duration of taking these 
supplements: 
Product brand and 
name (1) 
Recommended dose (2) 
Duration of taking 
supplements e.g. 1 
week, 1 month, 6 
months, ongoing. (3) 
Multi vitamins and 
minerals (1)  
   
Fatty acids (2)     
Probiotics (3)     
Amino acids (4)     
Herbal products (5)     
Slimming aids (6)     
B vitamin formulas (7)     
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Vitamin C formulas (8)     
Vitamin D formulas (9)     
Vitamin E formulas (10)     
Calcium formulas (11)     
Chromium formulas (12)     
Iron formulas (13)     
Magnesium formulas 
(14)  
   
Specific vitamins (15)     
Specific minerals (16)     
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Brain and nervous 
system support (17)  
   
Cardiovascular products 
(18)  
   
Energy support (19)     
Female health products 
(20)  
   
Gastrointestinal support 
(21)  
   
Glandular formulas (22)     
Immune support (23)     
Inflammatory formulas 
(24)  
   
Joint support (25)     
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Liver support (26)     
Male health products 
(27)  
   
Muscle support (28)     
Other (please state) (29)     
Other (please state) (30)     
Other (please state) (31)     
 
 
End of Block: Supplement Recommendations 
 
Start of Block: Test recommendations 
 
Q11 Test recommendations  
    
Were tests recommended?  
o Yes  (1)  
o No  (2)  
 
Skip To: End of Block If Test recommendations   Were tests recommended?  = No 
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Q16 Please 
indicate which 
tests were 
undertaken, 
provide the test 
name,  whom 
provided the test, 
test result and 
further information 
: 
Test details e.g. 
name, biomarker 
(1) 
Source of test e.g. 
GP, biolab, 
doctors data, 
Genova 
diagnostics etc. (2) 
Test results (3) 
Further 
information (4) 
Allergy or 
intolerance testing 
(1)  
    
Amino acid 
analysis (2)  
    
Biochemistry / 
haematology 
profile (3)  
    
Cholesterol (4)      
Fasting sugar and 
haemogolbin A1c 
(5)  
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Fasting lipid panel 
(6)  
    
Fatty acids profile 
(7)  
    
Gastrointestinal 
profile (8)  
    
Genetic or 
genomic 
assessment (9)  
    
Hormone analysis 
(10)  
    
Inflammatory 
markers (11)  
    
Liver function 
assessment (12)  
    
Nutritional profile 
(13)  
    
441 
Oxidative stress 
profile (14)  
    
Specific minerals 
(15)  
    
Specific vitamins 
(16)  
    
Thyroid function 
test (17)  
    
Toxic metal screen 
(18)  
    
Other (please 
state): (19)  
    
Other (please 
state): (20)  
    
 
 
End of Block: Test recommendations 
 
Start of Block: Referral Recommendations 
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Q13 Referral recommendations  
    
Were any recommendations made for further support? 
o Yes  (1)  
o No  (2)  
 
Skip To: End of Survey If Referral recommendations   Were any recommendations made for further support? = No 
 
 
Q14 Please indicate which referrals were followed-up: 
▢ Bariatric surgery  (1)  
▢ Other health care professional (please stat):e  (2) 
________________________________________________ 
▢ Other (please state):  (3) 
________________________________________________ 
▢ Counselling/psychological support  (4)  
▢ Personal trainer/gym  (5)  
▢ Eating disorder support  (6)  
▢ General practitioner  (7)  
▢ Life coaching  (8)  
▢ Sleep apnoea assessment  (9)  
 
 
 
Q17 Please provide any further information as a result from referrals: 
________________________________________________________________ 
________________________________________________________________ 
________________________________________________________________ 
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________________________________________________________________ 
________________________________________________________________ 
 
End of Block: Referral Recommendations 
 
Start of Block: The End 
 
Q18 Please click save to complete this form. 
 Thank you very much for your involvement in this research project. 
 Please inform michelle@cnelm.com that you have completed this form so a  PDF of this 
completed tool can be sent to you.   If you have any queries please contact michelle@cnelm.co.uk 
or call 07879 403321. 
 
 
 
Q21 Data may be inspected by the Chair of the Health Studies Ethics sub-committee and the 
Chair of the School of Social Sciences Ethics committee of Middlesex University, if required by 
institutional audits about the correctness of procedures. Although this would happen in strict 
confidentiality, please write NO if you do not wish your data to be included in audits. 
________________________________________________________________ 
 
End of Block: The End 
 
 
